DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY			SEQUENCE	CHANGE
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	"15-year breast cancer-specific survival (ER positive, PR positive, and HER2 negative)"	"35,550 European ancestry individuals"	NA	15q23	15	71344902		THSD4			ENSG00000187720			rs8030394-?	rs8030394	0	8030394	intron_variant	0	NR	1E-8	8		2.47	[1.81-3.37]	NR [10000000] (imputed)	N	"survival time, estrogen-receptor positive breast cancer, breast carcinoma, HER2 negative breast carcinoma, progesterone-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0009780, http://www.ebi.ac.uk/efo/EFO_0009782"	GCST90029047	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	"15-year breast cancer-specific survival (ER positive or PR positive, and HER2 negative treated with chemotherapy)"	"10,394 European ancestry individuals"	NA	2q36.3	2	229507632		DNER			ENSG00000187957			rs62192052-?	rs62192052	0	62192052	intron_variant	0	NR	3E-9	8.522878745280337		0.15	[0.08-0.28]	NR [10000000] (imputed)	N	"survival time, estrogen-receptor positive breast cancer, breast carcinoma, HER2 negative breast carcinoma, progesterone-receptor positive breast cancer, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0009780, http://www.ebi.ac.uk/efo/EFO_0009782, http://purl.obolibrary.org/obo/GO_0097327"	GCST90029048	Genome-wide genotyping array				
4/28/2016	25964295	Khan S	5/11/2015	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/25964295	Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	"352 European ancestry cases with endocrine therapy, 254 European ancestry cases without endocrine therapy, 597 European ancestry controls"	"3,330 European ancestry cases with endocrine therapy, 42 European ancestry cases without endocrine therapy, 1,351 European ancestry controls"	19q13.41	19	51942133	ZNF613	ZNF613			ENSG00000176024			rs8113308-G	rs8113308	0	8113308	intron_variant	0	0.152	6E-7	6.221848749616356		1.69	[1.37-2.07]	Illumina [486478]	N	"survival time, estrogen-receptor positive breast cancer, breast carcinoma, response to endocrine therapy"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0007613"	GCST002901	Genome-wide genotyping array				
3/27/2019	28864454	Lacson JCA	9/1/2017	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28864454	Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.	Breast cancer (progesterone-receptor positive)	"1,049 cases, 1,310 controls"	NA	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-T	rs2981579	0	2981579	intron_variant	0	NR	5E-7	6.301029995663981		1.23		Illumina [129771]	N	progesterone-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0009781	GCST007420	Exome genotyping array [Exome array]				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced proteinuria	"1,039 European ancestry individuals"	NA	5p15.2	5	14017958	intergenic	DNAH5 - TRIO	ENSG00000039139	ENSG00000038382		6140	125384	rs339947-A	rs339947	0	339947	intergenic_variant	1	0.14	2E-7	6.698970004336019		1.26	[0.79-1.73] unit increase	Illumina [828141]	N	"response to bevacizumab, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026610	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced proteinuria	"1,039 European ancestry individuals"	NA	12q15	12	68429335	intergenic	LINC02384			ENSG00000251301			rs7959783-?	rs7959783	0	7959783	intron_variant	0	0.26	7E-6	5.154901959985743		0.73	[0.42-1.04] unit increase	Illumina [828141]	N	"response to bevacizumab, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026610	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced proteinuria	"1,039 European ancestry individuals"	NA	2p21	2	44675221	C2orf34	CAMKMT			ENSG00000143919			rs12612153-?	rs12612153	0	12612153	intron_variant	0	0.11	7E-6	5.154901959985743		1.15	[0.64-1.66] unit increase	Illumina [828141]	N	"response to bevacizumab, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026610	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced proteinuria	"1,039 European ancestry individuals"	NA	1p31.3	1	64905735	JAK1	JAK1			ENSG00000162434			rs4916009-?	rs4916009	0	4916009	intron_variant	0	0.09	9E-6	5.045757490560675		1.24	[0.69-1.79] unit increase	Illumina [828141]	N	"response to bevacizumab, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026610	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	15-year breast cancer-specific survival (ER positive treated with endocrine therapy)	"30,137 European ancestry individuals"	NA	3q25.2	3	155285814		LINC01487 - STRIT1	ENSG00000241336	ENSG00000240045		27048	4413	rs4679741-?	rs4679741	0	4679741	intergenic_variant	1	NR	2E-7	6.698970004336019		1.18	[1.11-1.26]	NR [10000000] (imputed)	N	"survival time, estrogen-receptor positive breast cancer, breast carcinoma, response to endocrine therapy"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0007613"	GCST90029045	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	3q25.1	3	150755819	SIAH2	SIAH2			ENSG00000181788			rs60538652-A	rs60538652	0	60538652	intron_variant	0	0.65	6E-7	6.221848749616356		1.26	[1.15-1.38]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	6q23.3	6	135969804	PDE7B	PDE7B			ENSG00000171408			rs11154838-C	rs11154838	0	11154838	intron_variant	0	0.75	1E-6	6		1.27	[1.15-1.40]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	6q25.1	6	151623479	"CCDC170, ESR1"	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		2286	33212	rs9383936-A	rs9383936	0	9383936	intergenic_variant	1	0.34	1E-10	10		1.35	[1.23-1.48]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	7q21.3	7	93992935	BET1	"BET1, BET1-AS1"			"ENSG00000105829, ENSG00000236861"			rs10953105-G	rs10953105	0	10953105	intron_variant	0	0.88	1E-6	6		1.37	[1.21-1.56]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	8q12.3	8	61692700	ASPH	ASPH			ENSG00000198363			rs2350923-T	rs2350923	0	2350923	intron_variant	0	0.76	8E-7	6.096910013008056		1.28	[1.16-1.42]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	9p21.3	9	21995942	CDKN2B-AS1	CDKN2B-AS1			ENSG00000240498			rs78545330-A	rs78545330	0	78545330	non_coding_transcript_exon_variant	0	0.26	3E-6	5.522878745280337		1.26	[1.14-1.39]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	9p13.3	9	34129841	DCAF12	DCAF12 - UBAP1	ENSG00000198876	ENSG00000165006		2442	49164	rs10814070-T	rs10814070	0	10814070	intergenic_variant	1	0.75	2E-6	5.698970004336019		1.26	[1.15-1.39]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	10q26.13	10	121589148	FGFR2	FGFR2			ENSG00000066468			rs2912774-T	rs2912774	0	2912774	intron_variant	0	0.42	6E-7	6.221848749616356		1.25	[1.14-1.36]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	10q26.2	10	127011685	DOCK1	DOCK1			ENSG00000150760			rs9418690-C	rs9418690	0	9418690	intron_variant	0	0.76	1E-6	6		1.28	[1.16-1.41]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	12p11.23	12	26617956	ITPR2	ITPR2			ENSG00000123104			rs4964006-T	rs4964006	0	4964006	intron_variant	0	0.98	2E-6	5.698970004336019		1.96	[1.49-2.58]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	12q22	12	95623181	"PGAM1P5, NTN4"	PGAM1P5			ENSG00000257150			rs67129489-G	rs67129489	0	67129489	intron_variant	0	0.15	9E-7	6.045757490560675		1.36	[1.20-1.53]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	13q12.3	13	29862831	Intergenic	UBL3 - Metazoa_SRP	ENSG00000122042	ENSG00000274701		12214	1541	rs278050-C	rs278050	0	278050	intergenic_variant	1	0.21	4E-6	5.3979400086720375		1.28	[1.15-1.42]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.32	9E-9	8.045757490560675		1.31	[1.19-1.44]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	17q25.1	17	72983988	SLC39A11	SLC39A11			ENSG00000133195			rs4969001-T	rs4969001	0	4969001	intron_variant	0	0.86	7E-6	5.154901959985743		1.32	[1.17-1.49]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	20q11.23	20	37635373	Intergenic	LINC00489 - CTNNBL1	ENSG00000225759	ENSG00000132792		12254	58582	rs73107564-A	rs73107564	0	73107564	intergenic_variant	1	0.89	2E-7	6.698970004336019		1.43	[1.25-1.63]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	3q25.1	3	150750021	SIAH2	SIAH2			ENSG00000181788			rs6788895-G	rs6788895	0	6788895	intron_variant	0	0.6	2E-6	5.698970004336019		1.23	[NR]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	6q25.1	6	151627231	"CCDC170, ESR1"	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	0.36	1E-9	9		1.3	[NR]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	10q26.13	10	121586602	FGFR2	FGFR2			ENSG00000066468			rs2981575-G	rs2981575	0	2981575	intron_variant	0	0.43	2E-8	7.698970004336019		1.27	[NR]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
12/14/2018	30323354	Lee JY	10/15/2018	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30323354	"BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts."	BRCA1/2-negative high-risk breast cancer	"1,469 Korean ancestry cases, 5,979 Korean ancestry controls"	NA	16q12.1	16	52565276	"CASC16, TOX3"	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.26	2E-9	8.698970004336019		1.31	[NR]	"Affymetrix, Illumina [3378933] (imputed)"	N	BRCAX breast cancer	http://www.ebi.ac.uk/efo/EFO_0009443	GCST006719	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	15-year breast cancer-specific survival (ER negative treated with chemotherapy)	"6,852 European ancestry individuals"	NA	3p25.1	3	14520620		GRIP2			ENSG00000144596			rs1106333-?	rs1106333	0	1106333	intron_variant	0	NR	6E-8	7.221848749616356		1.68	[1.39-2.03]	NR [10000000] (imputed)	N	"estrogen-receptor negative breast cancer, survival time, breast carcinoma, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305, http://purl.obolibrary.org/obo/GO_0097327"	GCST90029046	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	5-year breast cancer-specific survival (ER negative treated with chemotherapy)	"6,411 European ancestry individuals"	NA	4p14	4	35960832		ARAP2			ENSG00000047365			rs78754389-?	rs78754389	0	78754389	intron_variant	0	NR	2E-8	7.698970004336019		1.79	[1.46-2.2]	NR [10000000] (imputed)	N	"estrogen-receptor negative breast cancer, survival time, breast carcinoma, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305, http://purl.obolibrary.org/obo/GO_0097327"	GCST90029059	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	5-year breast cancer-specific survival (ER negative treated with chemotherapy)	"6,411 European ancestry individuals"	NA	8p21.2	8	27131567		MIR548H4 - STMN4	ENSG00000221616	ENSG00000015592		82604	103741	rs117685664-?	rs117685664	0	117685664	intergenic_variant	1	NR	5E-8	7.301029995663981		0.26	[0.16-0.42]	NR [10000000] (imputed)	N	"estrogen-receptor negative breast cancer, survival time, breast carcinoma, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305, http://purl.obolibrary.org/obo/GO_0097327"	GCST90029059	Genome-wide genotyping array				
10/19/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced hypertension	"1,039 European ancestry individuals"	NA	3q25.31	3	156314389	KCNAB1	KCNAB1			ENSG00000169282			rs6770663-G	rs6770663	0	6770663	intron_variant	0	0.09	4E-6	5.3979400086720375		0.58	[0.33-0.83] unit increase	Illumina [833710]	N	"response to bevacizumab, hypertension"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537"	GCST90026609	Genome-wide genotyping array				
10/19/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced hypertension	"1,039 European ancestry individuals"	NA	4p15.2	4	24995076	intergenic	CCDC149 - LGI2	ENSG00000181982	ENSG00000153012		14872	3771	rs13135230-A	rs13135230	0	13135230	intergenic_variant	1	0.28	1E-6	6		0.47	[0.27-0.67] unit increase	Illumina [833710]	N	"response to bevacizumab, hypertension"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537"	GCST90026609	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	17p13.3	17	1391192	YWHAE	YWHAE			ENSG00000108953			rs16945809-A	rs16945809	0	16945809	intron_variant	0	0.06	2E-6	5.698970004336019		0.94	unit increase	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	9q22.2	9	90129014	intergenic	IL6RP1 - OR7E31P	ENSG00000234910	ENSG00000185074		46445	87025	rs7038808-?	rs7038808	0	7038808	intergenic_variant	1	0.15	5E-6	5.301029995663981		0.85	unit increase	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	8q24.22	8	135208692	intergenic	RPL23AP56 - LINC01591	ENSG00000244413	ENSG00000254083		229413	25439	rs1564470-?	rs1564470	0	1564470	intergenic_variant	1	0.32	5E-6	5.301029995663981		0.75	unit increase	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	16p13.2	16	9874646	GRIN2A	GRIN2A			ENSG00000183454			rs7204266-?	rs7204266	0	7204266	intron_variant	0	0.28	7E-6	5.154901959985743		0.69	unit increase	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	21q21.3	21	26398292	intergenic	CYYR1-AS1			ENSG00000197934			rs222151-?	rs222151	0	222151	intron_variant	0	0.22	9E-6	5.045757490560675		0.73	unit decrease	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
10/20/2021	34616010	Quintanilha JCF	10/6/2021	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/34616010	Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.	Bevacizumab-induced composite toxicity (either hypertension or proteinuria)	"1,039 European ancestry individuals"	NA	2q31.1	2	176070797	intergenic	LNPK - EVX2	ENSG00000144320	ENSG00000174279		67958	6675	rs1000032-?	rs1000032	0	1000032	intergenic_variant	1	0.19	9E-6	5.045757490560675		0.63	unit increase	Illumina [828141]	N	"response to bevacizumab, hypertension, Proteinuria"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0000537, http://purl.obolibrary.org/obo/HP_0000093"	GCST90026611	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	6q25.1	6	151621059	NR	CCDC170			ENSG00000120262			rs3757322-G	rs3757322	0	3757322	3_prime_UTR_variant	0	NR	6E-9	8.221848749616356		1.26	1.16-1.36	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	6q25.1	6	151631197	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		10004	25494	rs9397437-A	rs9397437	0	9397437	regulatory_region_variant	1	NR	5E-9	8.301029995663981		1.5	1.31-1.71	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	6q25.1	6	151666222	NR	ESR1			ENSG00000091831			rs9383938-T	rs9383938	0	9383938	intron_variant	0	NR	3E-9	8.522878745280337		1.47	1.30-1.67	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	10p12.31	10	21668300	NR	MLLT10			ENSG00000078403			rs2183271-C	rs2183271	0	2183271	intron_variant	0	NR	3E-7	6.522878745280337		1.22	1.13-1.31	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	11q13.3	11	69516650	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21698	124506	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	NR	1E-11	11		1.61	1.4-1.85	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	11q13.3	11	69516874	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21922	124282	rs554219-G	rs554219	0	554219	regulatory_region_variant	1	NR	3E-11	10.522878745280337		1.45	1.3-1.62	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/21/2021	32785646	Maguire S	8/12/2020	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/32785646	Common susceptibility loci for male breast cancer.	Breast cancer (male)	"1,380 European ancestry cases, 3,620 European ancestry controls"	"810 European ancestry cases, 1,026 European ancestry controls"	11q13.3	11	69564393	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		69441	76763	rs75915166-A	rs75915166	0	75915166	intergenic_variant	1	NR	8E-8	7.096910013008056		1.53	1.31-1.79	Illumina [8074073] (imputed)	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST011526	Genome-wide genotyping array				
4/2/2014	24080446	Rudolph A	11/4/2013	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	"676 European ancestry cases, 9,266 European ancestry controls"	3q13.33	3	119542528	CD80	CD80			ENSG00000121594			rs7648642-?	rs7648642	0	7648642	intron_variant	0	NR	5E-6	5.301029995663981		1.5625	[1.28-1.89]	Illumina [2500000] (imputed)	N	"invasive lobular carcinoma, hormone replacement therapy"	"http://www.ebi.ac.uk/efo/EFO_0000553, http://www.ebi.ac.uk/efo/EFO_0003961"	GCST002266	Genome-wide genotyping array				
4/2/2014	24080446	Rudolph A	11/4/2013	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Lobular breast cancer (menopausal hormone therapy interaction)	541 European ancestry cases	"676 European ancestry cases, 9,266 European ancestry controls"	17q12	17	34662519	TMEM132E	TMEM132E - CCT6B	ENSG00000181291	ENSG00000132141		23201	265340	rs11654964-?	rs11654964	0	11654964	intergenic_variant	1	NR	3E-6	5.522878745280337		1.67	[1.35-2.06]	Illumina [2500000] (imputed)	N	"invasive lobular carcinoma, hormone replacement therapy"	"http://www.ebi.ac.uk/efo/EFO_0000553, http://www.ebi.ac.uk/efo/EFO_0003961"	GCST002266	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	13q13.1	13	32295727	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	1q22	1	155216951	GBAP1	"GBAP1, GBAP1"			"ENSG00000160766, ENSG00000291137"			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	1q22	1	155212052	MTX1	MTX1			ENSG00000173171			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	1q32.2	1	210816167	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7		1.1111112	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	3q26.2	3	169043635	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		5219	39864	rs75316749-G	rs75316749	0	75316749	intergenic_variant	1	NR	2E-7	6.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236405	ENSG00000226577		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000234745		45362	6868	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	9E-6	5.045757490560675		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000179344	ENSG00000235040		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6q14.1	6	80398959	Intergenic	RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		24390	71112	rs4604234-C	rs4604234	0	4604234	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	9p21.3	9	21951903	Intergenic	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		14252	15026	rs12349081-A	rs12349081	0	12349081	intron_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	9p21.3	9	22062135	"CDKN2B, AS1"	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	12q24.12	12	111446804	SH2B3	"SH2B3, ATXN2"			"ENSG00000111252, ENSG00000204842"			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array			MNGPALQPSSPSSAPSASPAAAPRGWSEFCELHAVAAARELARQYWLFAREHPQHAPLRAELVSLQFTDLFQRYFCREVRDGRAPGRDYRDTGRGPPAKAEASPEPGPGPAAPGLPKARSSEELAPPRPPGPCSFQHFRRSLRHIFRRRSAGELPAAHTAAAPGTPGEAAETPARPGLAKKFLPWSLAREPPPEALKEAVLRYSLADEASMDSGARWQRGRLALRRAPGPDGPDRVLELFDPPKSSRPKLQAACSSIQEVRWCTRLEMPDNLYTFVLKVKDRTDIIFEVGDEQQLNSWMAELSECTGRGLESTEAEMHIPSALEPSTSSSPRGSTDSLNQGASPGGLLDPACQKTDHFLSCYPWFHGPISRVKAAQLVQLQGPDAHGVFLVRQSETRRGEYVLTFNFQGIAKHLRLSLTERGQCRVQHLHFPSVVDMLHHFQRSPIPLECGAACDVRLSSYVVVVSQPPGSCNTVLFPFSLPHWDSESLPHWGSELGLPHLSSSGCPRGLSPEGLPGRSSPPEQIFHLVPSPEELANSLQHLEHEPVNRARDSDYEMDSSSRSHLRAIDNQYTPL	"W262R, W262G, W302R"
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array			MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPIIFKEQGLTLPLYQSPVKELDKFKLDLGRNVPNSRHKSLRTVKTKMDQADDVSCPLLNSCLSESPVVLQCTHVTPQRDKSVVCGSLFHTPKFVKGRQTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIVRNEEASETVFPHDTTANVKSYFSNHDESLKKNDRFIASVTDSENTNQREAASHGFGKTSGNSFKVNSCKDHIGKSMPNVLEDEVYETVVDTSEEDSFSLCFSKCRTKNLQKVRTSKTRKKIFHEANADECEKSKNQVKEKYSFVSEVEPNDTDPLDSNVANQKPFESGSDKISKEVVPSLACEWSQLTLSGLNGAQMEKIPLLHISSCDQNISEKDLLDTENKRKKDFLTSENSLPRISSLPKSEKPLNEETVVNKRDEEQHLESHTDCILAVKQAISGTSPVASSFQGIKKSIFRIRESPKETFNASFSGHMTDPNFKKETEASESGLEIHTVCSQKEDSLCPNLIDNGSWPATTTQNSVALKNAGLISTLKKKTNKFIYAIHDETSYKGKKIPKDQKSELINCSAQFEANAFEAPLTFANADSGLLHSSVKRSCSQNDSEEPTLSLTSSFGTILRKCSRNETCSNNTVISQDLDYKEAKCNKEKLQLFITPEADSLSCLQEGQCENDPKSKKVSDIKEEVLAAACHPVQHSKVEYSDTDFQSQKSLLYDHENASTLILTPTSKDVLSNLVMISRGKESYKMSDKLKGNNYESDVELTKNIPMEKNQDVCALNENYKNVELLPPEKYMRVASPSRKVQFNQNTNLRVIQKNQEETTSISKITVNPDSEELFSDNENNFVFQVANERNNLALGNTKELHETDLTCVNEPIFKNSTMVLYGDTGDKQATQVSIKKDLVYVLAEENKNSVKQHIKMTLGQDLKSDISLNIDKIPEKNNDYMNKWAGLLGPISNHSFGGSFRTASNKEIKLSEHNIKKSKMFFKDIEEQYPTSLACVEIVNTLALDNQKKLSKPQSINTVSAHLQSSVVVSDCKNSHITPQMLFSKQDFNSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSYILQKSTFEVPENQMTILKTTSEECRDADLHVIMNAPSIGQVDSSKQFEGTVEIKRKFAGLLKNDCNKSASGYLTDENEVGFRGFYSAHGTKLNVSTEALQKAVKLFSDIENISEETSAEVHPISLSSSKCHDSVVSMFKIENHNDKTVSEKNNKCQLILQNNIEMTTGTFVEEITENYKRNTENEDNKYTAASRNSHNLEFDGSDSSKNDTVCIHKDETDLLFTDQHNICLKLSGQFMKEGNTQIKEDLSDLTFLEVAKAQEACHGNTSNKEQLTATKTEQNIKDFETSDTFFQTASGKNISVAKESFNKIVNFFDQKPEELHNFSLNSELHSDIRKNKMDILSYEETDIVKHKILKESVPVGTGNQLVTFQGQPERDEKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQGTSEITSFSHQWAKTLKYREACKDLELACETIEITAAPKCKEMQNSLNNDKNLVSIETVVPPKLLSDNLCRQTENLKTSKSIFLKVKVHENVEKETAKSPATCYTNQSPYSVIENSALAFYTSCSRKTSVSQTSLLEAKKWLREGIFDGQPERINTADYVGNYLYENNSNSTIAENDKNHLSEKQDTYLSNSSMSNSYSYHSDEVYNDSGYLSKNKLDSGIEPVLKNVEDQKNTSFSKVISNVKDANAYPQTVNEDICVEELVTSSSPCKNKNAAIKLSISNSNNFEVGPPAFRIASGKIVCVSHETIKKVKDIFTDSFSKVIKENNENKSKICQTKIMAGCYEALDDSEDILHNSLDNDECSTHSHKVFADIQSEEILQHNQNMSGLEKVSKISPCDVSLETSDICKCSIGKLHKSVSSANTCGIFSTASGKSVQVSDASLQNARQVFSEIEDSTKQVFSKVLFKSNEHSDQLTREENTAIRTPEHLISQKGFSYNVVNSSAFSGFSTASGKQVSILESSLHKVKGVLEEFDLIRTEHSLHYSPTSRQNVSKILPRVDKRNPEHCVNSEMEKTCSKEFKLSNNLNVEGGSSENNHSIKVSPYLSQFQQDKQQLVLGTKVSLVENIHVLGKEQASPKNVKMEIGKTETFSDVPVKTNIEVCSTYSKDSENYFETEAVEIAKAFMEDDELTDSKLPSHATHSLFTCPENEEMVLSNSRIGKRRGEPLILVGEPSIKRNLLNEFDRIIENQEKSLKASKSTPDGTIKDRRLFMHHVSLEPITCVPFRTTKERQEIQNPNFTAPGQEFLSKSHLYEHLTLEKSSSNLAVSGHPFYQVSATRNEKMRHLITTGRPTKVFVPPFKTKSHFHRVEQCVRNINLEENRQKQNIDGHGSDDSKNKINDNEIHQFNKNNSNQAVAVTFTKCEEEPLDLITSLQNARDIQDMRIKKKQRQRVFPQPGSLYLAKTSTLPRISLKAAVGGQVPSACSHKQLYTYGVSKHCIKINSKNAESFQFHTEDYFGKESLWTGKGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPKLISRIWVYNHYRWIIWKLAAMECAFPKEFANRCLSPERVLLQLKYRYDTEIDRSRRSAIKKIMERDDTAAKTLVLCVSDIISLSANISETSSNKTSSADTQKVAIIELTDGWYAVKAQLDPPLLAVLKNGRLTVGQKIILHGAELVGSPDACTPLEAPESLMLKISANSTRPARWYTKLGFFPDPRPFPLPLSSLFSDGGNVGCVDVIIQRAYPIQWMEKTSSGLYIFRNEREEEKEAAKYVEAQQKRLEALFTKIQEEFEEHEENTTKPYLPSRALTRQQVRALQDGAELYEAVKNAADPAYLEGYFSEEQLRALNNHRQMLNDKKQAQIQLEIRKAMESAEQKEQGLSRDVTTVWKLRIVSYSKKEKDSVILSIWRPSSDLYSLLTEGKRYRIYHLATSKSKSKSERANIQLAATKKTQYQQLPVSDEILFQIYQPREPLHFSKFLDPDFQPSCSEVDLIGFVVSVVKKTGLAPFVYLSDECYNLLAIKFWIDLNEDIIKPHMLIAASNLQWRPESKSGLLTLFAGDFSVFSASPKEGHFQETFNKMKNTVENIDILCNEAENKLMHILHANDPKWSTPTKDCTSGPYTAQIIPGTGNKLLMSSPNCEIYYQSPLSLCMAKRKSVSTPVSAQMTSKSCKGEKEIDDQKNCKKRRALDFLSRLPLPPPVSPICTFVSPAAQKAFQPPRSCGTKYETPIKKKELNSPQMTPFKKFNEISLLESNSIADEELALINTQALLSGSTGEKQFISVSESTRTAPTSSEDYLRLKRRCTTSLIKEQESSQASTEECEKNKQDTITTKKYI	K3326*
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	17q12	17	37741642	HNF1B	HNF1B			ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	19p13.11	19	17279482	BABAM1	"USHBP1, BABAM1"			"ENSG00000130307, ENSG00000105393"			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	4E-7	6.3979400086720375		1.1	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-C	rs11907546	0	11907546	intergenic_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	13q13.1	13	32265853	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467	intron_variant	0	NR	1E-7	7		1.2	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003587	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2257	1014	rs186507655-A	rs186507655	0	186507655	regulatory_region_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	1q22	1	155212373	MTX1	MTX1			ENSG00000173171			rs2075570-T	rs2075570	0	2075570	splice_polypyrimidine_tract_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	3p24.1	3	27285723	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	4q24	4	105140377	Intergenic	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606	5498	rs7679673-A	rs7679673	0	7679673	intron_variant	1	NR	1E-10	10	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	5q11.2	5	56737113	Intergenic	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		130881	78436	rs1862626-T	rs1862626	0	1862626	intergenic_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p22.1	6	29785031	Intergenic	IFITM4P - HLA-V	ENSG00000235821	ENSG00000290710		33883	7203	rs147680653-G	rs147680653	1	9258375	intergenic_variant	1	NR	1E-6	6	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236405	ENSG00000226577		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000234745		45362	6868	rs115392158-G	rs115392158	1	2507997	intron_variant	1	NR	3E-7	6.522878745280337	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000179344	ENSG00000235040		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	9p21.3	9	22062135	"CDKN2B, AS1"	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	10q26.13	10	121575416	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	11q13.3	11	69227030	Intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		64590	67121	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	11q22.3	11	103813371	Intergenic	DYNC2H1 - MIR4693	ENSG00000187240	ENSG00000264200		333508	36535	rs148883465-G	rs148883465	0	148883465	intron_variant	1	NR	3E-8	7.522878745280337	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	12q13.12	12	49251457	TUBA1C	TUBA1C			ENSG00000167553			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	12q13.13	12	52918828	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	12q24.12	12	111446804	SH2B3	"SH2B3, ATXN2"			"ENSG00000111252, ENSG00000204842"			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000708, http://www.ebi.ac.uk/efo/EFO_0000571"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	13q13.1	13	32394673	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818	splice_polypyrimidine_tract_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	14q24.1	14	68559662	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	17q12	17	37741642	HNF1B	HNF1B			ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	19p13.11	19	17279482	BABAM1	"USHBP1, BABAM1"			"ENSG00000130307, ENSG00000105393"			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-T	rs11907546	0	11907546	intergenic_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	11q22.3	11	103745837	Intergenic	DYNC2H1 - MIR4693	ENSG00000187240	ENSG00000264200		265974	104069	rs141752671-G	rs141752671	0	141752671	intron_variant	1	NR	1E-7	7	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	12q24.12	12	111621753	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
2/3/2017	27197191	Fehringer G	4/20/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	"Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations."	Cancer (pleiotropy)	"5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls"	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			"Affymetrix, Illumina [9916564] (imputed)"	N	"lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_1001515, http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708"	GCST003588	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	1p36.12	1	21295043		"ECE1, ECE1-AS1"			"ENSG00000117298, ENSG00000231105"			rs213051-T	rs213051	0	213051	intron_variant	0	0.698	8E-7	6.096910013008056		0.667	[0.57-0.77]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	9p13.3	9	34723038		CCL21 - FAM205A	ENSG00000137077	ENSG00000205108		12902	15	rs10814138-C	rs10814138	0	10814138	intron_variant	1	0.691	3E-6	5.522878745280337		0.753	[0.67-0.84]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	10p15.3	10	1450403		ADARB2			ENSG00000185736			rs74122632-T	rs74122632	0	74122632	intron_variant	0	0.904	2E-7	6.698970004336019		0.636	[0.54-0.74]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	17q12	17	35960344		LYZL6 - CCL16	ENSG00000275722	ENSG00000275152		16631	16149	rs62078064-G	rs62078064	0	62078064	intergenic_variant	1	0.721	3E-6	5.522878745280337		0.683	[0.58-0.78]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	17q25.3	17	81211408		CEP131			ENSG00000141577			rs9913021-A	rs9913021	0	9913021	intron_variant	0	0.535	2E-6	5.698970004336019		1.324	[1.18-1.47]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
4/25/2022	34981446	Nazarian A	1/3/2022	J Appl Genet	www.ncbi.nlm.nih.gov/pubmed/34981446	Genome-wide analysis of genetic predisposition to common polygenic cancers.	Breast cancer	"677 European ancestry cases, 7,842 European ancestry controls"	NA	21q22.13	21	37823970		KCNJ6			ENSG00000157542			rs11910276-C	rs11910276	0	11910276	intron_variant	0	0.912	2E-6	5.698970004336019		0.644	[0.54-0.75]	"Affymetrix, Illumina [2575640] (imputed)"	N	breast cancer	http://purl.obolibrary.org/obo/MONDO_0007254	GCST90101893	Genome-wide genotyping array				
12/2/2012	23001122	Orr N	9/23/2012	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	"823 European ancestry cases, 2,795 European ancestry controls"	"438 European ancestry cases, 474 European ancestry controls"	1p31.1	1	84156830	PRKACB	PRKACB			ENSG00000142875			rs903263-?	rs903263	0	903263	intron_variant	0	NR	1E-6	6		1.27	[1.10-1.34]	Illumina [447760]	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST001690	Genome-wide genotyping array				
12/2/2012	23001122	Orr N	9/23/2012	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	"823 European ancestry cases, 2,795 European ancestry controls"	"438 European ancestry cases, 474 European ancestry controls"	14q24.1	14	68232877	RAD51B	RAD51B			ENSG00000182185			rs1314913-?	rs1314913	0	1314913	intron_variant	0	NR	3E-13	12.522878745280337		1.57	[1.39-1.77]	Illumina [447760]	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST001690	Genome-wide genotyping array				
12/2/2012	23001122	Orr N	9/23/2012	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23001122	Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.	Breast cancer (male)	"823 European ancestry cases, 2,795 European ancestry controls"	"438 European ancestry cases, 474 European ancestry controls"	16q12.1	16	52552429	"LOC643174, TOX3"	CASC16			ENSG00000249231			rs3803662-?	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	NR	4E-15	14.397940008672037		1.5	[1.35-1.66]	Illumina [447760]	N	male breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0006861	GCST001690	Genome-wide genotyping array				
7/17/2018	29423119	Khan S	11/28/2017	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in breast cancer (estrogen-receptor positive)	"2,971 European ancestry individuals, 165 individuals"	NA	8p21.2	8	23579239	"RHOBTB2, PDLIM2"	SLC25A37 - RNU4-71P	ENSG00000147454	ENSG00000252067		3776	20787	rs2314686-?	rs2314686	0	2314686	regulatory_region_variant	1	NR	2E-8	7.698970004336019		1.89	[1.66-2.11]	Illumina [275827] (imputed)	N	"event free survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST005901	Genome-wide genotyping array				
3/27/2019	28864454	Lacson JCA	9/1/2017	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28864454	Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.	Breast cancer (estrogen-receptor positive)	"1,325 cases, 1,310 controls"	NA	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-T	rs2981579	0	2981579	intron_variant	0	NR	4E-7	6.3979400086720375		1.23		Illumina [129771]	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST007415	Exome genotyping array [Exome array]				
3/27/2019	28864454	Lacson JCA	9/1/2017	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28864454	Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.	Breast cancer (estrogen-receptor positive)	"1,325 cases, 1,310 controls"	NA	16q12.1	16	52565276	CASC16	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	NR	7E-6	5.154901959985743		1.23		Illumina [129771]	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST007415	Exome genotyping array [Exome array]				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	9q34.2	9	133279294		ABO - Y_RNA	ENSG00000175164	ENSG00000202522		3270	58434	rs495828-G	rs495828	0	495828	intergenic_variant	1	NR	7E-11	10.154901959985743				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	9p22.2	9	16915023		BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180	138878	rs3814113-T	rs3814113	0	3814113	intergenic_variant	1	NR	2E-43	42.69897000433602				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	10p12.31	10	21545607		MLLT10			ENSG00000078403			rs7098100-G	rs7098100	0	7098100	intron_variant	0	NR	4E-27	26.397940008672037				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	14q32.11	14	91283251		CCDC88C			ENSG00000015133			rs2277509-C	rs2277509	0	2277509	intron_variant	0	NR	2E-11	10.698970004336019				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	14q32.12	14	92636964		RIN3			ENSG00000100599			rs10498635-C	rs10498635	0	10498635	intron_variant	0	NR	9E-13	12.045757490560675				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	15q26.1	15	90969037		"PRC1, PRC1-AS1"			"ENSG00000198901, ENSG00000258725"			rs2290202-G	rs2290202	0	2290202	3_prime_UTR_variant	0	NR	4E-20	19.397940008672037				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	17q11.2	17	30909727		ADAP2			ENSG00000184060			rs35958868-G	rs35958868	0	35958868	intron_variant	0	NR	5E-13	12.301029995663981				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	17q21.31	17	45818287		"LINC02210-CRHR1, CRHR1, MAPT-AS1"			"ENSG00000263715, ENSG00000120088, ENSG00000264589"			rs4277389-A	rs4277389	0	4277389	intron_variant	0	NR	1E-23	23				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	17q22	17	55117408		STXBP4			ENSG00000166263			rs244353-G	rs244353	0	244353	intron_variant	0	NR	1E-31	31				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	19p13.11	19	17292224		ABHD8			ENSG00000127220			rs4808616-C	rs4808616	0	4808616	3_prime_UTR_variant	0	NR	2E-23	22.69897000433602				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	19p13.11	19	19419461		GATAD2A			ENSG00000167491			rs2916074-G	rs2916074	0	2916074	intron_variant	0	NR	2E-11	10.698970004336019				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	2q31.1	2	173348166		RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-G	rs1550623	0	1550623	intron_variant	1	NR	3E-9	8.522878745280337				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	2q33.1	2	201258272		CASP8			ENSG00000064012			rs3769823-A	rs3769823	0	3769823	missense_variant	0	NR	1E-16	16				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	21q11.2	21	14981210		NRIP1			ENSG00000180530			rs2822991-T	rs2822991	0	2822991	intron_variant	0	NR	6E-10	9.221848749616356				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	22q12.1	22	28643439		TTC28			ENSG00000100154			rs1474961-C	rs1474961	0	1474961	intron_variant	0	NR	2E-15	14.698970004336019				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	3p13	3	71486187		FOXP1			ENSG00000114861			rs9878602-T	rs9878602	0	9878602	intron_variant	0	NR	4E-8	7.3979400086720375				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	4q34.1	4	174924959		ADAM29			ENSG00000168594			rs6826366-G	rs6826366	0	6826366	intron_variant	0	NR	3E-28	27.522878745280337				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	4p14	4	38785595		TLR10 - TLR1	ENSG00000174123	ENSG00000174125		2605	5082	rs12233670-C	rs12233670	0	12233670	intergenic_variant	1	NR	8E-12	11.096910013008056				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	5p15.33	5	1279675		TERT			ENSG00000164362			rs10069690-C	rs10069690	0	10069690	intron_variant	0	NR	5E-23	22.30102999566398				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	6p23	6	13716491		RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		4656	70066	rs381551-G	rs381551	0	381551	intergenic_variant	1	NR	2E-12	11.698970004336019				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	6q25.1	6	151706820		ESR1			ENSG00000091831			rs851980-T	rs851980	0	851980	intron_variant	0	NR	9E-20	19.045757490560675				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	7q35	7	144377836		ARHGEF5			ENSG00000050327			rs720475-G	rs720475	0	720475	intron_variant	0	NR	9E-11	10.045757490560675				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	8q24.21	8	128192016		PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		4915	28488	rs7017073-T	rs7017073	0	7017073	intergenic_variant	1	NR	4E-14	13.397940008672037				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	8q21.13	8	75564502		HNF4G			ENSG00000164749			rs2941478-A	rs2941478	0	2941478	3_prime_UTR_variant	0	NR	5E-8	7.301029995663981				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	9q31.1	9	104094629		SMC2			ENSG00000136824			rs4743687-C	rs4743687	0	4743687	5_prime_UTR_variant	0	NR	5E-9	8.301029995663981				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	9q31.2	9	108123199		CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		25348	503634	rs630965-C	rs630965	0	630965	intergenic_variant	1	NR	1E-63	63				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	"122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls"	NA	10q26.13	10	121586676		FGFR2			ENSG00000066468			rs1219648-A	rs1219648	0	1219648	intron_variant	0	NR	4E-254	253.39794000867204				NR [NR]	N	"breast cancer, ovarian carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST90270342	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	9q34.2	9	133317947		LCN1P2			ENSG00000204031			rs9411395-G	rs9411395	0	9411395	intron_variant	0	NR	5E-26	25.30102999566398				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	1q22	1	155205599		THBS3			ENSG00000169231			rs370545-G	rs370545	0	370545	intron_variant	0	NR	3E-18	17.522878745280337				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	9q34.2	9	133402020		STKLD1			ENSG00000198870			rs17474001-T	rs17474001	0	17474001	intron_variant	0	NR	2E-26	25.69897000433602				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	9q34.2	9	133182801		GBGT1 - OBP2B	ENSG00000148288	ENSG00000171102		18868	22476	rs12216896-T	rs12216896	0	12216896	intergenic_variant	1	NR	2E-15	14.698970004336019				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	1q22	1	155752715		GON4L			ENSG00000116580			rs12134456-G	rs12134456	0	12134456	intron_variant	0	NR	9E-9	8.045757490560675				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	12q24.11	12	111162330		CUX2			ENSG00000111249			rs11065822-T	rs11065822	0	11065822	intron_variant	0	NR	1E-9	9				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or COVID-19 infection (pleiotropy)	"133,384 European ancestry breast cancer cases, 122,616 European ancestry COVID-19 cases, 2,589,029 European ancestry controls"	NA	1q22	1	156236330		"PMF1, PMF1-BGLAP"			"ENSG00000160783, ENSG00000260238"			rs1052067-A	rs1052067	0	1052067	missense_variant	0	NR	3E-8	7.522878745280337				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296487	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	22q12.1	22	28224596		TTC28			ENSG00000100154			rs9620778-A	rs9620778	0	9620778	intron_variant	0	NR	2E-10	9.698970004336019				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	17q21.31	17	46782349		WNT3			ENSG00000108379			rs70602-C	rs70602	0	70602	intron_variant	0	NR	2E-15	14.698970004336019				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	17q21.31	17	45983409		MAPT			ENSG00000186868			rs63750417-T	rs63750417	0	63750417	missense_variant	0	NR	4E-18	17.397940008672037				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	12q22	12	95633547		PGAM1P5			ENSG00000257150			rs2887022-G	rs2887022	0	2887022	intron_variant	0	NR	4E-13	12.397940008672037				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	12p11.22	12	27875470		RN7SKP15 - PTHLH	ENSG00000201612	ENSG00000087494		69080	82614	rs117191384-C	rs117191384	0	117191384	intergenic_variant	1	NR	1E-11	11				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	9q34.2	9	133278537		ABO - Y_RNA	ENSG00000175164	ENSG00000202522		2513	59191	rs11244061-T	rs11244061	0	11244061	intergenic_variant	1	NR	5E-11	10.301029995663981				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or hospitalized COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 32,519 European ancestry hospitalized COVID-19 cases, 2,176,594 European ancestry controls"	NA	17q21.31	17	45461157		PLEKHM1			ENSG00000225190			rs111423688-A	rs111423688	0	111423688	intron_variant	0	NR	3E-11	10.522878745280337				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296488	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	6q25.2	6	152111767		ESR1			ENSG00000091831			rs910416-T	rs910416	0	910416	intron_variant	0	NR	2E-29	28.69897000433602				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	17q21.31	17	45705327		LINC02210-CRHR1			ENSG00000263715			rs62056905-G	rs62056905	0	62056905	intron_variant	0	NR	9E-20	19.045757490560675				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	9q34.2	9	133271182		ABO			ENSG00000175164			rs550057-T	rs550057	0	550057	intron_variant	0	NR	1E-17	17				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	1q22	1	155177242		TRIM46			ENSG00000163462			rs3814316-A	rs3814316	0	3814316	synonymous_variant	0	NR	1E-13	13				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	17q21.31	17	46256057		MAPK8IP1P1 - ARL17B	ENSG00000262500	ENSG00000228696		11013	18727	rs2532363-T	rs2532363	0	2532363	intergenic_variant	1	NR	1E-10	10				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
10/30/2023	37636041	Zhao X	7/29/2023	iScience	www.ncbi.nlm.nih.gov/pubmed/37636041	A large-scale genome-wide cross-trait analysis for the effect of COVID-19 on female-specific cancers.	Breast cancer or critical COVID-19 (pleiotropy)	"133,384 European ancestry breast cancer cases, 13,769 European ancestry critical COVID-19 cases, 1,186,231 European ancestry controls"	NA	17q21.31	17	46779986		WNT3			ENSG00000108379			rs199512-C	rs199512	0	199512	intron_variant	0	NR	4E-18	17.397940008672037				NR [NR]	N	"breast cancer, COVID-19"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0100096"	GCST90296489	Genome-wide genotyping array				
11/15/2023	37296840	Nudelman K	5/23/2023	Cancers (Basel)	www.ncbi.nlm.nih.gov/pubmed/37296840	Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls.	"Longitudinal cognitive performance (attention, processing and executive function) x breast cancer interaction"	"325 European ancestry older female survivor cases, 340 European ancestry older controls"	NA	1q31.1	1	186065124		HMCN1			ENSG00000143341			rs76859653-?	rs76859653	0	76859653	intron_variant	0	NR	2E-8	7.698970004336019				"Affymetrix, Illumina [7661137] (imputed)"	N	"cognitive domain measurement, breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0009098, http://purl.obolibrary.org/obo/MONDO_0007254"	GCST90297546	Genome-wide genotyping array				
11/15/2023	37296840	Nudelman K	5/23/2023	Cancers (Basel)	www.ncbi.nlm.nih.gov/pubmed/37296840	Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls.	"Longitudinal cognitive performance (attention, processing and executive function) x breast cancer interaction"	"325 European ancestry older female survivor cases, 340 European ancestry older controls"	NA	2p16.3	2	48214304		VN1R18P - RN7SKP224	ENSG00000275423	ENSG00000201010		223778	3271	rs78786199-?	rs78786199	0	78786199	intron_variant	1	NR	2E-8	7.698970004336019				"Affymetrix, Illumina [7661137] (imputed)"	N	"cognitive domain measurement, breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0009098, http://purl.obolibrary.org/obo/MONDO_0007254"	GCST90297546	Genome-wide genotyping array				
7/17/2018	29423119	Khan S	11/28/2017	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in breast cancer (estrogen-receptor positive)	"2,971 European ancestry individuals, 165 individuals"	NA	8p21.2	8;8;8	23578869;23608232;23579239	"PDLIM2, RHOBTB2"	SLC25A37 - RNU4-71P; RNU4-71P - SINHCAFP3; SLC25A37 - RNU4-71P						rs4996307-?; rs992531-?; 2314686-?	rs4996307; rs992531; rs2314686	0		regulatory_region_variant; intergenic_variant; regulatory_region_variant		0.0693	2E-7	6.698970004336019		1.71	[1.4-2.07]	Illumina [275827] (imputed)	N	"event free survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST005901	Genome-wide genotyping array				
7/17/2018	29423119	Khan S	11/28/2017	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	"2,629 European ancestry individuals, 122 individuals"	NA	5q21.3	5	105742977	RAB9P1	RAB9BP1 - RNA5SP189	ENSG00000232159	ENSG00000201790		642879	180017	rs7701292-?	rs7701292	0	7701292	intergenic_variant	1	NR	2E-8	7.698970004336019		1.79	[1.59-1.99]	Illumina [275827] (imputed)	N	"event free survival time, estrogen-receptor positive breast cancer, response to endocrine therapy"	"http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0007613"	GCST005900	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in ER positive breast cancer	"2,407 European ancestry individuals"	NA	13q12.13	13	25011287		RPL34P27 - LSP1P1	ENSG00000232858	ENSG00000269099		22362	6117	rs113113429-?	rs113113429	0	113113429	intergenic_variant	1	NR	3E-8	7.522878745280337				Illumina [NR] (imputed)	N	"overall survival, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90104810	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	1q43	1	241870961		EXO1			ENSG00000174371			rs72755295-A	rs72755295	0	72755295	intron_variant	0	NR	3E-12	11.522878745280337				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	2q35	2	217047714		DIRC3-AS1			ENSG00000233143			rs77549302-T	rs77549302	0	77549302	intron_variant	0	NR	2E-9	8.698970004336019				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	3p24.1	3	27226825		NEK10			ENSG00000163491			rs7626646-T	rs7626646	0	7626646	intron_variant	0	NR	6E-9	8.221848749616356				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	5p15.33	5	1296643		TERT - MIR4457	ENSG00000164362	ENSG00000263670		1575	12667	rs33987166-T	rs33987166	0	33987166	intergenic_variant	1	NR	1E-8	8				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	5q31.1	5	133102666		HSPA4			ENSG00000170606			rs62375245-T	rs62375245	0	62375245	intron_variant	0	NR	1E-10	10				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	6p21.2	6	36681143		CDKN1A			ENSG00000124762			rs3176337-A	rs3176337	0	3176337	intron_variant	0	NR	1E-8	8				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	6q25.1	6	151703850		ESR1			ENSG00000091831			rs851982-T	rs851982	0	851982	intron_variant	0	NR	2E-11	10.698970004336019				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	8q23.1	8	105365713		ZFPM2			ENSG00000169946			rs17211035-T	rs17211035	0	17211035	intron_variant	0	NR	3E-8	7.522878745280337				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	9q33.1	9	116482904		ASTN2			ENSG00000148219			rs7030607-A	rs7030607	0	7030607	intron_variant	0	NR	1E-10	10				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	10p12.31	10	21535690		MLLT10			ENSG00000078403			rs10828248-A	rs10828248	0	10828248	intron_variant	0	NR	5E-21	20.30102999566398				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	10p12.31	10	21595802		MLLT10			ENSG00000078403			rs12217370-A	rs12217370	0	12217370	intron_variant	0	NR	1E-8	8				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	17q11.2	17	30836573		ATAD5			ENSG00000176208			rs117662433-A	rs117662433	0	117662433	intron_variant	0	NR	5E-8	7.301029995663981				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	17q11.2	17	30924623		ADAP2			ENSG00000184060			rs35840638-A	rs35840638	0	35840638	intron_variant	0	NR	2E-12	11.698970004336019				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	17p13.1	17	7668434		TP53			ENSG00000141510			rs78378222-T	rs78378222	0	78378222	3_prime_UTR_variant	0	NR	2E-34	33.69897000433602				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	20p12.3	20	5967581		MCM8			ENSG00000125885			rs16991615-A	rs16991615	0	16991615	missense_variant	0	NR	2E-13	12.698970004336019				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	22q13.1	22	40322096		TNRC6B			ENSG00000100354			rs4821942-A	rs4821942	0	4821942	intron_variant	0	NR	2E-23	22.69897000433602				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER positive breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 69,501 European ancestry ER+ve BC cases, 373,479 European ancestry controls"	NA	22q13.1	22	40130210		TNRC6B			ENSG00000100354			rs9611271-A	rs9611271	0	9611271	intron_variant	0	NR	2E-9	8.698970004336019				NR [8175419] (imputed)	N	"Uterine leiomyoma, estrogen-receptor positive breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90134421	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in ER negative breast cancer	393 European ancestry individuals	NA	2p16.1	2	56342129		CCDC85A			ENSG00000055813			rs11690772-?	rs11690772	0	11690772	intron_variant	0	NR	2E-7	6.698970004336019				Illumina [NR] (imputed)	N	"estrogen-receptor negative breast cancer, overall survival"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000638"	GCST90104812	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	5p15.33	5	1279913		TERT			ENSG00000164362			rs2242652-A	rs2242652	0	2242652	intron_variant	0	NR	9E-43	42.045757490560675				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	5p15.33	5	1276758		TERT			ENSG00000164362			rs56345976-A	rs56345976	0	56345976	intron_variant	0	NR	2E-14	13.698970004336019				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	5p15.33	5	1287390		TERT			ENSG00000164362			rs7710703-T	rs7710703	0	7710703	intron_variant	0	NR	5E-18	17.30102999566398				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	5p15.33	5	1283197		TERT			ENSG00000164362			rs7713218-A	rs7713218	0	7713218	intron_variant	0	NR	5E-18	17.30102999566398				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	6q25.1	6	151705939		ESR1			ENSG00000091831			rs851981-A	rs851981	0	851981	intron_variant	0	NR	4E-10	9.397940008672037				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	11q22.3	11	108485953		POGLUT3			ENSG00000178202			rs10789665-T	rs10789665	0	10789665	intron_variant	0	NR	3E-14	13.522878745280337				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	11q22.3	11	108444879		C11orf65			ENSG00000166323			rs149934734-T	rs149934734	0	149934734	intron_variant	0	NR	3E-32	31.522878745280337				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	11q22.3	11	108640104		EXPH5 - DDX10	ENSG00000110723	ENSG00000178105		46336	24954	rs188691509-A	rs188691509	0	188691509	intergenic_variant	1	NR	6E-9	8.221848749616356				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	11q22.3	11	108488962		POGLUT3			ENSG00000178202			rs72993806-C	rs72993806	0	72993806	intron_variant	0	NR	8E-16	15.096910013008056				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	17q11.2	17	30924623		ADAP2			ENSG00000184060			rs35840638-A	rs35840638	0	35840638	intron_variant	0	NR	2E-9	8.698970004336019				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	17p13.1	17	7668434		TP53			ENSG00000141510			rs78378222-T	rs78378222	0	78378222	3_prime_UTR_variant	0	NR	4E-36	35.39794000867204				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	20p12.3	20	5967581		MCM8			ENSG00000125885			rs16991615-A	rs16991615	0	16991615	missense_variant	0	NR	8E-12	11.096910013008056				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	22q13.1	22	40243702		TNRC6B			ENSG00000100354			rs143521471-T	rs143521471	0	143521471	intron_variant	0	NR	4E-18	17.397940008672037				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or ER negative breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 21,468 European ancestry ER-ve BC cases, 373,479 European ancestry controls"	NA	22q13.1	22	40130210		TNRC6B			ENSG00000100354			rs9611271-A	rs9611271	0	9611271	intron_variant	0	NR	1E-9	9				NR [8175424] (imputed)	N	"Uterine leiomyoma, estrogen-receptor negative breast cancer"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_1000650"	GCST90134422	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	1q22	1	155176305		TRIM46			ENSG00000163462			rs4971059-G	rs4971059	0	4971059	intron_variant	0	NR	4E-11	10.397940008672037				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	1p34.1	1	46135245		P3R3URF-PIK3R3			ENSG00000278139			rs1707302-A	rs1707302	0	1707302	intron_variant	0	NR	7E-9	8.154901959985743				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	10q21.2	10	62687592		LINC02929 - ALDH7A1P4	ENSG00000285551	ENSG00000234489		15581	53616	rs224121-A	rs224121	0	224121	intron_variant	1	NR	2E-8	7.698970004336019				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	10q22.3	10	79129101		ZMIZ1			ENSG00000108175			rs7097066-G	rs7097066	0	7097066	intron_variant	0	NR	7E-22	21.154901959985743				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	11p15.5	11	2003314		H19			ENSG00000130600			rs4930103-G	rs4930103	0	4930103	intron_variant	0	NR	2E-9	8.698970004336019				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	14q32.12	14	92636964		RIN3			ENSG00000100599			rs10498635-C	rs10498635	0	10498635	intron_variant	0	NR	5E-12	11.301029995663981				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	19p13.11	19	17292224		ABHD8			ENSG00000127220			rs4808616-C	rs4808616	0	4808616	3_prime_UTR_variant	0	NR	4E-8	7.3979400086720375				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	2q31.1	2	173348166		RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-G	rs1550623	0	1550623	intron_variant	1	NR	7E-10	9.154901959985743				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	5p15.33	5	1297373		TERT - MIR4457	ENSG00000164362	ENSG00000263670		2305	11937	rs2736108-C	rs2736108	0	2736108	regulatory_region_variant	1	NR	5E-24	23.30102999566398				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	5p15.33	5	1308437		TERT - MIR4457	ENSG00000164362	ENSG00000263670		13369	873	rs4635969-G	rs4635969	0	4635969	intergenic_variant	1	NR	2E-9	8.698970004336019				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	5q31.1	5	133105610		HSPA4			ENSG00000170606			rs13718-A	rs13718	0	13718	3_prime_UTR_variant	0	NR	9E-9	8.045757490560675				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	5q11.2	5	56733416		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		127184	82133	rs16886181-T	rs16886181	0	16886181	intergenic_variant	1	NR	5E-122	121.30102999566398				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	6p22.2	6	25982782		TRIM38			ENSG00000112343			rs13212534-G	rs13212534	0	13212534	intron_variant	0	NR	6E-9	8.221848749616356				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	6p22.1	6	27283600		PRSS16 - POM121L2	ENSG00000112812	ENSG00000158553		26976	2303	rs13207082-A	rs13207082	0	13207082	intergenic_variant	1	NR	5E-11	10.301029995663981				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	6p22.1	6	28364364		ZKSCAN3			ENSG00000189298			rs13214023-G	rs13214023	0	13214023	intron_variant	0	NR	8E-13	12.096910013008056				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	6p22.1	6	29931900		HLA-K - HLA-U	ENSG00000230795	ENSG00000228078		2668	2201	rs2524005-G	rs2524005	0	2524005	intron_variant	1	NR	4E-8	7.3979400086720375				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	6p21.33	6	31757453		"MSH5, MSH5-SAPCD1"			"ENSG00000204410, ENSG00000255152"			rs3117574-G	rs3117574	0	3117574	5_prime_UTR_variant	0	NR	4E-10	9.397940008672037				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
6/19/2023	36819030	Guo H	2/3/2023	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or lung cancer (pleiotropy)	"122,977 breast cancer cases, 11,348 lung cancer cases, 121,835 controls"	NA	9p21.3	9	22003224		"CDKN2B-AS1, CDKN2B"			"ENSG00000240498, ENSG00000147883"			rs3217992-C	rs3217992	0	3217992	3_prime_UTR_variant	0	NR	2E-21	20.69897000433602				NR [NR]	N	"breast cancer, lung cancer"	"http://purl.obolibrary.org/obo/MONDO_0007254, http://purl.obolibrary.org/obo/MONDO_0008903"	GCST90270343	Genome-wide genotyping array				
7/29/2014	24325915	Purrington KS	12/9/2013	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"1,529 European ancestry cases, 3,399 European ancestry controls"	"2,148 European ancestry cases, 1,309 European ancestry controls"	1q32.1	1	204549714	MDM4	MDM4			ENSG00000198625			rs4245739-C	rs4245739	0	4245739	3_prime_UTR_variant	0	NR	4E-6	5.3979400086720375		1.19	[1.11-1.29]	Illumina [NR] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST002305	Genome-wide genotyping array				
7/29/2014	24325915	Purrington KS	12/9/2013	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"1,529 European ancestry cases, 3,399 European ancestry controls"	"2,148 European ancestry cases, 1,309 European ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-A	rs10069690	0	10069690	intron_variant	0	NR	1E-7	7		1.24	[1.14-1.34]	Illumina [NR] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST002305	Genome-wide genotyping array				
7/29/2014	24325915	Purrington KS	12/9/2013	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"1,529 European ancestry cases, 3,399 European ancestry controls"	"2,148 European ancestry cases, 1,309 European ancestry controls"	6q25.1	6	151592978	ESR1	CCDC170			ENSG00000120262			rs3757318-A	rs3757318	0	3757318	intron_variant	0	NR	9E-6	5.045757490560675		1.33	[1.17-1.51]	Illumina [NR] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST002305	Genome-wide genotyping array				
7/29/2014	24325915	Purrington KS	12/9/2013	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"1,529 European ancestry cases, 3,399 European ancestry controls"	"2,148 European ancestry cases, 1,309 European ancestry controls"	19p13.11	19	17283315	intergenic	ANKLE1			ENSG00000160117			rs2363956-C	rs2363956	0	2363956	missense_variant	0	NR	2E-8	7.698970004336019		1.2195	[1.14-1.3]	Illumina [NR] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST002305	Genome-wide genotyping array				
7/29/2014	24325915	Purrington KS	12/9/2013	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/24325915	Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"1,529 European ancestry cases, 3,399 European ancestry controls"	"2,148 European ancestry cases, 1,309 European ancestry controls"	12p11.22	12	28002147	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-G	rs10771399	0	10771399	intergenic_variant	1	NR	2E-8	7.698970004336019		1.3889	[1.25-1.56]	Illumina [NR] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST002305	Genome-wide genotyping array				
3/20/2017	28171663	Huo D	9/4/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor positive)	"1795 African American cases, 99 African ancestry cases, 4,150 African American controls, 624 African ancestry controls"	"1093 African American cases, 2939 African American controls"	2q35	2	217029040	intergenic	DIRC3-AS1			ENSG00000233143			rs12998806-G	rs12998806	0	12998806	intron_variant	0	0.86	2E-8	7.698970004336019		1.34	[1.21-1.48]	Illumina [16147413] (imputed)	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST003781	Genome-wide genotyping array				
3/20/2017	28171663	Huo D	9/4/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls"	"573 African American cases, 2,939 African American controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	2E-10	9.698970004336019		1.3	[1.20-1.41]	Illumina [16147413] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003780	Genome-wide genotyping array				
3/20/2017	28171663	Huo D	9/4/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"1349 African American cases, 42 African ancestry cases, 4,150 African American controls, 624 African ancestry controls"	"573 African American cases, 2,939 African American controls"	3q26.31	3	172550013	TNFSF10	TNFSF10 - LINC02068	ENSG00000121858	ENSG00000223387		26538	10875	rs13074711-T	rs13074711	0	13074711	regulatory_region_variant	1	0.69	2E-8	7.698970004336019		1.29	[1.18-1.40]	Illumina [16147413] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003780	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	2q35	2	217056046	NR	DIRC3-AS1			ENSG00000233143			rs4442975-?	rs4442975	0	4442975	intron_variant	0	NR	5E-18	17.30102999566398		1.15	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	3p24.1	3	27359756	NR	NEK10			ENSG00000163491			rs11715126-?	rs11715126	0	11715126	intron_variant	0	NR	2E-12	11.698970004336019		0.89	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	5p12	5	44926416	NR	MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		105988	328532	rs10043344-?	rs10043344	0	10043344	intergenic_variant	1	NR	5E-10	9.301029995663981		1.11	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	5q11.2	5	56715530	NR	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		109298	100019	rs7714232-?	rs7714232	0	7714232	intergenic_variant	1	NR	6E-22	21.221848749616356		1.22	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	10q26.13	10	121586602	NR	FGFR2			ENSG00000066468			rs2981575-?	rs2981575	0	2981575	intron_variant	0	NR	2E-54	53.69897000433602		1.29	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	11q13.3	11	69516215	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21263	124941	rs661204-?	rs661204	0	661204	regulatory_region_variant	1	NR	9E-23	22.045757490560675		1.25	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	16q12.1	16	52565276	NR	CASC16			ENSG00000249231			rs4784227-?	rs4784227	0	4784227	intron_variant	0	NR	7E-39	38.15490195998574		1.27	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
3/30/2021	32808324	Hu J	8/17/2020	Genet Epidemiol	www.ncbi.nlm.nih.gov/pubmed/32808324	Supervariants identification for breast cancer.	Breast cancer	"5,653 cases, 28,241 controls"	NA	22q12.1	22	28365160	NR	TTC28			ENSG00000100154			rs62237617-?	rs62237617	0	62237617	intron_variant	0	NR	8E-16	15.096910013008056		2.86	[NR]	NR [41502298] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST011433	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	14q32.11	14	91374725		CCDC88C			ENSG00000015133			rs941764-?	rs941764	0	941764	intron_variant	0	NR	6E-8	7.221848749616356		1.08453	[1.06-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	16p12.2	16	23621362		PALB2			ENSG00000083093			rs180177132-?	rs180177132	0	180177132	stop_gained	0	NR	1E-12	12		4.54031	[4.12-4.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-?	rs4784227	0	4784227	intron_variant	0	NR	1E-44	44		1.25172	[1.22-1.28]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	16q23.2	16	80617763		CDYL2			ENSG00000166446			rs873994-?	rs873994	0	873994	intron_variant	0	NR	4E-7	6.3979400086720375		1.08962	[1.06-1.12]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	17q11.2	17	30894259		ATAD5			ENSG00000176208			rs62070652-?	rs62070652	0	62070652	intron_variant	0	NR	1E-6	6		0.922689	[0.89-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	17q22	17	59334310		YPEL2			ENSG00000175155			rs72831252-?	rs72831252	0	72831252	intron_variant	0	NR	2E-6	5.698970004336019		1.16088	[1.1-1.22]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	18p11.31	18	5491083		EPB41L3			ENSG00000082397			rs74609852-?	rs74609852	0	74609852	intron_variant	0	NR	1E-5	5		0.863168	[0.8-0.93]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	18q11.2	18	26901308		AQP4-AS1			ENSG00000260372			rs17621185-?	rs17621185	0	17621185	intron_variant	0	NR	3E-8	7.522878745280337		0.904648	[0.87-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	18q12.1	18	27859862		PA2G4P3 - CDH2	ENSG00000263405	ENSG00000170558		406205	73017	rs4471777-?	rs4471777	0	4471777	intergenic_variant	1	NR	7E-6	5.154901959985743		0.925971	[0.89-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	21q21.1	21	15196204		LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		128367	294326	rs7275695-?	rs7275695	0	7275695	intron_variant	1	NR	4E-6	5.3979400086720375		0.93113	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	22q13.1	22	40481631		MRTFA			ENSG00000196588			rs6001932-?	rs6001932	0	6001932	intron_variant	0	NR	7E-9	8.154901959985743		1.14588	[1.1-1.19]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	22q13.2	22	40600363		MRTFA			ENSG00000196588			rs17002034-?	rs17002034	0	17002034	intron_variant	0	NR	6E-11	10.221848749616356		1.1628	[1.12-1.21]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	8p11.23	8	36990191		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		54066	104959	rs10086016-?	rs10086016	0	10086016	intergenic_variant	1	NR	1E-8	8		0.893158	[0.85-0.93]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	8q24.21	8	127343372		"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-?	rs13281615	0	13281615	intron_variant	0	NR	3E-9	8.522878745280337		1.08956	[1.06-1.12]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	9p24.2	9	2636130		VLDLR			ENSG00000147852			rs35889561-?	rs35889561	0	35889561	intron_variant	0	NR	1E-6	6		0.779251	[0.68-0.88]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	9q31.2	9	107543834		PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-?	rs10759243	0	10759243	intergenic_variant	1	NR	1E-6	6		1.07986	[1.05-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	9q31.2	9	108074792		RPL31P43 - CHCHD4P2	ENSG00000213557	ENSG00000237360		34200	22640	rs10816625-?	rs10816625	0	10816625	regulatory_region_variant	1	NR	4E-9	8.397940008672037		1.17795	[1.12-1.23]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	9q33.1	9	116630004		ASTN2			ENSG00000148219			rs1885244-?	rs1885244	0	1885244	intron_variant	0	NR	3E-6	5.522878745280337		0.933716	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10p12.31	10	21535798		MLLT10			ENSG00000078403			rs10828249-?	rs10828249	0	10828249	intron_variant	0	NR	5E-8	7.301029995663981		1.08436	[1.06-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q21.2	10	62518923		ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-?	rs10995190	0	10995190	intron_variant	1	NR	3E-6	5.522878745280337		0.906918	[0.87-0.95]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q22.3	10	79081391		ZMIZ1			ENSG00000108175			rs704010-?	rs704010	0	704010	intron_variant	0	NR	2E-7	6.698970004336019		1.07761	[1.05-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q25.1	10	110044796		ADD3			ENSG00000148700			rs61881617-?	rs61881617	0	61881617	intron_variant	0	NR	4E-6	5.3979400086720375		1.1514	[1.09-1.21]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q26.12	10	121335498		LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		149532	75418	rs35098964-?	rs35098964	0	35098964	intergenic_variant	1	NR	8E-8	7.096910013008056		0.917879	[0.89-0.95]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q26.13	10	121586602		FGFR2			ENSG00000066468			rs2981575-?	rs2981575	0	2981575	intron_variant	0	NR	1E-66	66		1.28222	[1.25-1.31]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	10q26.13	10	121738911		ATE1			ENSG00000107669			rs11200120-?	rs11200120	0	11200120	intron_variant	0	NR	4E-7	6.3979400086720375		1.11435	[1.07-1.16]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	11p15.5	11	1871355		LSP1			ENSG00000130592			rs4980389-?	rs4980389	0	4980389	5_prime_UTR_variant	0	NR	4E-7	6.3979400086720375		0.927573	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	11p15.3	11	11964514		DKK3			ENSG00000050165			rs3206824-?	rs3206824	0	3206824	missense_variant	0	NR	4E-6	5.3979400086720375		0.925242	[0.89-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	11q13.3	11	69529047		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		34095	112109	rs75296154-?	rs75296154	0	75296154	intergenic_variant	1	NR	7E-14	13.154901959985743		1.28229	[1.22-1.35]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	11q13.3	11	69646918		CCND1			ENSG00000110092			rs34507830-?	rs34507830	0	34507830	intron_variant	0	NR	2E-7	6.698970004336019		1.26234	[1.17-1.35]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	11q24.3	11	129604878		RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		66764	7238	rs7936804-?	rs7936804	0	7936804	intron_variant	1	NR	2E-6	5.698970004336019		0.933902	[0.91-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	12p11.22	12	28013134		PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		40401	120115	rs2590275-?	rs2590275	0	2590275	intergenic_variant	1	NR	5E-8	7.301029995663981		0.907977	[0.87-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	12q22	12	95633983		PGAM1P5			ENSG00000257150			rs17356907-?	rs17356907	0	17356907	intron_variant	0	NR	4E-12	11.397940008672037		0.896146	[0.87-0.93]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	12q24.21	12	115377059		TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		609070	215545	rs1391713-?	rs1391713	0	1391713	regulatory_region_variant	1	NR	6E-7	6.221848749616356		0.927587	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA											chr13:32914174-?	chr13:32914174	0			1	NR	1E-5	5		8.72761	[7.77-9.69]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	14q13.3	14	36683145		SLC25A21			ENSG00000183032			rs8003014-?	rs8003014	0	8003014	intron_variant	0	NR	5E-6	5.301029995663981		1.0682	[1.04-1.1]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	14q24.1	14	68132775		RAD51B			ENSG00000182185			rs2588833-?	rs2588833	0	2588833	intron_variant	0	NR	8E-6	5.096910013008056		1.0883	[1.05-1.13]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	14q24.1	14	68539170		RAD51B			ENSG00000182185			rs71423318-?	rs71423318	0	71423318	intron_variant	0	NR	3E-7	6.522878745280337		0.921671	[0.89-0.95]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	1p36.22	1	10536284		PEX14			ENSG00000142655			rs12375-?	rs12375	0	12375	synonymous_variant	0	NR	1E-5	5		0.934209	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	1p11.2	1	121538815		"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-?	rs11249433	0	11249433	intron_variant	0	NR	5E-8	7.301029995663981		1.08184	[1.05-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	2q33.1	2	201279205		CASP8			ENSG00000064012			rs10931936-?	rs10931936	0	10931936	intron_variant	0	NR	6E-6	5.221848749616356		1.07496	[1.04-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	2q34	2	212678034		ERBB4 - LINC01878	ENSG00000178568	ENSG00000234308		139193	117266	rs17331821-?	rs17331821	0	17331821	intron_variant	1	NR	1E-6	6		1.08238	[1.05-1.11]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	2q35	2	217041109		DIRC3-AS1			ENSG00000233143			rs13387042-?	rs13387042	0	13387042	intron_variant	0	NR	5E-23	22.30102999566398		0.868092	[0.84-0.9]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	3p24.1	3	27123683		NEK10			ENSG00000163491			rs1522151-?	rs1522151	0	1522151	intron_variant	0	NR	1E-9	9		0.916751	[0.89-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	3p24.1	3	27327393		NEK10			ENSG00000163491			rs3920005-?	rs3920005	0	3920005	intron_variant	0	NR	8E-14	13.096910013008056		0.898155	[0.87-0.93]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	3q25.2	3	152872749		P2RY1 - HMGN2P13	ENSG00000169860	ENSG00000241810		31310	194529	rs60489888-?	rs60489888	0	60489888	intergenic_variant	1	NR	4E-6	5.3979400086720375		0.917786	[0.88-0.95]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p15.33	5	1297373		TERT - MIR4457	ENSG00000164362	ENSG00000263670		2305	11937	rs2736108-?	rs2736108	0	2736108	regulatory_region_variant	1	NR	1E-6	6		0.926523	[0.9-0.96]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	44701316		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		42747	14877	rs714130-?	rs714130	0	714130	intergenic_variant	1	NR	7E-9	8.154901959985743		1.0876	[1.06-1.12]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	44874903		MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		54475	380045	rs7716600-?	rs7716600	0	7716600	regulatory_region_variant	1	NR	7E-8	7.154901959985743		1.09502	[1.06-1.13]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	44992878		MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		172450	262070	rs72759918-?	rs72759918	0	72759918	intergenic_variant	1	NR	6E-6	5.221848749616356		0.911678	[0.87-0.95]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	45286186		HCN1			ENSG00000164588			rs72759957-?	rs72759957	0	72759957	intron_variant	0	NR	9E-8	7.045757490560675		0.895227	[0.85-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	45427835		HCN1			ENSG00000164588			rs72762052-?	rs72762052	0	72762052	intron_variant	0	NR	7E-7	6.154901959985743		0.90123	[0.86-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	45846518		HCN1 - EMB	ENSG00000164588	ENSG00000170571		150020	4549674	rs72765759-?	rs72765759	0	72765759	intergenic_variant	1	NR	9E-7	6.045757490560675		0.899374	[0.86-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5p12	5	46005944		HCN1 - EMB	ENSG00000164588	ENSG00000170571		309446	4390248	rs145901335-?	rs145901335	0	145901335	intergenic_variant	1	NR	4E-7	6.3979400086720375		0.892376	[0.85-0.94]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5q11.2	5	56727256		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		121024	88293	rs16886165-?	rs16886165	0	16886165	intergenic_variant	1	NR	1E-20	20		1.18785	[1.15-1.22]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5q11.2	5	56977866		MIER3 - C12orf29P1	ENSG00000155545	ENSG00000250480		6191	142930	rs10036895-?	rs10036895	0	10036895	intergenic_variant	1	NR	2E-12	11.698970004336019		1.11114	[1.08-1.14]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	5q33.3	5	158829110		EBF1			ENSG00000164330			rs11954193-?	rs11954193	0	11954193	intron_variant	0	NR	1E-9	9		1.09165	[1.06-1.12]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	6q25.1	6	151615542		CCDC170			ENSG00000120262			rs6929137-?	rs6929137	0	6929137	missense_variant	0	NR	2E-13	12.698970004336019		1.11645	[1.09-1.15]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/19/2021	34290314	Brandes N	7/21/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Breast cancer	"10,682 White British ancestry cases, 138,504 White British ancestry controls"	NA	7q36.1	7	151987209		GALNTL5			ENSG00000106648			rs75797831-?	rs75797831	0	75797831	missense_variant	0	NR	8E-6	5.096910013008056		1.63522	[1.42-1.85]	NR [682398]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90027052	Genome-wide genotyping array				
10/26/2015	25824743	Haryono SJ	1/1/2015	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.	Breast cancer	"89 Indonesian ancestry cases, 46 Indonesian ancestry controls"	NA	18p11.22	18	8716323	SOGA2	MTCL1			ENSG00000168502			rs2111836-G	rs2111836	0	2111836	intron_variant	0	0.22	7E-6	5.154901959985743		1.32	[1.17-1.44]	Affymetrix [292887]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002735	Genome-wide genotyping array				
10/26/2015	25824743	Haryono SJ	1/1/2015	Asian Pac J Cancer Prev	www.ncbi.nlm.nih.gov/pubmed/25824743	A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.	Breast cancer	"89 Indonesian ancestry cases, 46 Indonesian ancestry controls"	NA	2p12	2	79716982	CTNNA2	CTNNA2			ENSG00000066032			rs13025833-A	rs13025833	0	13025833	intron_variant	0	0.52	1E-7	7		1.2	[1.13-1.33]	Affymetrix [292887]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002735	Genome-wide genotyping array				
12/1/2021	34737426	Jiang L	11/4/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737426	A generalized linear mixed model association tool for biobank-scale data.	"Cancer code, self-reported: breast cancer (UKB data field 20001_1002)"	"10,152 European ancestry cases, 446,124 European ancestry controls"	NA	22q12.1	22	28365160		TTC28			ENSG00000100154			rs62237617-T	rs62237617	0	62237617	intron_variant	0	0.001824	1E-16	16		1.62	[1.24-2] unit increase	NR [11842647] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90041886	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr2:202145612-?	chr2:202145612	0			1	NR	3E-8	7.522878745280337		0.12128	[0.083-0.16] unit decrease	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr3:150451759-?	chr3:150451759	0			1	NR	6E-11	10.221848749616356		0.15017	[0.11-0.19] unit increase	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr5:44678534-?	chr5:44678534	0			1	NR	6E-11	10.221848749616356		0.14352	[0.11-0.18] unit increase	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr5:56042972-?	chr5:56042972	0			1	NR	3E-9	8.522878745280337		0.19644	[0.14-0.26] unit increase	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr6:151949582-?	chr6:151949582	0			1	NR	4E-15	14.397940008672037		0.18754	[0.15-0.23] unit increase	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr10:123333997-?	chr10:123333997	0			1	NR	2E-21	20.69897000433602		0.18819	[0.15-0.22] unit decrease	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
3/30/2023	36777999	Nam K	10/5/2022	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/36777999	"Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits."	Breast cancer	"251,000 East Asian ancestry individuals"	NA											chr16:52599188-?	chr16:52599188	0			1	NR	1E-25	25		0.25621	[0.21-0.3] unit increase	NR [6907490] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90255473	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr9:32193749-?	chr9:32193749	0			1	NR	7E-6	5.154901959985743		5.01	[2.49-10.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr10:50620166-?	chr10:50620166	0			1	NR	4E-7	6.3979400086720375		5.33	[2.78-10.19]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr11:95383824-?	chr11:95383824	0			1	NR	6E-6	5.221848749616356		4.02	[2.2-7.33]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr13:41138380-?	chr13:41138380	0			1	NR	6E-6	5.221848749616356		3.92	[2.17-7.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr13:100114405-?	chr13:100114405	0			1	NR	9E-6	5.045757490560675		5.33	[2.54-11.16]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr13:114740054-?	chr13:114740054	0			1	NR	8E-6	5.096910013008056		2.4	[1.63-3.52]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr14:38687337-?	chr14:38687337	0			1	NR	1E-6	6		3.5	[2.12-5.78]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr15:25821836-?	chr15:25821836	0			1	NR	2E-6	5.698970004336019		4.39	[2.39-8.05]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr15:87454804-?	chr15:87454804	0			1	NR	9E-6	5.045757490560675		5.29	[2.54-11.02]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr17:6611412-?	chr17:6611412	0			1	NR	8E-6	5.096910013008056		3.61	[2.06-6.33]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr17:6939522-?	chr17:6939522	0			1	NR	6E-6	5.221848749616356		3.98	[2.19-7.24]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr17:9145968-?	chr17:9145968	0			1	NR	4E-6	5.3979400086720375		0.31	[0.19-0.51]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr22:27841795-?	chr22:27841795	0			1	NR	9E-6	5.045757490560675		3.09	[1.88-5.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr22:38701977-?	chr22:38701977	0			1	NR	3E-6	5.522878745280337		5.01	[2.54-9.87]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chrX:42297787-?	chrX:42297787	0			1	NR	4E-6	5.3979400086720375		0.18	[0.08-0.37]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr1:229253206-?	chr1:229253206	0			1	NR	1E-5	5		2.8	[1.77-4.42]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr1:232991175-?	chr1:232991175	0			1	NR	7E-6	5.154901959985743		0.25	[0.13-0.45]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr2:74096619-?	chr2:74096619	0			1	NR	4E-6	5.3979400086720375		5.78	[2.75-12.18]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr2:79223167-?	chr2:79223167	0			1	NR	6E-6	5.221848749616356		4.97	[2.48-9.94]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr2:109742046-?	chr2:109742046	0			1	NR	5E-6	5.301029995663981		3.21	[1.95-5.3]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr3:21504737-?	chr3:21504737	0			1	NR	3E-6	5.522878745280337		3.56	[2.09-6.09]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr4:136006776-?	chr4:136006776	0			1	NR	3E-6	5.522878745280337		3.91	[2.21-6.93]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr5:16791556-?	chr5:16791556	0			1	NR	5E-6	5.301029995663981		3.55	[2.07-6.11]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr5:166120727-?	chr5:166120727	0			1	NR	4E-6	5.3979400086720375		3.83	[2.17-6.78]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr8:52718273-?	chr8:52718273	0			1	NR	5E-7	6.301029995663981		6.39	[3.1-13.18]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr9:95839157-?	chr9:95839157	0			1	NR	1E-7	7		2.16	[1.62-2.87]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr1:68321350-?	chr1:68321350	0			1	NR	9E-6	5.045757490560675		2.94	[1.82-4.72]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr11:93628219-?	chr11:93628219	0			1	NR	7E-7	6.154901959985743		4.4	[2.45-7.9]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr1:201418452-?	chr1:201418452	0			1	NR	1E-6	6		0.49	[0.37-0.66]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr12:45974582-?	chr12:45974582	0			1	NR	2E-6	5.698970004336019		2.9	[1.87-4.48]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr12:63340694-?	chr12:63340694	0			1	NR	3E-6	5.522878745280337		0.23	[0.12-0.43]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr3:141111009-?	chr3:141111009	0			1	NR	1E-6	6		4.11	[2.31-7.3]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr13:64364440-?	chr13:64364440	0			1	NR	2E-6	5.698970004336019		2.22	[1.6-3.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr4:97915038-?	chr4:97915038	0			1	NR	9E-6	5.045757490560675		3.06	[1.87-5.0]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr13:109606557-?	chr13:109606557	0			1	NR	4E-6	5.3979400086720375		3.86	[2.18-6.84]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr5:122933898-?	chr5:122933898	0			1	NR	8E-6	5.096910013008056		4.4	[2.29-8.45]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr13:114740054-?	chr13:114740054	0			1	NR	9E-6	5.045757490560675		1.93	[1.44-2.59]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr5:163771269-?	chr5:163771269	0			1	NR	6E-6	5.221848749616356		4.71	[2.41-9.21]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr6:36669500-?	chr6:36669500	0			1	NR	8E-6	5.096910013008056		2.56	[1.69-3.87]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr6:48246688-?	chr6:48246688	0			1	NR	3E-6	5.522878745280337		4.16	[2.28-7.58]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr6:150440290-?	chr6:150440290	0			1	NR	5E-8	7.301029995663981		0.3	[0.2-0.47]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr7:78690794-?	chr7:78690794	0			1	NR	7E-6	5.154901959985743		0.47	[0.34-0.65]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr7:88838813-?	chr7:88838813	0			1	NR	8E-6	5.096910013008056		0.4	[0.27-0.6]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr7:127831420-?	chr7:127831420	0			1	NR	5E-7	6.301029995663981		3.68	[2.21-6.11]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr18:61262367-?	chr18:61262367	0			1	NR	9E-6	5.045757490560675		3.12	[1.89-5.16]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr8:88432637-?	chr8:88432637	0			1	NR	3E-6	5.522878745280337		3.55	[2.09-6.04]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr21:19481486-?	chr21:19481486	0			1	NR	2E-6	5.698970004336019		0.17	[0.08-0.35]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr22:25384365-?	chr22:25384365	0			1	NR	2E-6	5.698970004336019		3.21	[1.99-5.19]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr9:84216805-?	chr9:84216805	0			1	NR	8E-7	6.096910013008056		2.28	[1.65-3.17]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chrX:51874979-?	chrX:51874979	0			1	NR	1E-5	5		2.01	[1.48-2.74]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr1:66522795-?	chr1:66522795	0			1	NR	3E-6	5.522878745280337		4	[2.25-7.13]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr9:110654829-?	chr9:110654829	0			1	NR	3E-6	5.522878745280337		2.56	[1.73-3.8]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr1:109478645-?	chr1:109478645	0			1	NR	4E-6	5.3979400086720375		2.86	[1.83-4.45]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr11:119592623-?	chr11:119592623	0			1	NR	8E-6	5.096910013008056		5.04	[2.48-10.26]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr2:186683-?	chr2:186683	0			1	NR	5E-6	5.301029995663981		2.68	[1.76-4.09]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr2:159271033-?	chr2:159271033	0			1	NR	8E-9	8.096910013008056		4.42	[2.67-7.33]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr12:129337340-?	chr12:129337340	0			1	NR	3E-6	5.522878745280337		2.87	[1.85-4.46]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr4:32879561-?	chr4:32879561	0			1	NR	2E-6	5.698970004336019		2.18	[1.58-3.01]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr13:91347480-?	chr13:91347480	0			1	NR	6E-6	5.221848749616356		3.95	[2.18-7.17]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr5:66829536-?	chr5:66829536	0			1	NR	4E-6	5.3979400086720375		2.49	[1.69-3.67]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr13:114437544-?	chr13:114437544	0			1	NR	5E-7	6.301029995663981		3.25	[2.05-5.13]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr5:159173642-?	chr5:159173642	0			1	NR	1E-6	6		2.08	[1.55-2.8]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr14:24314648-?	chr14:24314648	0			1	NR	3E-6	5.522878745280337		4.01	[2.23-7.2]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr14:95274450-?	chr14:95274450	0			1	NR	6E-6	5.221848749616356		2.19	[1.56-3.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr15:63721938-?	chr15:63721938	0			1	NR	1E-6	6		3.66	[2.17-6.17]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr16:7170393-?	chr16:7170393	0			1	NR	5E-7	6.301029995663981		3.33	[2.08-5.33]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr17:13468081-?	chr17:13468081	0			1	NR	1E-6	6		3.76	[2.2-6.43]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr18:1463192-?	chr18:1463192	0			1	NR	4E-6	5.3979400086720375		3.44	[2.03-5.82]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr18:5950114-?	chr18:5950114	0			1	NR	6E-6	5.221848749616356		1.96	[1.47-2.62]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr8:72441946-?	chr8:72441946	0			1	NR	6E-6	5.221848749616356		2.03	[1.49-2.76]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr20:40922844-?	chr20:40922844	0			1	NR	8E-6	5.096910013008056		1.94	[1.45-2.59]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr8:103828170-?	chr8:103828170	0			1	NR	4E-6	5.3979400086720375		2.39	[1.65-3.48]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr8:103932487-?	chr8:103932487	0			1	NR	3E-6	5.522878745280337		2.39	[1.66-3.44]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chrX:23604900-?	chrX:23604900	0			1	NR	7E-6	5.154901959985743		3.11	[1.9-5.11]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chr9:94666793-?	chr9:94666793	0			1	NR	3E-6	5.522878745280337		2.87	[1.85-4.47]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Aromatase inhibitors induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	400 White ancestry individuals	NA											chrX:69302269-?	chrX:69302269	0			1	NR	1E-6	6		3.16	[1.98-5.02]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134417	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr1:240652415-?	chr1:240652415	0			1	NR	3E-6	5.522878745280337		3.9	[2.2-6.91]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr1:244982865-?	chr1:244982865	0			1	NR	9E-6	5.045757490560675		3.03	[1.86-4.95]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:119350062-?	chr2:119350062	0			1	NR	2E-6	5.698970004336019		3.17	[1.96-5.13]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:137400283-?	chr2:137400283	0			1	NR	2E-6	5.698970004336019		3.31	[2.02-5.43]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:137501389-?	chr2:137501389	0			1	NR	8E-7	6.096910013008056		3.38	[2.08-5.49]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:172595690-?	chr2:172595690	0			1	NR	5E-6	5.301029995663981		3.86	[2.16-6.89]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:173088653-?	chr2:173088653	0			1	NR	2E-6	5.698970004336019		4.07	[2.29-7.23]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:192420461-?	chr2:192420461	0			1	NR	7E-7	6.154901959985743		3.02	[1.95-4.67]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr2:217103149-?	chr2:217103149	0			1	NR	1E-6	6		0.25	[0.14-0.44]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr3:115908434-?	chr3:115908434	0			1	NR	6E-6	5.221848749616356		3.56	[2.06-6.18]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr4:183757618-?	chr4:183757618	0			1	NR	9E-6	5.045757490560675		0.15	[0.07-0.35]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr5:170747723-?	chr5:170747723	0			1	NR	9E-6	5.045757490560675		2.73	[1.75-4.26]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr6:471619-?	chr6:471619	0			1	NR	3E-7	6.522878745280337		2.95	[1.95-4.47]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr6:48565631-?	chr6:48565631	0			1	NR	4E-6	5.3979400086720375		4.04	[2.23-7.31]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr6:53457697-?	chr6:53457697	0			1	NR	6E-6	5.221848749616356		4.11	[2.23-7.58]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:32557457-?	chr7:32557457	0			1	NR	7E-6	5.154901959985743		2.62	[1.72-3.99]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:32829130-?	chr7:32829130	0			1	NR	7E-6	5.154901959985743		2.32	[1.61-3.35]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:40772453-?	chr7:40772453	0			1	NR	8E-6	5.096910013008056		5.33	[2.56-11.08]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:78690736-?	chr7:78690736	0			1	NR	4E-6	5.3979400086720375		0.4	[0.27-0.59]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:88911626-?	chr7:88911626	0			1	NR	8E-6	5.096910013008056		0.26	[0.15-0.47]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr7:127820117-?	chr7:127820117	0			1	NR	4E-6	5.3979400086720375		3.11	[1.92-5.03]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr8:79795967-?	chr8:79795967	0			1	NR	8E-6	5.096910013008056		4	[2.18-7.36]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr8:95713518-?	chr8:95713518	0			1	NR	7E-6	5.154901959985743		0.4	[0.26-0.59]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Exemestane induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	201 White ancestry individuals	NA											chr8:104720276-?	chr8:104720276	0			1	NR	4E-6	5.3979400086720375		4.65	[2.41-8.95]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134418	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr8:52903681-?	chr8:52903681	0			1	NR	5E-7	6.301029995663981		4.55	[2.52-8.22]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr9:16287769-?	chr9:16287769	0			1	NR	2E-7	6.698970004336019		5.09	[2.75-9.42]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr9:19156592-?	chr9:19156592	0			1	NR	3E-6	5.522878745280337		0.19	[0.09-0.38]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr10:4766939-?	chr10:4766939	0			1	NR	4E-6	5.3979400086720375		3.01	[1.89-4.8]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr10:122720383-?	chr10:122720383	0			1	NR	5E-7	6.301029995663981		4.63	[2.54-8.43]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr11:34220894-?	chr11:34220894	0			1	NR	2E-6	5.698970004336019		5.22	[2.64-10.31]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr12:2024092-?	chr12:2024092	0			1	NR	1E-5	5		3.37	[1.97-5.77]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr13:37841344-?	chr13:37841344	0			1	NR	3E-8	7.522878745280337		5.91	[3.16-11.06]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr14:20863677-?	chr14:20863677	0			1	NR	6E-7	6.221848749616356		3.06	[1.97-4.75]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr17:4967826-?	chr17:4967826	0			1	NR	3E-6	5.522878745280337		3.1	[1.93-4.99]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr17:46096126-?	chr17:46096126	0			1	NR	9E-6	5.045757490560675		2.75	[1.76-4.3]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr17:72469172-?	chr17:72469172	0			1	NR	3E-6	5.522878745280337		3.26	[1.98-5.36]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr21:46924977-?	chr21:46924977	0			1	NR	1E-6	6		4.59	[2.47-8.52]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chr22:25384365-?	chr22:25384365	0			1	NR	8E-6	5.096910013008056		4.13	[2.21-7.7]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chrX:88743847-?	chrX:88743847	0			1	NR	6E-6	5.221848749616356		7.42	[3.13-17.61]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
9/8/2022	35776183	Hertz DL	7/1/2022	Support Care Cancer	www.ncbi.nlm.nih.gov/pubmed/35776183	Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.	Letrozole induced musculoskeletal syndrome in HR+ non-metastatic breast cancer	319 White ancestry individuals	NA											chrX:144162142-?	chrX:144162142	0			1	NR	7E-6	5.154901959985743		3.54	[2.04-6.14]	NR [NR] (imputed)	N	"musculoskeletal system disease, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0009676, http://purl.obolibrary.org/obo/GO_0061477"	GCST90134419	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor positive)	"4,299 African ancestry cases, 10,193 African ancestry controls, 69,501 European ancestry cases, 105,974 European ancestry controls"	NA	1p13.3	1	109637134		AMPD2 - RPL7P8	ENSG00000116337	ENSG00000235045		5083	14236	rs17024629-T	rs17024629	0	17024629	intergenic_variant	1	0.16	1E-6	6		0.95	[0.93-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST90026462	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor positive)	"4,299 African ancestry cases, 10,193 African ancestry controls, 69,501 European ancestry cases, 105,974 European ancestry controls"	NA	5q31.1	5	132466255		"IRF1-AS1, IRF1"			"ENSG00000197536, ENSG00000125347"			rs2522057-C	rs2522057	0	2522057	intron_variant	0	0.6	3E-7	6.522878745280337		0.96	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST90026462	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor positive)	"4,299 African ancestry cases, 10,193 African ancestry controls, 69,501 European ancestry cases, 105,974 European ancestry controls"	NA	15q24.1	15	74854991		SCAMP2			ENSG00000140497			rs1869959-A	rs1869959	0	1869959	intron_variant	0	0.3	6E-8	7.221848749616356		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST90026462	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor negative)	"2,636 African ancestry cases, 10,193 African ancestry controls, 21,468 European ancestry cases, 105,974 European ancestry controls"	NA	1q41	1	215243092		KCNK2 - VDAC1P10	ENSG00000082482	ENSG00000232809		6002	133392	rs5780828-TA	rs5780828	0	5780828	intergenic_variant	1	NR	2E-6	5.698970004336019	(conditioned on rs67931591)	0.94	[0.92-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST90026463	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor negative)	"2,636 African ancestry cases, 10,193 African ancestry controls, 21,468 European ancestry cases, 105,974 European ancestry controls"	NA	1q41	1	215156950		KCNK2			ENSG00000082482			rs67931591-G	rs67931591	0	67931591	intron_variant	0	0.65	4E-8	7.3979400086720375		0.94	[0.92-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST90026463	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor negative)	"2,636 African ancestry cases, 10,193 African ancestry controls, 21,468 European ancestry cases, 105,974 European ancestry controls"	NA	7q11.23	7	74944369		SPDYE12 - CASTOR2	ENSG00000184616	ENSG00000274070		29291	20336	rs1637365-T	rs1637365	0	1637365	intergenic_variant	1	0.32	1E-8	8		1.08	[1.05-1.11]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST90026463	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor negative)	"21,468 European ancestry cases, 105,974 European ancestry controls"	NA	1q41	1	215156950		KCNK2			ENSG00000082482			rs67931591-G	rs67931591	0	67931591	intron_variant	0	0.68	5E-7	6.301029995663981		0.94	[0.92-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST90026469	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer (estrogen-receptor negative)	"21,468 European ancestry cases, 105,974 European ancestry controls"	NA	7q11.23	7	74944369		SPDYE12 - CASTOR2	ENSG00000184616	ENSG00000274070		29291	20336	rs1637365-T	rs1637365	0	1637365	intergenic_variant	1	0.28	9E-7	6.045757490560675		1.07	[1.04-1.1]	"Affymetrix, Illumina [NR] (imputed)"	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST90026469	Genome-wide genotyping array				
6/16/2020	31904872	Chou WC	1/6/2020	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	1q24.2	1	168570139	"MCF-7,T47D"	XCL2 - XCL1	ENSG00000143185	ENSG00000143184		26142	6466	rs76462307-?	rs76462307	0	76462307	intergenic_variant	1	NR	1E-6	6				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array				
6/16/2020	31904872	Chou WC	1/6/2020	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	3q13.31	3	116561041	intergenic	"LSAMP, LINC00903"			"ENSG00000185565, ENSG00000241397"			rs1401069-?	rs1401069	0	1401069	intron_variant	0	NR	5E-7	6.301029995663981				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array				
6/16/2020	31904872	Chou WC	1/6/2020	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	6p12.3	6	46573494	intergenic	"CYP39A1, RCAN2-DT"			"ENSG00000146233, ENSG00000236466"			rs2178052-?	rs2178052	0	2178052	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array				
6/16/2020	31904872	Chou WC	1/6/2020	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	11q23.3	11	121289351	intergenic	RPS4XP12 - SC5D	ENSG00000244400	ENSG00000109929		38373	3330	rs1560409-?	rs1560409	0	1560409	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA				LOC100506029							chr1:101579551-A	chr1:101579551	0			1	0.1747	6E-6	5.221848749616356		0.322	[0.18-0.46] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	14q24.2	14	70423423	"ADAM21, LOC105370555, C14orf55"	ADAM21			ENSG00000139985			rs12586722-A	rs12586722	0	12586722	intron_variant	0	0.155	1E-6	6		0.3	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	GCST004362	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	14q24.2	14	70452982	PLEKHD1	ADAM21			ENSG00000139985			rs8014252-G	rs8014252	0	8014252	intron_variant	0	0.1556	2E-6	5.698970004336019		0.2981	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	GCST004362	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	19p13.12	19	14774988	"EMR2, ADGRE2"	ADGRE2			ENSG00000127507			rs57712673-A	rs57712673	0	57712673	intron_variant	0	0.349	1E-7	7		0.36	[0.23-0.49] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	7p14.2	7	36899717	ELMO1	ELMO1			ENSG00000155849			rs59964204-A	rs59964204	0	59964204	intron_variant	0	0.096	3E-7	6.522878745280337		0.45	[0.28-0.62] pg/mL decrease	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	10q23.2	10	86667452	LDB3	LDB3			ENSG00000122367			rs34346910-C	rs34346910	0	34346910	intron_variant	0	0.111	6E-7	6.221848749616356		0.49	[0.3-0.68] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	8q24.3	8	142925688	"LOC100288248, CYP11B2"	CYP11B2 - LY6E-DT	ENSG00000179142	ENSG00000247317		7845	56050	rs6988985-C	rs6988985	0	6988985	intergenic_variant	1	0.461	7E-7	6.154901959985743		0.25	[0.15-0.35] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	10p14	10	8346355	LOC100507143	LINC00708 - KRT8P37	ENSG00000232170	ENSG00000213771		78013	167332	rs7075481-G	rs7075481	0	7075481	intergenic_variant	1	0.1279	8E-7	6.096910013008056		0.3776	[0.23-0.53] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	12p12.1	12	21178615	SLCO1B1	SLCO1B1			ENSG00000134538			rs4149056-C	rs4149056	0	4149056	missense_variant	0	0.136	4E-11	10.397940008672037		0.5	[0.35-0.65] pg/mL increase	Illumina [8203257] (imputed)	N	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	GCST004359	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	12p12.1	12	21215863	SLCO1B1	SLCO1B1			ENSG00000134538			rs2900478-A	rs2900478	0	2900478	intron_variant	0	0.14	7E-10	9.154901959985743		0.48	[0.33-0.63] pg/mL increase	Illumina [8203257] (imputed)	N	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	GCST004359	Genome-wide genotyping array				
3/25/2021	32701512	Cairns J	7/23/2020	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	11q14.1	11	83983729	DLG2	DLG2			ENSG00000150672			rs2449598-A	rs2449598	0	2449598	intron_variant	0	0.4808	2E-10	9.698970004336019		0.4897	[0.34-0.64] unit decrease	Illumina [up to 8000000] (imputed)	N	"estrogen measurement, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477"	GCST011407	Genome-wide genotyping array				
3/25/2021	32701512	Cairns J	7/23/2020	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	16q21	16	64410685	CDH11	LINC02165 - PPIAP48	ENSG00000261014	ENSG00000260187		654801	325240	rs1437153-G	rs1437153	0	1437153	intron_variant	1	0.0618	3E-9	8.522878745280337		0.4028	[0.27-0.53] unit decrease	Illumina [up to 8000000] (imputed)	N	"estrogen measurement, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477"	GCST011407	Genome-wide genotyping array				
3/25/2021	32701512	Cairns J	7/23/2020	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-?	rs6981827	0	6981827	intron_variant	0	NR	2E-8	7.698970004336019	(estradiol)			Illumina [up to 8000000] (imputed)	N	"estrogen measurement, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477"	GCST011407	Genome-wide genotyping array				
3/25/2021	32701512	Cairns J	7/23/2020	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-?	rs6981827	0	6981827	intron_variant	0	NR	2E-8	7.698970004336019	(estrone)			Illumina [up to 8000000] (imputed)	N	"estrogen measurement, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477"	GCST011407	Genome-wide genotyping array				
3/25/2021	32701512	Cairns J	7/23/2020	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-C	rs6981827	0	6981827	intron_variant	0	0.0502	2E-8	7.698970004336019	(estrone and estradiol)	0.5978	[0.39-0.8] unit decrease	Illumina [up to 8000000] (imputed)	N	"estrogen measurement, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477"	GCST011407	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	1p31.1	1	76397851	NR	ST6GALNAC3			ENSG00000184005			rs4369272-G	rs4369272	0	4369272	intron_variant	0	0.2554	5E-6	5.301029995663981		0.2719	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	18q22.3	18	72975319	NR	NETO1-DT - LINC02864	ENSG00000263958	ENSG00000263711		93915	175922	rs9945951-A	rs9945951	0	9945951	intergenic_variant	1	0.0126	4E-6	5.3979400086720375		2.0573	[1.19-2.93] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232353879	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2570	24845	rs6715187-G	rs6715187	0	6715187	intergenic_variant	1	0.1826	8E-8	7.096910013008056		0.3644	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232355544	intergenic	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		4235	23180	rs28845026-T	rs28845026	0	28845026	intergenic_variant	1	0.1987	5E-8	7.301029995663981		0.3673	[0.24-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232353552	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2243	25172	rs6729965-C	rs6729965	0	6729965	intergenic_variant	1	0.183	9E-8	7.045757490560675		0.3641	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	7q11.22	7	71535629	NR	GALNT17			ENSG00000185274			rs6460664-C	rs6460664	0	6460664	intron_variant	0	0.3768	2E-6	5.698970004336019		0.2535	[0.15-0.36] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2p21	2	42794053	NR	HAAO - FTOP1	ENSG00000162882	ENSG00000226491		1460	3172	rs1065643-G	rs1065643	0	1065643	intron_variant	1	0.09075	1E-6	6		0.4449	[0.27-0.62] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	10p11.23	10	29653623	NR	SVIL			ENSG00000197321			rs77628230-T	rs77628230	0	77628230	intron_variant	0	0.0278	5E-7	6.301029995663981		0.7739	[0.48-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	5p15.31	5	9317600	NR	SEMA5A			ENSG00000112902			rs12658330-G	rs12658330	0	12658330	intron_variant	0	0.0207	5E-6	5.301029995663981		0.902	[0.52-1.28] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	15q26.3	15	99507178	NR	LINC03080 - RPL7P5	ENSG00000259341	ENSG00000241562		72018	44204	rs8038589-T	rs8038589	0	8038589	TF_binding_site_variant	1	0.0206	3E-6	5.522878745280337		0.9179	[0.54-1.3] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	7q22.3	7	105858521	NR	ATXN7L1			ENSG00000146776			rs62482803-A	rs62482803	0	62482803	intron_variant	0	0.2132	3E-6	5.522878745280337		0.3058	[0.18-0.43] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	7q11.22	7	71534157	NR	GALNT17			ENSG00000185274			rs11769266-G	rs11769266	0	11769266	intron_variant	0	0.3817	3E-6	5.522878745280337		0.2495	[0.15-0.35] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	7q11.22	7	71534123	NR	GALNT17			ENSG00000185274			rs4557585-G	rs4557585	0	4557585	intron_variant	0	0.3817	3E-6	5.522878745280337		0.2495	[0.15-0.35] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	10p11.23	10	29652692	NR	SVIL			ENSG00000197321			rs80082057-T	rs80082057	0	80082057	intron_variant	0	0.0276	5E-7	6.301029995663981		0.7723	[0.47-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	10p11.23	10	29647954	NR	SVIL			ENSG00000197321			rs75690380-G	rs75690380	0	75690380	intron_variant	0	0.0277	6E-7	6.221848749616356		0.7692	[0.47-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	20p11.23	20	20984347	NR	LINC03083 - LINC00237	ENSG00000234104	ENSG00000225127		11785	101229	rs6106324-C	rs6106324	0	6106324	intergenic_variant	1	0.381	5E-6	5.301029995663981		0.2473	[0.14-0.35] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232350693	intergenic	ECEL1P3			ENSG00000230122			rs883013-T	rs883013	0	883013	intron_variant	0	0.1854	6E-8	7.221848749616356		0.3644	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58678226	NR	SLC38A7			ENSG00000103042			rs2280398-T	rs2280398	0	2280398	intron_variant	0	0.1213	2E-6	5.698970004336019		0.3795	[0.23-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232353782	intergenic	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2473	24942	rs6715083-T	rs6715083	0	6715083	intergenic_variant	1	0.1824	8E-8	7.096910013008056		0.3649	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58677628	NR	SLC38A7			ENSG00000103042			rs2280399-A	rs2280399	0	2280399	intron_variant	0	0.1214	2E-6	5.698970004336019		0.3752	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58661235	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		31350	3874	rs60979655-T	rs60979655	0	60979655	regulatory_region_variant	1	0.1129	5E-8	7.301029995663981		0.4378	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58659688	NR	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		29803	5421	rs60388585-C	rs60388585	0	60388585	intergenic_variant	1	0.1454	3E-6	5.522878745280337		0.3447	[0.2-0.49] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58673724	NR	SLC38A7			ENSG00000103042			rs59234479-A	rs59234479	0	59234479	intron_variant	0	0.1178	3E-6	5.522878745280337		0.3738	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58697980	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		13210	9151	rs11647748-G	rs11647748	0	11647748	intergenic_variant	1	0.1185	3E-6	5.522878745280337		0.3743	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	18q22.3	18	72975302	NR	NETO1-DT - LINC02864	ENSG00000263958	ENSG00000263711		93898	175939	rs9945654-G	rs9945654	0	9945654	intergenic_variant	1	0.0124	4E-6	5.3979400086720375		2.0652	[1.2-2.93] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	1p31.1	1	76398384	NR	ST6GALNAC3			ENSG00000184005			rs4949715-A	rs4949715	0	4949715	intron_variant	0	0.2557	5E-6	5.301029995663981		0.2716	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	1p31.1	1	76398018	NR	ST6GALNAC3			ENSG00000184005			rs4342892-A	rs4342892	0	4342892	intron_variant	0	0.2555	5E-6	5.301029995663981		0.272	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232353864	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2555	24860	rs6715387-A	rs6715387	0	6715387	intergenic_variant	1	0.1829	9E-8	7.045757490560675		0.3641	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	5q23.2	5	126041980	NR	RPSAP37 - LINC02039	ENSG00000241888	ENSG00000248107		73895	137585	rs12518356-G	rs12518356	0	12518356	intron_variant	1	0.3123	4E-6	5.3979400086720375		0.2618	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232352849	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		1540	25875	rs55738617-T	rs55738617	0	55738617	regulatory_region_variant	1	0.1812	9E-8	7.045757490560675		0.3646	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	8q22.1	8	97892687	NR	MATN2			ENSG00000132561			rs4489302-C	rs4489302	0	4489302	intron_variant	0	0.0143	3E-6	5.522878745280337		1.3599	[0.8-1.92] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	5q23.2	5	126046631	NR	RPSAP37 - LINC02039	ENSG00000241888	ENSG00000248107		78546	132934	rs10519881-G	rs10519881	0	10519881	intron_variant	1	0.3156	4E-6	5.3979400086720375		0.2607	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	12q23.1	12	96161387	NR	LINC02452			ENSG00000283422			rs77034926-A	rs77034926	0	77034926	non_coding_transcript_exon_variant	0	0.1805	2E-6	5.698970004336019		0.3403	[0.2-0.48] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	5q23.2	5	126045975	NR	RPSAP37 - LINC02039	ENSG00000241888	ENSG00000248107		77890	133590	rs7724529-T	rs7724529	0	7724529	intron_variant	1	0.3159	5E-6	5.301029995663981		0.2597	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58662802	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		32917	2307	rs11648166-G	rs11648166	0	11648166	regulatory_region_variant	1	0.1178	2E-8	7.698970004336019		0.4401	[0.29-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	18q23	18	76553300	NR	LINC00683			ENSG00000266256			rs62112924-A	rs62112924	0	62112924	intron_variant	0	0.033	2E-6	5.698970004336019		1.188	[0.7-1.67] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	19p13.2	19	8857556	NR	MUC16			ENSG00000181143			rs76164207-A	rs76164207	0	76164207	intron_variant	0	0.1655	4E-6	5.3979400086720375		0.4204	[0.24-0.6] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	10p11.23	10	29655323	NR	SVIL			ENSG00000197321			rs78721916-T	rs78721916	0	78721916	intron_variant	0	0.0224	2E-6	5.698970004336019		0.8776	[0.52-1.23] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58669872	NR	SLC38A7			ENSG00000103042			rs12598355-C	rs12598355	0	12598355	intron_variant	0	0.1193	1E-7	7		0.4221	[0.27-0.58] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58673228	NR	SLC38A7			ENSG00000103042			rs11639682-A	rs11639682	0	11639682	intron_variant	0	0.1204	8E-7	6.096910013008056		0.3938	[0.24-0.55] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	2q37.1	2	232350750	intergenic	ECEL1P3			ENSG00000230122			rs4996188-A	rs4996188	0	4996188	intron_variant	0	0.1851	7E-8	7.154901959985743		0.3631	[0.23-0.49] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58698951	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		14181	8180	rs11643617-C	rs11643617	0	11643617	regulatory_region_variant	1	0.1234	2E-6	5.698970004336019		0.3767	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58669712	SLC38A7	SLC38A7			ENSG00000103042			rs3784911-T	rs3784911	0	3784911	intron_variant	0	0.1191	4E-8	7.3979400086720375		0.4353	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58701769	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		16999	5362	rs73549255-A	rs73549255	0	73549255	intergenic_variant	1	0.1236	2E-6	5.698970004336019		0.3777	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58670592	SLC38A7	SLC38A7			ENSG00000103042			rs16960359-A	rs16960359	0	16960359	intron_variant	0	0.1189	5E-8	7.301029995663981		0.4324	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58668637	SLC38A7	SLC38A7			ENSG00000103042			rs76733922-C	rs76733922	0	76733922	intron_variant	0	0.1213	6E-8	7.221848749616356		0.4257	[0.27-0.58] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
4/29/2019	30648747	Dudenkov TM	1/16/2019	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	"634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals"	NA	16q21	16	58657060	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		27175	8049	rs12149056-A	rs12149056	0	12149056	intergenic_variant	1	0.1162	7E-8	7.154901959985743		0.4341	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array				
9/22/2015	25526632	Rafiq S	12/19/2014	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	"1,341 European ancestry cases"	"1,523 European ancestry cases"	16q24.1	16	86400840	"LOC732275, FOXF1"	LINC00917 - FENDRR	ENSG00000168367	ENSG00000268388		51152	73689	rs1728400-?	rs1728400	0	1728400	intergenic_variant	1	NR	6E-6	5.221848749616356		1.25	[1.13-1.39]	Illumina [6500000] (imputed)	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002727	Genome-wide genotyping array				
9/22/2015	25526632	Rafiq S	12/19/2014	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	"1,341 European ancestry cases"	"1,523 European ancestry cases"	10p14	10	11806793	"C10orf47, ECHDC3"	ECHDC3 - PROSER2	ENSG00000134463	ENSG00000148426		42723	16546	rs12358475-?	rs12358475	0	12358475	intergenic_variant	1	NR	2E-6	5.698970004336019		1.33	[1.19-1.49]	Illumina [6500000] (imputed)	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002727	Genome-wide genotyping array				
9/22/2015	25526632	Rafiq S	12/19/2014	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25526632	A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.	Breast cancer (survival)	"1,341 European ancestry cases"	"1,523 European ancestry cases"	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LDHBP3	ENSG00000248826	ENSG00000248950		134967	861311	rs421379-?	rs421379	0	421379	intergenic_variant	1	NR	1E-6	6		1.49	[1.27-1.75]	Illumina [6500000] (imputed)	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002727	Genome-wide genotyping array				
4/10/2014	24143190	Low SK	10/15/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	"2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls"	"2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls"	10q26.13	10	121580797	FGFR2	FGFR2			ENSG00000066468			rs2981578-C	rs2981578	0	2981578	intron_variant	0	0.514	1E-12	12		1.225	[1.158-1.296]	Illumina [5335291] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002234	Genome-wide genotyping array				
4/10/2014	24143190	Low SK	10/15/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	"2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls"	"2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls"	16q12.2	16	52601088	"TOX3, LOC643714"	CASC16			ENSG00000249231			rs12922061-T	rs12922061	0	12922061	intron_variant	0	0.241	4E-10	9.397940008672037		1.231	[1.153-1.314]	Illumina [5335291] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002234	Genome-wide genotyping array				
4/10/2014	24143190	Low SK	10/15/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	"2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls"	"2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls"	16q12.1	16	52552429	"TOX3, LOC643714"	CASC16			ENSG00000249231			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.522	3E-11	10.522878745280337		1.213	[1.146-1.284]	Illumina [5335291] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002234	Genome-wide genotyping array				
4/10/2014	24143190	Low SK	10/15/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24143190	Genome-wide association study of breast cancer in the Japanese population.	Breast cancer	"2,642 Japanese ancestry cases, 2,099 Japanese ancestry controls"	"2,885 Japanese ancestry cases, 3,395 Japanese ancestry controls"	12p13.1	12	14257551	ATF7IP	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		2325	99291	rs17221259-G	rs17221259	0	17221259	regulatory_region_variant	1	0.204	7E-6	5.154901959985743		1.252	[1.136-1.381]	Illumina [5335291] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002234	Genome-wide genotyping array				
11/6/2012	22951594	Elgazzar S	9/6/2012	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	"1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls"	"1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls"	3q25.1	3	150750021	SIAH2	SIAH2			ENSG00000181788			rs6788895-G	rs6788895	0	6788895	intron_variant	0	0.65	9E-8	7.045757490560675		1.22	[1.13-1.31]	Illumina [453627]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001667	Genome-wide genotyping array				
11/6/2012	22951594	Elgazzar S	9/6/2012	J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22951594	A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.	Breast cancer	"1,086 Japanese ancestry cases, 1,816 Japanese ancestry controls"	"1,653 Japanese ancestry cases, 2,797 Japanese ancestry controls"	10q26.13	10	121573063	FGFR2	FGFR2			ENSG00000066468			rs3750817-T	rs3750817	0	3750817	intron_variant	0	0.49	8E-8	7.096910013008056		1.22	[NR]	Illumina [453627]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001667	Genome-wide genotyping array				
2/28/2009	19219042	Zheng W	2/15/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19219042	Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.	Breast cancer	"1,505 Chinese ancestry cases, 1,522 Chinese ancestry controls"	"5,026 Chinese ancestry cases, 2,476 Chinese ancestry controls, 1,591 European ancestry cases, 1,466 European ancestry controls"	6q25.1	6	151627231	"ESR1, C6orf97"	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	0.37	2E-15	14.698970004336019		1.29	[1.21-1.37]	Affymetrix [up to 607728]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000343	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	2p16.1	2	59272212	intergenic	LINC01793			ENSG00000222030			rs10490113-?	rs10490113	0	10490113	intron_variant	0	NR	5E-6	5.301029995663981				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	15q21.1	15	48608389	FBN1	FBN1			ENSG00000166147			rs1876206-?	rs1876206	0	1876206	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	12q21.1	12	73596057	intergenic	LINC02444 - RPL31P48	ENSG00000258123	ENSG00000243164		387740	52609	rs1154865-?	rs1154865	0	1154865	intergenic_variant	1	NR	7E-7	6.154901959985743				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	18q21.2	18	55997051	intergenic	LINC01416			ENSG00000260930			rs1978503-?	rs1978503	0	1978503	non_coding_transcript_exon_variant	0	NR	1E-6	6				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	7q11.22	7	67594280	intergenic	STAG3L4 - MTATP6P21	ENSG00000291153	ENSG00000226392		231330	33551	rs10263639-?	rs10263639	0	10263639	intergenic_variant	1	NR	3E-6	5.522878745280337				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	17q21.33	17	50196930	COL1A1	COL1A1			ENSG00000108821			rs2075555-?	rs2075555	0	2075555	intron_variant	0	NR	8E-8	7.096910013008056				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	21q21.3	21	29805194	GRIK1	GRIK1			ENSG00000171189			rs458685-?	rs458685	0	458685	intron_variant	0	NR	6E-6	5.221848749616356				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	5q34	5	164462274	intergenic	"LINC02143, LINC03000"			"ENSG00000253236, ENSG00000241956"			rs6556756-?	rs6556756	0	6556756	intron_variant	0	NR	5E-7	6.301029995663981				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
9/10/2008	17903305	Murabito JM	9/19/2007	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	"58 cases, 665 controls"	NA	13q32.1	13	95222702	ABCC4	ABCC4			ENSG00000125257			rs1926657-?	rs1926657	0	1926657	intron_variant	0	NR	2E-6	5.698970004336019				Affymetrix [70897]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000079	Genome-wide genotyping array				
10/14/2008	18463975	Kibriya MG	5/8/2008	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/18463975	A pilot genome-wide association study of early-onset breast cancer.	Breast cancer	"26 European ancestry cases, 3 Hispanic cases, 1 African American case, 26 European ancestry controls, 3 Hispanic controls, 1 African American control"	NA	16q23.1	16	74438798	GLG1	CLEC18B - GLG1; No mapped genes; No mapped genes						rs10871290-?; SNP_A-2032347-?; SNP_A-2196879-?	rs10871290; SNP_A-2032347; SNP_A-2196879	0	10871290; SNP_A-2032347; SNP_A-2196879	intron_variant		0.34	4E-7	6.3979400086720375				Affymetrix [200220]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000187	Genome-wide genotyping array				
2/14/2012	22232737	Shu XO	1/9/2012	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	"1,950 Chinese ancestry cases"	"4,160 Chinese ancestry cases"	16q22.3	16	73405456	intergenic	"LINC01568, ZFHX3"			"ENSG00000258779, ENSG00000140836"			rs9934948-C	rs9934948	0	9934948	intron_variant	0	NR	6E-6	5.221848749616356	(Total Mortality)	1.29	[1.16-1.44]	Affymetrix [613031]	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST001373	Genome-wide genotyping array				
2/14/2012	22232737	Shu XO	1/9/2012	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	"1,950 Chinese ancestry cases"	"4,160 Chinese ancestry cases"	14q24.1	14	68283210	RAD51L1	RAD51B			ENSG00000182185			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	1E-7	7	(Total Mortality)	1.49	[1.28-1.72]	Affymetrix [613031]	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST001373	Genome-wide genotyping array				
2/14/2012	22232737	Shu XO	1/9/2012	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22232737	Novel genetic markers of breast cancer survival identified by a genome-wide association study.	Breast cancer (survival)	"1,950 Chinese ancestry cases"	"4,160 Chinese ancestry cases"	14q24.1	14	68283210	RAD51L1	RAD51B			ENSG00000182185			rs3784099-A	rs3784099	0	3784099	intron_variant	0	NR	3E-7	6.522878745280337	(Recurrence)	1.43	[1.25-1.64]	Affymetrix [613031]	N	"event free survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST001373	Genome-wide genotyping array				
4/13/2011	21424380	Sehrawat B	3/19/2011	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	"302 European ancestry female cases, 321 European ancestry female controls"	"1,153 European ancestry female cases, 1,215 European ancestry female controls"	5p15.2	5	10467590	ROPN1L	ROPN1L			ENSG00000145491			rs1092913-T	rs1092913	0	1092913	intron_variant	0	0.13	2E-6	5.698970004336019		1.45	[1.24-1.69]	Affymetrix [782838]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001012	Genome-wide genotyping array				
4/13/2011	21424380	Sehrawat B	3/19/2011	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/21424380	Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.	Breast cancer	"302 European ancestry female cases, 321 European ancestry female controls"	"1,153 European ancestry female cases, 1,215 European ancestry female controls"	19q13.41	19	51869723	ZNF577	ZNF577			ENSG00000161551			rs10411161-T	rs10411161	0	10411161	3_prime_UTR_variant	0	0.13	7E-6	5.154901959985743		1.42	[1.22-1.65]	Affymetrix [782838]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001012	Genome-wide genotyping array				
3/26/2013	23319801	Rafiq S	1/14/2013	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	"1,516 European ancestry early-onset cases"	1p13.2	1	114128347	SYT6	SYT6			ENSG00000134207			rs2774307-?	rs2774307	0	2774307	intron_variant	0	0.26	8E-6	5.096910013008056		1.3	[1.16-1.47]	Illumina [487496]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001816	Genome-wide genotyping array				
3/26/2013	23319801	Rafiq S	1/14/2013	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	"1,516 European ancestry early-onset cases"	1q23.3	1	164720525	PBX1	PBX1			ENSG00000185630			rs1387389-?	rs1387389	0	1387389	intron_variant	0	0.36	4E-6	5.3979400086720375		1.28	[1.16-1.43]	Illumina [487496]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001816	Genome-wide genotyping array				
3/26/2013	23319801	Rafiq S	1/14/2013	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	"1,516 European ancestry early-onset cases"	5q14.3	5	91979496	ARRDC3	PCBP2P3 - LDHBP3	ENSG00000248826	ENSG00000248950		134967	861311	rs421379-?	rs421379	0	421379	intergenic_variant	1	0.05	1E-6	6		1.61	[1.33-1.96]	Illumina [487496]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001816	Genome-wide genotyping array				
3/26/2013	23319801	Rafiq S	1/14/2013	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	"1,516 European ancestry early-onset cases"	15q22.2	15	61410580	RORa	RORA - LINC02349	ENSG00000069667	ENSG00000259284		181278	319185	rs3884558-?	rs3884558	0	3884558	intron_variant	1	0.07	4E-6	5.3979400086720375		1.46	[1.24-1.72]	Illumina [487496]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001816	Genome-wide genotyping array				
3/26/2013	23319801	Rafiq S	1/14/2013	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/23319801	Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.	Breast cancer (prognosis)	536 European ancestry early-onset cases	"1,516 European ancestry early-onset cases"	17p13.1	17	9186907	NTN1	NTN1			ENSG00000065320			rs3785982-?	rs3785982	0	3785982	intron_variant	0	0.12	8E-6	5.096910013008056		1.4	[1.21-1.62]	Illumina [487496]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001816	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA											chr10:123340431-GC	chr10:123340431	0			1	NR	3E-104	103.52287874528034		1.2751	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA											chr9:110303808-T	chr9:110303808	0			1	NR	4E-10	9.397940008672037		1.0912265	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA											chr17:44184819-CAAAGGT	chr17:44184819	0			1	NR	2E-10	9.698970004336019		1.0906	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA											chr10:22336421-C	chr10:22336421	0			1	NR	2E-8	7.698970004336019		1.2640626	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
12/1/2021	34737426	Jiang L	11/4/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737426	A generalized linear mixed model association tool for biobank-scale data.	"Cancer code, self-reported: breast cancer (UKB data field 20001_1002)"	"10,152 European ancestry cases, 446,124 European ancestry controls"	NA	5p12	5	44917420		MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		96992	337528	rs182431363-C	rs182431363	0	182431363	intergenic_variant	1	0.003063	4E-10	9.397940008672037		0.9	[0.62-1.18] unit increase	NR [11842647] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90041886	Genome-wide genotyping array				
9/2/2021	34018994	Xu JK	3/22/2021	Chin Med J (Engl)	www.ncbi.nlm.nih.gov/pubmed/34018994	Genome-wide long non-coding RNA association study on Han Chinese women identifies lncHSAT164 as a novel susceptibility gene for breast cancer.	Breast cancer	"1,496 Han Chinese ancestry cases, 1,257 Han Chinese ancestry controls"	"4,138 Han Chinese ancestry cases, 5,051 Han Chinese ancestry controls"	6q25.1	6	151630085	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		8892	26606	rs9397435-?	rs9397435	0	9397435	regulatory_region_variant	1	NR	4E-38	37.39794000867204		1.41	[1.32-1.50]	Illumina [up to 800000]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST012281	Targeted genotyping array				
9/2/2021	34018994	Xu JK	3/22/2021	Chin Med J (Engl)	www.ncbi.nlm.nih.gov/pubmed/34018994	Genome-wide long non-coding RNA association study on Han Chinese women identifies lncHSAT164 as a novel susceptibility gene for breast cancer.	Breast cancer	"1,496 Han Chinese ancestry cases, 1,257 Han Chinese ancestry controls"	"4,138 Han Chinese ancestry cases, 5,051 Han Chinese ancestry controls"	12q24.13	12	112080999	NR	NAA25			ENSG00000111300			rs11066150-?	rs11066150	0	11066150	intron_variant	0	NR	2E-8	7.698970004336019		1.13	[1.07-1.20]	Illumina [up to 800000]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST012281	Targeted genotyping array				
9/2/2021	34018994	Xu JK	3/22/2021	Chin Med J (Engl)	www.ncbi.nlm.nih.gov/pubmed/34018994	Genome-wide long non-coding RNA association study on Han Chinese women identifies lncHSAT164 as a novel susceptibility gene for breast cancer.	Breast cancer	"1,496 Han Chinese ancestry cases, 1,257 Han Chinese ancestry controls"	"4,138 Han Chinese ancestry cases, 5,051 Han Chinese ancestry controls"	22q12.2	22	30027471	NR	"HORMAD2-AS1, MTMR3"			"ENSG00000227117, ENSG00000100330"			rs12537-?	rs12537	0	12537	3_prime_UTR_variant	0	NR	9E-7	6.045757490560675		0.88	[0.82-0.95]	Illumina [up to 800000]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST012281	Targeted genotyping array				
9/2/2021	34018994	Xu JK	3/22/2021	Chin Med J (Engl)	www.ncbi.nlm.nih.gov/pubmed/34018994	Genome-wide long non-coding RNA association study on Han Chinese women identifies lncHSAT164 as a novel susceptibility gene for breast cancer.	Breast cancer	"1,496 Han Chinese ancestry cases, 1,257 Han Chinese ancestry controls"	"4,138 Han Chinese ancestry cases, 5,051 Han Chinese ancestry controls"	19q13.33	19	50659499	NR	SHANK1			ENSG00000161681			rs62112521-?	rs62112521	0	62112521	3_prime_UTR_variant	0	NR	9E-6	5.045757490560675		0.92	[0.87-0.98]	Illumina [up to 800000]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST012281	Targeted genotyping array				
6/22/2022	35267517	Barnekow E	2/25/2022	Cancers (Basel)	www.ncbi.nlm.nih.gov/pubmed/35267517	"A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16."	Breast cancer	"3,200 Swedish ancestry cases, 5,021 Swedish ancestry controls"	NA	10q26.13	10	121577603		FGFR2			ENSG00000066468			rs2912780-?	rs2912780	0	2912780	intron_variant	0	NR	2E-20	19.69897000433602		1.36	[1.27-1.45]	Illumina [332906] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90104709	Genome-wide genotyping array				
6/22/2022	35267517	Barnekow E	2/25/2022	Cancers (Basel)	www.ncbi.nlm.nih.gov/pubmed/35267517	"A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16."	Breast cancer	"3,200 Swedish ancestry cases, 5,021 Swedish ancestry controls"	NA	11q13.3	11	69513996		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		19044	127160	rs614367-?	rs614367	0	614367	intergenic_variant	1	NR	5E-10	9.301029995663981		1.31	[1.2-1.42]	Illumina [332906] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90104709	Genome-wide genotyping array				
6/22/2022	35267517	Barnekow E	2/25/2022	Cancers (Basel)	www.ncbi.nlm.nih.gov/pubmed/35267517	"A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16."	Breast cancer	"3,200 Swedish ancestry cases, 5,021 Swedish ancestry controls"	NA	16q12.1	16	52526301		TOX3			ENSG00000103460			rs12918816-?	rs12918816	0	12918816	intron_variant	0	NR	3E-18	17.522878745280337		1.37	[1.27-1.47]	Illumina [332906] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90104709	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	17q11.2	17	30884649		ATAD5			ENSG00000176208			rs7223535-A	rs7223535	0	7223535	intron_variant	0	NR	3E-15	14.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	20q13.33	20	63745150		"ZBTB46-AS2, ZBTB46"			"ENSG00000229299, ENSG00000130584"			rs2281925-A	rs2281925	0	2281925	3_prime_UTR_variant	0	NR	5E-8	7.301029995663981				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	22q13.1	22	40029970		FAM83F			ENSG00000133477			rs3752470-A	rs3752470	0	3752470	3_prime_UTR_variant	0	NR	1E-10	10				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	22q13.1	22	40322096		TNRC6B			ENSG00000100354			rs4821942-A	rs4821942	0	4821942	intron_variant	0	NR	6E-30	29.221848749616356				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	1p13.3	1	109687477		GSTM2			ENSG00000213366			rs4147562-A	rs4147562	0	4147562	intron_variant	0	NR	3E-9	8.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	1q43	1	241860596		EXO1			ENSG00000174371			rs4149909-A	rs4149909	0	4149909	missense_variant	0	NR	9E-15	14.045757490560675				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	2p11.2	2	88647093		EIF2AK3			ENSG00000172071			rs13001657-A	rs13001657	0	13001657	intron_variant	0	NR	2E-8	7.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	2p25.1	2	11540277		GREB1			ENSG00000196208			rs35417544-T	rs35417544	0	35417544	intron_variant	0	NR	6E-22	21.221848749616356				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	3q26.33	3	179394446		MFN1			ENSG00000171109			rs62408878-T	rs62408878	0	62408878	3_prime_UTR_variant	0	NR	7E-9	8.154901959985743				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1279675		TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	NR	2E-42	41.69897000433602				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1299098		TERT - MIR4457	ENSG00000164362	ENSG00000263670		4030	10212	rs2735948-A	rs2735948	0	2735948	intergenic_variant	1	NR	3E-8	7.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1299955		TERT - MIR4457	ENSG00000164362	ENSG00000263670		4887	9355	rs2853667-A	rs2853667	0	2853667	intergenic_variant	1	NR	2E-13	12.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1296643		TERT - MIR4457	ENSG00000164362	ENSG00000263670		1575	12667	rs33987166-T	rs33987166	0	33987166	intergenic_variant	1	NR	8E-11	10.096910013008056				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5q31.1	5	133106571		HSPA4 - RPL6P15	ENSG00000170606	ENSG00000240611		122	65647	rs56083805-T	rs56083805	0	56083805	regulatory_region_variant	1	NR	3E-11	10.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1276758		TERT			ENSG00000164362			rs56345976-A	rs56345976	0	56345976	intron_variant	0	NR	2E-11	10.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	5p15.33	5	1297143		TERT - MIR4457	ENSG00000164362	ENSG00000263670		2075	12167	rs6554754-T	rs6554754	0	6554754	regulatory_region_variant	1	NR	4E-30	29.397940008672037				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	6p21.2	6	36681143		CDKN1A			ENSG00000124762			rs3176337-A	rs3176337	0	3176337	intron_variant	0	NR	8E-11	10.096910013008056				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	6q25.1	6	151702056		ESR1			ENSG00000091831			rs851984-A	rs851984	0	851984	intron_variant	0	NR	3E-23	22.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	9q33.1	9	116476088		ASTN2			ENSG00000148219			rs12555322-A	rs12555322	0	12555322	intron_variant	0	NR	3E-11	10.522878745280337				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	10p12.31	10	21595802		MLLT10			ENSG00000078403			rs12217370-A	rs12217370	0	12217370	intron_variant	0	NR	4E-9	8.397940008672037				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	12q24.12	12	111621753		ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	4E-9	8.397940008672037				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	10p12.31	10	21744013		MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	NR	2E-23	22.69897000433602				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	11p13	11	35282517		"SLC1A2, SLC1A2-AS1"			"ENSG00000110436, ENSG00000255004"			rs10768124-T	rs10768124	0	10768124	intron_variant	0	NR	2E-8	7.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	11q13.1	11	65584591		EHBP1L1			ENSG00000173442			rs2298615-T	rs2298615	0	2298615	non_coding_transcript_exon_variant	0	NR	2E-8	7.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	11q13.3	11	69578229		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		83277	62927	rs55811218-T	rs55811218	0	55811218	intergenic_variant	1	NR	2E-8	7.698970004336019				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	12q24.13	12	112468611		PTPN11			ENSG00000179295			rs11066320-A	rs11066320	0	11066320	intron_variant	0	NR	1E-9	9				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	13q14.3	13	50519978		"DLEU7, DLEU1"			"ENSG00000186047, ENSG00000176124"			rs9316500-T	rs9316500	0	9316500	3_prime_UTR_variant	0	NR	1E-8	8				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	16q13	16	56345880		GNAO1			ENSG00000087258			rs3790110-T	rs3790110	0	3790110	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
9/8/2022	35803233	Wu X	7/1/2022	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/35803233	Investigating the shared genetic architecture of uterine leiomyoma and breast cancer: A genome-wide cross-trait analysis.	Uterine leiomyoma or breast cancer (pleiotropy)	"35,474 European ancestry UL cases, 133,384 European ancestry BC cases, 381,294 European ancestry controls"	NA	17q11.2	17	30836573		ATAD5			ENSG00000176208			rs117662433-A	rs117662433	0	117662433	intron_variant	0	NR	5E-10	9.301029995663981				NR [8170973] (imputed)	N	"Uterine leiomyoma, breast carcinoma"	"http://purl.obolibrary.org/obo/HP_0000131, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90134420	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"8,602 European ancestry triple negative cases, 9,414 European ancestry BRCA1 mutation carrier cases, 100,971 European ancestry controls"	NA	6p21.32	6	33272092	NR	RPS18			ENSG00000231500			rs17215231-C	rs17215231	0	17215231	5_prime_UTR_variant	0	0.92	9E-13	12.045757490560675		1.1764705	[1.12-1.23]	Illumina [~ 9700000] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST010100	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"8,602 European ancestry triple negative cases, 9,414 European ancestry BRCA1 mutation carrier cases, 100,971 European ancestry controls"	NA	12q24.31	12	120997672	NR	HNF1A			ENSG00000135100			rs2464195-G	rs2464195	0	2464195	splice_region_variant	0	0.63	3E-8	7.522878745280337		1.0752687	[1.04-1.1]	Illumina [~ 9700000] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST010100	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"	"8,602 European ancestry triple negative cases, 9,414 European ancestry BRCA1 mutation carrier cases, 100,971 European ancestry controls"	NA	17p13.1	17	7668434	NR	TP53			ENSG00000141510			rs78378222-T	rs78378222	0	78378222	3_prime_UTR_variant	0	0.99	1E-8	8		1.4492754	[1.3-1.61]	Illumina [~ 9700000] (imputed)	N	triple-negative breast cancer	http://www.ebi.ac.uk/efo/EFO_0005537	GCST010100	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	12p12.1	12	21168436	SLCO1B1	SLCO1B1			ENSG00000134538			rs10841753-C	rs10841753	0	10841753	intron_variant	0	0.208	3E-12	11.522878745280337		0.43	[0.31-0.55] unit decrease	Illumina [8203257] (imputed)	N	"estrone conjugate measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007971, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004360	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	7q21.13	7	90874752	CDK14	CDK14			ENSG00000058091			rs10953024-C	rs10953024	0	10953024	intron_variant	0	0.088	1E-6	6		0.49	[0.29-0.69] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	2q37.2	2	236277682	ASB18	GBX2-AS1			ENSG00000233611			rs1453308-A	rs1453308	0	1453308	intron_variant	0	0.198	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	18p11.23	18	7807950	PTPRM	PTPRM			ENSG00000173482			rs16952550-C	rs16952550	0	16952550	intron_variant	0	0.171	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	15q21.2	15	51261712	CYP19A1	"CYP19A1, MIR4713HG"			"ENSG00000137869, ENSG00000259240"			rs17601876-A	rs17601876	0	17601876	intron_variant	0	0.5	4E-6	5.3979400086720375		0.24	[0.14-0.34] unit increase	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	2q37.2	2	236278055	ASB18	GBX2-AS1			ENSG00000233611			rs1453307-G	rs1453307	0	1453307	intron_variant	0	0.1638	3E-6	5.522878745280337		0.3463	[0.2-0.49] unit increase	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	17q22	17	58163947	OR4D2	OR4D1 - OR4D2	ENSG00000141194	ENSG00000255713		4362	3035	rs16942732-T	rs16942732	0	16942732	intergenic_variant	1	0.2054	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	11q24.2	11	126175935	RPUSD4	NAP1L1P1 - RPUSD4	ENSG00000254759	ENSG00000165526		107334	26161	rs7105310-G	rs7105310	0	7105310	non_coding_transcript_exon_variant	1	0.1072	7E-6	5.154901959985743		0.3841	[0.22-0.55] unit increase	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	1q42.13	1	230289344	GALNT2	GALNT2 - PGBD5	ENSG00000143641	ENSG00000177614		7222	25146	rs16851421-G	rs16851421	0	16851421	intergenic_variant	1	0.3271	8E-6	5.096910013008056		0.2489	[0.14-0.36] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	5q23.1	5	117038818	RPL35AP15	LINC02214 - RPL35AP15	ENSG00000251311	ENSG00000243758		276609	262286	rs113883744-T	rs113883744	0	113883744	intergenic_variant	1	0.2103	8E-6	5.096910013008056		0.2971	[0.17-0.43] unit increase	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	17q22	17	58165213	LOC100419764	OR4D1 - OR4D2	ENSG00000141194	ENSG00000255713		5628	1769	rs1468574-A	rs1468574	0	1468574	intergenic_variant	1	0.2052	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	7p14.3	7	34103644	BMPER	BMPER			ENSG00000164619			rs1420338-G	rs1420338	0	1420338	intron_variant	0	0.3988	7E-6	5.154901959985743		0.2432	[0.14-0.35] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	9p24.1	9	8211949	PTPRD	DMAC1 - PTPRD	ENSG00000137038	ENSG00000153707		323569	102297	rs1416584-G	rs1416584	0	1416584	intergenic_variant	1	0.0787	6E-6	5.221848749616356		0.4453	[0.25-0.64] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
7/17/2017	28429243	Dudenkov TM	4/20/2017	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	"707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases"	NA	10p12.2	10	23061174	ARMC3	ARMC3 - MSRB2	ENSG00000165309	ENSG00000148450		22651	34405	rs3858207-C	rs3858207	0	3858207	intron_variant	1	0.4898	5E-6	5.301029995663981		0.2398	[0.14-0.34] unit decrease	Illumina [8203257] (imputed)	N	"androstenedione measurement, estrone measurement"	"http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970"	GCST004361	Genome-wide genotyping array				
11/27/2018	30161160	Onishi H	8/30/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30161160	A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	275 East Asian ancestry individuals	72 East Asian or Asian ancestry individuals	4q34.3	4	181490427	NR	LINC02500 - TEMN3-AS1	ENSG00000249460	ENSG00000251336		225282	329592	rs4861477-C	rs4861477	0	4861477	intergenic_variant	1	0.15	8E-6	5.096910013008056				Illumina [519335] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST006615	Genome-wide genotyping array				
11/27/2018	30161160	Onishi H	8/30/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30161160	A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	275 East Asian ancestry individuals	72 East Asian or Asian ancestry individuals	4q34.3	4	181486725	NR	LINC02500 - TEMN3-AS1	ENSG00000249460	ENSG00000251336		221580	333294	rs17198973-C	rs17198973	0	17198973	intergenic_variant	1	0.35	6E-6	5.221848749616356				Illumina [519335] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST006615	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr3:82546639-?	chr3:82546639	0			1	NR	1E-6	6		0.08	[0.03-0.23]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr3:89160571-?	chr3:89160571	0			1	NR	1E-6	6		3.45	[1.7-7.02]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr3:89267181-?	chr3:89267181	0			1	NR	2E-6	5.698970004336019		3.45	[1.69-7.01]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr4:95870904-?	chr4:95870904	0			1	NR	1E-6	6				NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr5:89895303-?	chr5:89895303	0			1	NR	1E-6	6		1.47	[0.99-2.18]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr6:143547597-?	chr6:143547597	0			1	NR	5E-7	6.301029995663981				NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr7:41251035-?	chr7:41251035	0			1	NR	3E-7	6.522878745280337		4.17	[1.99-8.72]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr7:69233868-?	chr7:69233868	0			1	NR	7E-7	6.154901959985743		61.86	[17.26-221.69]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr7:101215013-?	chr7:101215013	0			1	NR	2E-6	5.698970004336019		2.29	[1.28-4.12]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr9:133818764-?	chr9:133818764	0			1	NR	2E-6	5.698970004336019				NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr10:15592642-?	chr10:15592642	0			1	NR	3E-7	6.522878745280337		1.62	[1.05-2.48]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr11:126180020-?	chr11:126180020	0			1	NR	2E-6	5.698970004336019		0.67	[0.45-1.01]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER positive)	"1,062 European ancestry individuals"	NA											chr12:26231825-?	chr12:26231825	0			1	NR	1E-6	6		0.57	[0.36-0.92]	NR [NR] (imputed)	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST90061437	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:2:39084988-?	chr:2:39084988	0			1	NR	5E-6	5.301029995663981				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:2:47532756-?	chr:2:47532756	0			1	NR	8E-6	5.096910013008056				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:2:196222319-?	chr:2:196222319	0			1	NR	3E-6	5.522878745280337		0.2	[0.09-0.46]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:58534198-?	chr:3:58534198	0			1	NR	3E-6	5.522878745280337				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:88947488-?	chr:3:88947488	0			1	NR	8E-6	5.096910013008056		0.1	[0.04-0.28]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:89050449-?	chr:3:89050449	0			1	NR	4E-6	5.3979400086720375		0.06	[0.02-0.18]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:89287971-?	chr:3:89287971	0			1	NR	5E-6	5.301029995663981		0.06	[0.02-0.18]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:89389302-?	chr:3:89389302	0			1	NR	4E-6	5.3979400086720375		0.06	[0.02-0.17]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:3:197211822-?	chr:3:197211822	0			1	NR	3E-6	5.522878745280337				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:4:95870904-?	chr:4:95870904	0			1	NR	2E-6	5.698970004336019				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:4:122608442-?	chr:4:122608442	0			1	NR	5E-6	5.301029995663981		37.1	[10.7-129.0]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:4:189505149-?	chr:4:189505149	0			1	NR	5E-6	5.301029995663981		3.59	[1.71-7.51]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:5:54933175-?	chr:5:54933175	0			1	NR	6E-6	5.221848749616356				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:6:87565268-?	chr:6:87565268	0			1	NR	3E-6	5.522878745280337		2.16	[1.22-3.82]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:6:143547597-?	chr:6:143547597	0			1	NR	5E-7	6.301029995663981				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:7:103522248-?	chr:7:103522248	0			1	NR	2E-6	5.698970004336019		0.27	[0.13-0.57]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:7:105998889-?	chr:7:105998889	0			1	NR	2E-6	5.698970004336019		0.47	[0.27-0.82]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:7:136056065-?	chr:7:136056065	0			1	NR	5E-6	5.301029995663981		10.7	[3.89-29.2]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:10:37677669-?	chr:10:37677669	0			1	NR	3E-6	5.522878745280337		2.19	[1.23-3.88]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:10:75687931-?	chr:10:75687931	0			1	NR	9E-6	5.045757490560675		25.1	[7.62-82.7]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:10:77887494-?	chr:10:77887494	0			1	NR	3E-6	5.522878745280337		0.47	[0.26-0.82]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:10:104352925-?	chr:10:104352925	0			1	NR	1E-7	7				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:11:2161955-?	chr:11:2161955	0			1	NR	9E-6	5.045757490560675		7.18	[2.82-18.3]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:11:36421759-?	chr:11:36421759	0			1	NR	6E-6	5.221848749616356		4.56	[2.03-10.3]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:11:123042276-?	chr:11:123042276	0			1	NR	5E-6	5.301029995663981		41.3	[11.7-147.0]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:13:35782262-?	chr:13:35782262	0			1	NR	6E-6	5.221848749616356		1.94	[1.13-3.32]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:18:7264435-?	chr:18:7264435	0			1	NR	6E-6	5.221848749616356		0.08	[0.03-0.22]	NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
1/10/2022	34611289	Escala-Garcia M	10/5/2021	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34611289	Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.	Breast cancer-specific survival (ER negative)	"1,062 European ancestry individuals"	NA											chr:20:13988796-?	chr:20:13988796	0			1	NR	9E-6	5.045757490560675				NR [NR] (imputed)	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST90061438	Genome-wide genotyping array				
12/16/2022	35653140	Fasching PA	6/2/2022	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/35653140	Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients.	Adverse response to chemotherapy in breast cancer (grade 3/4 neutropenic or leukopenic events)	"1,679 European ancestry cases with events, 1,643 European ancestry cases without events"	NA	16q13	16	57022152		NLRC5			ENSG00000140853			rs4784750-T	rs4784750	0	4784750	intron_variant	0	0.273	2E-8	7.698970004336019		1.38	[1.23-1.54]	Illumina [8860000] (imputed)	N	"neutropenia, leukopenia, chemotherapy-induced cytotoxicity measurement"	"http://purl.obolibrary.org/obo/MONDO_0001475, http://www.ebi.ac.uk/efo/EFO_0004233, http://www.ebi.ac.uk/efo/EFO_0010978"	GCST90244025	Genome-wide genotyping array				
12/16/2022	35653140	Fasching PA	6/2/2022	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/35653140	Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients.	Adverse response to chemotherapy in breast cancer (grade 3/4 neutropenic or leukopenic events)	"1,679 European ancestry cases with events, 1,643 European ancestry cases without events"	NA	13q33.3	13	108276718		TNFSF13B			ENSG00000102524			rs16972207-G	rs16972207	0	16972207	intron_variant	0	0.185	3E-8	7.522878745280337		1.54	[1.32-1.79]	Illumina [8860000] (imputed)	N	"neutropenia, leukopenia, chemotherapy-induced cytotoxicity measurement"	"http://purl.obolibrary.org/obo/MONDO_0001475, http://www.ebi.ac.uk/efo/EFO_0004233, http://www.ebi.ac.uk/efo/EFO_0010978"	GCST90244025	Genome-wide genotyping array				
5/16/2015	25327703	Fejerman L	10/20/2014	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	"1,497 Latino cases, 3,213 Latino controls"	"1,643 Latino cases, 4,971 Latino controls"	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.31	3E-9	8.522878745280337		1.38	[1.24-1.54]	"Affymetrix, Illumina [7229558] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002662	Genome-wide genotyping array				
5/16/2015	25327703	Fejerman L	10/20/2014	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25327703	Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.	Breast cancer	"1,497 Latino cases, 3,213 Latino controls"	"1,643 Latino cases, 4,971 Latino controls"	6q25.1	6	151633699	ESR1	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		12506	22992	rs140068132-A	rs140068132	0	140068132	TF_binding_site_variant	1	0.93	9E-18	17.045757490560675		1.67	[1.49-1.89]	"Affymetrix, Illumina [7229558] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002662	Genome-wide genotyping array				
2/12/2016	25956309	Palomba G	5/10/2015	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	"1,367 Sardinian cases, 1,658 Sardinian controls"	"201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls"	10q26.13	10	121577603	FGFR2	FGFR2			ENSG00000066468			rs2912780-?	rs2912780	0	2912780	intron_variant	0	0.506	4E-6	5.3979400086720375		1.302	(1.164-1.456)	Affymetrix [2067645] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002895	Genome-wide genotyping array				
2/12/2016	25956309	Palomba G	5/10/2015	BMC Cancer	www.ncbi.nlm.nih.gov/pubmed/25956309	Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.	Breast cancer	"1,367 Sardinian cases, 1,658 Sardinian controls"	"201 Sardinian cases, 1,467 Sardinian controls, 61,485 European ancestry cases, 60,860 European ancestry controls"	16q12.1	16	52532542	TOX3	TOX3			ENSG00000103460			rs2193094-?	rs2193094	0	2193094	intron_variant	0	0.478	2E-7	6.698970004336019		1.337	(1.198-1.491)	Affymetrix [2067645] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002895	Genome-wide genotyping array				
6/16/2008	18326623	Gold B	3/11/2008	Proc Natl Acad Sci U S A	www.ncbi.nlm.nih.gov/pubmed/18326623	Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.	Breast cancer	"249 Ashkenazi Jewish non-BRCA1/2 carriers cases, 299 Ashkenazi Jewish non-BRCA1/2 carriers controls"	"1,193 Ashkenazi Jewish non-BRCA1/2 carriers  cases,1,166 Ashkenazi Jewish non-BRCA1/2 carriers controls"	6q22.33	6	127279485	"ECHDC1, RNF146"	RNF146			ENSG00000118518			rs2180341-G	rs2180341	0	2180341	intron_variant	0	0.21	3E-8	7.522878745280337		1.41	[1.25-1.59]	Affymetrix [150080]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000162	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	14q24.1	14;14;14;14;14;14	68507560;68500665;68505059;68508657;68497029;68506829		RAD51B; RAD51B; RAD51B; RAD51B; RAD51B; RAD51B						rs10132579-?; rs737387-?; rs2842347-?; rs2842346-?; rs765899-?; rs757369-?	rs10132579; rs737387; rs2842347; rs2842346; rs765899; rs757369	0		intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant		NR	2E-6	5.698970004336019		1.67	[1.35-2.08]	Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	4q27	4;4	121205653;121200339	TNIP3	TNIP3; TNIP3						rs13116936-G; rs17435444-A	rs13116936; rs17435444	0		intron_variant; intron_variant		0.64	3E-7	6.522878745280337		1.23	[1.13-1.33]	Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	1p36.23	1;1;1;1;1	8334176;8335500;8330828;8326670;8335381	SLC45A1	SLC45A1; SLC45A1; SLC45A1; SLC45A1; SLC45A1						rs12711517-?; rs7535752-?; rs2289731-?; rs9628987-?; rs2305016-?	rs12711517; rs7535752; rs2289731; rs9628987; rs2305016	0		intron_variant; missense_variant; synonymous_variant; intron_variant; intron_variant		NR	5E-6	5.301029995663981		1.23	[1.12-1.35]	Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	10p15.1	10;10;10	5630056;5628312;5623811		LASTR; LASTR; LASTR						rs4414128-?; rs2386661-?; rs17141741-?	rs4414128; rs2386661; rs17141741	0		intron_variant; intron_variant; intron_variant		NR	5E-6	5.301029995663981		1.27	[1.14-1.39]	Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	10q22.3	10	79295869		ZMIZ1			ENSG00000108175			rs12355688-T	rs12355688	0	12355688	non_coding_transcript_exon_variant	0	0.22	6E-6	5.221848749616356		1.24	[1.13-1.36]	Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	1p36.23	1;1	8335500;8326670		SLC45A1; SLC45A1						rs7535752-?; rs9628987-?	rs7535752; rs9628987	0		missense_variant; intron_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	3p26.1	3;3	7242282;7220327		GRM7; GRM7						rs1810320-?; rs6797852-?	rs1810320; rs6797852	0		intron_variant; intron_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	4q27	4;4	121205653;121185138		TNIP3; TNIP3						rs13116936-?; rs17051310-?	rs13116936; rs17051310	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	4q27	4;4	121189820;121215608		TNIP3; TNIP3						rs921551-?; rs4455437-?	rs921551; rs4455437	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	4q27	4;4	121222509;121200339		TNIP3; TNIP3						rs6835704-?; rs17435444-?	rs6835704; rs17435444	0		intron_variant; intron_variant		NR	2E-6	5.698970004336019				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	5p15.32	5;5	5324870;5320143		ADAMTS16 - ALG3P1; ADAMTS16						rs16875333-?; rs3806872-?	rs16875333; rs3806872	0		intergenic_variant; 3_prime_UTR_variant		NR	3E-6	5.522878745280337				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	12q22	12;12	94149730;94138989		PLXNC1; RN7SKP263 - PLXNC1						rs2230754-?; rs11613298-?	rs2230754; rs11613298	0		synonymous_variant; regulatory_region_variant		NR	5E-6	5.301029995663981				Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
6/6/2013	23468962	Song C	2/28/2013	PLoS One	www.ncbi.nlm.nih.gov/pubmed/23468962	A genome-wide scan for breast cancer risk haplotypes among African American women.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	NA	17q23.2	17;17	61314018;61319088		BCAS3; BCAS3						rs3785856-?; rs10853029-?	rs3785856; rs10853029	0		intron_variant; intron_variant		NR	8E-6	5.096910013008056	(Haplotype-?????)			Illumina [1006480]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001879	Genome-wide genotyping array				
10/15/2010	20872241	Li J	9/26/2010	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	"2,702 European ancestry female cases, 5,726 European ancestry controls"	"Up to 7,386 cases, 7,576 controls"	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.3	4E-7	6.3979400086720375		1.22	[1.13-1.32]	Illumina [285984]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000811	Genome-wide genotyping array				
10/15/2010	20872241	Li J	9/26/2010	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	"2,702 European ancestry female cases, 5,726 European ancestry controls"	"Up to 7,386 cases, 7,576 controls"	5p12	5	44874903	MRPS30	MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		54475	380045	rs7716600-A	rs7716600	0	7716600	regulatory_region_variant	1	0.23	7E-7	6.154901959985743		1.24	[1.14-1.34]	Illumina [285984]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000811	Genome-wide genotyping array				
10/15/2010	20872241	Li J	9/26/2010	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	"2,702 European ancestry female cases, 5,726 European ancestry controls"	"Up to 7,386 cases, 7,576 controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-?	rs13387042	0	13387042	intron_variant	0	0.53	9E-6	5.045757490560675		1.18	[1.10-1.27]	Illumina [285984]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000811	Genome-wide genotyping array				
10/15/2010	20872241	Li J	9/26/2010	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/20872241	A combined analysis of genome-wide association studies in breast cancer.	Breast cancer	"2,702 European ancestry female cases, 5,726 European ancestry controls"	"Up to 7,386 cases, 7,576 controls"	10q26.13	10	121586676	FGFR2	FGFR2			ENSG00000066468			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.42	2E-13	12.698970004336019		1.32	[1.22-1.42]	Illumina [285984]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000811	Genome-wide genotyping array				
6/16/2008	17529973	Hunter DJ	5/27/2007	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529973	A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"874 European ancestry cases, 1,478 European ancestry controls, 302 cases, 594 controls"	10q26.13	10	121586676	FGFR2	FGFR2			ENSG00000066468			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.4	1E-10	10		1.2	[1.07-1.42]	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000036	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	5q11.2	5	56736057	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-C	rs889312	0	889312	intergenic_variant	1	0.28	5E-9	8.301029995663981		1.22	[1.14-1.30]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.42	4E-31	30.397940008672037		1.43	[1.35-1.53]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	10q21.2	10	62518923	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-G	rs10995190	0	10995190	intron_variant	1	0.85	5E-15	14.301029995663981		1.16	[1.10-1.22]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	8q24.21	8	127375606	intergenic	"PCAT1, CASC8, POU5F1B"			"ENSG00000253438, ENSG00000246228, ENSG00000212993"			rs1562430-T	rs1562430	0	1562430	intron_variant	0	0.58	6E-7	6.221848749616356		1.17	[1.10-1.25]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.49	2E-10	9.698970004336019		1.21	[1.14-1.29]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	11p15.5	11	1920716	LSP1	TNNT3			ENSG00000130595			rs909116-T	rs909116	0	909116	intron_variant	0	0.53	7E-7	6.154901959985743		1.17	[1.10-1.24]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	3p24.1	3	27374522	SLC4A7	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	6E-7	6.221848749616356		1.16	[1.10-1.24]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	9p21.3	9	22062135	"CDKN2A, CDKN2B"	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	3E-8	7.522878745280337		1.09	[1.04-1.14]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	10q22.3	10	79081391	ZMIZ1	ZMIZ1			ENSG00000108175			rs704010-A	rs704010	0	704010	intron_variant	0	0.39	4E-9	8.397940008672037		1.07	[1.03-1.11]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	3E-15	14.522878745280337		1.3	[1.22-1.39]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	6q25.1	6	151592978	"ESR1, C6orf97"	CCDC170			ENSG00000120262			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	3E-6	5.522878745280337		1.3	[1.17-1.46]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	10p15.1	10	5844771	"ANKRD16, FBXO18"	GDI2 - ANKRD16	ENSG00000057608	ENSG00000134461		2639	16845	rs2380205-C	rs2380205	0	2380205	regulatory_region_variant	1	0.57	5E-7	6.301029995663981		1.06	[1.02-1.10]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
6/2/2010	20453838	Turnbull C	5/9/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20453838	Genome-wide association study identifies five new breast cancer susceptibility loci.	Breast cancer	"3,659 European ancestry cases, 4,897 European ancestry controls"	"12,576 European ancestry cases, 12,223 European ancestry controls"	11q13.3	11	69513996	"FGF3, MYEOV, CCND1, ORAOV1, FGF19, FGF4"	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		19044	127160	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	3E-15	14.522878745280337		1.15	[1.10-1.20]	Illumina [582886]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000678	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.52	2E-10	9.698970004336019		1.16	[1.11-1.22]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	3p24.1	3	27374522	SLC4A7	SLC4A7			ENSG00000033867			rs4973768-C	rs4973768	0	4973768	3_prime_UTR_variant	0	0.49	2E-8	7.698970004336019		1.14	[1.09-1.19]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	8q24.21	8	127375606	intergenic	"PCAT1, CASC8, POU5F1B"			"ENSG00000253438, ENSG00000246228, ENSG00000212993"			rs1562430-A	rs1562430	0	1562430	intron_variant	0	0.6	3E-11	10.522878745280337		1.16	[1.11-1.22]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	16q12.2	16	52601252	TOX3	CASC16			ENSG00000249231			rs3112612-T	rs3112612	0	3112612	intron_variant	0	0.43	4E-10	9.397940008672037		1.15	[1.10-1.21]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	6q25.1	6	151618215	ESR1	CCDC170			ENSG00000120262			rs3734805-C	rs3734805	0	3734805	3_prime_UTR_variant	0	0.08	1E-7	7		1.19	[1.11-1.27]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	10q26.13	10	121865675	FGFR2	ATE1			ENSG00000107669			rs10510102-G	rs10510102	0	10510102	intron_variant	0	0.17	2E-6	5.698970004336019		1.12	[1.07-1.17]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	5p12	5	44662413	intergenic	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		3844	53780	rs4415084-T	rs4415084	0	4415084	intergenic_variant	1	0.42	8E-11	10.096910013008056		1.17	[1.11-1.22]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	10q26.13	10	121586676	FGFR2	FGFR2			ENSG00000066468			rs1219648-?	rs1219648	0	1219648	intron_variant	0	0.42	1E-30	30		1.31	[1.25-1.37]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/19/2015	21263130	Fletcher O	1/24/2011	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21263130	Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.	Breast cancer	"2,839 European ancestry cases, 3,507 European ancestry controls"	"9,041 European ancestry cases, 8,980 European ancestry controls"	9q31.2	9	108126198	"KLF4, ACTL7A, RAD23B"	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		28347	500635	rs865686-T	rs865686	0	865686	regulatory_region_variant	1	0.61	2E-10	9.698970004336019		1.12	[1.09-1.18]	Illumina [~ 296114]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000952	Genome-wide genotyping array				
4/24/2013	23354978	Rinella ES	1/25/2013	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	"477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls"	"203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols"	6p22.3	6	19443704	intergenic	LNC-LBCS			ENSG00000228412			rs16882214-?	rs16882214	0	16882214	intron_variant	0	0.81	2E-6	5.698970004336019	(Meta P value)	1.43	[NR]	Affymetrix [435632]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001831	Genome-wide genotyping array				
4/24/2013	23354978	Rinella ES	1/25/2013	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	"477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls"	"203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols"	15q24.3	15	77977130	intergenic	ADAMTS7P3			ENSG00000261143			rs12906542-?	rs12906542	0	12906542	intron_variant	0	0.93	7E-7	6.154901959985743	(Meta P value)	2	[NR]	Affymetrix [435632]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001831	Genome-wide genotyping array				
4/24/2013	23354978	Rinella ES	1/25/2013	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/23354978	Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.	Breast cancer	"477 Ashkenazi Jewish cases, 524 Ashkenazi Jewish controls"	"203 Ashkenazi Jewish cases, 263 Ashkenazi Jewish contols"	10q26.13	10	121579461	FGFR2	FGFR2			ENSG00000066468			rs1078806-C	rs1078806	0	1078806	intron_variant	0	0.39	2E-6	5.698970004336019	(Pooled P value)	1.43	[NR]	Affymetrix [435632]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001831	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	2q33.1	2	201502898	"TRAK2, ALS2CR11"	C2CD6			ENSG00000155754			rs2540431-T	rs2540431	0	2540431	intron_variant	0	0.313	2E-8	7.698970004336019		1.131	[1.083-1.181]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	3q25.1	3	150762029	SIAH2	"SIAH2, SIAH2-AS1"			"ENSG00000181788, ENSG00000244265"			rs1838337-G	rs1838337	0	1838337	non_coding_transcript_exon_variant	0	0.627	1E-8	8		1.128	[1.082-1.176]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	5p12	5	44663035	"FGF10, MRPS30"	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		4466	53158	rs7701466-T	rs7701466	0	7701466	intergenic_variant	1	0.492	2E-10	9.698970004336019		1.138	[1.094-1.184]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	5q11.2	5	56757111	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		150879	58438	rs79160707-T	rs79160707	0	79160707	TF_binding_site_variant	1	0.1	5E-8	7.301029995663981		1.2	[1.124-1.282]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	6q25.1	6	151632992	"CCDC170, ESR1"	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		11799	23699	rs6900157-C	rs6900157	0	6900157	intergenic_variant	1	0.269	5E-10	9.301029995663981		1.147	[1.099-1.198]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	10q26.13	10	121579140	FGFR2	FGFR2			ENSG00000066468			rs2912778-G	rs2912778	0	2912778	intron_variant	0	0.507	1E-19	19		1.201	[1.155-1.25]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	12p11.22	12	28000060	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		27327	133189	rs805583-G	rs805583	0	805583	intergenic_variant	1	0.76	3E-10	9.522878745280337		1.17	[1.114-1.228]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	12q24.21	12	115397580	UBA52P7	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		629591	195024	rs10744856-G	rs10744856	0	10744856	intergenic_variant	1	0.626	1E-8	8		1.13	[1.083-1.178]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	16q12.1	16	52565276	"TOX3, CASC16"	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.235	2E-24	23.69897000433602		1.271	[1.214-1.331]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	1p22.3	1	87385737	LOC100505768	LINC01364 - RNA5SP52	ENSG00000227290	ENSG00000199318		14054	67503	rs11161996-C	rs11161996	0	11161996	intergenic_variant	1	0.6498	8E-7	6.096910013008056		1.1040659	[1.06-1.15]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	1q32.2	1	210196877	SYT14	SYT14 - SERTAD4-AS1	ENSG00000143469	ENSG00000203706		25488	34579	rs11119434-T	rs11119434	0	11119434	intergenic_variant	1	0.1609	8E-7	6.096910013008056		1.1362	[1.08008-1.19525]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	2p13.3	2	69900097	SNRNP27	"MXD1, SNRNP27"			"ENSG00000059728, ENSG00000124380"			rs6716937-G	rs6716937	0	6716937	intron_variant	0	0.4074	4E-7	6.3979400086720375		1.10278	[1.06198-1.14514]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	3q13.11	3	105145487	ALCAM	EZRP1 - ALCAM	ENSG00000243635	ENSG00000170017		642221	221422	rs9862599-G	rs9862599	0	9862599	intergenic_variant	1	0.0761	1E-8	8		1.21574	[1.13634-1.30069]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	5q11.2	5	56928893	MIER3	MIER3			ENSG00000155545			rs61154548-T	rs61154548	0	61154548	non_coding_transcript_exon_variant	0	0.0645	8E-7	6.096910013008056		1.20178	[1.11733-1.29261]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	6q25.1	6	152034021	ESR1	ESR1			ENSG00000091831			rs9479169-C	rs9479169	0	9479169	intron_variant	0	0.4907	1E-7	7		1.1070544	[1.07-1.15]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	9q33.3	9	126707167	LMX1B	LMX1B - ZBTB43	ENSG00000136944	ENSG00000169155		6135	97839	rs62578156-G	rs62578156	0	62578156	regulatory_region_variant	1	0.1108	5E-6	5.301029995663981		1.1455	[1.08033-1.2146]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	12p12.1	12	24884534	BCAT1	BCAT1			ENSG00000060982			rs10842422-T	rs10842422	0	10842422	intron_variant	0	0.3213	3E-6	5.522878745280337		1.0985	[1.05616-1.14253]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	12p11.22	12	29205522	FAR2	FAR2			ENSG00000064763			rs7315643-T	rs7315643	0	7315643	intron_variant	0	0.7756	2E-7	6.698970004336019		1.1332666	[1.08-1.19]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	15q21.2	15	51321455	CYP19A1	CYP19A1			ENSG00000137869			rs1004983-A	rs1004983	0	1004983	intron_variant	0	0.3476	3E-6	5.522878745280337		1.09858	[1.05626-1.14259]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	18q12.3	18	44813855	SETBP1	SETBP1			ENSG00000152217			rs9945779-A	rs9945779	0	9945779	intron_variant	0	0.8892	7E-7	6.154901959985743		1.1705326	[1.1-1.25]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	21q22.12	21	34726347	"CLIC6, RUNX1"	LINC00160			ENSG00000230978			rs75286142-G	rs75286142	0	75286142	intron_variant	0	0.1763	2E-9	8.698970004336019		1.15694	[1.10285-1.21369]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	21q22.12	21	34738904	LOC107985515	LINC00160 - LINC01426	ENSG00000230978	ENSG00000234380		1700	6852	rs16992204-?	rs16992204	0	16992204	intergenic_variant	1	NR	4E-8	7.3979400086720375		1.1516186	[1.1-1.21]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	5p12	5	44706396	"LOC102723839, RN7SL383P"	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-?	rs10941679	0	10941679	intergenic_variant	1	NR	3E-9	8.522878745280337		1.132975	[1.09-1.18]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	5p12	5	44662413	"LOC102723839, RN7SL383P"	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		3844	53780	rs4415084-?	rs4415084	0	4415084	intergenic_variant	1	NR	3E-9	8.522878745280337		1.12907	[1.08486-1.17509]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
2/19/2020	31757997	Low SK	11/22/2019	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31757997	Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.	Breast cancer	"6,669 Japanese ancestry cases, 21,930 Japanese ancestry controls"	"981 Japanese ancestry cases, 1,394 Japanese ancestry controls"	12q24.21	12	115398717	intergenic	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-?	rs1292011	0	1292011	regulatory_region_variant	1	NR	3E-8	7.522878745280337		1.12981	[1.08197-1.17975]	Illumina [4946503] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST009665	Genome-wide genotyping array				
11/24/2020	31173346	Wang S	6/27/2019	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31173346	Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.	Breast cancer somatic mutation signature APOBEC C>T	"974 European, African American and Asian ancestry individuals"	NA	15q21.2	15	52152636		GNB5			ENSG00000069966			rs578194564-?	rs578194564	0	578194564	intron_variant	0	NR	1E-6	6				Affymetrix [7177790] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010760	Genome-wide genotyping array				
11/24/2020	31173346	Wang S	6/27/2019	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31173346	Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.	Breast cancer somatic mutation signature APOBEC C>G	"974 European, African American and Asian ancestry individuals"	NA	15q21.2	15	52152636		GNB5			ENSG00000069966			rs578194564-?	rs578194564	0	578194564	intron_variant	0	NR	1E-6	6				Affymetrix [7177790] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010759	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer	"2,801 European ancestry individuals, 450 East Asian ancestry individuals, 392 Hispanic or Latin American individuals, 330 African American or Afro-Caribbean individuals"	NA	15q23	15	70737412		UACA			ENSG00000137831			rs11855431-C	rs11855431	0	11855431	intron_variant	0	NR	9E-8	7.045757490560675				Illumina [NR] (imputed)	N	"overall survival, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90104805	Genome-wide genotyping array				
2/5/2016	25867717	Song N	4/13/2015	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	"1,732 Korean ancestry cases"	"1,494 Korean ancestry cases"	15q25.1	15	79777420	MTHFS	TFDP1P3 - RNU6-667P	ENSG00000259493	ENSG00000252995		217116	39929	rs166870-T	rs166870	0	166870	intergenic_variant	1	0.13	3E-7	6.522878745280337	(HR+ HER2-)	2.3	[1.67-3.15]	Affymetrix [2210580] (imputed)	N	"disease free survival, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000409, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002847	Genome-wide genotyping array				
2/5/2016	25867717	Song N	4/13/2015	PLoS One	www.ncbi.nlm.nih.gov/pubmed/25867717	Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.	Disease-free survival in breast cancer	"1,732 Korean ancestry cases"	"1,494 Korean ancestry cases"	10q21.1	10	53506471	PCDH15	RNA5SP318 - PCDH15	ENSG00000252161	ENSG00000150275		48183	296300	rs10825036-G	rs10825036	0	10825036	intergenic_variant	1	0.32	4E-7	6.3979400086720375	(HR- HER2-)	2.26	[1.34-3.81]	Affymetrix [2210580] (imputed)	N	"disease free survival, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000409, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002847	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	6q25.1	6	151592978		CCDC170			ENSG00000120262			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.26	1E-6	6		1.15	[1.09-1.22]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	6q25.1	6	151627231		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	0.35	7E-15	14.154901959985743		1.22	[1.16-1.29]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	10q26.13	10	121577821		FGFR2			ENSG00000066468			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.55	3E-11	10.522878745280337		1.19	[1.11-1.23]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	22q13.1	22	38962032		APOBEC3A			ENSG00000128383			rs12628403-C	rs12628403	0	12628403	intron_variant	0	0.27	4E-6	5.3979400086720375		1.17	[1.09-1.25]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	10q26.13	10	121586676	NR	FGFR2			ENSG00000066468			rs1219648-G	rs1219648	0	1219648	intron_variant	0	0.39	6E-9	8.221848749616356		1.17	[1.11-1.23]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	10q26.13	10	121592803	NR	FGFR2			ENSG00000066468			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.68	2E-8	7.698970004336019		1.18	[1.11-1.23]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	1p22.3	1	87313534	LMO4	LINC02801 - LMO4	ENSG00000284240	ENSG00000143013		48793	15346	rs12118297-G	rs12118297	0	12118297	intergenic_variant	1	0.62	4E-8	7.3979400086720375		1.1	[1.06-1.14]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
1/10/2017	27354352	Han MR	6/27/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/27354352	Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci.	Breast cancer	"7,619 East Asian ancestry cases, 6,286 East Asian ancestry controls"	"6,605 East Asian ancestry cases, 8,543 East Asian ancestry controls"	21q22.12	21	34738904	LINC00160	LINC00160 - LINC01426	ENSG00000230978	ENSG00000234380		1700	6852	rs16992204-C	rs16992204	0	16992204	intergenic_variant	1	0.12	5E-8	7.301029995663981		1.13	[1.07-1.18]	"Affymetrix, Illumina [668499] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003520	Genome-wide genotyping array				
7/28/2020	29871690	Bensen JT	6/5/2018	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/29871690	"A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women."	Breast cancer	"3,663 African American cases, 4,687 African American controls"	NA	17q25.3	17	81041898	BAIAP2	BAIAP2			ENSG00000175866			rs9913477-G	rs9913477	0	9913477	intron_variant	0	0.06	3E-7	6.522878745280337		1.44	[1.26???1.65]	Illumina [300008]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010347	Exome genotyping array [Exome array]				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	22q12.2	22	29217531		EMID1			ENSG00000186998			rs132383-A	rs132383	0	132383	intron_variant	0	NR	5E-7	6.301029995663981		1.2458	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p12	5	45757203		HCN1 - EMB	ENSG00000164588	ENSG00000170571		60705	4638989	rs1852599-C	rs1852599	0	1852599	intergenic_variant	1	NR	2E-8	7.698970004336019		1.0896807	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10p12.31	10	21533927		MLLT10			ENSG00000078403			rs10828247-G	rs10828247	0	10828247	intron_variant	0	NR	3E-13	12.522878745280337		1.0887316	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	9q31.2	9	108010759		RPS15AP27 - RPL31P43	ENSG00000236783	ENSG00000213557		46714	29454	rs60778117-T	rs60778117	0	60778117	intergenic_variant	1	NR	5E-9	8.301029995663981		1.0863662	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	12p13.1	12	14265892		GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		10666	90950	rs11055888-G	rs11055888	0	11055888	intergenic_variant	1	NR	6E-9	8.221848749616356		1.0829543	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	22q12.1	22	28156710		TTC28			ENSG00000100154			rs62237573-T	rs62237573	0	62237573	intron_variant	0	NR	8E-9	8.096910013008056		1.3493456	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	4q34.1	4	174932364		ADAM29			ENSG00000168594			rs7686118-A	rs7686118	0	7686118	intron_variant	0	NR	2E-7	6.698970004336019		1.0778185	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5q14.2	5	82161539		ATG10			ENSG00000152348			rs2407064-A	rs2407064	0	2407064	intron_variant	0	NR	3E-8	7.522878745280337		1.0743446	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	3q12.1	3	100149260		CMSS1			ENSG00000184220			rs9289981-T	rs9289981	0	9289981	intron_variant	0	NR	4E-10	9.397940008672037		1.0731916	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	6q14.1	6	81545215		TENT5A			ENSG00000112773			rs9361840-G	rs9361840	0	9361840	intron_variant	0	NR	8E-8	7.096910013008056		1.0731916	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q34	2	212679737		ERBB4 - LINC01878	ENSG00000178568	ENSG00000234308		140896	115563	rs774002109-A	rs774002109	0	774002109	intron_variant	1	0.379307	4E-8	7.3979400086720375		1.0729614	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	20q13.13	20	50346469		LINC01271 - RN7SL636P	ENSG00000233077	ENSG00000244376		24983	82721	rs6020465-G	rs6020465	0	6020465	intergenic_variant	1	NR	5E-7	6.301029995663981		1.0705492	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8p12	8	29614831		LINC02948 - RPL17P33	ENSG00000253182	ENSG00000243844		50490	17260	rs56283082-A	rs56283082	0	56283082	regulatory_region_variant	1	NR	2E-7	6.698970004336019		1.06929	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8q23.1	8	105330554		ZFPM2			ENSG00000169946			rs61051244-CAT	rs61051244	0	61051244	intron_variant	0	NR	8E-7	6.096910013008056		1.0680337	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	1p11.2	1	121538815		"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	NR	8E-9	8.096910013008056		1.0668942	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	11q24.3	11	129584212		RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		46098	27904	rs10736577-G	rs10736577	0	10736577	intergenic_variant	1	NR	8E-8	7.096910013008056		1.0634904	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q35	2	217432009		DIRC3			ENSG00000231672			rs16857611-T	rs16857611	0	16857611	intron_variant	0	NR	8E-7	6.096910013008056		1.0633773	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	14q32.11	14	91374725		CCDC88C			ENSG00000015133			rs941764-G	rs941764	0	941764	intron_variant	0	NR	2E-7	6.698970004336019		1.0626993	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	1q21.2	1	149934520		MTMR11			ENSG00000014914			rs11205303-C	rs11205303	0	11205303	missense_variant	0	NR	5E-7	6.301029995663981		1.0584251	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	9q33.1	9	116562650		ASTN2			ENSG00000148219			rs1321917-G	rs1321917	0	1321917	intron_variant	0	NR	2E-7	6.698970004336019		1.0604	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	3p24.1	3	27347329		NEK10			ENSG00000163491			rs112238765-C	rs112238765	0	112238765	intron_variant	0	NR	1E-18	18		1.1053	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	12p11.22	12	28021884		PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-C	rs7297051	0	7297051	TF_binding_site_variant	1	NR	5E-15	14.301029995663981		1.1124	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10q21.2	10	62528323		LINC02929			ENSG00000285551			rs10995193-A	rs10995193	0	10995193	intron_variant	0	NR	5E-12	11.301029995663981		1.1194	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	12q22	12	95632961		PGAM1P5			ENSG00000257150			rs61938093-C	rs61938093	0	61938093	intron_variant	0	NR	8E-18	17.096910013008056		1.1284	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q35	2	217056046		DIRC3-AS1			ENSG00000233143			rs4442975-G	rs4442975	0	4442975	intron_variant	0	NR	2E-28	27.69897000433602		1.1311	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5q33.3	5	158834155		EBF1			ENSG00000164330			rs17715065-C	rs17715065	0	17715065	intron_variant	0	NR	1E-11	11		1.078	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	21q21.1	21	15192241		LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		124404	298289	rs7282349-C	rs7282349	0	7282349	non_coding_transcript_exon_variant	1	NR	1E-10	10		1.0809	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p12	5	45333758		HCN1			ENSG00000164588			rs55821517-T	rs55821517	0	55821517	intron_variant	0	NR	3E-9	8.522878745280337		1.0813	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	12q24.21	12	115377060		TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		609071	215544	rs725677-C	rs725677	0	725677	regulatory_region_variant	1	NR	7E-12	11.154901959985743		1.0834	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	14q24.1	14	68174380		RAD51B			ENSG00000182185			rs5809370-C	rs5809370	0	5809370	intron_variant	0	NR	9E-7	6.045757490560675		1.084	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10q26.12	10	121335694		LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		149728	75222	rs9421409-G	rs9421409	0	9421409	intergenic_variant	1	NR	4E-9	8.397940008672037		1.084	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	14q13.3	14	36663564		PAX9			ENSG00000198807			rs2236007-G	rs2236007	0	2236007	intron_variant	0	NR	2E-9	8.698970004336019		1.0873	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	14q24.1	14	68513118		RAD51B			ENSG00000182185			rs11624333-T	rs11624333	0	11624333	intron_variant	0	NR	4E-11	10.397940008672037		1.0875	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	17q21.31	17	45594371		DND1P1 - MAPK8IP1P2	ENSG00000264070	ENSG00000263503		7442	6498	rs2463523-A	rs2463523	0	2463523	regulatory_region_variant	1	NR	3E-10	9.522878745280337		1.0887	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	16q12.2	16	53790314		FTO			ENSG00000140718			rs62033406-A	rs62033406	0	62033406	intron_variant	0	NR	3E-14	13.522878745280337		1.0901	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5q11.2	5	56926293		MIER3			ENSG00000155545			rs11957276-G	rs11957276	0	11957276	intron_variant	0	NR	5E-11	10.301029995663981		1.0933	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	20q11.21	20	33298440		BPIFB1			ENSG00000125999			rs4911315-A	rs4911315	0	4911315	intron_variant	0	0.105592	8E-7	6.096910013008056		1.0935	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8p11.23	8	36995695		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		59570	99455	rs10096213-C	rs10096213	0	10096213	regulatory_region_variant	1	NR	3E-9	8.522878745280337		1.094	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10q26.13	10	121684227		FGFR2 - ATE1	ENSG00000066468	ENSG00000107669		85769	25166	rs12354821-T	rs12354821	0	12354821	intergenic_variant	1	NR	3E-10	9.522878745280337		1.0954	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q33.1	2	201316524		"FLACC1, CASP8"			"ENSG00000155749, ENSG00000064012"			rs1830298-C	rs1830298	0	1830298	intron_variant	0	NR	9E-14	13.045757490560675		1.0961	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	15q21.2	15	49580388		FAM227B			ENSG00000166262			rs8027730-C	rs8027730	0	8027730	intron_variant	0	0.516078	3E-8	7.522878745280337		1.0638	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q31.1	2	171568284		CYBRD1 - RPL21P38	ENSG00000071967	ENSG00000233934		10155	18809	rs11675683-A	rs11675683	0	11675683	regulatory_region_variant	1	NR	4E-8	7.3979400086720375		1.0666	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8q22.3	8	101466731		RN7SL563P - GRHL2	ENSG00000239211	ENSG00000083307		68798	25708	rs514192-A	rs514192	0	514192	intron_variant	1	NR	5E-8	7.301029995663981		1.0667	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	18q11.2	18	26904324		AQP4-AS1			ENSG00000260372			rs3974648-C	rs3974648	0	3974648	intron_variant	0	NR	5E-7	6.301029995663981		1.0724	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	9p21.3	9	21966222		MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		28571	707	rs3731257-G	rs3731257	0	3731257	intron_variant	1	NR	5E-8	7.301029995663981		1.0733	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p15.33	5	1296644		TERT - MIR4457	ENSG00000164362	ENSG00000263670		1576	12666	rs2736109-C	rs2736109	0	2736109	intergenic_variant	1	NR	2E-8	7.698970004336019		1.0744	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	11p15.5	11	1892909		LSP1 - LINC01150	ENSG00000130592	ENSG00000229671		642	4106	rs576603-C	rs576603	0	576603	intergenic_variant	1	NR	2E-8	7.698970004336019		1.0767	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	17q11.2	17	30894259		ATAD5			ENSG00000176208			rs62070652-C	rs62070652	0	62070652	intron_variant	0	NR	6E-9	8.221848749616356		1.0768	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10q22.3	10	79085654		ZMIZ1			ENSG00000108175			rs1250009-G	rs1250009	0	1250009	intron_variant	0	NR	4E-9	8.397940008672037		1.0778	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	17q21.31	17	46751565		NSF			ENSG00000073969			rs199533-G	rs199533	0	199533	synonymous_variant	0	NR	5E-8	7.301029995663981		1.078	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	22q12.1	22	28682717		TTC28 - CHEK2	ENSG00000100154	ENSG00000183765		2877	5026	rs75174485-G	rs75174485	0	75174485	intergenic_variant	1	NR	1E-7	7		1.3468013	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	1p36.22	1	10370245		KIF1B			ENSG00000054523			rs187373836-A	rs187373836	0	187373836	intron_variant	0	NR	5E-7	6.301029995663981		1.3374349	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	NR	8E-82	81.09691001300806		1.2685527	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	11q13.3	11	69646918		CCND1			ENSG00000110092			rs34507830-T	rs34507830	0	34507830	intron_variant	0	NR	3E-8	7.522878745280337		1.2291052	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	11q13.3	11	69516874		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21922	124282	rs554219-G	rs554219	0	554219	regulatory_region_variant	1	NR	1E-34	34		1.2226434	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p12	5	44593979		LINC02224			ENSG00000249203			rs138096085-C	rs138096085	0	138096085	intron_variant	0	NR	4E-9	8.397940008672037		1.2026458	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5q11.2	5	56711512		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		105280	104037	rs7709971-A	rs7709971	0	7709971	regulatory_region_variant	1	NR	6E-35	34.221848749616356		1.1953143	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	6q25.1	6	151630867		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		9674	25824	rs9397436-G	rs9397436	0	9397436	regulatory_region_variant	1	NR	4E-18	17.397940008672037		1.1938874	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p12	5	44476770		FGF10-AS1 - LINC02224	ENSG00000248464	ENSG00000249203		62781	18329	rs12520604-C	rs12520604	0	12520604	intergenic_variant	1	NR	5E-8	7.301029995663981		1.1734335	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	22q13.2	22	40619879		MRTFA			ENSG00000196588			rs5995881-G	rs5995881	0	5995881	intron_variant	0	NR	4E-16	15.397940008672037		1.1558021	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	6q25.1	6	151734843		ESR1			ENSG00000091831			rs6904031-T	rs6904031	0	6904031	intron_variant	0	NR	6E-9	8.221848749616356		1.1423349	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	5p12	5	44706396		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	NR	8E-25	24.096910013008056		1.1381744	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q14.2	2	120667763		Y_RNA - GLI2	ENSG00000202522	ENSG00000074047		16389	67860	rs6752414-T	rs6752414	0	6752414	intergenic_variant	1	0.07653	2E-9	8.698970004336019		1.1307101	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	10q26.13	10	121819548		ATE1			ENSG00000107669			rs4478919-A	rs4478919	0	4478919	intron_variant	0	NR	5E-8	7.301029995663981		1.1305822	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	1q32.1	1	203770556		LAX1			ENSG00000122188			rs778040878-A	rs778040878	1	71728312	intron_variant	0	NR	7E-7	6.154901959985743		1.1304545	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8q21.13	8	75448402		HNF4G			ENSG00000164749			rs189268208-G	rs189268208	0	189268208	intron_variant	0	NR	7E-10	9.154901959985743		1.1225865	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	2q14.2	2	120488037		LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21819	163236	rs12616849-C	rs12616849	0	12616849	intergenic_variant	1	NR	3E-9	8.522878745280337		1.1220826	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	21q11.2	21	14988523		NRIP1			ENSG00000180530			rs559044903-G	rs559044903	0	559044903	intron_variant	0	NR	6E-7	6.221848749616356		1.1201972	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	1q32.1	1	201468704		PHLDA3			ENSG00000174307			rs35383942-T	rs35383942	0	35383942	missense_variant	0	NR	6E-7	6.221848749616356		1.1191941	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	8q24.21	8	127338463		"PCAT1, CASC8, POU5F1B"			"ENSG00000253438, ENSG00000246228, ENSG00000212993"			rs747171037-C	rs747171037	0	747171037	intron_variant	0	NR	5E-20	19.30102999566398		1.1087704	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	9q31.2	9	108131272		CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		33421	495561	rs5899787-CT	rs5899787	0	5899787	intergenic_variant	1	NR	3E-16	15.522878745280337		1.100352	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	16q23.2	16	80610766		CDYL2			ENSG00000166446			rs11150296-C	rs11150296	0	11150296	intron_variant	0	NR	8E-12	11.096910013008056		1.0952903	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
11/13/2020	32887889	Rashkin SR	9/4/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Breast cancer	"17,881 European ancestry cases, 410,350 European ancestry controls"	NA	6q25.2	6	152111767		ESR1			ENSG00000091831			rs910416-T	rs910416	0	910416	intron_variant	0	NR	6E-16	15.221848749616356		1.0945709	NR	Affymetrix [7846216] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90011804	Genome-wide genotyping array				
12/7/2015	25890600	Guo Q	4/18/2015	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	"23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases"		14q24.1	14	67599772	NR	PIGH			ENSG00000100564			rs7149859-?	rs7149859	0	7149859	intron_variant	0	NR	7E-7	6.154901959985743	(ER +ve)	1.22	[1.13-1.33]	"Affymetrix, Illumina [9000000] (imputed)"	N	"survival time, estrogen-receptor positive breast cancer"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649"	GCST002861	Genome-wide genotyping array				
12/7/2015	25890600	Guo Q	4/18/2015	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	"23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases"		11q24.2	11	125389528	"HEPACAM, HEPN1, CCDC15, SLC37A2, TMEM218, FEZ1, MGC39545, STT3A, CHEK1, ACRV1, PATE1, PATE2, PATE3, PATE4, HYLS1, PKNOX2, ROBO4"	PKNOX2			ENSG00000165495			rs2059614-?	rs2059614	0	2059614	intron_variant	0	0.06	1E-9	9	(ER -ve)	1.9	[1.54-2.33]	"Affymetrix, Illumina [9000000] (imputed)"	N	"estrogen-receptor negative breast cancer, survival time"	"http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0000714"	GCST002861	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	15q21.1	15	46737708	SEMA6D	RN7SKP101 - SEMA6D	ENSG00000223308	ENSG00000137872		17196	446393	rs16958536-?	rs16958536	0	16958536	intron_variant	1	0.22	4E-6	5.3979400086720375	"(Breast cancer, telangiectasia, multivariable analysis)"	1.66		Illumina [2417493] (imputed)	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	10p12.31	10	21147293	C10orf113	NEBL			ENSG00000078114			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	8E-6	5.096910013008056	"(Breast cancer, overall toxicity, multivariable analysis)"	3.28		Illumina [2417493] (imputed)	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	17q12	17	35565049	SLFN14	SLFN14 - SNHG30	ENSG00000236320	ENSG00000267321		4230	3001	rs2840044-?	rs2840044	0	2840044	intergenic_variant	1	0.33	8E-6	5.096910013008056	"(Breast cancer, overal toxicity, multivariable analysis)"	1.56		Illumina [2417493] (imputed)	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	5q21.1	5	101043689	ST8SIA4	ST8SIA4 - RN7SL802P	ENSG00000113532	ENSG00000277506		140407	538141	rs575018-?	rs575018	0	575018	intergenic_variant	1	0.34	7E-7	6.154901959985743	"(Breast cancer, overall toxicity, univariable analysis)"	0.13	[NR] unit decrease	Illumina [2417493] (imputed)	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	6p25.1	6	6550516	LY86-AS1	LY86-AS1			ENSG00000216863			rs17142289-?	rs17142289	0	17142289	intron_variant	0	0.02	4E-6	5.3979400086720375	"(Breast cancer, overall toxicity, univariable analysis)"	0.35	[NR] unit increase	Illumina [2417493] (imputed)	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
3/20/2017	28171663	Huo D	9/4/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer	"3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls"	"1,984 African American cases, 2,939 African American controls"	3q26.31	3	172550013	TNFSF10	TNFSF10 - LINC02068	ENSG00000121858	ENSG00000223387		26538	10875	rs13074711-T	rs13074711	0	13074711	regulatory_region_variant	1	0.69	2E-6	5.698970004336019		1.14	[1.08-1.21]	Illumina [16147413] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003782	Genome-wide genotyping array				
3/20/2017	28171663	Huo D	9/4/2016	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer	"3962 African American cases, 711 African ancestry cases, 4,150 African ancestry controls, 624 African ancestry controls"	"1,984 African American cases, 2,939 African American controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.6	5E-6	5.301029995663981		1.13	[1.07-1.19]	Illumina [16147413] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003782	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	5q11.2	5	56727256	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		121024	88293	rs16886165-G	rs16886165	0	16886165	intergenic_variant	1	0.15	5E-7	6.301029995663981		1.23	[1.12-1.35] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	1p11.2	1	121538815	intergenic	"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-C	rs11249433	0	11249433	intron_variant	0	0.39	7E-10	9.154901959985743		1.16	[1.09-1.24] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	14q24.1	14	68567965	RAD51L1	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.76	2E-7	6.698970004336019		1.06	[1.01-1.14] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.51	2E-8	7.698970004336019		1.25	[1.15-1.37] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	1E-9	9		1.16	[1.07-1.27] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/3/2009	19330030	Thomas G	3/29/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330030	A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).	Breast cancer	"1,145 European ancestry cases, 1,142 European ancestry controls"	"8,625 European ancestry cases, 9,657 European ancestry controls"	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-T	rs2981579	0	2981579	intron_variant	0	0.41	2E-10	9.698970004336019		1.17	[1.07-1.27] (Het)	Illumina [528173]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000365	Genome-wide genotyping array				
4/28/2012	22452962	Kim HC	3/27/2012	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22452962	A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.	Breast cancer	"2,273 Korean ancestry cases, 2,052 Korean ancestry controls"	"4,049 Korean ancestry cases, 3,845 Korean ancestry controls"	2q34	2	212432139	ERBB4	ERBB4			ENSG00000178568			rs13393577-T	rs13393577	0	13393577	intron_variant	0	0.051	9E-14	13.045757490560675		1.53	[1.37-1.70]	Affymetrix [555525]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001457	Genome-wide genotyping array				
7/11/2012	22532574	Stevens KN	4/24/2012	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22532574	Identification of a novel percent mammographic density locus at 12q24.	Percent mammographic density	"1,241 European ancestry female individuals"	"9,126 European ancestry individuals"	12q24.21	12	114430333	"TBX5, TBX3"	TBX5-AS1 - RN7SKP216	ENSG00000255399	ENSG00000222982		17501	74543	rs1265507-?	rs1265507	0	1265507	regulatory_region_variant	1	NR	1E-8	8				Illumina [2510880]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001489	Genome-wide genotyping array				
7/12/2010	20585626	Long J	6/24/2010	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20585626	Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.	Breast cancer	"2,073 Chinese ancestry cases, 2,084 Chinese ancestry controls"	"15,159 East Asian ancestry cases, 12,993 East Asian ancestry controls, 2,797 European ancestry cases, 2,662 European ancestry controls"	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.24	1E-28	28	(all races combined)	1.24	[1.20-1.29]	Affymetrix [684457]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000709	Genome-wide genotyping array				
3/17/2012	22383897	Long J	2/23/2012	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	"2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls"	"up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls"	6q25.1	6	149287738	TAB2	TAB2			ENSG00000055208			rs9485372-G	rs9485372	0	9485372	intron_variant	0	0.55	4E-12	11.397940008672037		1.11	[1.09-1.15]	Affymetrix [690947]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001420	Genome-wide genotyping array				
3/17/2012	22383897	Long J	2/23/2012	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	"2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls"	"up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls"	6q25.1	6	151974478	ESR1	ESR1			ENSG00000091831			rs9383951-G	rs9383951	0	9383951	intron_variant	0	0.9	2E-6	5.698970004336019		1.14	[1.08-1.19]	Affymetrix [690947]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001420	Genome-wide genotyping array				
3/17/2012	22383897	Long J	2/23/2012	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22383897	Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.	Breast cancer	"2,918 Chinese ancestry cases, 2,324 Chinese ancestry controls"	"up to 16,173 East Asian ancestry cases, up to 18,282 East Asian ancestry controls"	11q24.3	11	129603795	"TMEM45B, BARX2"	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		65681	8321	rs7107217-C	rs7107217	0	7107217	intron_variant	1	0.36	5E-7	6.301029995663981		1.08	[1.05-1.11]	Affymetrix [690947]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001420	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	1p11.2	1	121538815		"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	NR	9E-13	12.045757490560675		0.0825	[0.06-0.105] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA											chr1:149025528-C	chr1:149025528	0			1	NR	2E-10	9.698970004336019		0.1893	[0.13-0.25] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	1p22.2	1	87980553		PKN2-AS1			ENSG00000237505			rs17130230-A	rs17130230	0	17130230	intron_variant	0	NR	3E-8	7.522878745280337		0.1193	[0.077-0.162] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q14.2	2	120421585		INHBB - LINC01101	ENSG00000163083	ENSG00000280409		69782	42750	rs117515012-A	rs117515012	0	117515012	intergenic_variant	1	NR	2E-8	7.698970004336019		0.2728	[0.18-0.37] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q33.1	2	201288502		"CASP8, FLACC1"			"ENSG00000064012, ENSG00000155749"			rs700635-A	rs700635	0	700635	3_prime_UTR_variant	0	NR	5E-16	15.301029995663981		0.088	[0.067-0.109] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q34	2	212672736		ERBB4 - LINC01878	ENSG00000178568	ENSG00000234308		133895	122564	rs9967727-G	rs9967727	0	9967727	intron_variant	1	NR	4E-8	7.3979400086720375		0.0613	[0.039-0.083] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q35	2	217056046		DIRC3-AS1			ENSG00000233143			rs4442975-T	rs4442975	0	4442975	intron_variant	0	NR	7E-32	31.154901959985743		0.1273	[0.11-0.15] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	3q25.1	3	150720263		"SNRPCP3, ERICH6-AS1"			"ENSG00000244668, ENSG00000240137"			rs59885616-T	rs59885616	0	59885616	non_coding_transcript_exon_variant	0	NR	4E-14	13.397940008672037		0.1446	[0.11-0.18] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	3p24.1	3	27312225		NEK10			ENSG00000163491			rs552647-A	rs552647	0	552647	intron_variant	0	NR	3E-20	19.522878745280337		0.094	[0.074-0.114] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	4q34.1	4	174906885		ADAM29			ENSG00000168594			rs7697216-C	rs7697216	0	7697216	intron_variant	0	NR	1E-12	12		0.1033	[0.075-0.132] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5p15.33	5	1293971		TERT			ENSG00000164362			rs2736098-T	rs2736098	0	2736098	synonymous_variant	0	NR	3E-8	7.522878745280337		0.0632	[0.041-0.086] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5q33.3	5	158800890		EBF1			ENSG00000164330			rs12332693-A	rs12332693	0	12332693	intron_variant	0	NR	3E-13	12.522878745280337		0.0734	[0.054-0.093] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5p12	5	44706396		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	NR	1E-30	30		0.1282	[0.11-0.15] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5q11.2	5	56758507		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		152275	57042	rs112776581-T	rs112776581	0	112776581	intergenic_variant	1	NR	1E-21	21		0.1928	[0.15-0.23] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	6q25.1	6	149255943		"TAB2-AS1, TAB2"			"ENSG00000225924, ENSG00000055208"			rs7758080-G	rs7758080	0	7758080	intron_variant	0	NR	1E-10	10		0.0701	[0.049-0.091] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	6q25.1	6	151628671		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		7478	28020	rs6913578-C	rs6913578	0	6913578	regulatory_region_variant	1	NR	2E-30	29.69897000433602		0.1267	[0.11-0.15] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	7q34	7	140242504		RNU1-58P - PPP1R2P6	ENSG00000199283	ENSG00000241661		472	50248	rs11977670-A	rs11977670	0	11977670	TF_binding_site_variant	1	NR	4E-8	7.3979400086720375		0.055	[0.035-0.075] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	8q24.21	8	127345678		"PCAT1, CASC8, POU5F1B"			"ENSG00000253438, ENSG00000246228, ENSG00000212993"			rs10447995-A	rs10447995	0	10447995	intron_variant	0	NR	1E-22	22		0.1002	[0.08-0.12] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	8p11.23	8	36997193		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		61068	97957	rs10092900-G	rs10092900	0	10092900	regulatory_region_variant	1	NR	2E-17	16.69897000433602		0.1058	[0.081-0.13] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	9q31.2	9	108131272		CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		33421	495561	rs397692178-CT	rs397692178	1	5899787	intergenic_variant	1	NR	1E-17	17		0.0998	[0.077-0.123] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	10q26.13	10	121580918		FGFR2			ENSG00000066468			rs35054928-G	rs35054928	0	35054928	intron_variant	0	NR	9E-106	105.04575749056067		0.2194	[0.2-0.24] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	10p12.31	10	21522558		SKIDA1			ENSG00000180592			rs11012730-A	rs11012730	0	11012730	intron_variant	0	NR	3E-10	9.522878745280337		0.0747	[0.052-0.098] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	10q21.2	10	62513267		ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		32979	7181	rs10995187-A	rs10995187	0	10995187	intron_variant	1	NR	3E-11	10.522878745280337		0.1054	[0.074-0.136] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	10q22.3	10	79092621		ZMIZ1			ENSG00000108175			rs1268974-G	rs1268974	0	1268974	intron_variant	0	NR	2E-11	10.698970004336019		0.0695	[0.049-0.09] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	11q24.3	11	129603585		RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		65471	8531	rs57382399-TGTGA	rs57382399	0	57382399	intron_variant	1	NR	6E-12	11.221848749616356		0.0686	[0.049-0.088] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	11p15.5	11	1874478		LSP1			ENSG00000130592			rs4980386-A	rs4980386	0	4980386	intron_variant	0	NR	9E-17	16.045757490560675		0.0874	[0.067-0.108] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	11q13.3	11	69516650		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21698	124506	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	NR	1E-40	40		0.2991	[0.26-0.34] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	12q23.2	12	101548001		SPIC - MYBPC1	ENSG00000166211	ENSG00000196091		61004	20352	rs189084037-A	rs189084037	0	189084037	intergenic_variant	1	NR	1E-8	8		0.302	[0.2-0.41] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	12q24.21	12	115398717		TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-G	rs1292011	0	1292011	regulatory_region_variant	1	NR	1E-13	13		0.0757	[0.056-0.096] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	12p13.1	12	14262448		GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		7222	94394	rs150460514-A	rs150460514	0	150460514	intergenic_variant	1	NR	3E-8	7.522878745280337		0.0681	[0.044-0.092] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	12p11.22	12	28021884		PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-T	rs7297051	0	7297051	TF_binding_site_variant	1	NR	7E-15	14.154901959985743		0.0922	[0.069-0.115] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	12q22	12	95632961		PGAM1P5			ENSG00000257150			rs61938093-T	rs61938093	0	61938093	intron_variant	0	NR	1E-16	16		0.0904	[0.069-0.112] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	14q13.3	14	36658205		PAX9			ENSG00000198807			rs12885612-A	rs12885612	0	12885612	intron_variant	0	NR	8E-9	8.096910013008056		0.069	[0.045-0.093] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	14q24.1	14	68512268		RAD51B			ENSG00000182185			rs35378451-C	rs35378451	0	35378451	intron_variant	0	NR	4E-15	14.397940008672037		0.095	[0.071-0.119] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	16p12.2	16	23636404		PALB2			ENSG00000083093			rs515726080-G	rs515726080	0	515726080	intron_variant	0	NR	6E-18	17.221848749616356		3.6691	[2.84-4.5] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	NR	4E-92	91.39794000867204		0.2382	[0.22-0.26] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	16q12.2	16	53776774		FTO			ENSG00000140718			rs7193144-C	rs7193144	0	7193144	intron_variant	0	NR	3E-16	15.522878745280337		0.0864	[0.066-0.107] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	16q23.3	16	82143565		HSD17B2-AS1 - MPHOSPH6	ENSG00000261235	ENSG00000135698		3934	4233	rs373491984-G	rs373491984	0	373491984	intergenic_variant	1	NR	2E-8	7.698970004336019		0.0989	[0.064-0.134] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	17q11.2	17	30887862		ATAD5			ENSG00000176208			rs113934718-A	rs113934718	0	113934718	intron_variant	0	NR	1E-8	8		0.072	[0.047-0.097] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	18q11.2	18	26920652		"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs232320-C	rs232320	0	232320	intron_variant	0	NR	6E-9	8.221848749616356		0.0624	[0.041-0.083] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	18q12.3	18	45309052		SLC14A2			ENSG00000132874			rs11082442-G	rs11082442	0	11082442	intron_variant	0	NR	3E-11	10.522878745280337		0.0709	[0.05-0.092] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	21q21.1	21	15200268		LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		132431	290262	rs145928162-T	rs145928162	0	145928162	intron_variant	1	NR	3E-11	10.522878745280337		0.0746	[0.053-0.097] unit decrease	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	21q22.12	21	34746798		LINC01426			ENSG00000234380			rs12483725-A	rs12483725	0	12483725	intron_variant	0	NR	7E-9	8.154901959985743		0.1467	[0.097-0.196] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	22q12.1	22	28365160		TTC28			ENSG00000100154			rs62237617-T	rs62237617	0	62237617	intron_variant	0	NR	6E-36	35.221848749616356		1.3134	[1.11-1.52] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	22q13.1	22	38962032		APOBEC3A			ENSG00000128383			rs12628403-C	rs12628403	0	12628403	intron_variant	0	NR	9E-14	13.045757490560675		0.1131	[0.083-0.143] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"17,389 European ancestry cases, 240,341 European ancestry controls, 6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	22q13.2	22	40618081		MRTFA			ENSG00000196588			rs569369507-GT	rs569369507	1	66504883	intron_variant	0	NR	3E-12	11.522878745280337		0.1436	[0.1-0.18] unit increase	"Affymetrix, Illumina [25794640] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018799	Genome-wide genotyping array				
10/13/2012	22923054	Chen F	8/25/2012	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/22923054	A genome-wide association study of breast cancer in women of African ancestry.	Breast cancer	"3,016 African American cases, 2,745 African American controls"	"3,533 African ancestry cases, 11,046 African ancestry controls"	14q31.3	14	87829256	GALC	LINC02330 - GALC	ENSG00000258770	ENSG00000054983		173962	8564	rs4322600-G	rs4322600	0	4322600	intron_variant	1	0.78	4E-6	5.3979400086720375		1.18	[1.10-1.27]	Illumina [2067098] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001648	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	"69 European ancestry cases, 2,144 European ancestry controls"	NA	2q14.3	2	123261223	intergenic	LINC01826 - ELOAP1	ENSG00000232740	ENSG00000235640		187742	434079	rs1519277-T	rs1519277	0	1519277	intergenic_variant	1	0.06	2E-7	6.698970004336019		3.12	[1.96-4.96]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005110	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	"69 European ancestry cases, 2,144 European ancestry controls"	NA	17q24.3	17	71440368	CASC17	RNU7-155P - MYL6P5	ENSG00000238759	ENSG00000228118		142150	180610	rs11651604-C	rs11651604	0	11651604	regulatory_region_variant	1	0.16	6E-7	6.221848749616356		2.12	[1.50-3.01]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005110	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	"69 European ancestry cases, 2,144 European ancestry controls"	NA	1q32.3	1	213369363	RPS6KC1	RPS6KC1 - RPL31P13	ENSG00000136643	ENSG00000228646		94589	59345	rs17020562-C	rs17020562	0	17020562	intergenic_variant	1	0.0005	7E-8	7.154901959985743		44.52	[15.06-131.62]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005110	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors	"207 European ancestry female cases, 2,774 European ancestry female controls"	NA	2q37.3	2	236525150	IQCA1	IQCA1 - ACKR3	ENSG00000132321	ENSG00000144476		17615	42637	rs114971217-A	rs114971217	0	114971217	intergenic_variant	1	2.0E-4	6E-7	6.221848749616356				"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005111	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors	"207 European ancestry female cases, 2,774 European ancestry female controls"	NA	7q36.3	7	158170200	PTPRN2	PTPRN2			ENSG00000155093			rs117114682-G	rs117114682	0	117114682	intron_variant	0	0.03	4E-7	6.3979400086720375		2.23	[1.52-3.26]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005111	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors	"207 European ancestry female cases, 2,774 European ancestry female controls"	NA	11q13.2	11	68164294	SUV420H1	KMT5B			ENSG00000110066			rs4930561-A	rs4930561	0	4930561	intron_variant	0	0.49	3E-7	6.522878745280337		1.59	[1.30-1.92]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005111	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors	"207 European ancestry female cases, 2,774 European ancestry female controls"	NA	22q12.1	22	27215781	intergenic	RNU6-1066P - LINC01638	ENSG00000200443	ENSG00000233521		179790	5568	rs147512482-G	rs147512482	0	147512482	intergenic_variant	1	0.001	2E-7	6.698970004336019		3.85	[1.67-8.9]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005111	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors	"207 European ancestry female cases, 2,774 European ancestry female controls"	NA	1q32.3	1	213369363	RPS6KC1	RPS6KC1 - RPL31P13	ENSG00000136643	ENSG00000228646		94589	59345	rs17020562-C	rs17020562	0	17020562	intergenic_variant	1	0.001	3E-7	6.522878745280337		4.9	[2.08-11.54]	"Affymetrix, Illumina [16958466] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005111	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q14.2	2	120421585		INHBB - LINC01101	ENSG00000163083	ENSG00000280409		69782	42750	rs117515012-A	rs117515012	0	117515012	intergenic_variant	1	0.043741543	2E-8	7.698970004336019		0.2727515	[0.18-0.37] unit increase	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	2q33.1	2	201288355		"CASP8, FLACC1"			"ENSG00000064012, ENSG00000155749"			rs1035142-G	rs1035142	0	1035142	3_prime_UTR_variant	0	0.657757811	3E-9	8.522878745280337		0.12015145	[0.081-0.16] unit decrease	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	3q25.1	3	150754603		SIAH2			ENSG00000181788			rs2120596-A	rs2120596	0	2120596	intron_variant	0	0.332069863	8E-14	13.096910013008056		0.15327482	[0.11-0.19] unit decrease	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5p12	5	44672840		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		14271	43353	rs55788307-C	rs55788307	0	55788307	intergenic_variant	1	0.579554342	4E-14	13.397940008672037		0.14701666	[0.11-0.19] unit increase	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	5q11.2	5	56758507		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		152275	57042	rs112776581-T	rs112776581	0	112776581	intergenic_variant	1	0.096941444	2E-9	8.698970004336019		0.19353114	[0.13-0.26] unit increase	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	6q25.1	6	151628447		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		7254	28244	rs6557160-C	rs6557160	0	6557160	regulatory_region_variant	1	0.243400665	6E-17	16.221848749616356		0.18653153	[0.14-0.23] unit increase	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	10q26.13	10	121581496		FGFR2			ENSG00000066468			rs377595512-C	rs377595512	1	45631539	intron_variant	0	0.509351515	8E-22	21.096910013008056		0.18367667	[0.15-0.22] unit decrease	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
12/14/2021	34594039	Sakaue S	9/30/2021	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34594039	A cross-population atlas of genetic associations for 220 human phenotypes.	Breast cancer	"6,325 East Asian ancestry cases, 73,225 East Asian ancestry controls"	NA	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.22859754	1E-28	28		0.2545143	[0.21-0.3] unit increase	Illumina [13401000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90018579	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1q32.1	1	202209914	LGR6	LGR6			ENSG00000133067			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.6	9E-10	9.045757490560675		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1q32.1	1	204549714	MDM4	MDM4			ENSG00000198625			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	6E-15	14.221848749616356		1.13	[1.11-1.19]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1p36.22	1	10503552	PEX14	PEX14			ENSG00000142655			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.6799999999999999	2E-9	8.698970004336019		1.1111112	[1.08-1.15]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2p24.1	2	19121042	Intergenic	LINC01376			ENSG00000236204			rs12710696-?	rs12710696	0	12710696	intron_variant	0	0.36	2E-8	7.698970004336019		1.1	[1.06-1.13]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q14.2	2	120330606	INHBB	RALB - INHBB	ENSG00000144118	ENSG00000163083		35896	15530	rs11903787-?	rs11903787	0	11903787	intergenic_variant	1	0.75	9E-7	6.045757490560675		1.1111112	[1.06-1.16]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5p15.33	5	1279913	TERT	TERT			ENSG00000164362			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.2	3E-14	13.522878745280337		1.18	[1.13-1.23]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5p15.33	5	1282204	TERT	TERT			ENSG00000164362			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.34	2E-6	5.698970004336019		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5p15.33	5	1297373	TERT	TERT - MIR4457	ENSG00000164362	ENSG00000263670		2305	11937	rs2736108-?	rs2736108	0	2736108	regulatory_region_variant	1	0.71	1E-8	8		1.1235955	[1.08-1.16]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q25.1	6	151597721	ESR1	CCDC170			ENSG00000120262			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.08	9E-15	14.045757490560675		1.2	[1.18-1.32]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		3824	31674	rs11155804-?	rs11155804	0	11155804	intergenic_variant	1	0.34	8E-18	17.096910013008056		1.16	[1.12-1.19]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	10q21.2	10	62518923	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-?	rs10995190	0	10995190	intron_variant	1	0.84	4E-8	7.3979400086720375		1.1235955	[1.08-1.18]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	12p11.22	12	28002147	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.88	4E-13	12.397940008672037		1.2658228	[1.15-1.28]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.2	16	53779455	FTO	FTO			ENSG00000140718			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.5900000000000001	3E-7	6.522878745280337		1.098901	[1.05-1.12]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19p13.11	19	17283116	ADHB8	ANKLE1			ENSG00000160117			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	8E-19	18.096910013008056		1.16	[1.13-1.20]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	11p15.5	11	1880867	LSP1	LSP1			ENSG00000130592			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.44	3E-6	5.522878745280337		1.08	[1.05-1.12]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	12p11.22	12	28021884	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-?	rs7297051	0	7297051	TF_binding_site_variant	1	0.76	1E-14	14		1.1627907	[1.12-1.2]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.24	1E-14	14		1.15	[1.11-1.19]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.2	16	53821379	FTO	FTO			ENSG00000140718			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	3E-8	7.522878745280337		1.11	[1.07-1.15]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19p13.11	19	17278895	MERIT40	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	1E-12	12		1.15	[1.11-1.20]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2p23.2	2	28896719	WDR43	WDR43			ENSG00000163811			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.76	3E-6	5.522878745280337		1.0869565	[1.05-1.14]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q33.1	2	200878871	"PPIL3, CLK1, FAM126B, NDUFB3"	PPIL3			ENSG00000240344			rs115635831-?	rs115635831	0	115635831	intron_variant	0	0.015	1E-6	6		1.36	[1.20-1.54]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	13q22.1	13	73232845	"KLF5, KLF12"	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		5585	174923	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.32	3E-7	6.522878745280337		1.09	[1.05-1.13]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	9p21.3	9	22062135	NR	CDKN2B-AS1			ENSG00000240498			rs1011970-?	rs1011970	0	1011970	intron_variant	0	0.17	2E-6	5.698970004336019		1.11	[1.06-1.15]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	12q22	12	95633983	NR	PGAM1P5			ENSG00000257150			rs17356907-?	rs17356907	0	17356907	intron_variant	0	0.7	3E-6	5.522878745280337		1.098901	[1.69-1.14]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor negative)	"4,939 European ancestry cases, 14,352 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	13q13.1	13	32398489	NR	BRCA2			ENSG00000139618			rs11571833-?	rs11571833	0	11571833	stop_gained	0	0.01	6E-6	5.221848749616356		1.32	[1.20-1.43]	Illumina [10909381] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST003842	Genome-wide genotyping array				
4/2/2014	24080446	Rudolph A	11/4/2013	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	"2,920 European ancestry cases"	"7,689 European ancestry cases, 9,266 European ancestry controls"	13q12.3	13	28590646	POMP	FLT1 - EIF4A1P7	ENSG00000102755	ENSG00000235472		95501	8187	rs9579199-?	rs9579199	0	9579199	intergenic_variant	1	NR	8E-6	5.096910013008056		1.2048	[1.11-1.32]	Illumina [2500000] (imputed)	N	"breast carcinoma, hormone replacement therapy"	"http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0003961"	GCST002265	Genome-wide genotyping array				
4/2/2014	24080446	Rudolph A	11/4/2013	Endocr Relat Cancer	www.ncbi.nlm.nih.gov/pubmed/24080446	Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.	Breast cancer (menopausal hormone therapy interaction)	"2,920 European ancestry cases"	"7,689 European ancestry cases, 9,266 European ancestry controls"	16q23.3	16	81924693	PLCG2	PLCG2			ENSG00000197943			rs7192724-?	rs7192724	0	7192724	intron_variant	0	NR	3E-6	5.522878745280337		1.24	[1.13-1.36]	Illumina [2500000] (imputed)	N	"breast carcinoma, hormone replacement therapy"	"http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0003961"	GCST002265	Genome-wide genotyping array				
11/12/2014	24785509	Barnett GC	4/28/2014	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	"579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases"	"516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases"	10p12.31	10	21147293	C10orf113	NEBL			ENSG00000078114			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	6E-6	5.221848749616356	"(All samples, overall toxicity, multivariable analysis)"	3.39		Illumina [2417493] (imputed)	N	"response to radiation, prostate carcinoma, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002431	Genome-wide genotyping array				
6/16/2008	17529974	Stacey SN	5/27/2007	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	"1,599 European ancestry cases, 11,546 European ancestry controls"	"2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.5	1E-13	13		1.2	[1.14-1.26]	Illumina [311524]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000037	Genome-wide genotyping array				
6/16/2008	17529974	Stacey SN	5/27/2007	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17529974	Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.	Breast cancer	"1,599 European ancestry cases, 11,546 European ancestry controls"	"2,954 European ancestry cases, 5,967 European ancestry controls, Up to 561 Japanese ancestry cases, Up to 565 Japanese ancestry control, Up to 422 African American cases, Up to 448 African American controls, Up to 418 Hispanic cases, Up to 422 Hispanic controls, Up to 148 cases, Up to 293 controls"	16q12.1	16	52552429	TNRC9	CASC16			ENSG00000249231			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	6E-19	18.221848749616356		1.28	[1.21-1.35]	Illumina [311524]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000037	Genome-wide genotyping array				
9/30/2011	21908515	Cai Q	9/9/2011	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	"2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls"	"15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls"	7q32.3	7	130969092	NR	LINC-PINT			ENSG00000231721			rs2048672-C	rs2048672	0	2048672	intron_variant	0	0.45	6E-6	5.221848749616356		1.11	[1.05-1.17]	Affymetrix [684457]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001224	Genome-wide genotyping array				
9/30/2011	21908515	Cai Q	9/9/2011	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21908515	Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.	Breast cancer	"2,062 East Asian ancestry cases, 2,066 East Asian ancestry controls"	"15,091 East Asian ancestry cases, 14,877 East Asian ancestry controls"	10q21.2	10	62492218	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		11930	28230	rs10822013-T	rs10822013	0	10822013	intron_variant	1	0.47	6E-9	8.221848749616356		1.12	[1.06-1.18]	Affymetrix [684457]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001224	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q32.12	14	92637727		RIN3			ENSG00000100599			rs11627032-T	rs11627032	0	11627032	intron_variant	0	NR	2E-10	9.698970004336019		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1q41	1	217047232		ESRRG			ENSG00000196482			rs11117758-A	rs11117758	0	11117758	intron_variant	0	NR	4E-9	8.397940008672037		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q12.2	16	53779455		FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	NR	5E-24	23.30102999566398		1.06	[1.05-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3q25.1	3	150746484		SIAH2			ENSG00000181788			rs73006998-A	rs73006998	0	73006998	intron_variant	0	0.22	1E-10	10		0.93	[0.9-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1q32.1	1	203797203		"ZC3H11A, ZBED6"			"ENSG00000058673, ENSG00000257315"			rs4951011-G	rs4951011	0	4951011	5_prime_UTR_variant	0	NR	2E-8	7.698970004336019		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q14.3	5	91436408		ARRDC3-AS1			ENSG00000281357			rs10474352-C	rs10474352	0	10474352	intron_variant	0	NR	1E-16	16		1.06	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q25.1	6	149287738		TAB2			ENSG00000055208			rs9485372-G	rs9485372	0	9485372	intron_variant	0	NR	8E-12	11.096910013008056		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q25.1	6	151627231		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	NR	3E-74	73.52287874528034		1.11	[1.1-1.13]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q21.2	10	62492218		ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		11930	28230	rs10822013-T	rs10822013	0	10822013	intron_variant	1	NR	3E-27	26.522878745280337		1.06	[1.05-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11q24.3	11	129603795		RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		65681	8321	rs7107217-C	rs7107217	0	7107217	intron_variant	1	NR	4E-17	16.397940008672037		1.05	[1.04-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	15q26.1	15	90968837		"PRC1-AS1, PRC1"			"ENSG00000258725, ENSG00000198901"			rs2290203-G	rs2290203	0	2290203	3_prime_UTR_variant	0	NR	2E-19	18.69897000433602		1.06	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	NR	2E-240	239.69897000433602		1.24	[1.22-1.25]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	21q22.12	21	34738904		LINC00160 - LINC01426	ENSG00000230978	ENSG00000234380		1700	6852	rs16992204-C	rs16992204	0	16992204	intergenic_variant	1	NR	8E-10	9.096910013008056		1.13	[1.08-1.17]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	22q13.1	22	38962032		APOBEC3A			ENSG00000128383			rs12628403-C	rs12628403	0	12628403	intron_variant	0	NR	3E-17	16.522878745280337		1.09	[1.07-1.11]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p36.22	1	10506158		PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	NR	2E-23	22.69897000433602		1.06	[1.05-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p36.13	1	18480845		IGSF21 - KLHDC7A	ENSG00000117154	ENSG00000179023		102362	85	rs2992756-T	rs2992756	0	2992756	intergenic_variant	1	NR	5E-17	16.30102999566398		1.05	[1.04-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p34.2	1	40914768		CITED4 - UBE2V1P8	ENSG00000179862	ENSG00000233118		52405	27483	rs4233486-T	rs4233486	0	4233486	intergenic_variant	1	NR	2E-8	7.698970004336019		1.04	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p34.1	1	46135245		P3R3URF-PIK3R3			ENSG00000278139			rs1707302-A	rs1707302	0	1707302	intron_variant	0	NR	3E-10	9.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p32.3	1	50380361		LINC02808 - HMGB1P45	ENSG00000284696	ENSG00000229316		59169	18464	rs140850326-CAAAGGGCAAGATCTCCTTTTT	rs140850326	0	140850326	intergenic_variant	1	NR	3E-7	6.522878745280337		1.03	[1.02-1.04]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p14.1	3	63982224		ATXN7			ENSG00000163635			rs1053338-A	rs1053338	0	1053338	missense_variant	0	NR	7E-10	9.154901959985743		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p13.2	1	113905767		DCLRE1B			ENSG00000118655			rs11552449-T	rs11552449	0	11552449	missense_variant	0	NR	1E-9	9		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p12	1	117687599		VDAC2P3 - PNRC2P1	ENSG00000213262	ENSG00000228217		45960	90488	rs7529522-T	rs7529522	0	7529522	regulatory_region_variant	1	NR	5E-10	9.301029995663981		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3q23	3	141394018		ZBTB38			ENSG00000177311			rs34207738-CTT	rs34207738	0	34207738	intron_variant	0	NR	2E-15	14.698970004336019		0.95	[0.94-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3q26.31	3	172567447		LINC02068			ENSG00000223387			rs58058861-A	rs58058861	0	58058861	intron_variant	0	NR	3E-12	11.522878745280337		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	4p14	4	38814717		TLR1			ENSG00000174125			rs6815814-A	rs6815814	0	6815814	intron_variant	0	NR	1E-11	11		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"											4:84370124-TA	4:84370124	0			1	NR	4E-10	9.397940008672037		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q25.2	6	152115881		ESR1			ENSG00000091831			rs2747652-T	rs2747652	0	2747652	intron_variant	0	NR	6E-28	27.221848749616356		0.94	[0.93-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7p15.3	7	21901342		"DNAH11, CDCA7L"			"ENSG00000105877, ENSG00000164649"			rs7971-A	rs7971	0	7971	3_prime_UTR_variant	0	NR	2E-7	6.698970004336019		1.03	[1.02-1.04]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7p15.1	7	28317270		CREB5			ENSG00000146592			rs17156577-T	rs17156577	0	17156577	intron_variant	0	NR	2E-8	7.698970004336019		0.95	[0.93-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q21.2	7	92001306		AKAP9			ENSG00000127914			rs6964587-T	rs6964587	0	6964587	missense_variant	0	NR	3E-12	11.522878745280337		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q21.3	7	94484487		COL1A2 - RNU6-1328P	ENSG00000164692	ENSG00000222870		53260	10812	rs17268829-T	rs17268829	0	17268829	intergenic_variant	1	NR	4E-15	14.397940008672037		0.95	[0.94-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q22.1	7	101909160		CUX1			ENSG00000257923			rs71559437-A	rs71559437	0	71559437	intron_variant	0	NR	1E-12	12		0.93	[0.92-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q32.3	7	130982362		LINC-PINT			ENSG00000231721			rs4593472-T	rs4593472	0	4593472	intron_variant	0	NR	2E-13	12.698970004336019		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q34	7	140242504		RNU1-58P - PPP1R2P6	ENSG00000199283	ENSG00000241661		472	50248	rs11977670-A	rs11977670	0	11977670	TF_binding_site_variant	1	NR	1E-19	19		1.05	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	7q35	7	144377836		ARHGEF5			ENSG00000050327			rs720475-A	rs720475	0	720475	intron_variant	0	NR	2E-11	10.698970004336019		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8p23.3	8	220692		RPL23AP53			ENSG00000223508			rs66823261-T	rs66823261	0	66823261	intron_variant	0	NR	1E-8	8		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8p12	8	29652100		RPL17P33 - LINC00589	ENSG00000243844	ENSG00000251191		19456	21822	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	NR	8E-26	25.096910013008056		1.07	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8p11.23	8	37000965		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		64840	94185	rs13365225-A	rs13365225	0	13365225	intergenic_variant	1	NR	1E-23	23		1.07	[1.06-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q21.13	8	75318066		CASC9			ENSG00000249395			rs6472903-T	rs6472903	0	6472903	intron_variant	0	NR	1E-23	23		1.08	[1.07-1.1]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q21.13	8	75505702		HNF4G			ENSG00000164749			rs2943559-A	rs2943559	0	2943559	intron_variant	0	NR	7E-19	18.154901959985743		0.91	[0.9-0.93]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q22.3	8	101466731		RN7SL563P - GRHL2	ENSG00000239211	ENSG00000083307		68798	25708	rs514192-A	rs514192	0	514192	intron_variant	1	NR	1E-11	11		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q23.1	8	105346392		ZFPM2			ENSG00000169946			rs12546444-A	rs12546444	0	12546444	intron_variant	0	NR	4E-12	11.397940008672037		1.07	[1.05-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q23.3	8	116197325		LINC00536			ENSG00000249917			rs13267382-A	rs13267382	0	13267382	intron_variant	0	NR	2E-12	11.698970004336019		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q24.13	8	123597926		RN7SKP155 - KLHL38	ENSG00000251840	ENSG00000175946		8880	46516	rs58847541-A	rs58847541	0	58847541	intergenic_variant	1	NR	5E-13	12.301029995663981		1.06	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q24.13	8	123745421		ANXA13 - FAM91A1	ENSG00000104537	ENSG00000176853		8019	23018	rs17350191-T	rs17350191	0	17350191	intergenic_variant	1	NR	1E-10	10		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q24.21	8	127343372		"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-A	rs13281615	0	13281615	intron_variant	0	NR	2E-55	54.69897000433602		0.91	[0.9-0.92]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	8q24.21	8	128182395		PVT1			ENSG00000249859			rs11780156-T	rs11780156	0	11780156	intron_variant	0	NR	2E-9	8.698970004336019		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q31.2	9	107543834		PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	NR	3E-21	20.522878745280337		1.06	[1.05-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q31.2	9	108074792		RPL31P43 - CHCHD4P2	ENSG00000213557	ENSG00000237360		34200	22640	rs10816625-A	rs10816625	0	10816625	regulatory_region_variant	1	NR	8E-27	26.096910013008056		0.9	[0.89-0.92]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q31.2	9	108074895		RPL31P43 - CHCHD4P2	ENSG00000213557	ENSG00000237360		34303	22537	rs13294895-T	rs13294895	0	13294895	regulatory_region_variant	1	NR	7E-17	16.154901959985743		1.07	[1.05-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q31.2	9	108133073		CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		35222	493760	rs676256-T	rs676256	0	676256	intergenic_variant	1	NR	3E-53	52.52287874528034		1.1	[1.09-1.12]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	4q22.1	4	88322666		PPM1K-DT			ENSG00000246375			rs10022462-T	rs10022462	0	10022462	intron_variant	0	NR	3E-10	9.522878745280337		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	4q24	4	105163621		TET2			ENSG00000168769			rs9790517-T	rs9790517	0	9790517	intron_variant	0	NR	2E-9	8.698970004336019		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	4q28.1	4	125922349		TMEM248P1 - LINC02379	ENSG00000249555	ENSG00000251649		198132	141779	rs77528541-T	rs77528541	0	77528541	intron_variant	1	NR	7E-10	9.154901959985743		0.94	[0.93-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	4q34.1	4	174925275		ADAM29			ENSG00000168594			rs6828523-A	rs6828523	0	6828523	intron_variant	0	NR	5E-27	26.30102999566398		0.91	[0.9-0.93]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5p15.33	5	344994		"PDCD6-AHRR, AHRR"			"ENSG00000288622, ENSG00000063438"			rs116095464-T	rs116095464	1	62641919	intron_variant	0	NR	6E-9	8.221848749616356		0.92	[0.9-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5p15.33	5	1279675		TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	NR	2E-20	19.69897000433602		1.06	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5p15.33	5	1296141		TERT - MIR4457	ENSG00000164362	ENSG00000263670		1073	13169	rs3215401-A	rs3215401	0	3215401	intergenic_variant	1	NR	3E-23	22.522878745280337		1.07	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5p13.3	5	32567626		SUB1			ENSG00000113387			rs2012709-T	rs2012709	0	2012709	intron_variant	0	NR	6E-8	7.221848749616356		1.03	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5p12	5	44706396		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-A	rs10941679	0	10941679	intergenic_variant	1	NR	1E-80	80		0.89	[0.88-0.9]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q11.1	5	50899260		PARP8 - LINC02106	ENSG00000151883	ENSG00000251573		52741	69957	rs35951924-A	rs35951924	0	35951924	regulatory_region_variant	1	NR	3E-10	9.522878745280337		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q11.2	5	56757896		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		151664	57653	rs62355902-A	rs62355902	0	62355902	intergenic_variant	1	NR	2E-86	85.69897000433602		0.87	[0.86-0.88]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q11.2	5	58888234		RAB3C - PDE4D	ENSG00000152932	ENSG00000113448		28840	80804	rs10472076-T	rs10472076	0	10472076	regulatory_region_variant	1	NR	2E-7	6.698970004336019		0.97	[0.96-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q11.2	5	59041654		PDE4D			ENSG00000113448			rs1353747-T	rs1353747	0	1353747	intron_variant	0	NR	3E-9	8.522878745280337		1.06	[1.04-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q14.2	5	82242227		ATG10			ENSG00000152348			rs7707921-A	rs7707921	0	7707921	intron_variant	0	NR	1E-12	12		1.05	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q22.1	5	111882089		NREP			ENSG00000134986			rs6882649-T	rs6882649	0	6882649	intron_variant	0	NR	6E-10	9.221848749616356		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q31.1	5	133071366		HSPA4			ENSG00000170606			rs6596100-T	rs6596100	0	6596100	intron_variant	0	NR	2E-8	7.698970004336019		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q33.3	5	158817075		EBF1			ENSG00000164330			rs1432679-T	rs1432679	0	1432679	intron_variant	0	NR	5E-37	36.30102999566398		0.93	[0.92-0.94]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	5q35.1	5	170164483		KRT18P41 - LINC01187	ENSG00000253219	ENSG00000249601		22543	27096	rs4562056-T	rs4562056	0	4562056	intergenic_variant	1	NR	5E-10	9.301029995663981		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6p23	6	13722291		RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		10456	64266	rs204247-A	rs204247	0	204247	intergenic_variant	1	NR	3E-14	13.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6p22.3	6	16399326		ATXN1			ENSG00000124788			rs3819405-T	rs3819405	0	3819405	intron_variant	0	NR	6E-7	6.221848749616356		0.97	[0.96-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6p22.3	6	20621007		CDKAL1			ENSG00000145996			rs2223621-T	rs2223621	0	2223621	intron_variant	0	NR	2E-8	7.698970004336019		1.03	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6p22.1	6	28958443		LINC01556 - KRT18P1	ENSG00000204709	ENSG00000228666		13906	10687	rs9257408-C	rs9257408	0	9257408	TF_binding_site_variant	1	NR	3E-7	6.522878745280337		1.03	[1.02-1.04]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q14.1	6	80384570		RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		10001	85501	rs12207986-A	rs12207986	0	12207986	intergenic_variant	1	NR	2E-10	9.698970004336019		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q14.1	6	81418669		RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		948241	72770	rs17529111-T	rs17529111	0	17529111	intergenic_variant	1	NR	3E-10	9.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	6q23.1	6	130027974		L3MBTL3			ENSG00000198945			rs6569648-T	rs6569648	0	6569648	intron_variant	0	NR	2E-12	11.698970004336019		1.05	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1q22	1	155176305		TRIM46			ENSG00000163462			rs4971059-A	rs4971059	0	4971059	intron_variant	0	NR	2E-10	9.698970004336019		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q32.33	14	104745925		ADSS1			ENSG00000185100			rs10623258-CTT	rs10623258	0	10623258	intron_variant	0	NR	8E-8	7.096910013008056		1.03	[1.02-1.04]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2p25.1	2	9995553		GRHL1			ENSG00000134317			rs113577745-C	rs113577745	0	113577745	intron_variant	0	NR	5E-10	9.301029995663981		0.94	[0.92-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2p24.1	2	19121042		LINC01376			ENSG00000236204			rs12710696-T	rs12710696	0	12710696	intron_variant	0	NR	6E-11	10.221848749616356		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2p23.3	2	24906604		ADCY3			ENSG00000138031			rs6725517-A	rs6725517	0	6725517	intron_variant	0	NR	5E-11	10.301029995663981		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q13	2	111168155		"MIR4435-2HG, BCL2L11"			"ENSG00000172965, ENSG00000153094"			rs71801447-CTTATGTT	rs71801447	1	3833441	3_prime_UTR_variant	0	NR	2E-7	6.698970004336019		0.94	[0.92-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q14.2	2	120487546		LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-T	rs4849887	0	4849887	intergenic_variant	1	NR	2E-25	24.69897000433602		0.91	[0.9-0.93]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q31.1	2	172108243		DLX2-DT			ENSG00000236651			rs2016394-A	rs2016394	0	2016394	intron_variant	0	NR	3E-12	11.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q31.1	2	173348166		RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-A	rs1550623	0	1550623	intron_variant	1	NR	6E-10	9.221848749616356		1.05	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q33.1	2	201316524		"FLACC1, CASP8"			"ENSG00000155749, ENSG00000064012"			rs1830298-T	rs1830298	0	1830298	intron_variant	0	NR	6E-24	23.221848749616356		0.94	[0.93-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q35	2	217056046		DIRC3-AS1			ENSG00000233143			rs4442975-T	rs4442975	0	4442975	intron_variant	0	NR	2E-97	96.69897000433602		0.88	[0.87-0.89]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q35	2	217098337		DIRC3-AS1			ENSG00000233143			rs34005590-A	rs34005590	0	34005590	intron_variant	0	NR	5E-41	40.30102999566398		0.82	[0.79-0.84]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q35	2	217431785		DIRC3			ENSG00000231672			rs16857609-T	rs16857609	0	16857609	intron_variant	0	NR	2E-31	30.69897000433602		1.07	[1.06-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	2q36.3	2	226362236		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		632349	296474	rs12479355-A	rs12479355	0	12479355	intergenic_variant	1	NR	4E-8	7.3979400086720375		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p26.1	3	4700592		ITPR1			ENSG00000150995			rs6762644-A	rs6762644	0	6762644	intron_variant	0	NR	1E-18	18		0.95	[0.94-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p24.1	3	27374522		SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	NR	5E-62	61.30102999566398		1.1	[1.09-1.11]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p24.1	3	30641447		TGFBR2			ENSG00000163513			rs12493607-C	rs12493607	0	12493607	intron_variant	0	NR	3E-16	15.522878745280337		1.05	[1.04-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p21.31	3	46825376		PRSS44P - PRSS42P	ENSG00000226074	ENSG00000178055		12890	4166	rs6796502-A	rs6796502	0	6796502	intergenic_variant	1	NR	7E-16	15.154901959985743		0.93	[0.91-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p22.3	1	87691240		PKN2-AS1			ENSG00000237505			rs17426269-A	rs17426269	0	17426269	intron_variant	0	NR	2E-8	7.698970004336019		1.05	[1.03-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3p13	3	71482962		FOXP1			ENSG00000114861			rs6805189-T	rs6805189	0	6805189	intron_variant	0	NR	4E-8	7.3979400086720375		1.03	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	3q12.1	3	100004736		"CMSS1, FILIP1L"			"ENSG00000184220, ENSG00000168386"			rs9833888-T	rs9833888	0	9833888	intron_variant	0	NR	3E-10	9.522878745280337		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1p11.2	1	121538815		"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-A	rs11249433	0	11249433	intron_variant	0	NR	8E-54	53.096910013008056		0.91	[0.89-0.92]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1q21.1	1	145790097		RNF115			ENSG00000265491			rs12405132-T	rs12405132	0	12405132	intron_variant	0	NR	5E-9	8.301029995663981		0.96	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	1q21.2	1	149955122		OTUD7B			ENSG00000264522			rs12048493-A	rs12048493	0	12048493	intron_variant	0	NR	4E-14	13.397940008672037		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q33.1	9	116551207		"ASTN2-AS1, ASTN2"			"ENSG00000229105, ENSG00000148219"			rs1895062-A	rs1895062	0	1895062	intron_variant	0	NR	1E-13	13		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	9q33.3	9	126634155		LMX1B			ENSG00000136944			rs10760444-A	rs10760444	0	10760444	intron_variant	0	NR	8E-14	13.096910013008056		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"											rs8176636-T	rs8176636	0	8176636		1	NR	5E-10	9.301029995663981		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10p14	10	9046151		LINC02676 - LINC00709	ENSG00000234752	ENSG00000230014		131555	229682	rs67958007-T	rs67958007	0	67958007	intergenic_variant	1	NR	5E-10	9.301029995663981		1.06	[1.04-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10p12.31	10	21744013		MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	NR	2E-19	18.69897000433602		1.06	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10p12.31	10	22026914		DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		23145	136078	rs11814448-A	rs11814448	0	11814448	intergenic_variant	1	NR	4E-18	17.397940008672037		0.84	[0.8-0.87]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q21.2	10	62540131		LINC02929			ENSG00000285551			rs10995201-A	rs10995201	0	10995201	intron_variant	0	NR	5E-52	51.30102999566398		1.14	[1.12-1.16]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q22.3	10	79081391		ZMIZ1			ENSG00000108175			rs704010-T	rs704010	0	704010	intron_variant	0	NR	3E-38	37.52287874528034		1.08	[1.06-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q23.33	10	93532431		CEP55 - FFAR4	ENSG00000138180	ENSG00000186188		3339	34234	rs140936696-CAA	rs140936696	1	59954380	intergenic_variant	1	NR	5E-8	7.301029995663981		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q25.2	10	113014168		TCF7L2			ENSG00000148737			rs7904519-A	rs7904519	0	7904519	intron_variant	0	NR	2E-13	12.698970004336019		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q26.12	10	121334387		LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		148421	76529	rs11199914-T	rs11199914	0	11199914	intergenic_variant	1	NR	4E-13	12.397940008672037		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q26.13	10	121580797		FGFR2			ENSG00000066468			rs2981578-T	rs2981578	0	2981578	intron_variant	0	NR	2E-291	290.69897000433605		0.81	[0.81-0.82]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	10q26.13	10	121589810		FGFR2			ENSG00000066468			rs45631563-A	rs45631563	0	45631563	intron_variant	0	NR	1E-35	35		1.21	[1.18-1.25]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11p15.5	11	803017		PIDD1			ENSG00000177595			rs6597981-A	rs6597981	0	6597981	3_prime_UTR_variant	0	NR	3E-12	11.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11p15.5	11	1887776		LSP1			ENSG00000130592			rs3817198-T	rs3817198	0	3817198	intron_variant	0	NR	6E-21	20.221848749616356		0.94	[0.93-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11q13.1	11	65815595		OVOL1 - CFL1	ENSG00000172818	ENSG00000172757		18381	7427	rs3903072-T	rs3903072	0	3903072	intergenic_variant	1	NR	6E-12	11.221848749616356		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11q13.3	11	69564393		LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		69441	76763	rs75915166-A	rs75915166	0	75915166	intergenic_variant	1	NR	1E-96	96		1.3	[1.27-1.33]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	11q24.3	11	129591276		RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-T	rs11820646	0	11820646	regulatory_region_variant	1	NR	3E-15	14.522878745280337		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12p13.1	12	14260997		GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		5771	95845	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	NR	2E-20	19.69897000433602		1.06	[1.05-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12p11.22	12	28021884		PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-T	rs7297051	0	7297051	TF_binding_site_variant	1	NR	6E-72	71.22184874961636		0.89	[0.87-0.9]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12q21.31	12	84615658		RPL6P25 - SLC6A15	ENSG00000213270	ENSG00000072041		1463468	243833	rs202049448-T	rs202049448	0	202049448	intergenic_variant	1	NR	9E-7	6.045757490560675		1.03	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12q22	12	95633983		PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	NR	1E-40	40		1.09	[1.07-1.1]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12q24.21	12	115398717		TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	1	NR	1E-47	47		1.09	[1.08-1.1]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	12q24.31	12	120394343		RPS27P25 - COX6A1	ENSG00000239881	ENSG00000111775		22655	43747	rs206966-T	rs206966	0	206966	intron_variant	1	NR	5E-8	7.301029995663981		1.05	[1.03-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	13q22.1	13	73383544		RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		156284	24224	rs6562760-A	rs6562760	0	6562760	intergenic_variant	1	NR	1E-9	9		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q13.3	14	36663564		PAX9			ENSG00000198807			rs2236007-A	rs2236007	0	2236007	intron_variant	0	NR	1E-25	25		0.93	[0.92-0.94]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q24.1	14	68193711		RAD51B			ENSG00000182185			rs2588809-T	rs2588809	0	2588809	intron_variant	0	NR	1E-14	14		1.07	[1.05-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q24.1	14	68567965		RAD51B			ENSG00000182185			rs999737-T	rs999737	0	999737	intron_variant	0	NR	1E-38	38		0.91	[0.9-0.92]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	14q32.11	14	91374725		CCDC88C			ENSG00000015133			rs941764-A	rs941764	0	941764	intron_variant	0	NR	2E-13	12.698970004336019		0.96	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q12.2	16	53821379		FTO			ENSG00000140718			rs11075995-A	rs11075995	0	11075995	intron_variant	0	NR	3E-11	10.522878745280337		1.04	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q12.2	16	54648152		LINC02183 - CRNDE	ENSG00000283304	ENSG00000245694		89052	197037	rs28539243-A	rs28539243	0	28539243	intron_variant	1	NR	1E-15	15		1.05	[1.04-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q13	16	56387075		AMFR			ENSG00000159461			rs2432539-A	rs2432539	0	2432539	intron_variant	0	NR	3E-10	9.522878745280337		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q23.2	16	80616908		CDYL2			ENSG00000166446			rs13329835-A	rs13329835	0	13329835	intron_variant	0	NR	3E-28	27.522878745280337		0.92	[0.91-0.94]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	16q24.2	16	87051631		LINC02188 - LINC02181	ENSG00000261175	ENSG00000232190		309548	6153	rs4496150-A	rs4496150	0	4496150	intergenic_variant	1	NR	2E-10	9.698970004336019		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	17q11.2	17	30903503		TEFM			ENSG00000172171			rs146699004-G	rs146699004	1	10612648	intron_variant	0	NR	6E-10	9.221848749616356		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	17q22	17	55132413		STXBP4			ENSG00000166263			rs2787486-A	rs2787486	0	2787486	intron_variant	0	NR	2E-34	33.69897000433602		1.08	[1.07-1.09]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	18q11.2	18	26757460		AQP4-AS1			ENSG00000260372			rs527616-C	rs527616	0	527616	intron_variant	0	NR	8E-16	15.096910013008056		0.95	[0.94-0.96]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	18q11.2	18	26990703		"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs1436904-T	rs1436904	0	1436904	intron_variant	0	NR	8E-16	15.096910013008056		1.05	[1.04-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	18q12.1	18	27821241		PA2G4P3 - CDH2	ENSG00000263405	ENSG00000170558		367584	111638	rs36194942-A	rs36194942	0	36194942	intergenic_variant	1	NR	3E-6	5.522878745280337		1.03	[1.02-1.04]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	18q12.1	18	32397726		GAREM1			ENSG00000141441			rs117618124-T	rs117618124	0	117618124	intron_variant	0	NR	1E-11	11		1.11	[1.08-1.15]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	18q12.3	18	44819625		SETBP1			ENSG00000152217			rs6507583-A	rs6507583	0	6507583	intron_variant	0	NR	1E-13	13		1.08	[1.06-1.11]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	19p13.12	19	13843757		MIR23AHG - NANOS3	ENSG00000267519	ENSG00000187556		829	18306	rs2594714-A	rs2594714	0	2594714	regulatory_region_variant	1	NR	4E-10	9.397940008672037		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	19p13.11	19	18460331		ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	NR	2E-31	30.69897000433602		1.07	[1.06-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	19p13.11	19	19434887		GATAD2A			ENSG00000167491			rs2965183-A	rs2965183	0	2965183	intron_variant	0	NR	1E-11	11		1.04	[1.03-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	19q13.31	19	43782361		KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	NR	2E-14	13.698970004336019		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	19q13.32	19	45679774		GIPR			ENSG00000010310			rs71338792-A	rs71338792	0	71338792	intron_variant	0	NR	3E-10	9.522878745280337		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	20q13.13	20	50329374		LINC01271 - RN7SL636P	ENSG00000233077	ENSG00000244376		7888	99816	rs6122906-A	rs6122906	0	6122906	intergenic_variant	1	NR	4E-11	10.397940008672037		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	21q21.1	21	15148511		LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		80674	342019	rs2823093-A	rs2823093	0	2823093	intergenic_variant	1	NR	2E-21	20.69897000433602		0.94	[0.92-0.95]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	22q13.1	22	38172826		PLA2G6			ENSG00000184381			rs738321-C	rs738321	0	738321	intron_variant	0	NR	7E-14	13.154901959985743		1.05	[1.03-1.06]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	22q13.1	22	40480230		MRTFA			ENSG00000196588			rs6001930-T	rs6001930	0	6001930	intron_variant	0	NR	5E-34	33.30102999566398		0.9	[0.89-0.92]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	5q11.2	5	56758507		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		152275	57042	rs112776581-T	rs112776581	0	112776581	intergenic_variant	1	0.11	4E-14	13.397940008672037	(conditional)	1.21	[1.15-1.27]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	6q25.1	6	151687847		ESR1			ENSG00000091831			rs2941741-A	rs2941741	0	2941741	intron_variant	0	0.13	8E-10	9.096910013008056	(conditional)	1.13	[1.08-1.17]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	9p21.3	9	22006349		"CDKN2B, CDKN2B-AS1"			"ENSG00000147883, ENSG00000240498"			rs974336-T	rs974336	0	974336	intron_variant	0	0.22	6E-9	8.221848749616356	(conditional)	1.1	[1.06-1.13]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	10q21.2	10	62540572		LINC02929			ENSG00000285551			rs78053936-A	rs78053936	0	78053936	intron_variant	0	0.8	2E-8	7.698970004336019	(conditional)	1.11	[1.07-1.15]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	12q24.21	12	115563598		TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		795609	29006	rs61929345-T	rs61929345	0	61929345	intergenic_variant	1	0.16	5E-8	7.301029995663981	(conditional)	1.11	[1.07-1.15]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	16q12.1	16	52552565		CASC16			ENSG00000249231			rs3803661-A	rs3803661	0	3803661	intron_variant	0	0.63	4E-8	7.3979400086720375	(conditional)	1.08	[1.05-1.12]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	18q12.3	18	45304061		SLC14A2			ENSG00000132874			rs12455117-A	rs12455117	0	12455117	intron_variant	0	0.68	2E-8	7.698970004336019	(conditional)	1.09	[1.06-1.12]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"35,035 East Asian ancestry cases, 35,771 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	NA	21q21.1	21	15189384		LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		121547	301146	rs2823126-A	rs2823126	0	2823126	intergenic_variant	1	0.28	1E-10	10	(conditional)	0.9	[0.88-0.93]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90091211	Genome-wide genotyping array				
12/20/2021	32139696	Shu X	3/5/2020	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32139696	Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants.	Breast cancer	"24,206 East Asian ancestry cases, 24,775 East Asian ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	"10,829 East Asian ancestry cases, 10,996 East Asian ancestry controls, 5,958 Asian ancestry cases, 5,684 Asian ancestry controls"	22q13.31	22	45887417		ATXN10 - WNT7B	ENSG00000130638	ENSG00000188064		42110	32949	rs28512361-A	rs28512361	0	28512361	intron_variant	1	NR	1E-8	8		1.06	[1.04-1.08]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90090980	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	6q12	6	66197278	AC002485.1	NUFIP1P1 - RNU7-66P	ENSG00000218890	ENSG00000238949		102369	531565	rs112319963-?	rs112319963	0	112319963	intergenic_variant	1	0.01	2E-6	5.698970004336019		4	[2.22-7.69]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	6p23	6	14107800	CD83	RNF182 - CD83	ENSG00000180537	ENSG00000112149		127490	9456	rs71564305-?	rs71564305	0	71564305	intergenic_variant	1	0.04	3E-6	5.522878745280337		2.3255813	[1.59-20]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	3q25.1	3	151704793	AADACL2	LINC02066 - AADACL2	ENSG00000241151	ENSG00000197953		46827	29123	rs9834244-?	rs9834244	0	9834244	intergenic_variant	1	0.09	8E-7	6.096910013008056		1.6949153	[1.37-2.7]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	8q22.3	8	103189173	BAALC	"BAALC, BAALC-AS1"			"ENSG00000164929, ENSG00000247081"			rs12548629-?	rs12548629	0	12548629	intron_variant	0	0.27	3E-7	6.522878745280337		1.4084507	[1.23-1.72]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	9q21.32	9	83217469	RP11-439K3.1	RN7SKP242 - FRMD3-AS1	ENSG00000251776	ENSG00000229109		16241	1819	rs13293114-?	rs13293114	0	13293114	intergenic_variant	1	0.36	4E-6	5.3979400086720375		1.3157895	[1.18-1.56]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	20q12	20	39049018	DHX35	DHX35 - LINC01734	ENSG00000101452	ENSG00000230324		9295	164759	rs6071641-?	rs6071641	0	6071641	regulatory_region_variant	1	0.42	6E-6	5.221848749616356		1.3157895	[1.18-1.59]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	6q27	6	166308998	PRR18	PRR18 - SFT2D1	ENSG00000176381	ENSG00000198818		550	10730	rs4075454-?	rs4075454	0	4075454	intergenic_variant	1	0.49	5E-6	5.301029995663981		1.2987013	[1.16-1.52]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	12q24.33	12	130560585	RIMBP2	RIMBP2			ENSG00000060709			rs7975553-?	rs7975553	0	7975553	intron_variant	0	0.43	6E-6	5.221848749616356		1.2987013	[1.16-1.47]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	20q12	20	39051206	DHX35	DHX35 - LINC01734	ENSG00000101452	ENSG00000230324		11483	162571	rs742276-?	rs742276	0	742276	intergenic_variant	1	0.44	9E-6	5.045757490560675		1.2987013	[1.15-1.52]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	11p15.4	11	7379559	SYT9	SYT9			ENSG00000170743			rs1023996-G	rs1023996	0	1023996	intron_variant	0	0.58	2E-6	5.698970004336019		1.32	[1.18-1.48]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	10p12.2	10	23995722	KIAA1217	KIAA1217			ENSG00000120549			rs11013837-T	rs11013837	0	11013837	intron_variant	0	0.77	6E-6	5.221848749616356		1.37	[1.19-1.58]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	7p14.1	7	38728314	VPS41	VPS41			ENSG00000006715			rs1468348-T	rs1468348	0	1468348	intron_variant	0	0.8	5E-6	5.301029995663981		1.39	[1.25-1.6]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	19q13.41	19	52526945	ZNF808	ZNF578 - ZNF808	ENSG00000258405	ENSG00000198482		10063	707	rs162277-C	rs162277	0	162277	regulatory_region_variant	1	0.79	7E-6	5.154901959985743		1.41	[1.26-1.63]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	7p14.1	7	38712494	VPS41	FAM183BP - VPS41	ENSG00000164556	ENSG00000006715		25457	10480	rs7794030-A	rs7794030	0	7794030	intergenic_variant	1	0.81	1E-6	6		1.43	[1.29-1.65]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	4p16.2	4	4794716	MSX1	STX18-AS1 - LINC01396	ENSG00000247708	ENSG00000273396		7357	49472	rs34775372-C	rs34775372	0	34775372	intergenic_variant	1	0.92	6E-6	5.221848749616356		1.69	[1.33-2.13]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA				intergenic							chr1:34655226-?	chr1:34655226	0			1	0.95	7E-6	5.154901959985743		2.05	[1.48-2.84]]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	19q13.42	19	55035675	GP6	"GP6-AS1, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6, GP6"			"ENSG00000267265, ENSG00000275633, ENSG00000278316, ENSG00000275931, ENSG00000277439, ENSG00000278670, ENSG00000274050, ENSG00000276065, ENSG00000276211, ENSG00000274566, ENSG00000088053"			rs112822051-C	rs112822051	0	112822051	intron_variant	0	0.97	3E-6	5.522878745280337		2.56	[1.67-3.93]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
8/1/2018	29698419	Pande M	4/26/2018	PLoS One	www.ncbi.nlm.nih.gov/pubmed/29698419	Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.	Breast cancer and/or colorectal cancer	"589 European ancestry colorectal cancer with a family history of breast cancer cases, 378 European ancestry breast cancer cases with a family history of colorectal cancer cases, 18 European ancestry breast and colorectal cancer cases, 1,769 European ancestry controls"	NA	20p11.23	20	19518790	SLC24A3	SLC24A3			ENSG00000185052			rs113118767-T	rs113118767	0	113118767	intron_variant	0	0.99	9E-6	5.045757490560675		4.02	[1.99-8.13]	Illumina [6220060] (imputed)	N	"colorectal cancer, breast carcinoma"	"http://purl.obolibrary.org/obo/MONDO_0005575, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST006035	Genome-wide genotyping array				
4/1/2015	25038754	Cai Q	7/20/2014	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	"Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1."	Breast cancer	"2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls"	"5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls"	1q32.1	1	203797203	ZC3H11A	"ZC3H11A, ZBED6"			"ENSG00000058673, ENSG00000257315"			rs4951011-G	rs4951011	0	4951011	5_prime_UTR_variant	0	0.282	9E-9	8.045757490560675	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002537	Genome-wide genotyping array				
4/1/2015	25038754	Cai Q	7/20/2014	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	"Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1."	Breast cancer	"2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls"	"5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls"	5q14.3	5	91436408	ARRDC3	ARRDC3-AS1			ENSG00000281357			rs10474352-C	rs10474352	0	10474352	intron_variant	0	0.482	2E-9	8.698970004336019	(East Asian)	1.09	[1.06-1.12]	Affymetrix [up to 1930412] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002537	Genome-wide genotyping array				
4/1/2015	25038754	Cai Q	7/20/2014	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	"Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1."	Breast cancer	"2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls"	"5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls"	15q26.1	15	90968837	PRC1	"PRC1-AS1, PRC1"			"ENSG00000258725, ENSG00000198901"			rs2290203-G	rs2290203	0	2290203	3_prime_UTR_variant	0	0.504	4E-8	7.3979400086720375	(East Asian)	1.08	[1.05-1.11]	Affymetrix [up to 1930412] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002537	Genome-wide genotyping array				
4/1/2015	25038754	Cai Q	7/20/2014	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25038754	"Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1."	Breast cancer	"2,867 Chinese ancestry cases, 2,285 Chinese ancestry controls, 2,246 Korean ancestry cases, 2,052 Korean ancestry controls"	"5,029 Chinese ancestry cases, 5,302 Chinese ancestry controls, 6,066 Korean ancestry cases, 8,003 Korean ancestry controls, 6,572 Japanese ancestry cases, 6,539 Japanese ancestry controls, 16,003 European ancestry cases, 41,335 European ancestry controls"	18q11.2	18	23196687	NR	CABLES1			ENSG00000134508			rs11082321-A	rs11082321	0	11082321	intron_variant	0	0.21	7E-7	6.154901959985743	(East Asian)	1.08	[NR]	Affymetrix [up to 1930412] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002537	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	"131 European ancestry cases, 493 European ancestry controls"	NA	7q36.3	7	158170200	PTPRN2	PTPRN2			ENSG00000155093			rs117114682-G	rs117114682	0	117114682	intron_variant	0	0.02	2E-7	6.698970004336019		2.55	[1.61-4.02]	"Affymetrix, Illumina [16958466] (imputed)"	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST005112	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	"131 European ancestry cases, 493 European ancestry controls"	NA	1q32.3	1	213850882	PROX1	PROX1-AS1			ENSG00000230461			rs4342822-G	rs4342822	0	4342822	intron_variant	0	0.46	7E-9	8.154901959985743		1.92	[1.49-2.44]	"Affymetrix, Illumina [16958466] (imputed)"	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST005112	Genome-wide genotyping array				
1/9/2018	29059430	Morton LM	11/1/2017	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29059430	Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.	Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	"131 European ancestry cases, 493 European ancestry controls"	NA	11q23.3	11	117199645	TAGLN	TAGLN			ENSG00000149591			rs74949440-T	rs74949440	0	74949440	5_prime_UTR_variant	0	0.02	6E-8	7.221848749616356		2.59	[1.62-4.16]	"Affymetrix, Illumina [16958466] (imputed)"	N	"response to radiation, breast carcinoma"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST005112	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	1p13.3	1	109637134		AMPD2 - RPL7P8	ENSG00000116337	ENSG00000235045		5083	14236	rs17024629-T	rs17024629	0	17024629	intergenic_variant	1	0.16	3E-8	7.522878745280337		0.95	[0.94-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	5q31.1	5	132466255		"IRF1-AS1, IRF1"			"ENSG00000197536, ENSG00000125347"			rs2522057-C	rs2522057	0	2522057	intron_variant	0	0.6	1E-8	8		0.97	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	7q11.23	7	74944369		SPDYE12 - CASTOR2	ENSG00000184616	ENSG00000274070		29291	20336	rs1637365-T	rs1637365	0	1637365	intergenic_variant	1	0.31	4E-7	6.3979400086720375		1.04	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q24.1	15	74854991		SCAMP2			ENSG00000140497			rs1869959-A	rs1869959	0	1869959	intron_variant	0	0.3	5E-8	7.301029995663981		0.96	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q24.2	15	75436134		SIN3A			ENSG00000169375			rs60381548-CA	rs60381548	0	60381548	intron_variant	0	0.27	7E-9	8.154901959985743		0.96	[0.95-0.97]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"9,241 African ancestry cases, 10,193 African ancestry controls, 122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q26.3	15	100366889		SPATA41 - CERS3-AS1	ENSG00000189419	ENSG00000259430		16164	6047	rs181337095-A	rs181337095	1	12441640	intergenic_variant	1	0.84	2E-8	7.698970004336019		1.05	[1.04-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026461	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	1p13.3	1	109637134		AMPD2 - RPL7P8	ENSG00000116337	ENSG00000235045		5083	14236	rs17024629-T	rs17024629	0	17024629	intergenic_variant	1	0.16	1E-6	6		0.96	[0.94-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	5q31.1	5	132466255		"IRF1-AS1, IRF1"			"ENSG00000197536, ENSG00000125347"			rs2522057-C	rs2522057	0	2522057	intron_variant	0	0.59	9E-8	7.045757490560675		0.97	[0.96-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	7q11.23	7	74944369		SPDYE12 - CASTOR2	ENSG00000184616	ENSG00000274070		29291	20336	rs1637365-T	rs1637365	0	1637365	intergenic_variant	1	0.28	3E-6	5.522878745280337		1.04	[1.02-1.05]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q24.1	15	74854991		SCAMP2			ENSG00000140497			rs1869959-A	rs1869959	0	1869959	intron_variant	0	0.3	4E-7	6.3979400086720375		0.97	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q24.2	15	75436134		SIN3A			ENSG00000169375			rs60381548-CA	rs60381548	0	60381548	intron_variant	0	0.25	4E-7	6.3979400086720375		0.96	[0.95-0.98]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
11/19/2021	34234117	Adedokun B	7/7/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/34234117	Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women.	Breast cancer	"122,977 European ancestry cases, 105,974 European ancestry controls"	NA	15q26.3	15	100366889		SPATA41 - CERS3-AS1	ENSG00000189419	ENSG00000259430		16164	6047	rs181337095-A	rs181337095	1	12441640	intergenic_variant	1	0.87	3E-7	6.522878745280337		1.05	[1.03-1.07]	"Affymetrix, Illumina [NR] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90026467	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	10q26.13	10	121581496		FGFR2			ENSG00000066468			rs377595512-C	rs377595512	1	45631539	intron_variant	0	0.513325516	4E-24	23.397940008672037		0.8166771	[0.785289052-0.849319691]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	12p11.22	12	27987344		PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		14611	145905	rs1314084-T	rs1314084	0	1314084	intergenic_variant	1	0.837677862	4E-8	7.3979400086720375		1.1657724	[1.10391199-1.231099387]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	16q12.1	16	52565276		CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.229797027	4E-21	20.397940008672037		1.249785	[1.19319124-1.309062956]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	18q12.3	18	45304061		SLC14A2			ENSG00000132874			rs12455117-T	rs12455117	0	12455117	intron_variant	0	0.302885169	4E-8	7.3979400086720375		0.8866379	[0.849420099-0.925486452]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	21q22.12	21	34746798		LINC01426			ENSG00000234380			rs12483725-A	rs12483725	0	12483725	intron_variant	0	0.168742185	2E-9	8.698970004336019		1.1749938	[1.114850279-1.238381921]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	3q25.1	3	150762314		"SIAH2-AS1, SIAH2"			"ENSG00000244265, ENSG00000181788"			rs146383533-TTTTC	rs146383533	0	146383533	non_coding_transcript_exon_variant	0	0.349384138	1E-11	11		0.86398584	[0.828337909-0.901167893]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	5p12	5	44672681		LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		14112	43512	rs10941678-A	rs10941678	0	10941678	intergenic_variant	1	0.57826253	7E-12	11.154901959985743		1.1487857	[1.104188921-1.195183824]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	5q11.2	5	56758507		C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		152275	57042	rs112776581-T	rs112776581	0	112776581	intergenic_variant	1	0.09528834	6E-9	8.221848749616356		1.2234231	[1.143234678-1.309236175]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
2/26/2021	32514122	Ishigaki K	6/8/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32514122	Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.	Breast cancer	"5,552 Japanese ancestry cases, 89,731 Japanese ancestry controls"	NA	6q25.1	6	151628177		CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6984	28514	rs7763637-A	rs7763637	0	7763637	TF_binding_site_variant	1	0.243384187	5E-13	12.301029995663981		1.1814078	[1.129184761-1.236046211]	Illumina [8919992] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST90013695	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	4p13	4	42225480	"BEND4, ATP8A1, SHISA3"	BEND4 - SHISA3	ENSG00000188848	ENSG00000178343		72602	172008	rs17530621-T	rs17530621	0	17530621	intron_variant	1	0.107	4E-6	5.3979400086720375				NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	3q13.11	3	103342570	MIR548AB	NDUFA4P2 - MIR548AB	ENSG00000236691	ENSG00000265328		101340	181463	rs6804462-C	rs6804462	0	6804462	intergenic_variant	1	0.039	3E-6	5.522878745280337				NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	2q33.1	2	201647726	MPP4	MPP4			ENSG00000082126			rs11894115-T	rs11894115	0	11894115	missense_variant	0	0.395	5E-6	5.301029995663981	(adjusted)			NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	8q21.11	8	73291487	"RPL7, RDH10"	RPL7			ENSG00000147604			rs58328254-A	rs58328254	0	58328254	non_coding_transcript_exon_variant	0	0.194	6E-6	5.221848749616356	(adjusted)			NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	17q22	17	52431359	"CA10, C17orf112"	LINC01982			ENSG00000263317			rs2113374-T	rs2113374	0	2113374	intron_variant	0	0.061	1E-6	6				NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	9q21.2	9	76808695	PRUNE2	"PCA3, PRUNE2"			"ENSG00000225937, ENSG00000106772"			rs117299725-A	rs117299725	0	117299725	non_coding_transcript_exon_variant	0	0.055	3E-6	5.522878745280337				NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
8/25/2020	32378780	Park B	5/7/2020	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/32378780	Genome-Wide Association Study of Genetic Variants Related to Anthracycline-Induced Cardiotoxicity in Early Breast Cancer.	Anthracycline-induced cardiotoxicity in early breast cancer	"42 Korean ancestry cases, 215 Korean ancestry controls"	NA	16q23.3	16	83599215	CDH13	CDH13			ENSG00000140945			rs147631684-A	rs147631684	0	147631684	intron_variant	0	0.03	5E-6	5.301029995663981				NR [346946]	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST010456	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA	19q13.2	19	40796801		"RAB4B, MIA-RAB4B, RAB4B-EGLN2"			"ENSG00000167578, ENSG00000268975, ENSG00000171570"			rs7937-G	rs7937	0	7937	3_prime_UTR_variant	0	0.499	2E-9	8.698970004336019		4.641	[2.83-6.45] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr12:62399799-?	chr12:62399799	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	7.60101	[4.78-10.43] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr12:87868498-?	chr12:87868498	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	3018.78	[1880.74-4156.82] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:237572128-?	chr1:237572128	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	7.35764	[4.53-10.18] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:237802083-?	chr1:237802083	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	4.24012	[2.68-5.8] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:40469726-?	chr1:40469726	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	4.32845	[2.82-5.84] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:40635457-?	chr1:40635457	0			1	NR	6E-8	7.221848749616356	(adjusted for BMI and age)	3.81085	[2.42-5.2] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr14:51191413-?	chr14:51191413	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	7.22534	[4.45-10] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:61340061-?	chr1:61340061	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	6.12149	[3.85-8.39] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr14:67518584-?	chr14:67518584	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	10.7142	[6.76-14.67] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:10747009-?	chr10:10747009	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	7664.19	[4836.65-10491.73] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr16:14267769-?	chr16:14267769	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.45442	[4.68-10.23] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:124519432-?	chr10:124519432	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	7.83348	[4.84-10.83] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr16:89403085-?	chr16:89403085	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	1593.87	[976.58-2211.16] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:53653695-?	chr10:53653695	0			1	NR	7E-8	7.154901959985743	(adjusted for BMI and age)	7565.12	[4740.11-10390.13] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:96352623-?	chr10:96352623	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	298.62	[185.33-411.91] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:124245417-?	chr11:124245417	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	5.63337	[3.63-7.63] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:125736286-?	chr11:125736286	0			1	NR	9E-8	7.045757490560675	(adjusted for BMI and age)	8.49866	[5.22-11.78] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:18800101-?	chr11:18800101	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	7.83522	[4.8-10.87] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:19079998-?	chr11:19079998	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.24386	[4.45-10.04] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:30591961-?	chr11:30591961	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	7.75267	[4.8-10.7] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:145112634-?	chr2:145112634	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	9.47505	[5.79-13.16] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:158481337-?	chr2:158481337	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.26094	[4.48-10.04] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:86383753-?	chr11:86383753	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	290.094	[182.54-397.65] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:164903262-?	chr2:164903262	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	7.37489	[4.55-10.2] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:165147193-?	chr2:165147193	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	282.96	[177.52-388.4] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr12:22298597-?	chr12:22298597	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	7.75013	[4.78-10.72] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:18575282-?	chr1:18575282	0			1	NR	1E-6	6	(adjusted for BMI and age)	7.22977	[4.46-10] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:218523861-?	chr1:218523861	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	7.35052	[4.54-10.16] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr13:31136156-?	chr13:31136156	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	7379.68	[4552.5-10206.86] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr13:37338715-?	chr13:37338715	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	572.896	[369.81-775.98] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr13:88533727-?	chr13:88533727	0			1	NR	9E-8	7.045757490560675	(adjusted for BMI and age)	8.93755	[5.6-12.28] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr14:21186596-?	chr14:21186596	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	7.21499	[4.46-9.97] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:40739498-?	chr1:40739498	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	2.43755	[1.53-3.35] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr14:66942487-?	chr14:66942487	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	7.19073	[4.43-9.95] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr1:96393837-?	chr1:96393837	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	44.7981	[27.7-61.89] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr15:90216983-?	chr15:90216983	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	5.21524	[3.19-7.24] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:115535228-?	chr10:115535228	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.21789	[5.17-11.27] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr16:71962196-?	chr16:71962196	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	2.99816	[1.85-4.14] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr10:3732457-?	chr10:3732457	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	14.2429	[9.23-19.25] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr16:89763741-?	chr16:89763741	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.60079	[4.79-10.42] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr18:12957148-?	chr18:12957148	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	105.955	[66.62-145.29] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr18:39466431-?	chr18:39466431	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.35526	[5.13-11.58] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr18:74221220-?	chr18:74221220	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	1.45119	[1.09-1.82] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA	19q13.2	19	40847202		CYP2A6			ENSG00000255974			rs56113850-T	rs56113850	0	56113850	intron_variant	0	0.46	2E-13	12.698970004336019	(adjusted for BMI and age)	4693.72	[3102.87-6284.57] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:140974641-?	chr2:140974641	0			1	NR	2E-8	7.698970004336019	(adjusted for BMI and age)	8.83726	[5.44-12.23] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:30756577-?	chr11:30756577	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	24.5621	[15.03-34.09] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr11:37904889-?	chr11:37904889	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	3578.01	[2207.26-4948.76] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:164698212-?	chr2:164698212	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	7.49144	[4.61-10.38] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr12:190052-?	chr12:190052	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	272.457	[167.04-377.87] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:192120617-?	chr2:192120617	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	7379.68	[4552.5-10206.86] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:207888497-?	chr2:207888497	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	3.95688	[2.43-5.48] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:223666953-?	chr2:223666953	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)	10.0703	[6.15-13.99] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:234120796-?	chr2:234120796	0			1	NR	1E-6	6	(adjusted for BMI and age)	3485.79	[2182.69-4788.89] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:46445356-?	chr2:46445356	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	7.53575	[4.77-10.3] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:61017655-?	chr2:61017655	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	6806.4	[4517.1-9095.7] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:81135543-?	chr2:81135543	0			1	NR	2E-8	7.698970004336019	(adjusted for BMI and age)	567.717	[373.03-762.4] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr2:8334810-?	chr2:8334810	0			1	NR	3E-8	7.522878745280337	(adjusted for BMI and age)	6.06219	[3.72-8.4] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr20:31217454-?	chr20:31217454	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	78.1053	[49.45-106.77] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr20:36937530-?	chr20:36937530	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	10.5901	[6.61-14.57] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr21:18595817-?	chr21:18595817	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	8.62058	[5.41-11.84] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr21:20169561-?	chr21:20169561	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	136.538	[84.91-188.17] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr21:22381398-?	chr21:22381398	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	1372.55	[843.47-1901.63] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr21:24969063-?	chr21:24969063	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	7565.12	[4740.11-10390.13] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr21:36009883-?	chr21:36009883	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	2010.62	[1251.41-2769.83] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr22:20305365-?	chr22:20305365	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	7664.19	[4836.65-10491.73] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr22:29586778-?	chr22:29586778	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.03168	[4.91-11.16] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr22:50919184-?	chr22:50919184	0			1	NR	1E-6	6	(adjusted for BMI and age)	81.061	[49.6-112.52] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:124384367-?	chr3:124384367	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.44696	[4.57-10.32] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:21960725-?	chr3:21960725	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	15.7066	[9.65-21.77] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:5105416-?	chr3:5105416	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	10.458	[6.56-14.35] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:51499076-?	chr3:51499076	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	7.00108	[4.53-9.47] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:88589768-?	chr3:88589768	0			1	NR	8E-8	7.096910013008056	(adjusted for BMI and age)	5.73395	[3.61-7.86] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr3:88833448-?	chr3:88833448	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.63938	[5.3-11.98] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:111423148-?	chr4:111423148	0			1	NR	8E-7	6.096910013008056	(adjusted for BMI and age)	356.558	[220.23-492.89] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:120325932-?	chr4:120325932	0			1	NR	6E-7	6.221848749616356	(adjusted for BMI and age)	10.9949	[6.95-15.04] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:172137853-?	chr4:172137853	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	8.01489	[4.89-11.14] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:26121279-?	chr4:26121279	0			1	NR	1E-6	6	(adjusted for BMI and age)	6.23136	[3.81-8.66] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:39020075-?	chr4:39020075	0			1	NR	1E-6	6	(adjusted for BMI and age)	9.20517	[5.78-12.63] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr4:469260-?	chr4:469260	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	2.02614	[1.24-2.81] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr5:127594512-?	chr5:127594512	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	8.23752	[5.21-11.27] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr5:134945087-?	chr5:134945087	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	3.66388	[2.27-5.06] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr5:31076996-?	chr5:31076996	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	7.87989	[5.03-10.73] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr5:77845543-?	chr5:77845543	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	12.0823	[7.55-16.61] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr5:94089117-?	chr5:94089117	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	2614.77	[1631.6-3597.94] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr6:139563884-?	chr6:139563884	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	4.47391	[2.91-6.04] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr6:43971181-?	chr6:43971181	0			1	NR	6E-8	7.221848749616356	(adjusted for BMI and age)	167.48	[108.23-226.73] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr7:109678047-?	chr7:109678047	0			1	NR	8E-8	7.096910013008056	(adjusted for BMI and age)	5.3356	[3.35-7.32] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr7:148308319-?	chr7:148308319	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	14.1942	[8.88-19.51] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr7:17003876-?	chr7:17003876	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	8.72974	[5.51-11.95] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr7:17115896-?	chr7:17115896	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	4.5872	[2.88-6.29] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr7:97618858-?	chr7:97618858	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	5.85417	[3.65-8.06] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:105935893-?	chr8:105935893	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	4.82465	[2.96-6.69] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:107479480-?	chr8:107479480	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	9.11969	[5.69-12.55] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:20118078-?	chr8:20118078	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	7.83701	[4.95-10.72] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:20347454-?	chr8:20347454	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	8.62065	[5.54-11.7] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:20687722-?	chr8:20687722	0			1	NR	1E-7	7	(adjusted for BMI and age)	7.28021	[4.46-10.1] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:23129776-?	chr8:23129776	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	317.7	[198.29-437.11] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:67221445-?	chr8:67221445	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	5.13636	[3.21-7.07] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:68344519-?	chr8:68344519	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	7.63217	[4.81-10.45] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:69703575-?	chr8:69703575	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.08224	[5.02-11.14] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr8:97732985-?	chr8:97732985	0			1	NR	5E-7	6.301029995663981	(adjusted for BMI and age)	7.06546	[4.33-9.8] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr9:18975010-?	chr9:18975010	0			1	NR	9E-7	6.045757490560675	(adjusted for BMI and age)	7.56375	[4.81-10.32] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr9:74975293-?	chr9:74975293	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	7.49425	[4.73-10.26] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr9:75089584-?	chr9:75089584	0			1	NR	3E-7	6.522878745280337	(adjusted for BMI and age)	8.23863	[5.21-11.27] unit decrease	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr9:75368467-?	chr9:75368467	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	4.68726	[2.93-6.44] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chr9:79978924-?	chr9:79978924	0			1	NR	4E-7	6.3979400086720375	(adjusted for BMI and age)	8.10293	[5.14-11.07] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chrX:12761506-?	chrX:12761506	0			1	NR	2E-7	6.698970004336019	(adjusted for BMI and age)	7.61012	[4.7-10.53] unit increase	Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
6/1/2022	34096894	Hertz DL	7/1/2021	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/34096894	Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.	Plasma letrozole concentrations in letrozole treated hormone-receptor-positive breast cancer	228 European ancestry individuals	NA											chrX:145845700-?	chrX:145845700	0			1	NR	7E-7	6.154901959985743	(adjusted for BMI and age)			Illumina [NR] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST90044900	Genome-wide genotyping array				
10/13/2021	33676726	Ahlstrom S	3/3/2021	Br J Anaesth	www.ncbi.nlm.nih.gov/pubmed/33676726	First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.	Rocuronium dose requirement in breast cancer surgery	918 European ancestry individuals	NA	12p12.1	12	21271069	SLCO1A2	SLCO1A2			ENSG00000084453			rs7967354-G	rs7967354	0	7967354	intron_variant	0	0.22	5E-11	10.301029995663981		0.1425	NR unit decrease	Illumina [653034]	N	response to neuromuscular blocker	http://www.ebi.ac.uk/efo/EFO_0600034	GCST012479	Genome-wide genotyping array				
10/13/2021	33676726	Ahlstrom S	3/3/2021	Br J Anaesth	www.ncbi.nlm.nih.gov/pubmed/33676726	First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.	Rocuronium dose requirement in breast cancer surgery	918 European ancestry individuals	NA	12p12.1	12	21355244	SLCO1A2	"SLCO1A2, IAPP"			"ENSG00000084453, ENSG00000121351"			rs11045995-G	rs11045995	0	11045995	intron_variant	0	0.18	1E-10	10		0.1473	NR unit decrease	Illumina [653034]	N	response to neuromuscular blocker	http://www.ebi.ac.uk/efo/EFO_0600034	GCST012479	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)	"1,852 European ancestry individuals"	NA	15q23	15	70759526		UACA			ENSG00000137831			rs62019060-G	rs62019060	0	62019060	intron_variant	0	NR	1E-8	8				Illumina [NR] (imputed)	N	"overall survival, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://purl.obolibrary.org/obo/GO_0097327"	GCST90104808	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)	"1,852 European ancestry individuals"	NA	19q13.12	19	36091745		WDR62			ENSG00000075702			rs35759606-T	rs35759606	0	35759606	intron_variant	0	NR	8E-6	5.096910013008056				Illumina [NR] (imputed)	N	"overall survival, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://purl.obolibrary.org/obo/GO_0097327"	GCST90104808	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	1p21.2	1	101409030	S1PR1	LINC01307 - LINC01709	ENSG00000231671	ENSG00000226715		18727	230479	rs74497159-?	rs74497159	0	74497159	regulatory_region_variant	1	NR	4E-7	6.3979400086720375		0.591	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	8q23.1	8	105277293	ZFPM2	ZFPM2			ENSG00000169946			rs3110366-?	rs3110366	0	3110366	intron_variant	0	NR	1E-6	6		0.394	[NR] unit decrease	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	9q34.11	9	129361675	C9orf106	LINC01503 - RN7SL159P	ENSG00000233901	ENSG00000242281		2126	8495	rs77526807-?	rs77526807	0	77526807	intergenic_variant	1	NR	2E-6	5.698970004336019		0.818	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	13q31.1	13	83495035	SLITRK1	RNU6-67P - SLITRK1	ENSG00000222791	ENSG00000178235		196868	382170	rs17076837-?	rs17076837	0	17076837	intergenic_variant	1	NR	2E-6	5.698970004336019		0.578	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	13q21.33	13	69848530	KLHL1	KLHL1			ENSG00000150361			rs61963755-?	rs61963755	0	61963755	intron_variant	0	NR	2E-6	5.698970004336019		0.674	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	8q23.1	8	105251146	ZFPM2	ZFPM2			ENSG00000169946			rs2342780-?	rs2342780	0	2342780	intron_variant	0	NR	2E-6	5.698970004336019		0.788	[NR] unit decrease	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	12p11.21	12	32640040	FGD4	FGD4			ENSG00000139132			rs10771973-?	rs10771973	0	10771973	intron_variant	0	NR	2E-6	5.698970004336019		0.451	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	8q23.1	8	105275744	ZFPM2	ZFPM2			ENSG00000169946			rs2342791-?	rs2342791	0	2342791	intron_variant	0	NR	3E-6	5.522878745280337		0.414	[NR] unit decrease	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	16q21	16	57393024	CX3CL1	CX3CL1 - CCL17	ENSG00000006210	ENSG00000102970		7980	11743	rs11076190-?	rs11076190	0	11076190	regulatory_region_variant	1	NR	3E-6	5.522878745280337		0.738	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	7p14.1	7	40927299	SUGCT	SUGCT - LINC01450	ENSG00000175600	ENSG00000232458		66536	37368	rs78777495-?	rs78777495	0	78777495	intergenic_variant	1	NR	3E-6	5.522878745280337		0.602	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	22q13.2	22	43328680	SCUBE1	SCUBE1			ENSG00000159307			rs9623812-?	rs9623812	0	9623812	intron_variant	0	NR	3E-6	5.522878745280337		0.34	[NR] unit decrease	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	7q32.1	7	128740695	CALU	CALU			ENSG00000128595			rs2060717-?	rs2060717	0	2060717	intron_variant	0	NR	3E-6	5.522878745280337		0.496	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	3q26.1	3	166544100	ZBBX	SSBL6P - LINC01326	ENSG00000244429	ENSG00000244321		249747	25593	rs6788186-?	rs6788186	0	6788186	intergenic_variant	1	NR	5E-6	5.301029995663981		0.282	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	7p14.1	7	40947421	SUGCT	SUGCT - LINC01450	ENSG00000175600	ENSG00000232458		86658	17246	rs78017515-?	rs78017515	0	78017515	intergenic_variant	1	NR	6E-6	5.221848749616356		0.621	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	5q14.3	5	92138315	LOC100129716	PCBP2P3 - LDHBP3	ENSG00000248826	ENSG00000248950		293786	702492	rs13168251-?	rs13168251	0	13168251	intron_variant	1	NR	7E-6	5.154901959985743		0.295	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	6q12	6	68149055	ADGRB3	Y_RNA - LINC02549	ENSG00000202522	ENSG00000226497		523591	77917	rs777619-?	rs777619	0	777619	intergenic_variant	1	NR	8E-6	5.096910013008056		0.416	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	22q11.21	22	19651952	SEPT5	LINC00895 - SEPTIN5	ENSG00000281548	ENSG00000184702		85113	62551	rs2188156-?	rs2188156	0	2188156	intergenic_variant	1	NR	8E-6	5.096910013008056		0.8	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
11/6/2020	32562552	Chua KC	6/20/2020	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/32562552	Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.	Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer	"1,324 European ancestry individuals"	NA	16q21	16	57925334	CNGB1	CNGB1			ENSG00000070729			rs57940640-?	rs57940640	0	57940640	intron_variant	0	NR	9E-6	5.045757490560675		0.552	[NR] unit increase	Illumina [6030476] (imputed)	N	"peripheral neuropathy, response to antimicrotubule agent"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0005260"	GCST010732	Genome-wide genotyping array				
3/18/2022	34834357	Velasco-Ruiz A	11/16/2021	Pharmaceutics	www.ncbi.nlm.nih.gov/pubmed/34834357	<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients.	Anthracycline-induced cardiotoxicity in breast cancer	"45 European ancestry cases, 90 European ancestry controls"	77 European ancestry individuals	19p13.3	19	637909		POLRMT - FGF22	ENSG00000099821	ENSG00000070388		4372	1970	rs62134260-?	rs62134260	0	62134260	regulatory_region_variant	1	NR	7E-6	5.154901959985743		4	[2.2-7.3]	Illumina [725785] (imputed)	N	"cardiotoxicity, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_1001482, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST90095482	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	21q22.13	21	36494182		"CLDN14-AS1, CLDN14"			"ENSG00000233818, ENSG00000159261"			rs2071049-G	rs2071049	0	2071049	intron_variant	0	0.22	2E-6	5.698970004336019		1.96		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	13q33.1	13	102489899		FGF14 - LINC00555	ENSG00000102466	ENSG00000261057		87442	99473	rs1927382-G	rs1927382	0	1927382	intergenic_variant	1	0.31	2E-6	5.698970004336019		0.46		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	9q34.11	9	129400140		RN7SL159P - LINC00963	ENSG00000242281	ENSG00000204054		29679	76806	rs10118507-A	rs10118507	0	10118507	intergenic_variant	1	0.11	5E-6	5.301029995663981		2.3		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	9q34.11	9	129400191		RN7SL159P - LINC00963	ENSG00000242281	ENSG00000204054		29730	76755	rs10118527-A	rs10118527	0	10118527	intergenic_variant	1	0.11	5E-6	5.301029995663981		2.3		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	11q14.3	11	92890183		FAT3			ENSG00000165323			rs7118248-A	rs7118248	0	7118248	intron_variant	0	0.36	6E-6	5.221848749616356		1.78		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
10/27/2023	37156489	Ahlstrom SE	5/8/2023	Acta Anaesthesiol Scand	www.ncbi.nlm.nih.gov/pubmed/37156489	Clinical and genetic factors associated with post-operative nausea and vomiting after propofol anaesthesia.	Post-operative nausea and vomiting in breast cancer surgery	"187 Finnish ancestry female cases, 628 Finnish ancestry female controls"	NA	2q33.1	2	200443394		SPATS2L			ENSG00000196141			rs1561296-A	rs1561296	0	1561296	intron_variant	0	0.44	6E-6	5.221848749616356		1.84		Illumina [653034]	N	post operative nausea and vomiting	http://www.ebi.ac.uk/efo/EFO_0004888	GCST90296446	Genome-wide genotyping array				
8/17/2017	28649644	Pivot X	2/23/2017	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/28649644	Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.	HER2 status in breast cancer	"5,473 European ancestry  HER2-negative cases, 3,230 European ancestry HER2-positive cases"	NA	2q31.1	2	172285284	NR	DLX2-DT - ITGA6	ENSG00000236651	ENSG00000091409		175302	142070	rs68130068-T	rs68130068	0	68130068	intron_variant	1	0.142	4E-6	5.3979400086720375				Illumina [914144] (imputed)	N	HER2 status	http://www.ebi.ac.uk/efo/EFO_0005514	GCST004528	Genome-wide genotyping array				
3/24/2017	27758888	Ingle JN	10/10/2016	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27758888	Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.	Breast cancer-free interval (treatment with aromatase inhibitor)	"6 African American recurrent cases, 134 African American controls without recurrence, 243 European ancestry recurrent cases, 4,216 European ancestry controls without recurrence, 3 Asian ancestry recurrent cases, 56 Asian ancestry controls without recurrence"	NA	8q21.11	8	74567389	"MIR2052HG, FLJ39080, LOC441355"	MIR5681A - MIR2052HG	ENSG00000266502	ENSG00000254349		18772	32386	rs13260300-?	rs13260300	0	13260300	regulatory_region_variant	1	NR	2E-7	6.698970004336019		1.64	[1.35-2.00]	Illumina [~ 7400000] (imputed)	N	"disease recurrence, response to aromatase inhibitor"	"http://www.ebi.ac.uk/efo/EFO_0004952, http://purl.obolibrary.org/obo/GO_0061477"	GCST003816	Genome-wide genotyping array				
7/4/2018	29278617	Sucheston-Campbell LE	2/1/2018	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/29278617	Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.	Taxane-induced peripheral neuropathy in breast cancer	"204 European ancestry cases with ??? grade 3 neuropathy, 1,919 European ancestry cases with < grade 3 neuropathy, 31 African American cases with ??? grade 3 neuropathy, 108 African American cases with <grade 3 neuropathy"	NA	7q21.3	7	93719703	GNGT1	GNGT1			ENSG00000127928			rs1858826-G	rs1858826	0	1858826	intron_variant	0	0.1	1E-7	7		3.448276	[2.17-5.56]	Illumina [at least 521600] (imputed)	N	"peripheral neuropathy, response to taxane"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0008580"	GCST005804	Genome-wide genotyping array				
7/4/2018	29278617	Sucheston-Campbell LE	2/1/2018	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/29278617	Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.	Taxane-induced peripheral neuropathy in breast cancer	"204 European ancestry cases with ??? grade 3 neuropathy, 1,919 European ancestry cases with < grade 3 neuropathy, 31 African American cases with ??? grade 3 neuropathy, 108 African American cases with <grade 3 neuropathy"	NA	17p13.3	17	797882	NXN	MRM3 - NXN	ENSG00000171861	ENSG00000167693		5373	1428	rs910920-A	rs910920	0	910920	intergenic_variant	1	0.31	5E-6	5.301029995663981		1.754386	[1.37-2.22]	Illumina [at least 521600] (imputed)	N	"peripheral neuropathy, response to taxane"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0008580"	GCST005804	Genome-wide genotyping array				
7/4/2018	29278617	Sucheston-Campbell LE	2/1/2018	Pharmacogenet Genomics	www.ncbi.nlm.nih.gov/pubmed/29278617	Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.	Taxane-induced peripheral neuropathy in breast cancer	"204 European ancestry cases with ??? grade 3 neuropathy, 1,919 European ancestry cases with < grade 3 neuropathy, 31 African American cases with ??? grade 3 neuropathy, 108 African American cases with <grade 3 neuropathy"	NA	4q32.3	4	164448974	MIR5684	MARCHF1 - RNU6-284P	ENSG00000145416	ENSG00000223037		64924	171758	rs1857798-C	rs1857798	0	1857798	intergenic_variant	1	0.38	8E-6	5.096910013008056		2.2727273	[1.52-3.45]	Illumina [at least 521600] (imputed)	N	"peripheral neuropathy, response to taxane"	"http://www.ebi.ac.uk/efo/EFO_0003100, http://www.ebi.ac.uk/efo/EFO_0008580"	GCST005804	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with Par-4 dependent chemotherapy	949 European ancestry individuals	NA	15q23	15	70646106		SALRNA2 - UACA	ENSG00000280515	ENSG00000137831		8792	8448	rs720251-T	rs720251	0	720251	intergenic_variant	1	NR	4E-9	8.397940008672037		2.79		Illumina [NR] (imputed)	N	"overall survival, response to Par-4 dependent chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0021535"	GCST90104806	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with Par-4 dependent chemotherapy	"949 European ancestry individuals, 195 East Asian ancestry individuals, 168 Hispanic or Latin American individuals, 149 African American or Afro-Caribbean individuals"	"609 European ancestry individuals, 2,750 East Asian ancestry individuals"	15q23	15	70646106		SALRNA2 - UACA	ENSG00000280515	ENSG00000137831		8792	8448	rs720251-T	rs720251	0	720251	intergenic_variant	1	NR	1E-11	11				Illumina [NR] (imputed)	N	"overall survival, response to Par-4 dependent chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0021535"	GCST90104807	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)	"1,852 European ancestry individuals, 255 East Asian ancestry individuals, 224 Hispanic or Latin American individuals, 181 African American or Afro-Caribbean individuals"	NA	21q11.2	21	13369377		FGF7P2 - ANKRD30BP1	ENSG00000185390	ENSG00000175302		18729	14872	rs2747349-T	rs2747349	0	2747349	intergenic_variant	1	NR	4E-7	6.3979400086720375				Illumina [NR] (imputed)	N	"overall survival, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://purl.obolibrary.org/obo/GO_0097327"	GCST90104809	Genome-wide genotyping array				
7/20/2022	35322040	Zhu Q	3/23/2022	NPJ Breast Cancer	www.ncbi.nlm.nih.gov/pubmed/35322040	UACA locus is associated with breast cancer chemoresistance and survival.	Overall survival in breast cancer treated with chemotherapy (excluding Par-4 dependent chemotherapy)	"1,852 European ancestry individuals, 255 East Asian ancestry individuals, 224 Hispanic or Latin American individuals, 181 African American or Afro-Caribbean individuals"	NA	19q13.12	19	36091745		WDR62			ENSG00000075702			rs35759606-T	rs35759606	0	35759606	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [NR] (imputed)	N	"overall survival, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0000638, http://purl.obolibrary.org/obo/GO_0097327"	GCST90104809	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		5q13.3	5	76143375	SV2C	SV2C			ENSG00000122012			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	6E-8	7.221848749616356		3.3	[NR]	Illumina [up to 810372] (imputed)	N	"response to bevacizumab, chemotherapy-induced hypertension"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0005942"	GCST002567	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		22q13.31	22	44080184	PARVB	PARVB			ENSG00000188677			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-6	5.3979400086720375		1.72	[NR]	Illumina [up to 810372] (imputed)	N	"response to bevacizumab, chemotherapy-induced hypertension"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0005942"	GCST002567	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		11q24.1	11	123393934	intergenic	GRAMD1B			ENSG00000023171			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	1E-6	6		1.82	[NR]	Illumina [up to 810372] (imputed)	N	"response to bevacizumab, chemotherapy-induced hypertension"	"http://www.ebi.ac.uk/efo/EFO_0005943, http://www.ebi.ac.uk/efo/EFO_0005942"	GCST002567	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		5q13.3	5	76143375	SV2C	SV2C			ENSG00000122012			rs6453204-?	rs6453204	0	6453204	intron_variant	0	NR	5E-8	7.301029995663981		2.2	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		22q13.31	22	44080184	PARVB	PARVB			ENSG00000188677			rs130318-?	rs130318	0	130318	intron_variant	0	NR	4E-7	6.3979400086720375		1.7	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		11q24.1	11	123393934	intergenic	GRAMD1B			ENSG00000023171			rs1943466-?	rs1943466	0	1943466	intron_variant	0	NR	6E-7	6.221848749616356		1.69	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		2q14.2	2	119990995	intergenic	PTPN4 - RPL27P7	ENSG00000088179	ENSG00000233741		6096	2204	rs11685222-?	rs11685222	0	11685222	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.98	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		2p24.2	2	18106253	intergenic	KCNS3			ENSG00000170745			rs12467348-?	rs12467348	0	12467348	intron_variant	0	NR	9E-6	5.045757490560675		2.05	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		3p24.1	3	30677040	TGFBR2	TGFBR2			ENSG00000163513			rs3773651-?	rs3773651	0	3773651	intron_variant	0	NR	7E-6	5.154901959985743		2.15	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		12p12.3	12	19774866	intergenic	RNU1-146P - TCP1P3	ENSG00000200885	ENSG00000256849		50267	166655	rs2731620-?	rs2731620	0	2731620	intergenic_variant	1	NR	7E-6	5.154901959985743		1.59	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		5q35.2	5	174280232	intergenic	NSG2 - LINC01411	ENSG00000170091	ENSG00000249306		36731	56063	rs6878584-?	rs6878584	0	6878584	intergenic_variant	1	NR	7E-6	5.154901959985743		2.27	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		6q24.2	6	143412439	intergenic	PARLP2 - ADAT2	ENSG00000217648	ENSG00000189007		69056	10393	rs2496589-?	rs2496589	0	2496589	intergenic_variant	1	NR	5E-6	5.301029995663981		1.7	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		8p23.1	8	10403043	MSRA	MSRA			ENSG00000175806			rs1962073-?	rs1962073	0	1962073	intron_variant	0	NR	2E-6	5.698970004336019		1.69	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		8p23.1	8	9932039	intergenic	MIR124-1HG - MSRA-DT	ENSG00000253230	ENSG00000260093		12806	118446	rs11786541-?	rs11786541	0	11786541	intergenic_variant	1	NR	2E-6	5.698970004336019		1.65	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		10p15.1	10	6195193	PFKFB3	PFKFB3			ENSG00000170525			rs11257188-?	rs11257188	0	11257188	intron_variant	0	NR	9E-6	5.045757490560675		2.19	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
4/23/2015	25117820	Schneider BP	8/12/2014	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/25117820	Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.	Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	"255 European ancestry cases, 387 European ancestry controls"		11q21	11	96198321	MAML2	MAML2			ENSG00000184384			rs479825-?	rs479825	0	479825	intron_variant	0	NR	6E-6	5.221848749616356		1.64	[NR]	Illumina [up to 810372] (imputed)	N	cumulative dose response to bevacizumab	http://www.ebi.ac.uk/efo/EFO_0005944	GCST002566	Genome-wide genotyping array				
3/28/2017	27764800	Cox DG	10/14/2016	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in HER2 negative breast cancer	"4,267 French ancestry estrogen receptor positive cases,  1,185 French ancestry estrogen receptor negative cases"	NA	10q26.13	10	121592706	FGFR2	FGFR2			ENSG00000066468			rs3135724-?	rs3135724	0	3135724	intron_variant	0	NR	5E-11	10.301029995663981		1.79	[1.49 - 2.13]?	Illumina [914144] (imputed)	N	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512	GCST003823	Genome-wide genotyping array				
3/28/2017	27764800	Cox DG	10/14/2016	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/27764800	GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.	Estrogen receptor status in breast cancer	"6,211 French ancestry estrogen receptor positive cases, 2,516 French ancestry estrogen receptor negative cases"	NA	10q26.13	10	121594355	FGFR2	FGFR2			ENSG00000066468			rs3135718-?	rs3135718	0	3135718	intron_variant	0	NR	6E-12	11.221848749616356		1.33	[1.23 - 1.45]	Illumina [914144] (imputed)	N	estrogen receptor status	http://www.ebi.ac.uk/efo/EFO_0005512	GCST003821	Genome-wide genotyping array				
3/22/2021	32756886	Nunez-Torres R	8/5/2020	JAMA Dermatol	www.ncbi.nlm.nih.gov/pubmed/32756886	Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.	Persistent chemotherapy-induced alopecia in breast cancer	"51 European ancestry cases, 122 European ancestry controls"	"20 European ancestry cases, 22 European ancestry controls"	7q21.12	7	87574963	ABCB1	ABCB1			ENSG00000085563			rs1202179-C	rs1202179	0	1202179	intron_variant	0	NR	4E-8	7.3979400086720375		4.05	[2.46-6.67]	Illumina [693898]	N	"chemotherapy-induced alopecia, response to docetaxel trihydrate"	"http://www.ebi.ac.uk/efo/EFO_0005400, http://purl.obolibrary.org/obo/GO_1902519"	GCST011316	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	15q24.2	15	75039102	PPCDC	PPCDC			ENSG00000138621			rs147451859-G	rs147451859	0	147451859	intron_variant	0	0.07	6E-9	8.221848749616356		1.74	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	2q14.1	2	112624477	RPS20P11	CHCHD5 - SLC20A1-DT	ENSG00000125611	ENSG00000237753		35202	17355	rs17587029-G	rs17587029	0	17587029	intergenic_variant	1	0.05	3E-8	7.522878745280337		1.84	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	12p12.3	12	16001304	DERA	DERA			ENSG00000023697			rs6488809-T	rs6488809	0	6488809	intron_variant	0	0.06	3E-7	6.522878745280337		1.74	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	6q13	6	71740732	RIMS1	RNU4-66P - RIMS1	ENSG00000202069	ENSG00000079841		88121	145818	rs1410669-G	rs1410669	0	1410669	intergenic_variant	1	0.07	5E-7	6.301029995663981		1.71	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	2p24.1	2	20885650	C2orf43	LINC02850 - APOB	ENSG00000236436	ENSG00000084674		23989	115779	rs11096688-T	rs11096688	0	11096688	intergenic_variant	1	0.1	7E-7	6.154901959985743		1.45	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	7q21.3	7	93388705	CCDC132	VPS50 - CALCR	ENSG00000004766	ENSG00000004948		27582	35781	rs73419340-A	rs73419340	0	73419340	intergenic_variant	1	0.06	8E-7	6.096910013008056		0.49	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	14q22.3	14	56410241	PELI2	LINC02284			ENSG00000259719			rs1189020-T	rs1189020	0	1189020	intron_variant	0	0.06	9E-7	6.045757490560675		1.61	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	12p11.22	12	29733920	TMTC1	TMTC1			ENSG00000133687			rs78264913-C	rs78264913	0	78264913	intron_variant	0	0.05	1E-6	6		1.53	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	5p15.31	5	6784082	PAPD7	LINC02236			ENSG00000251365			rs77569618-A	rs77569618	0	77569618	intron_variant	0	0.09	1E-6	6		1.48	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
12/3/2019	31371054	Ruddy KJ	7/29/2019	Fertil Steril	www.ncbi.nlm.nih.gov/pubmed/31371054	Genetic predictors of chemotherapy-related amenorrhea in?women with breast cancer.	Adverse response to chemotherapy (amenorrhea) in breast cancer	"457 European ancestry amenorrheic cases, 711 European ancestry post-chemotherapy menses cases"	NA	8q24.22	8	131109670	ADCY8	ADCY8 - SNORA72	ENSG00000155897	ENSG00000201944		68761	323106	rs1119997-G	rs1119997	0	1119997	intergenic_variant	1	0.46	1E-6	6		1.3	[NR]	Illumina [5430816] (imputed)	N	"amenorrhea, response to antineoplastic agent"	"http://www.ebi.ac.uk/efo/EFO_0010269, http://purl.obolibrary.org/obo/GO_0097327"	GCST009153	Genome-wide genotyping array				
8/7/2019	31196165	Lee E	6/13/2019	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31196165	Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.	Acute post-radiotherapy pain in breast cancer	"136 Hispanic cases, 75 European ancestry cases, 102 African ancestry cases, 45 cases, 265 Hispanic controls, 282 European ancestry controls, 194 African ancestry controls, 45 controls"	NA	13q32.1	13	95027878	"ABCC4, MRP4"	ABCC4			ENSG00000125257			rs4584690-T	rs4584690	0	4584690	intron_variant	0	0.18	5E-6	5.301029995663981		1.85	[1.85-2.42]	Illumina [1344832] (imputed)	N	"response to radiation, pain"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0003843"	GCST008388	Genome-wide genotyping array				
8/7/2019	31196165	Lee E	6/13/2019	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31196165	Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.	Acute post-radiotherapy pain in breast cancer	"136 Hispanic cases, 75 European ancestry cases, 102 African ancestry cases, 45 cases, 265 Hispanic controls, 282 European ancestry controls, 194 African ancestry controls, 45 controls"	NA	17q12	17	35011428	"RFFL, LIG3"	RFFL			ENSG00000092871			rs16970540-T	rs16970540	0	16970540	3_prime_UTR_variant	0	0.1	2E-6	5.698970004336019		2.2	[1.59-3.04]	Illumina [1344832] (imputed)	N	"response to radiation, pain"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0003843"	GCST008388	Genome-wide genotyping array				
8/7/2019	31196165	Lee E	6/13/2019	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31196165	Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.	Acute post-radiotherapy pain in breast cancer	"136 Hispanic cases, 75 European ancestry cases, 102 African ancestry cases, 45 cases, 265 Hispanic controls, 282 European ancestry controls, 194 African ancestry controls, 45 controls"	NA	Xp22.2	X	13459192	EGFL6	LINC01203 - EGFL6	ENSG00000226985	ENSG00000198759		56157	110409	rs73633565-G	rs73633565	0	73633565	intergenic_variant	1	0.16	8E-6	5.096910013008056		1.9	[1.43-2.52]	Illumina [1344832] (imputed)	N	"response to radiation, pain"	"http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0003843"	GCST008388	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56733416	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		127184	82133	rs16886181-?	rs16886181	0	16886181	intergenic_variant	1	0.18	9E-14	13.045757490560675		1.26	[1.18-1.34]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56874986	MAP3K1	MAP3K1			ENSG00000095015			rs16886448-?	rs16886448	0	16886448	intron_variant	0	0.07	2E-12	11.698970004336019		1.37	[1.25-1.49]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56838449	MAP3K1	MAP3K1			ENSG00000095015			rs16886397-?	rs16886397	0	16886397	intron_variant	0	0.07	4E-12	11.397940008672037		1.36	[1.25-1.49]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56882284	MAP3K1	MAP3K1			ENSG00000095015			rs3822625-?	rs3822625	0	3822625	synonymous_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.24-1.48]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56826517	MAP3K1	MAP3K1			ENSG00000095015			rs16886364-?	rs16886364	0	16886364	intron_variant	0	0.07	5E-12	11.301029995663981		1.36	[1.25-1.48]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56699208	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		92976	116341	rs16886113-?	rs16886113	0	16886113	intergenic_variant	1	0.08	4E-11	10.397940008672037		1.35	[1.23-1.47]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56857565	MAP3K1	MAP3K1			ENSG00000095015			rs1017226-?	rs1017226	0	1017226	intron_variant	0	0.08	6E-11	10.221848749616356		1.33	[1.22-1.45]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56960656	MAP3K1	MIER3			ENSG00000155545			rs7726354-?	rs7726354	0	7726354	intron_variant	0	0.06	7E-11	10.154901959985743		1.37	[1.24-1.50]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56899963	MAP3K1	MAP3K1 - SETD9	ENSG00000095015	ENSG00000155542		3811	9297	rs12655019-?	rs12655019	0	12655019	intergenic_variant	1	0.1	3E-10	9.522878745280337		1.27	[1.18-1.37]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56688029	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		81797	127520	rs16886034-?	rs16886034	0	16886034	intergenic_variant	1	0.08	2E-9	8.698970004336019		1.36	[1.23-1.51]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56736057	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-?	rs889312	0	889312	intergenic_variant	1	0.29	1E-8	8		1.29	[NR]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	11q13.3	11	69513996	CCND1	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		19044	127160	rs614367-?	rs614367	0	614367	intergenic_variant	1	0.16	1E-8	8		1.34	[NR]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	3p24.1	3	27302153	SLC4A7	NEK10			ENSG00000163491			rs653465-?	rs653465	0	653465	intron_variant	0	0.54	5E-12	11.301029995663981		1.18	[1.12-1.23]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	5q11.2	5	56872885	MAP3K1	MAP3K1			ENSG00000095015			rs2229882-?	rs2229882	0	2229882	synonymous_variant	0	0.06	1E-14	14		1.45	[1.32-1.60]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	8q24.21	8	127375779	intergenic	"POU5F1B, CASC8, PCAT1"			"ENSG00000212993, ENSG00000246228, ENSG00000253438"			rs2392780-?	rs2392780	0	2392780	intron_variant	0	0.6	1E-8	8		1.15	[1.10-1.20]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	10q26.13	10	121589148	FGFR2	FGFR2			ENSG00000066468			rs2912774-?	rs2912774	0	2912774	intron_variant	0	0.44	3E-27	26.522878745280337		1.29	[1.23-1.35]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	11q13.3	11	69492927	CCND1	LINC01488			ENSG00000285094			rs537626-?	rs537626	0	537626	non_coding_transcript_exon_variant	0	0.18	2E-15	14.698970004336019		1.29	[1.21-1.37]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
10/17/2014	24493630	Ahsan H	2/3/2014	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24493630	A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.	Breast cancer (early onset)	"3,523 European ancestry young female cases, 2,702 European ancestry young female controls"	"3,470 European ancestry young female cases, 5,475 European ancestry young female controls"	16q12.1	16	52541995	TOX3	TOX3			ENSG00000103460			rs4784223-?	rs4784223	0	4784223	intron_variant	0	0.29	6E-21	20.221848749616356		1.27	[1.21-1.34]	Illumina [1265548] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST002346	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	16q12.1	16	52552429	"TNRC9, LOC643714"	CASC16			ENSG00000249231			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.25	1E-36	36		1.2	[1.16-1.24]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	10q26.13	10	121592803	FGFR2	FGFR2			ENSG00000066468			rs2981582-A	rs2981582	0	2981582	intron_variant	0	0.38	2E-76	75.69897000433602		1.26	[1.23-1.30]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	8q24.21	8	127343372	intergenic	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-C	rs13281615	0	13281615	intron_variant	0	0.4	5E-12	11.301029995663981		1.08	[1.05-1.11]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	5p12	5	45285616	intergenic	HCN1			ENSG00000164588			rs981782-C	rs981782	0	981782	intron_variant	0	0.53	9E-6	5.045757490560675		1.04	[1.01-1.08]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	5q11.2	5	56736057	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-C	rs889312	0	889312	intergenic_variant	1	0.28	7E-20	19.154901959985743		1.13	[1.10-1.16]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
6/16/2008	17529967	Easton DF	5/27/2007	Nature	www.ncbi.nlm.nih.gov/pubmed/17529967	Genome-wide association study identifies novel breast cancer susceptibility loci.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"4,364 East Asian ancestry cases, 24,174 European ancestry controls, 3,564 East Asian ancestry controls, 24,391 European ancestry controls"	11p15.5	11	1887776	LSP1	LSP1			ENSG00000130592			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.3	3E-9	8.522878745280337		1.07	[1.04-1.11]	Perlegen [205586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000035	Genome-wide genotyping array				
12/9/2010	21060860	Gaudet MM	10/28/2010	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21060860	Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.	Breast cancer in BRCA2 mutation carriers	"899 European ancestry cases, 804 European ancestry controls"	"1,264 European ancestry cases, 1,222 European ancestry controls"	10q26.13	10	121586602	FGFR2	FGFR2			ENSG00000066468			rs2981575-?	rs2981575	0	2981575	intron_variant	0	0.42	1E-8	8		1.28	[1.18-1.39]	Affymetrix [592163]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000846	Genome-wide genotyping array				
3/14/2019	23544012	Gaudet MM	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544012	Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.	Breast cancer in BRCA2 mutation carriers	"4,330 European ancestry affected women, 3,881 European ancestry unaffected women"	NA	10q26.13	10	121591810	FGFR2	FGFR2			ENSG00000066468			rs2420946-A	rs2420946	0	2420946	intron_variant	0	0.39	2E-14	13.698970004336019		1.27	[1.19-1.34]	Illumina [at least 200908] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007302	Targeted genotyping array [iCOGS]				
3/14/2019	23544012	Gaudet MM	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544012	Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.	Breast cancer in BRCA2 mutation carriers	"4,330 European ancestry affected women, 3,881 European ancestry unaffected women"	NA	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.27	5E-11	10.301029995663981		1.24	[1.16-1.32]	Illumina [at least 200908] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007302	Targeted genotyping array [iCOGS]				
3/14/2019	23544012	Gaudet MM	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544012	Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.	Breast cancer in BRCA2 mutation carriers	"4,330 European ancestry affected women, 3,881 European ancestry unaffected women"	NA	6p24.3	6	10456473	"C6orf218, TFAP2A"	MIR5689HG			ENSG00000229401			rs9348512-C	rs9348512	0	9348512	non_coding_transcript_exon_variant	0	0.65	4E-8	7.3979400086720375		1.18	[1.11-1.25]	Illumina [at least 200908] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007302	Targeted genotyping array [iCOGS]				
3/14/2019	23544012	Gaudet MM	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544012	Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.	Breast cancer in BRCA2 mutation carriers	"4,330 European ancestry affected women, 3,881 European ancestry unaffected women"	NA	Xq27.1	X	138931625	FGF13	FGF13			ENSG00000129682			rs619373-A	rs619373	0	619373	intron_variant	0	0.07	3E-6	5.522878745280337		1.3	[1.17-1.45]	Illumina [at least 200908] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007302	Targeted genotyping array [iCOGS]				
3/14/2019	23544012	Gaudet MM	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544012	Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.	Breast cancer in BRCA2 mutation carriers	"4,330 European ancestry affected women, 3,881 European ancestry unaffected women"	NA	2p22.2	2	38150263	C2orf58	CYP1B1-AS1			ENSG00000232973			rs184577-G	rs184577	0	184577	intron_variant	0	0.75	4E-6	5.3979400086720375		1.18	[1.10-1.27]	Illumina [at least 200908] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007302	Targeted genotyping array [iCOGS]				
11/13/2017	19330027	Ahmed S	5/1/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"38,430 European ancestry cases, 2,572 East Asian ancestry cases, 41,926 European ancestry controls, 2,059 East Asian ancestry controls"	3p24.1	3	27374522	"SLC4A7, NEK10"	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.46	4E-23	22.397940008672037		1.11	[1.08-1.13]	"Illumina, Perlegen [up to 206586]"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004948	Genome-wide genotyping array				
11/13/2017	19330027	Ahmed S	5/1/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"38,430 European ancestry cases, 2,572 East Asian ancestry cases, 41,926 European ancestry controls, 2,059 East Asian ancestry controls"	17q22	17	54979110	COX11	STXBP4			ENSG00000166263			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.73	1E-8	8		1.05	[1.03-1.09]	"Illumina, Perlegen [up to 206586]"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004948	Genome-wide genotyping array				
11/13/2017	19330027	Ahmed S	5/1/2009	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19330027	Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.	Breast cancer	"390 European ancestry cases, 364 European ancestry controls"	"11,645 European ancestry cases, 12,015 European ancestry controls"	3p24.1	3	27145111	"SLC4A7, NEK10"	NEK10			ENSG00000163491			rs1357245-G	rs1357245	0	1357245	intron_variant	0	0.54	2E-7	6.698970004336019		1.06	NR	Perlegen [up to 206586]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004949	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	9p21.3	9	22062135	NR	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.16	5E-7	6.301029995663981		1.05	[1.00-1.09] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q25.2	6	152115881	ESR1	ESR1			ENSG00000091831			rs2747652-C	rs2747652	0	2747652	intron_variant	0	0.52	2E-18	17.69897000433602		1.098901	[1.08-1.12]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	13q22.1	13	73383544	KLF5	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		156284	24224	rs6562760-G	rs6562760	0	6562760	intergenic_variant	1	0.76	9E-10	9.045757490560675		1.0869565	[1.05-1.11]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1q32.1	1	202218048	LGR6	LGR6			ENSG00000133067			rs6678914-G	rs6678914	0	6678914	intron_variant	0	0.59	3E-12	11.522878745280337		1.0869565	[1.06-1.11]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2p23.2	2	28897867	WDR43	WDR43			ENSG00000163811			rs4577244-C	rs4577244	0	4577244	intron_variant	0	0.66	2E-9	8.698970004336019		1.0869565	[1.05-1.11]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q35	2	217431785	NR	DIRC3			ENSG00000231672			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	2E-8	7.698970004336019		1.07	[1.03-1.10] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	12q22	12	95633983	NR	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.7	2E-8	7.698970004336019		1.0638298	[1.03-1.1] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q14.1	6	81418669	NR	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		948241	72770	rs17529111-C	rs17529111	0	17529111	intergenic_variant	1	0.22	2E-6	5.698970004336019		1.06	[1.02-1.10] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.2	16	53779455	NR	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.59	2E-10	9.698970004336019		1.0752687	[1.04-1.11] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19p13.11	19	17290595	ANKLE1	ANKLE1 - ABHD8	ENSG00000160117	ENSG00000127220		2949	1536	rs67397200-G	rs67397200	0	67397200	intergenic_variant	1	0.32	3E-37	36.52287874528034		1.17	[1.14-1.19]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	8q21.13	8	75505702	NR	HNF4G			ENSG00000164749			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.08	3E-6	5.522878745280337		1.1	[1.04-1.16] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16p13.3	16	4056787	ADCY9	ADCY9			ENSG00000162104			rs11076805-C	rs11076805	0	11076805	intron_variant	0	0.75	2E-8	7.698970004336019		1.0869565	[1.05-1.11]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19q13.31	19	43782361	NR	KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	0.46	5E-8	7.301029995663981		1.08	[1.05-1.12] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	11q22.3	11	108474789	KDELC2	POGLUT3			ENSG00000178202			rs11374964-G	rs11374964	0	11374964	3_prime_UTR_variant	0	0.58	4E-8	7.3979400086720375		1.0638298	[1.04-1.09]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19p13.11	19	18460331	NR	ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.66	6E-6	5.221848749616356		1.0416667	[1.01-1.08] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	19q12	19	29786822	CCNE1	C19orf12 - CCNE1	ENSG00000131943	ENSG00000105173		71033	25169	rs113701136-T	rs113701136	0	113701136	intergenic_variant	1	0.32	2E-7	6.698970004336019		1.07	[1.04-1.09]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	22q13.1	22	40480230	NR	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.1	2E-11	10.698970004336019		1.14	[1.08-1.19] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	8p23.3	8	220692	RPL23AP53	RPL23AP53			ENSG00000223508			rs66823261-C	rs66823261	0	66823261	intron_variant	0	0.23	6E-9	8.221848749616356		1.09	[1.06-1.12]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5q11.2	5	56757896	NR	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		151664	57653	rs62355902-T	rs62355902	0	62355902	intergenic_variant	1	0.16	2E-6	5.698970004336019		1.06	[1.02-1.11] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	18q12.1	18	32397726	NR	GAREM1			ENSG00000141441			rs117618124-T	rs117618124	0	117618124	intron_variant	0	0.95	5E-6	5.301029995663981		1.1904762	[1.1-1.3] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q35	2	217056046	NR	DIRC3-AS1			ENSG00000233143			rs4442975-G	rs4442975	0	4442975	intron_variant	0	0.5	3E-6	5.522878745280337		1.0638298	[1.02-1.09] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	14q24.1	14	68567965	NR	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	3E-8	7.522878745280337		1.0869565	[1.04-1.12] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	10q21.2	10	62540131	NR	LINC02929			ENSG00000285551			rs10995201-A	rs10995201	0	10995201	intron_variant	0	0.84	2E-9	8.698970004336019		1.0752687	[1.02-1.12] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	13q13.1	13	32398489	NR	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.01	2E-13	12.698970004336019		1.58	[1.35-1.84] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	14q32.12	14	92637727	NR	RIN3			ENSG00000100599			rs11627032-T	rs11627032	0	11627032	intron_variant	0	0.75	2E-6	5.698970004336019		1.0526316	[1.01-1.09] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-C	rs11820646	0	11820646	regulatory_region_variant	1	0.6	2E-7	6.698970004336019		1.0638298	[1.03-1.1] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	8q24.21	8	127343372	NR	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.41	9E-6	5.045757490560675		1.07	[1.03-1.10] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	8p11.23	8	37000965	NR	KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		64840	94185	rs13365225-A	rs13365225	0	13365225	intergenic_variant	1	0.82	1E-10	10		1.1111112	[1.06-1.16] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5q33.3	5	158817075	NR	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	1E-10	10		1.08	[1.04-1.11] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2p24.1	2	19121042	MIR4757	LINC01376			ENSG00000236204			rs12710696-T	rs12710696	0	12710696	intron_variant	0	0.37	7E-8	7.154901959985743		1.06	[1.04-1.09]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.2	16	53821379	FTO	FTO			ENSG00000140718			rs11075995-A	rs11075995	0	11075995	intron_variant	0	0.3	1E-10	10		1.09	[1.06-1.12]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1q32.1	1	204549714	MDM4	MDM4			ENSG00000198625			rs4245739-C	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	3E-23	22.522878745280337		1.14	[1.11-1.16]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q25.1	6	151621059	ESR1	CCDC170			ENSG00000120262			rs3757322-G	rs3757322	0	3757322	3_prime_UTR_variant	0	0.32	3E-31	30.522878745280337		1.15	[1.12-1.18]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q33.1	2	201316524	NR	"FLACC1, CASP8"			"ENSG00000155749, ENSG00000064012"			rs1830298-C	rs1830298	0	1830298	intron_variant	0	0.28	7E-7	6.154901959985743		1.08	[1.04-1.12] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	2E-35	34.69897000433602		1.18	[1.15-1.21]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	5p15.33	5	1296141	NR	TERT - MIR4457	ENSG00000164362	ENSG00000263670		1073	13169	rs3215401-A	rs3215401	0	3215401	intergenic_variant	1	0.69	6E-21	20.221848749616356		1.1363636	[1.1-1.18] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q23.1	6	130027974	L3MBTL3	L3MBTL3			ENSG00000198945			rs6569648-T	rs6569648	0	6569648	intron_variant	0	0.77	4E-8	7.3979400086720375		1.0752687	[1.05-1.11]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	16q12.1	16	52565276	NR	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.24	2E-26	25.69897000433602		1.14	[1.10-1.19] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	18q12.1	18	27821241	CDH2	PA2G4P3 - CDH2	ENSG00000263405	ENSG00000170558		367584	111638	rs36194942-A	rs36194942	0	36194942	intergenic_variant	1	0.7	3E-7	6.522878745280337		1.0638298	[1.04-1.1]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	2q14.2	2	120487546	NR	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.9	4E-9	8.397940008672037		1.1764705	[1.11-1.23] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	8q24.13	8	123745421	ANXA13	ANXA13 - FAM91A1	ENSG00000104537	ENSG00000176853		8019	23018	rs17350191-T	rs17350191	0	17350191	intergenic_variant	1	0.34	2E-8	7.698970004336019		1.07	[1.04-1.09]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	1p36.22	1	10506158	NR	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	4E-18	17.397940008672037		1.1235955	[1.09-1.16] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	11q22.3	11	108486410	KDELC2	POGLUT3			ENSG00000178202			rs74911261-G	rs74911261	0	74911261	missense_variant	0	0.98	2E-6	5.698970004336019		1.2195122	[1.12-1.33]	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	12p11.22	12	28021884	NR	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-C	rs7297051	0	7297051	TF_binding_site_variant	1	0.76	9E-25	24.045757490560675		1.1494253	[1.1-1.19] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	10q25.2	10	113014168	NR	TCF7L2			ENSG00000148737			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	8E-10	9.096910013008056		1.08	[1.04-1.11] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer (estrogen-receptor negative)	"14,135 European ancestry cases, 58,126 European ancestry controls"	"7,333 European ancestry cases, 42,468 European ancestry controls"	6q25.1	6	151631197	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		10004	25494	rs9397437-A	rs9397437	0	9397437	regulatory_region_variant	1	0.07	3E-40	39.52287874528034		1.32	[1.25-1.40] (Oncoarray)	Illumina [~ 11500000] (imputed)	N	estrogen-receptor negative breast cancer	http://www.ebi.ac.uk/efo/EFO_1000650	GCST005076	Genome-wide genotyping array				
11/30/2012	22976474	Siddiq A	9/13/2012	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	"3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls"	"562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls"	19p13.11	19	17282085	NR	"USHBP1, ANKLE1"			"ENSG00000130307, ENSG00000160117"			rs8100241-G	rs8100241	0	8100241	missense_variant	0	NR	4E-8	7.3979400086720375		1.14	[NR]	Illumina [2608509] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001683	Genome-wide genotyping array				
11/30/2012	22976474	Siddiq A	9/13/2012	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	"3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls"	"562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls"	6q25.1	6	151666222	NR	ESR1			ENSG00000091831			rs9383938-T	rs9383938	0	9383938	intron_variant	0	NR	2E-10	9.698970004336019		1.28	[NR]	Illumina [2608509] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001683	Genome-wide genotyping array				
11/30/2012	22976474	Siddiq A	9/13/2012	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	"3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls"	"562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls"	20q11.22	20	34000289	"RALY, EIF2S2, ASIP"	RALY			ENSG00000125970			rs2284378-T	rs2284378	0	2284378	intron_variant	0	0.31	1E-8	8		1.16	[1.10-1.22]	Illumina [2608509] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001683	Genome-wide genotyping array				
11/30/2012	22976474	Siddiq A	9/13/2012	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/22976474	A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.	Breast cancer	"3,666 European ancestry cases, 28,864 European ancestry controls, 1,004 African American cases, 2,744 African American controls"	"562 European ancestry cases, 6,410 European ancestry controls, 84 Japanese ancestry cases, 830 Japanese ancestry controls, 300 Latino cases, 1,164 Latino controls"	6q14.1	6	81483392	"FAM46A, C6orf37"	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		1012964	8047	rs17530068-C	rs17530068	0	17530068	intergenic_variant	1	0.24	3E-7	6.522878745280337		1.16	[1.10-1.23]	Illumina [2608509] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001683	Genome-wide genotyping array				
11/24/2011	22037553	Haiman CA	10/30/2011	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/22037553	A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.	Breast cancer	"1,004 African American cases, 2,745 African American controls,1,718 European ancestry cases, 3,670 European ancestry controls"	"2,292 European ancestry cases, 16,901 European ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	1E-10	10		1.18	[1.13-1.25]	Illumina [3154485] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001298	Genome-wide genotyping array				
10/7/2010	20852631	Antoniou AC	9/19/2010	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852631	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.	Breast cancer	"1,193 European ancestry cases, 1,190 European ancestry controls"	"2,974 European ancestry cases, 3,012 European ancestry controls"	19p13.11	19	17278895	"ANKLE1, C19orf62, ABHD8"	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.17	2E-9	8.698970004336019		1.26	[1.17-1.35]	Illumina [555616]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST000801	Genome-wide genotyping array				
12/7/2015	25890600	Guo Q	4/18/2015	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	"23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases"		2q24.3	2	162922103	"KCNH7, BC042876"	KCNH7 - RPL7P61	ENSG00000184611	ENSG00000230282		83336	230148	rs148760487-?	rs148760487	0	148760487	intergenic_variant	1	0.01	2E-8	7.698970004336019		1.88	[1.51-2.34]	"Affymetrix, Illumina [9000000] (imputed)"	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST002861	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	15-year breast cancer-specific survival (grade 3 tumor)	"22,737 European ancestry individuals"	NA	Xp22.31	X	9469423		TBL1X			ENSG00000101849			rs5934618-?	rs5934618	0	5934618	intron_variant	0	NR	1E-8	8		1.32	[1.2-1.45]	NR [10000000] (imputed)	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90029044	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	15-year breast cancer-specific survival (grade 3 tumor)	"22,737 European ancestry individuals"	NA	2q33.3	2	208183329		C2orf80			ENSG00000188674			rs66871326-?	rs66871326	1	35789824	intron_variant	0	NR	2E-7	6.698970004336019		0.85	[0.8-0.9]	NR [10000000] (imputed)	N	"survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90029044	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	15-year breast cancer-specific survival (treated with anthracyclines)	"11,183 European ancestry individuals"	NA	7p14.3	7	30204114		RPS27P16 - ZNRF2	ENSG00000225907	ENSG00000180233		36110	80483	rs34072391-?	rs34072391	1	538302905	intergenic_variant	1	NR	6E-8	7.221848749616356		1.27	[1.17-1.39]	NR [10000000] (imputed)	N	"survival time, breast carcinoma, response to anthracycline-based chemotherapy"	"http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0005257"	GCST90029057	Genome-wide genotyping array				
10/22/2021	34407845	Morra A	8/18/2021	Breast Cancer Res	www.ncbi.nlm.nih.gov/pubmed/34407845	Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.	5-year breast cancer-specific survival (treated with tamoxifen)	"16,279 European ancestry individuals"	NA	5q15	5	94931227		MCTP1			ENSG00000175471			rs72775397-?	rs72775397	0	72775397	3_prime_UTR_variant	0	NR	2E-7	6.698970004336019		1.36	[1.21-1.53]	NR [10000000] (imputed)	N	"response to tamoxifen, survival time, breast carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0009391, http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0000305"	GCST90029062	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42142508		CYP2D7			ENSG00000205702			rs56023519-?	rs56023519	0	56023519	missense_variant	0	NR	5E-35	34.30102999566398		0.407	[-0.471--0.342] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267629	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42252112		TCF20			ENSG00000100207			rs144273287-?	rs144273287	1	141467897	intron_variant	0	NR	2E-24	23.69897000433602		0.392	[-0.467--0.317] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267629	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42035242		WBP2NL			ENSG00000183066			rs133351-?	rs133351	0	133351	intron_variant	0	NR	2E-23	22.69897000433602		0.321	[0.258-0.384] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267629	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	41873624		SREBF2			ENSG00000198911			rs133291-?	rs133291	0	133291	intron_variant	0	NR	1E-17	17		0.317	[-0.39--0.244] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267629	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	41372858		TEF			ENSG00000167074			rs5751086-?	rs5751086	0	5751086	intron_variant	0	NR	4E-9	8.397940008672037		0.219	[-0.292--0.146] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267629	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42142507		CYP2D7			ENSG00000205702			rs3021082-?	rs3021082	0	3021082	stop_gained	0	NR	4E-9	8.397940008672037		0.153	[-0.204--0.102] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267630	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42035242		WBP2NL			ENSG00000183066			rs133351-?	rs133351	0	133351	intron_variant	0	NR	2E-8	7.698970004336019		0.137	[0.089-0.184] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267630	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42224934		TCF20			ENSG00000100207			rs5751245-?	rs5751245	0	5751245	intron_variant	0	NR	5E-14	13.301029995663981		0.173	[0.128-0.218] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267631	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42120362		NDUFA6-DT			ENSG00000237037			rs5751221-?	rs5751221	0	5751221	intron_variant	0	NR	7E-11	10.154901959985743		0.162	[0.113-0.21] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267631	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	41873624		SREBF2			ENSG00000198911			rs133291-?	rs133291	0	133291	intron_variant	0	NR	2E-9	8.698970004336019		0.147	[0.099-0.195] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267631	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42020052		WBP2NL			ENSG00000183066			rs133335-?	rs133335	0	133335	missense_variant	0	NR	2E-8	7.698970004336019		0.127	[-0.171--0.082] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267631	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	N-desmethyl tamoxifen levels in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42173993		TCF20			ENSG00000100207			rs2011944-?	rs2011944	0	2011944	intron_variant	0	NR	2E-8	7.698970004336019		0.143	[0.093-0.193] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267631	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen to N-desmethyl tamoxifen ratio  in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42142508		CYP2D7			ENSG00000205702			rs56023519-?	rs56023519	0	56023519	missense_variant	0	NR	3E-65	64.52287874528034		0.593	[-0.661--0.525] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267633	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen to N-desmethyl tamoxifen ratio  in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42252112		TCF20			ENSG00000100207			rs144273287-?	rs144273287	1	141467897	intron_variant	0	NR	7E-39	38.15490195998574		0.554	[-0.637--0.471] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267633	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen to N-desmethyl tamoxifen ratio  in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42035242		WBP2NL			ENSG00000183066			rs133351-?	rs133351	0	133351	intron_variant	0	NR	4E-34	33.39794000867204		0.438	[0.367-0.508] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267633	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	Endoxifen to N-desmethyl tamoxifen ratio  in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	41873624		SREBF2			ENSG00000198911			rs133291-?	rs133291	0	133291	intron_variant	0	NR	2E-30	29.69897000433602		0.468	[-0.548--0.388] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267633	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42142508		CYP2D7			ENSG00000205702			rs56023519-?	rs56023519	0	56023519	missense_variant	0	NR	4E-21	20.397940008672037		0.207	[-0.25--0.164] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42268966		TCF20			ENSG00000100207			rs5758689-?	rs5758689	0	5758689	intron_variant	0	NR	6E-13	12.221848749616356		0.184	[-0.234--0.134] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	42035242		WBP2NL			ENSG00000183066			rs133351-?	rs133351	0	133351	intron_variant	0	NR	7E-11	10.154901959985743		0.139	[0.097-0.181] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA											rs2267448-?	rs2267448	0	2267448		1	NR	7E-11	10.154901959985743		0.141	[0.099-0.184] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	22q13.2	22	41852856		SREBF2			ENSG00000198911			rs2267440-?	rs2267440	0	2267440	intron_variant	0	NR	5E-9	8.301029995663981		0.143	[0.095-0.19] unit increase	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
4/25/2023	36629403	Khor CC	1/11/2023	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/36629403	Cross-ancestry GWAS defines the extended CYP2D6 locus as the principal genetic determinant of endoxifen plasma concentrations.	(Z)-4-hydroxytamoxifen to tamoxifen ratio in tamoxifen-treated hormone-receptor-positive breast cancer	"148 Singaporean Chinese ancestry individuals, 69 Lebanese ancestry individuals, 280 German ancestry individuals"	NA	6p22.3	6	24876032		RIPOR2			ENSG00000111913			rs3792988-?	rs3792988	0	3792988	intron_variant	0	NR	3E-8	7.522878745280337		0.196	[-0.265--0.127] unit decrease	Illumina [4673513] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST90267634	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	7q22.3	7	106631389	NR	LARP1BP2 - CCDC71L	ENSG00000243438	ENSG00000253276		315646	22971	rs375468501-?	rs375468501	0	375468501	intron_variant	1	NR	3E-6	5.522878745280337		1.3377686	[1.18-1.51]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	16q22.1	16	67082698	NR	CBFB			ENSG00000067955			rs140538758-?	rs140538758	0	140538758	intron_variant	0	NR	6E-7	6.221848749616356		1.5044404	[1.28-1.77]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	9q21.12	9	70158086	NR	"MAMDC2-AS1, MAMDC2"			"ENSG00000204706, ENSG00000165072"			rs55686336-?	rs55686336	0	55686336	intron_variant	0	NR	3E-6	5.522878745280337		1.5113994	[1.27-1.80]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	22q12.1	22	27918624	NR	PITPNB			ENSG00000180957			rs62235635-?	rs62235635	0	62235635	intron_variant	0	NR	1E-6	6		1.6262683	[1.34-1.98]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	22q12.1	22	28365160	NR	TTC28			ENSG00000100154			rs62237617-?	rs62237617	0	62237617	intron_variant	0	NR	2E-6	5.698970004336019		1.6840287	[1.36-2.09]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	17p13.3	17	919380	NR	NXN			ENSG00000167693			rs118021774-?	rs118021774	0	118021774	intron_variant	0	NR	4E-6	5.3979400086720375		1.8284526	[1.42-2.36]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA				NR							chr5:1227088-?	chr5:1227088	0			1	NR	2E-6	5.698970004336019		1.1522056	[1.09-1.22]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	21q22.3	21	45497121	NR	"COL18A1, SLC19A1"			"ENSG00000182871, ENSG00000173638"			rs73370840-?	rs73370840	0	73370840	intron_variant	0	NR	9E-7	6.045757490560675		1.1648589	[1.10-1.24]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	14q12	14	24401845	NR	NYNRIN			ENSG00000205978			rs7160316-?	rs7160316	0	7160316	intron_variant	0	NR	2E-6	5.698970004336019		0.61414945	[0.50-0.75]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	4q35.1	4	185141891	NR	LINC02436 - SLC25A4	ENSG00000250754	ENSG00000151729		26391	1375	rs79116769-?	rs79116769	0	79116769	intergenic_variant	1	NR	6E-7	6.221848749616356		0.7772595	[0.70-0.86]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	17p13.3	17	3000998	NR	RAP1GAP2			ENSG00000132359			rs12938141-?	rs12938141	0	12938141	intron_variant	0	NR	5E-7	6.301029995663981		0.77756035	[0.70-0.86]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	6p25.2	6	2634705	NR	LINC02521			ENSG00000228718			rs6938753-?	rs6938753	0	6938753	non_coding_transcript_exon_variant	0	NR	1E-6	6		0.8705196	[0.82-0.92]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA				NR							chr7:41400313-?	chr7:41400313	0			1	NR	3E-6	5.522878745280337		0.8813266	[0.84-0.93]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	7q11.22	7	70935714	NR	AUTS2 - GALNT17	ENSG00000158321	ENSG00000185274		142208	196430	rs4717568-?	rs4717568	0	4717568	regulatory_region_variant	1	NR	1E-7	7		0.88204163	[0.84-0.92]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	9q33.1	9	116142133	NR	LINC00474 - PAPPA	ENSG00000204148	ENSG00000182752		216926	11658	rs204517-?	rs204517	0	204517	intergenic_variant	1	NR	3E-6	5.522878745280337		0.8883291	[0.85-0.93]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	10p15.2	10	3554755	NR	LINC02669 - KLF6	ENSG00000233321	ENSG00000067082		51840	221241	rs11251942-?	rs11251942	0	11251942	intron_variant	1	NR	5E-7	6.301029995663981		1.1186024	[1.07-1.17]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	10p14	10	7272478	NR	SFMBT2			ENSG00000198879			rs7082321-?	rs7082321	0	7082321	intron_variant	0	NR	1E-6	6		1.1424168	[1.08-1.21]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	5p13.3	5	32017440	NR	PDZD2			ENSG00000133401			rs11289719-?	rs11289719	0	11289719	intron_variant	0	NR	3E-6	5.522878745280337		1.1424453	[1.08-1.21]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	15q25.1	15	80763524	NR	ABHD17C - CEMIP	ENSG00000136379	ENSG00000103888		7903	15819	rs149479659-?	rs149479659	0	149479659	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1531807	[1.09-1.22]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA				NR							chr12:27965596-?	chr12:27965596	0			1	NR	4E-6	5.3979400086720375		1.1574948	[1.09-1.23]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	4q28.3	4	136496076	NR	TERF1P3 - LINC02511	ENSG00000249311	ENSG00000248869		139740	299843	rs12505589-?	rs12505589	0	12505589	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.1673031	[1.09-1.25]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	"4,116 European ancestry cases, 60,055 European ancestry controls"	NA	6q27	6	167818409	NR	LINC01558 - AFDN-DT	ENSG00000146521	ENSG00000198221		21537	3694	rs587150-?	rs587150	0	587150	intron_variant	1	NR	1E-6	6		1.2127603	[1.12-1.31]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	20q13.13	20	50148998	NR	"PEDS1-UBE2V1, PEDS1"			"ENSG00000124208, ENSG00000240849"			rs111410779-?	rs111410779	0	111410779	intron_variant	0	NR	2E-6	5.698970004336019		0.7558102	[0.67-0.85]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	1q32.3	1	214187549	NR	LINC02775			ENSG00000283518			rs1223809-?	rs1223809	0	1223809	non_coding_transcript_exon_variant	0	NR	6E-7	6.221848749616356		0.77497697	[0.70-0.86]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	15q26.1	15	89326435	NR	POLG			ENSG00000140521			rs2074885-?	rs2074885	0	2074885	intron_variant	0	NR	1E-6	6		0.8028575	[0.73-0.88]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	14q11.2	14	22010722	NR	TRAV19 - TRAV20	ENSG00000211799	ENSG00000211800		2541	29872	rs11846015-?	rs11846015	0	11846015	intergenic_variant	1	NR	3E-6	5.522878745280337		0.8028945	[0.73-0.88]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	Xp21.1	X	31787910	NR	DMD			ENSG00000198947			rs6628643-?	rs6628643	0	6628643	intron_variant	0	NR	2E-6	5.698970004336019		0.83806884	[0.78-0.90]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	21q21.1	21	18948980	NR	PPIAP22 - SLC6A6P1	ENSG00000198618	ENSG00000226818		90704	295563	rs2825231-?	rs2825231	0	2825231	intergenic_variant	1	NR	2E-6	5.698970004336019		0.8523688	[0.80-0.91]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	9p21.2	9	27382087	NR	MOB3B			ENSG00000120162			rs6475992-?	rs6475992	0	6475992	intron_variant	0	NR	2E-6	5.698970004336019		0.852871	[0.80-0.91]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	2p25.3	2	2250596	NR	MYT1L			ENSG00000186487			rs1895136-?	rs1895136	0	1895136	intron_variant	0	NR	2E-6	5.698970004336019		0.86301345	[0.81-0.92]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	2p12	2	77712387	NR	LRRTM4 - RPL38P2	ENSG00000176204	ENSG00000237077		119068	75995	rs1809591-?	rs1809591	0	1809591	intron_variant	1	NR	2E-6	5.698970004336019		1.1678296	[1.10-1.25]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	7p15.2	7	27406338	NR	HNRNPA1P73 - EIF4HP1	ENSG00000236569	ENSG00000233830		76804	51825	rs67918676-?	rs67918676	1	11454681	intron_variant	1	NR	1E-7	7		1.274184	[1.16-1.39]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	2q24.1	2	158326236	NR	CCDC148			ENSG00000153237			rs12617237-?	rs12617237	0	12617237	intron_variant	0	NR	2E-6	5.698970004336019		1.3453282	[1.19-1.52]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	5q31.1	5	133397775	NR	FSTL4			ENSG00000053108			rs28716841-?	rs28716841	0	28716841	intron_variant	0	NR	3E-6	5.522878745280337		1.3696141	[1.20-1.56]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	10p11.23	10	29793048	NR	SVIL - JCAD	ENSG00000197321	ENSG00000165757		56089	219755	rs72804888-?	rs72804888	0	72804888	intergenic_variant	1	NR	8E-7	6.096910013008056		1.5575172	[1.31-1.86]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	16p12.2	16	22796100	NR	LINC02890 - HS3ST2	ENSG00000260905	ENSG00000122254		182617	18062	rs35557655-?	rs35557655	0	35557655	intergenic_variant	1	NR	8E-7	6.096910013008056		1.6119925	[1.33-1.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	4p15.32	4	16585051	NR	LDB2			ENSG00000169744			rs111896170-?	rs111896170	0	111896170	intron_variant	0	NR	1E-6	6		1.7095189	[1.38-2.12]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	1q31.3	1	193939892	NR	RPL23AP22 - EEF1A1P14	ENSG00000237213	ENSG00000233057		182625	249075	rs79991130-?	rs79991130	0	79991130	intron_variant	1	NR	3E-6	5.522878745280337		1.7924654	[1.41-2.29]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	4p14	4	36239381	NR	ARAP2			ENSG00000047365			rs139805484-?	rs139805484	0	139805484	intron_variant	0	NR	2E-6	5.698970004336019		1.8205888	[1.42-2.34]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	5q33.1	5	152723754	NR	LINC01470			ENSG00000249484			rs147254607-?	rs147254607	0	147254607	non_coding_transcript_exon_variant	0	NR	5E-7	6.301029995663981		1.9110351	[1.48-2.46]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	4q28.3	4	135748515	NR	TARS2P1 - LINC00613	ENSG00000248104	ENSG00000248330		181358	118468	rs6837069-?	rs6837069	0	6837069	intergenic_variant	1	NR	1E-6	6		1.9211789	[1.48-2.50]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	2p14	2	67936028	NR	LINC01812 - FBXL12P1	ENSG00000237013	ENSG00000235968		110466	87666	rs146081883-?	rs146081883	0	146081883	intergenic_variant	1	NR	2E-6	5.698970004336019		1.9596248	[1.49-2.58]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	14q32.13	14	95068893	NR	LINC02279 - DICER1	ENSG00000258933	ENSG00000100697		105917	17335	rs146768547-?	rs146768547	0	146768547	intergenic_variant	1	NR	8E-7	6.096910013008056		1.9677978	[1.50-2.57]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	10q21.3	10	64959483	NR	LINC02671			ENSG00000224714			rs117521942-?	rs117521942	0	117521942	intron_variant	0	NR	3E-6	5.522878745280337		2.0097754	[1.50-2.69]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	10q21.3	10	64846439	NR	ANXA2P3 - LINC02671	ENSG00000216740	ENSG00000224714		19860	54697	rs117212863-?	rs117212863	0	117212863	intergenic_variant	1	NR	1E-6	6		2.051161	[1.53-2.75]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	5q13.1	5	68919169	NR	U8 - RN7SKP251	ENSG00000200191	ENSG00000276309		45082	51270	rs113232387-?	rs113232387	0	113232387	intron_variant	1	NR	2E-6	5.698970004336019		2.2127366	[1.59-3.08]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	11q23.2	11	113190040	NR	NCAM1			ENSG00000149294			rs184731128-?	rs184731128	0	184731128	intron_variant	0	NR	1E-6	6		2.901129	[1.88-4.47]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	16p13.3	16	1056795	NR	SOX8 - SSTR5-AS1	ENSG00000005513	ENSG00000261713		69816	7292	rs213667-?	rs213667	0	213667	intergenic_variant	1	NR	2E-6	5.698970004336019		0.34337574	[0.22-0.53]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA	5q14.3	5	84311324	NR	EDIL3			ENSG00000164176			rs2937080-?	rs2937080	0	2937080	intron_variant	0	NR	2E-6	5.698970004336019		0.4252747	[0.30-0.60]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor negative breast cancer	"2,125 European ancestry cases, 14,047 European ancestry controls"	NA				NR							chr6:168438325-?	chr6:168438325	0			1	NR	7E-7	6.154901959985743		0.51752573	[0.40-0.67]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007476	Genome-wide genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	1p36.13	1	16013277	HSPB7	SRARP - HSPB7	ENSG00000183888	ENSG00000173641		4470	751	rs1763604-C	rs1763604	0	1763604	TF_binding_site_variant	1	0.42085	7E-9	8.154901959985743		0.0372	[0.025-0.05] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	1q21.3	1	155016057	ZBTB7B	ZBTB7B			ENSG00000160685			rs77548871-C	rs77548871	0	77548871	intron_variant	0	0.0472	5E-9	8.301029995663981		0.0991	[0.066-0.132] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	2p11.2	2	85573959	NR	VAMP8			ENSG00000118640			rs13007211-A	rs13007211	0	13007211	intron_variant	0	0.6935	1E-9	9		0.0432	[0.029-0.057] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	2q13	2	111138666	BCL2L11	"MIR4435-2HG, BCL2L11"			"ENSG00000172965, ENSG00000153094"			rs17041869-A	rs17041869	0	17041869	intron_variant	0	0.8804	2E-9	8.698970004336019		0.0571	[0.038-0.076] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	4q24	4	105137029	TET2	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		162258	8846	rs57251748-CT	rs57251748	0	57251748	regulatory_region_variant	1	0.15	9E-12	11.045757490560675		0.0598	[0.043-0.077] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	7p15.1	7	27950149	JAZF1	JAZF1			ENSG00000153814			rs739704-A	rs739704	0	739704	intron_variant	0	0.2515	3E-14	13.522878745280337		0.0542	[0.04-0.068] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	7q35	7	144377836	ARHGEF5	ARHGEF5			ENSG00000050327			rs720475-A	rs720475	0	720475	intron_variant	0	0.25455	7E-12	11.154901959985743		0.0495	[0.035-0.064] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	8q24.21	8	126990792	PCAT1/PCAT2	PCAT1			ENSG00000253438			rs17762342-A	rs17762342	0	17762342	intron_variant	0	0.7935	2E-15	14.698970004336019		0.061	[0.046-0.076] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	8q24.21	8	128187668	MIR1208/PVT1	PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		567	32836	rs3802173-T	rs3802173	0	3802173	intergenic_variant	1	0.2261	3E-11	10.522878745280337		0.0521	[0.037-0.068] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	9p21.3	9	21956231	CDKN2A/CDKN2B	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		18580	10698	rs9657608-T	rs9657608	0	9657608	intron_variant	1	0.0923	1E-10	10		0.0685	[0.048-0.089] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	10p12.31	10	22010574	DNAJC1	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		6805	152418	rs7898685-A	rs7898685	0	7898685	regulatory_region_variant	1	0.2913	3E-10	9.522878745280337		0.0428	[0.029-0.056] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	10q25.3	10	113390512	HABP2	RNU7-165P - PPIAP39	ENSG00000238380	ENSG00000230018		37028	92104	rs568110-T	rs568110	0	568110	regulatory_region_variant	1	0.2057	5E-12	11.301029995663981		0.0523	[0.037-0.067] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	11q12.3	11	62126500	INCENP	INCENP			ENSG00000149503			rs7937840-T	rs7937840	0	7937840	intron_variant	0	0.26465	2E-9	8.698970004336019		0.0446	[0.03-0.059] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	11q13.2	11	66324772	NR	CD248 - RIN1	ENSG00000174807	ENSG00000174791		7728	5469	rs118151305-A	rs118151305	0	118151305	intergenic_variant	1	0.12004999999999999	6E-9	8.221848749616356		0.0672	[0.045-0.09] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	11q13.3	11	69138652	TPCN2	TPCN2 - SMIM38	ENSG00000162341	ENSG00000284713		2336	16826	rs72932523-A	rs72932523	0	72932523	intron_variant	1	0.10565	1E-9	9		0.0601	[0.041-0.08] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	14q32.11	14	91283251	CCDC88C	CCDC88C			ENSG00000015133			rs2277509-A	rs2277509	0	2277509	intron_variant	0	0.69865	9E-12	11.045757490560675		0.0466	[0.033-0.06] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	17q22	17	55135212	STXBP4	STXBP4			ENSG00000166263			rs2628317-A	rs2628317	0	2628317	intron_variant	0	0.72985	4E-16	15.397940008672037		0.0582	[0.044-0.072] unit increase	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
12/1/2020	27432226	Kar SP	7/17/2016	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types."	"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"	"62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls"	NA	19p13.11	19	19417997	GATAD2A	GATAD2A			ENSG00000167491			rs1469713-A	rs1469713	0	1469713	intron_variant	0	0.64405	1E-10	10		0.043	[0.03-0.056] unit decrease	Illumina [NR]	N	"prostate carcinoma, breast carcinoma, ovarian carcinoma"	"http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075"	GCST010797	Targeted genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5p15.1	5	16187419	intergenic	MARCHF11-DT - NACAP6	ENSG00000250448	ENSG00000248403		1834	4669	rs13162653-G	rs13162653	0	13162653	intergenic_variant	1	0.55	1E-10	10		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5p13.3	5	32567626	Intergenic	SUB1			ENSG00000113387			rs2012709-T	rs2012709	0	2012709	intron_variant	0	0.46	6E-9	8.221848749616356		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	3p24.1	3	30641447	NR	TGFBR2			ENSG00000163513			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.34	1E-8	8		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1q21.2	1	149955122	Intergenic	OTUD7B			ENSG00000264522			rs12048493-C	rs12048493	0	12048493	intron_variant	0	0.34	1E-9	9		1.07	[1.05-1.10]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	4q24	4	105163621	NR	TET2			ENSG00000168769			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.22	1E-9	9		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	3p21.31	3	46825376	Intergenic	PRSS44P - PRSS42P	ENSG00000226074	ENSG00000178055		12890	4166	rs6796502-G	rs6796502	0	6796502	intergenic_variant	1	0.91	2E-8	7.698970004336019		1.0869565	[1.05-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	1E-8	8		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6p22.1	6	28958443	Intergenic	LINC01556 - KRT18P1	ENSG00000204709	ENSG00000228666		13906	10687	rs9257408-C	rs9257408	0	9257408	TF_binding_site_variant	1	0.38	5E-8	7.301029995663981		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5p12	5	44706396	NR	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	5E-32	31.30102999566398		1.12	[1.1-1.15]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5q11.2	5	56736057	NR	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-C	rs889312	0	889312	intergenic_variant	1	0.28	1E-39	39		1.12	[1.1-1.15]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5q11.2	5	58888234	NR	RAB3C - PDE4D	ENSG00000152932	ENSG00000113448		28840	80804	rs10472076-C	rs10472076	0	10472076	regulatory_region_variant	1	0.38	2E-8	7.698970004336019		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5q11.2	5	59041654	NR	PDE4D			ENSG00000113448			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.9	3E-8	7.522878745280337		1.0869565	[1.05-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5q33.3	5	158817075	NR	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	4E-16	15.397940008672037		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6p25.3	6	1318643	NR	FOXQ1 - LINC01394	ENSG00000164379	ENSG00000281809		3885	3055	rs11242675-T	rs11242675	0	11242675	intergenic_variant	1	0.62	1E-7	7		1.0416667	[1.02-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	18q12.3	18	44819625	SETBP1	SETBP1			ENSG00000152217			rs6507583-A	rs6507583	0	6507583	intron_variant	0	0.93	3E-8	7.522878745280337		1.098901	[1.05-1.14]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6q14.1	6	81418669	NR	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		948241	72770	rs17529111-C	rs17529111	0	17529111	intergenic_variant	1	0.22	2E-10	9.698970004336019		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1p13.2	1	113905767	NR	DCLRE1B			ENSG00000118655			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.16	3E-9	8.522878745280337		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1p11.2	1	121538815	NR	"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	3E-27	26.522878745280337		1.09	[1.07-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	7q21.2	7	92001306	NR	AKAP9			ENSG00000127914			rs6964587-T	rs6964587	0	6964587	missense_variant	0	0.39	5E-7	6.301029995663981		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2q14.2	2	120487546	NR	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.9	2E-11	10.698970004336019		1.098901	[1.06-1.14]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8p12	8	29652100	NR	RPL17P33 - LINC00589	ENSG00000243844	ENSG00000251191		19456	21822	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	1E-12	12		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2q31.1	2	173348166	NR	RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.84	1E-6	6		1.0526316	[1.03-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8q21.13	8	75505702	NR	HNF4G			ENSG00000164749			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	1E-16	16		1.13	[1.09-1.17]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8q24.21	8	127343372	NR	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.4	6E-31	30.221848749616356		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2q35	2	217431785	NR	DIRC3			ENSG00000231672			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	1E-17	17		1.08	[1.06-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	9p21.3	9	22062135	NR	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	4E-9	8.397940008672037		1.06	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	16q12.2	16	53779455	NR	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	2E-14	13.698970004336019		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	16q12.2	16	53821379	NR	FTO			ENSG00000140718			rs11075995-A	rs11075995	0	11075995	intron_variant	0	0.24	1E-6	6		1.04	[1.02-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	16q23.2	16	80616908	NR	CDYL2			ENSG00000166446			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	2E-17	16.69897000433602		1.08	[1.06-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	17q22	17	54979110	NR	STXBP4			ENSG00000166263			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	5E-12	11.301029995663981		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	18q11.2	18	26757460	NR	AQP4-AS1			ENSG00000260372			rs527616-G	rs527616	0	527616	intron_variant	0	0.62	8E-13	12.096910013008056		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	18q11.2	18	26990703	NR	"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	3E-8	7.522878745280337		1.0416667	[1.03-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	19p13.11	19	17278895	NR	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.19	2E-6	5.698970004336019		1.04	[1.02-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	19p13.11	19	17283315	NR	ANKLE1			ENSG00000160117			rs2363956-T	rs2363956	0	2363956	missense_variant	0	0.49	2E-6	5.698970004336019		1.03	[1.01-1.05]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	19p13.11	19	18460331	NR	ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	4E-15	14.397940008672037		1.0752687	[1.06-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	19q13.31	19	43782361	NR	KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	0.46	8E-9	8.096910013008056		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	21q21.1	21	15148511	NR	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		80674	342019	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	3E-13	12.522878745280337		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	22q12.2	22	29225488	NR	EMID1			ENSG00000186998			rs132390-C	rs132390	0	132390	intron_variant	0	0.04	3E-9	8.522878745280337		1.14	[1.08-1.2]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	22q13.1	22	40480230	NR	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	2E-20	19.69897000433602		1.12	[1.09-1.16]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1q21.1	1	145790097	"LOC10028814, NBPF10, RNF115"	RNF115			ENSG00000265491			rs12405132-C	rs12405132	0	12405132	intron_variant	0	0.64	2E-7	6.698970004336019		1.0526316		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1q21.2	1	149955122	intergenic	OTUD7B			ENSG00000264522			rs12048493-C	rs12048493	0	12048493	intron_variant	0	0.34	2E-9	8.698970004336019		1.07	[1.05???1.10]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1q43	1	241870961	EXO1	EXO1			ENSG00000174371			rs72755295-G	rs72755295	0	72755295	intron_variant	0	0.03	3E-7	6.522878745280337		1.15	[1.09???1.22]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	3p21.31	3	46825376	intergenic	PRSS44P - PRSS42P	ENSG00000226074	ENSG00000178055		12890	4166	rs6796502-G	rs6796502	0	6796502	intergenic_variant	1	0.81	8E-7	6.096910013008056		1.0869565		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5p15.1	5	16187419	intergenic	MARCHF11-DT - NACAP6	ENSG00000250448	ENSG00000248403		1834	4669	rs13162653-G	rs13162653	0	13162653	intergenic_variant	1	0.55	2E-6	5.698970004336019		1.0526316		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5p13.3	5	32567626	intergenic	SUB1			ENSG00000113387			rs2012709-T	rs2012709	0	2012709	intron_variant	0	0.46	2E-6	5.698970004336019		1.05	[1.03???1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5q14.2	5	82242227	ATG10	ATG10			ENSG00000152348			rs7707921-A	rs7707921	0	7707921	intron_variant	0	0.77	4E-9	8.397940008672037		1.0752687		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	6p22.1	6	28958443	intergenic	LINC01556 - KRT18P1	ENSG00000204709	ENSG00000228666		13906	10687	rs9257408-C	rs9257408	0	9257408	TF_binding_site_variant	1	0.38	5E-7	6.301029995663981		1.05	[1.03???1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	7q32.3	7	130982362	FLJ43663	LINC-PINT			ENSG00000231721			rs4593472-C	rs4593472	0	4593472	intron_variant	0	0.65	4E-6	5.3979400086720375		1.0526316		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8q23.3	8	116197325	LINC00536	LINC00536			ENSG00000249917			rs13267382-A	rs13267382	0	13267382	intron_variant	0	0.36	5E-6	5.301029995663981		1.05	[1.03???1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	14q32.12	14	92637727	RIN3	RIN3			ENSG00000100599			rs11627032-T	rs11627032	0	11627032	intron_variant	0	0.74	1E-6	6		1.0638298		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA				ATAD5							chr17:29230520-G	chr17:29230520	0			1	0.8	1E-6	6		1.0752687		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	3p24.1	3	27374522	NR	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	3E-30	29.522878745280337		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1q21.1	1	145790097	"LOC10028814, NBPF10, RNF115"	RNF115			ENSG00000265491			rs12405132-C	rs12405132	0	12405132	intron_variant	0	0.64	8E-9	8.096910013008056		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	3p14.1	3	63982224	NR	ATXN7			ENSG00000163635			rs1053338-G	rs1053338	0	1053338	missense_variant	0	0.13	9E-9	8.045757490560675		1.08	[1.05-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1q43	1	241870961	EXO1	EXO1			ENSG00000174371			rs72755295-G	rs72755295	0	72755295	intron_variant	0	0.03	2E-8	7.698970004336019		1.15	[1.09-1.22]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	4q34.1	4	174925275	NR	ADAM29			ENSG00000168594			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.88	1E-15	15		1.1111112	[1.08-1.15]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5q14.2	5	82242227	ATG10	ATG10			ENSG00000152348			rs7707921-A	rs7707921	0	7707921	intron_variant	0	0.77	5E-11	10.301029995663981		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	5p15.33	5	1297373	NR	TERT - MIR4457	ENSG00000164362	ENSG00000263670		2305	11937	rs2736108-C	rs2736108	0	2736108	regulatory_region_variant	1	0.71	2E-9	8.698970004336019		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	7q32.3	7	130982362	FLJ43663	LINC-PINT			ENSG00000231721			rs4593472-C	rs4593472	0	4593472	intron_variant	0	0.65	2E-9	8.698970004336019		1.0526316	[1.03-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8p11.23	8	37000965	Intergenic	KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		64840	94185	rs13365225-A	rs13365225	0	13365225	intergenic_variant	1	0.83	1E-8	8		1.0526316	[1.02-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8q23.3	8	116197325	LINC00536	LINC00536			ENSG00000249917			rs13267382-A	rs13267382	0	13267382	intron_variant	0	0.36	2E-8	7.698970004336019		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	14q32.12	14	92637727	RIN3	RIN3			ENSG00000100599			rs11627032-T	rs11627032	0	11627032	intron_variant	0	0.74	4E-9	8.397940008672037		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"				ATAD5							chr17:29230520-GGT	chr17:29230520	0			1	0.8	3E-8	7.522878745280337		1.0752687	[1.04-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	17q25.3	17	79807926	Intergenic	CBX8 - LINC01977	ENSG00000141570	ENSG00000262772		6243	11157	rs745570-A	rs745570	0	745570	intergenic_variant	1	0.5	1E-9	9		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6p23	6	13722291	NR	RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		10456	64266	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.44	4E-10	9.397940008672037		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	1p36.22	1	10506158	NR	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	4E-11	10.397940008672037		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6q25.1	6	151597721	NR	CCDC170			ENSG00000120262			rs12662670-G	rs12662670	0	12662670	intron_variant	0	0.07	7E-27	26.154901959985743		1.17	[1.13-1.22]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	6q25.1	6	151627231	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	0.34	6E-24	23.221848749616356		1.08	[1.06-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2p24.1	2	19121042	NR	LINC01376			ENSG00000236204			rs12710696-T	rs12710696	0	12710696	intron_variant	0	0.36	4E-7	6.3979400086720375		1.04	[1.02-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	7q35	7	144377836	NR	ARHGEF5			ENSG00000050327			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	4E-10	9.397940008672037		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2q31.1	2	172108243	NR	DLX2-DT			ENSG00000236651			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	8E-6	5.096910013008056		1.0526316	[1.03-1.06]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8q21.13	8	75318066	NR	CASC9			ENSG00000249395			rs6472903-T	rs6472903	0	6472903	intron_variant	0	0.82	1E-16	16		1.098901	[1.08-1.12]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	2q35	2	217041109	NR	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.51	1E-55	55		1.1363636	[1.11-1.16]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	8q24.21	8	128182395	NR	PVT1			ENSG00000249859			rs11780156-T	rs11780156	0	11780156	intron_variant	0	0.16	2E-9	8.698970004336019		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	3p26.1	3	4700592	NR	ITPR1			ENSG00000150995			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	9E-12	11.045757490560675		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	9q31.2	9	107543834	NR	PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	0.29	3E-9	8.522878745280337		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	9q31.2	9	108126198	NR	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		28347	500635	rs865686-T	rs865686	0	865686	regulatory_region_variant	1	0.62	6E-34	33.221848749616356		1.1111112	[1.09-1.14]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10p12.31	10	21744013	NR	MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	0.29	1E-14	14		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10p12.31	10	22026914	NR	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		23145	136078	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	6E-17	16.221848749616356		1.27	[1.19-1.36]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10q21.2	10	62518923	NR	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-G	rs10995190	0	10995190	intron_variant	1	0.84	2E-37	36.69897000433602		1.1627907	[1.14-1.2]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10q22.3	10	79081391	NR	ZMIZ1			ENSG00000108175			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	3E-23	22.522878745280337		1.08	[1.06-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10q25.2	10	113014168	NR	TCF7L2			ENSG00000148737			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	9E-13	12.045757490560675		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10q26.12	10	121334387	NR	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		148421	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	8E-9	8.096910013008056		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	10q26.13	10	121577821	NR	FGFR2			ENSG00000066468			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	6E-164	163.22184874961636		1.27	[1.24-1.29]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11p15.5	11	1887776	NR	LSP1			ENSG00000130592			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	2E-13	12.698970004336019		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11q13.1	11	65815595	NR	OVOL1 - CFL1	ENSG00000172818	ENSG00000172757		18381	7427	rs3903072-G	rs3903072	0	3903072	intergenic_variant	1	0.53	1E-10	10		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11q13.3	11	69516650	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21698	124506	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	0.08	2E-86	85.69897000433602		1.34	[1.29-1.38]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11q13.3	11	69516874	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21922	124282	rs554219-G	rs554219	0	554219	regulatory_region_variant	1	0.12	2E-81	80.69897000433602		1.26	[1.23-1.3]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11q13.3	11	69564393	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		69441	76763	rs75915166-A	rs75915166	0	75915166	intergenic_variant	1	0.06	1E-57	57		1.31	[1.26-1.36]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-C	rs11820646	0	11820646	regulatory_region_variant	1	0.59	1E-10	10		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	12p13.1	12	14260997	NR	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		5771	95845	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	1E-7	7		1.04	[1.02-1.07]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	12p11.22	12	28002147	NR	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	5E-34	33.30102999566398		1.1627907	[1.12-1.2]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	12q22	12	95633983	NR	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.7	7E-21	20.154901959985743		1.098901	[1.08-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	12q24.21	12	115398717	NR	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	1	0.58	2E-21	20.69897000433602		1.0869565	[1.06-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	13q13.1	13	32398489	NR	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.01	6E-7	6.221848749616356		1.27	[1.15-1.4]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	14q13.3	14	36663564	NR	PAX9			ENSG00000198807			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	9E-13	12.045757490560675		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	14q24.1	14	68193711	NR	RAD51B			ENSG00000182185			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	2E-8	7.698970004336019		1.08	[1.05-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	14q24.1	14	68567965	NR	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	2E-21	20.69897000433602		1.0869565	[1.06-1.11]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	14q32.11	14	91374725	NR	CCDC88C			ENSG00000015133			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	6E-11	10.221848749616356		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
11/14/2017	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"15,748 European ancestry cases, 18,084 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls"	16q12.1	16	52552429	NR	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	4E-117	116.39794000867204		1.24	[1.21-1.26]	"Affymetrix, Illumina [~ 11600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004950	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8p12	8	29652100	NR	RPL17P33 - LINC00589	ENSG00000243844	ENSG00000251191		19456	21822	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	1E-10	10		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8q21.13	8	75318066	NR	CASC9			ENSG00000249395			rs6472903-T	rs6472903	0	6472903	intron_variant	0	0.8200000000000001	3E-13	12.522878745280337		1.098901	[1.08-1.12]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8q21.13	8	75505702	NR	HNF4G			ENSG00000164749			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	7E-11	10.154901959985743		1.13	[1.09-1.17]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8q24.21	8	127343372	NR	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.4	3E-22	21.522878745280337		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	8q24.21	8	128182395	NR	PVT1			ENSG00000249859			rs11780156-T	rs11780156	0	11780156	intron_variant	0	0.16	8E-7	6.096910013008056		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	9q31.2	9	107543834	NR	PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	0.29	7E-7	6.154901959985743		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	9q31.2	9	108126198	NR	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		28347	500635	rs865686-T	rs865686	0	865686	regulatory_region_variant	1	0.62	4E-27	26.397940008672037		1.1111112	[1.09-1.14]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10p12.31	10	21744013	NR	MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	0.29	8E-10	9.096910013008056		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10p12.31	10	22026914	NR	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		23145	136078	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	3E-13	12.522878745280337		1.27	[1.19-1.36]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10q21.2	10	62518923	NR	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-G	rs10995190	0	10995190	intron_variant	1	0.84	2E-29	28.69897000433602		1.1627907	[1.14-1.2]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10q22.3	10	79081391	NR	ZMIZ1			ENSG00000108175			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	3E-15	14.522878745280337		1.08	[1.06-1.1]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10q25.2	10	113014168	NR	TCF7L2			ENSG00000148737			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	5E-8	7.301029995663981		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	10q26.13	10	121577821	NR	FGFR2			ENSG00000066468			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	1E-128	128		1.27	[1.24-1.29]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	11p15.5	11	1887776	NR	LSP1			ENSG00000130592			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	1E-10	10		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	11q13.1	11	65815595	NR	OVOL1 - CFL1	ENSG00000172818	ENSG00000172757		18381	7427	rs3903072-G	rs3903072	0	3903072	intergenic_variant	1	0.53	3E-7	6.522878745280337		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	11q13.3	11	69516650	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21698	124506	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	0.08	2E-62	61.69897000433602		1.34	[1.29-1.38]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-C	rs11820646	0	11820646	regulatory_region_variant	1	0.5900000000000001	2E-7	6.698970004336019		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	12p11.22	12	28002147	NR	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	2E-22	21.69897000433602		1.1627907	[1.12-1.2]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	12q22	12	95633983	NR	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.7	6E-17	16.221848749616356		1.098901	[1.08-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	12q24.21	12	115398717	NR	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	1	0.5800000000000001	1E-16	16		1.0869565	[1.06-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	13q13.1	13	32398489	NR	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.01	2E-6	5.698970004336019		1.27	[1.15-1.4]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	14q13.3	14	36663564	NR	PAX9			ENSG00000198807			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	5E-10	9.301029995663981		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	14q24.1	14	68193711	NR	RAD51B			ENSG00000182185			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	4E-9	8.397940008672037		1.08	[1.05-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	14q24.1	14	68567965	NR	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	4E-13	12.397940008672037		1.0869565	[1.06-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	14q32.11	14	91374725	NR	CCDC88C			ENSG00000015133			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	2E-10	9.698970004336019		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	17q25.3	17	79807926	intergenic	CBX8 - LINC01977	ENSG00000141570	ENSG00000262772		6243	11157	rs745570-A	rs745570	0	745570	intergenic_variant	1	0.5	5E-7	6.301029995663981		1.0526316		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	18q12.3	18	44819625	SETBP1	SETBP1			ENSG00000152217			rs6507583-A	rs6507583	0	6507583	intron_variant	0	0.93	1E-6	6		1.098901		"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1p36.22	1	10506158	NR	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	9E-9	8.045757490560675		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1p13.2	1	113905767	NR	DCLRE1B			ENSG00000118655			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.16	6E-7	6.221848749616356		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	1p11.2	1	121538815	NR	"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	4E-20	19.397940008672037		1.09	[1.07-1.12]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	2q14.2	2	120487546	NR	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.9	5E-9	8.301029995663981		1.098901	[1.06-1.14]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	2q31.1	2	172108243	NR	DLX2-DT			ENSG00000236651			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	2E-6	5.698970004336019		1.0526316	[1.03-1.06]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	2q35	2	217041109	NR	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.51	9E-41	40.045757490560675		1.1363636	[1.11-1.16]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	3p26.1	3	4700592	NR	ITPR1			ENSG00000150995			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	6E-11	10.221848749616356		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	3p24.1	3	27374522	NR	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	5E-22	21.30102999566398		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	3p24.1	3	30641447	NR	TGFBR2			ENSG00000163513			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.34	7E-8	7.154901959985743		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	3p14.1	3	63982224	NR	ATXN7			ENSG00000163635			rs1053338-G	rs1053338	0	1053338	missense_variant	0	0.13	2E-7	6.698970004336019		1.08	[1.05-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	4q24	4	105163621	NR	TET2			ENSG00000168769			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.22	7E-6	5.154901959985743		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	4q34.1	4	174925275	NR	ADAM29			ENSG00000168594			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.88	3E-12	11.522878745280337		1.1111112	[1.08-1.15]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	2E-8	7.698970004336019		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5p12	5	44706396	NR	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	3E-26	25.522878745280337		1.12	[1.1-1.15]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5q11.2	5	56736057	NR	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-C	rs889312	0	889312	intergenic_variant	1	0.28	3E-27	26.522878745280337		1.12	[1.1-1.15]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5q11.2	5	58888234	NR	RAB3C - PDE4D	ENSG00000152932	ENSG00000113448		28840	80804	rs10472076-C	rs10472076	0	10472076	regulatory_region_variant	1	0.38	2E-6	5.698970004336019		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5q11.2	5	59041654	NR	PDE4D			ENSG00000113448			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.9	1E-6	6		1.0869565	[1.05-1.12]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	5q33.3	5	158817075	NR	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	4E-12	11.397940008672037		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	6p23	6	13722291	NR	RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		10456	64266	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.44	3E-7	6.522878745280337		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	6q14.1	6	81418669	NR	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		948241	72770	rs17529111-C	rs17529111	0	17529111	intergenic_variant	1	0.22	5E-7	6.301029995663981		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	6q25.1	6	151597721	NR	CCDC170			ENSG00000120262			rs12662670-G	rs12662670	0	12662670	intron_variant	0	0.07	1E-18	18		1.17	[1.13-1.22]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	7q21.2	7	92001306	NR	AKAP9			ENSG00000127914			rs6964587-T	rs6964587	0	6964587	missense_variant	0	0.39	1E-6	6		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	7q35	7	144377836	NR	ARHGEF5			ENSG00000050327			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	1E-8	8		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	16q12.1	16	52552429	NR	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	3E-86	85.52287874528034		1.24	[1.21-1.26]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	16q12.2	16	53779455	NR	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	7E-13	12.154901959985743		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	16q23.2	16	80616908	NR	CDYL2			ENSG00000166446			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	6E-12	11.221848749616356		1.08	[1.06-1.11]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	17q22	17	54979110	NR	STXBP4			ENSG00000166263			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	8E-9	8.096910013008056		1.0638298	[1.04-1.09]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	18q11.2	18	26757460	NR	AQP4-AS1			ENSG00000260372			rs527616-G	rs527616	0	527616	intron_variant	0	0.62	1E-7	7		1.0526316	[1.03-1.08]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	18q11.2	18	26990703	NR	"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	5E-6	5.301029995663981		1.0416667	[1.03-1.06]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	19p13.11	19	18460331	NR	ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	6E-14	13.221848749616356		1.0752687	[1.06-1.1]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	19q13.31	19	43782361	NR	KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	0.46	9E-7	6.045757490560675		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	21q21.1	21	15148511	NR	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		80674	342019	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	2E-12	11.698970004336019		1.0752687	[1.05-1.1]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	22q12.1	22	28725099	NR	CHEK2			ENSG00000183765			rs17879961-G	rs17879961	0	17879961	missense_variant	0	0.0049	8E-7	6.096910013008056		1.37	[1.21-1.55]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	22q12.2	22	29225488	NR	EMID1			ENSG00000186998			rs132390-C	rs132390	0	132390	intron_variant	0	0.04	4E-7	6.3979400086720375		1.14	[1.08-1.2]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
2/28/2019	25751625	Michailidou K	4/1/2015	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25751625	"Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer."	Breast cancer	"46,785 European ancestry cases, 42,892 European ancestry controls"	NA	22q13.1	22	40480230	NR	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	4E-14	13.397940008672037		1.12	[1.09-1.16]	"Affymetrix, Illumina [~ 14000000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST007236	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	6q25.1	6	151627231	intergenic	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-C	rs2046210	0	2046210	regulatory_region_variant	1	0.08	5E-9	8.301029995663981		1.28	[1.18-1.39]	Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	12p11.22	12	28002147	intergenic	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.86	8E-6	5.096910013008056		1.18	[1.1-1.27]	Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	1q32.1	1	204546897	MDM4	MDM4			ENSG00000198625			rs2290854-A	rs2290854	0	2290854	intron_variant	0	0.31	1E-7	7		1.13	[1.08-1.18]	Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	10q25.2	10	112974337	TCF7L2	TCF7L2			ENSG00000148737			rs11196174-G	rs11196174	0	11196174	intron_variant	0	0.28	8E-7	6.096910013008056		1.13	[1.07-1.18]	Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	7p21.3	7	8512984	NR	NXPH1			ENSG00000122584			rs765855-?	rs765855	0	765855	intron_variant	0	NR	4E-6	5.3979400086720375				Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
8/2/2013	23544013	Couch FJ	3/27/2013	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	"1,426 European ancestry cases, 1,301 European ancestry controls"	"6,031 European ancestry cases, 5,933 European ancestry controls"	19p13.11	19	17278895	intergenic	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-G	rs8170	0	8170	synonymous_variant	0	0.48	4E-13	12.397940008672037		1.19	[1.14-1.25]	Illumina [2568349] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001916	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	3p24.1	3	27374522	SLC4A7	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	2E-30	29.69897000433602		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	19q13.31	19	43782361	"C19orf61, KCNN4, LYPD5, ZNF283"	KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	0.46	2E-10	9.698970004336019		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	22q12.2	22	29225488	"EMID1, RHBDD3, EWSR1, CHEK2"	EMID1			ENSG00000186998			rs132390-C	rs132390	0	132390	intron_variant	0	0.036	3E-9	8.522878745280337		1.12	[1.07-1.18]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	22q13.1	22	40480230	MKL1	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.11	9E-19	18.045757490560675		1.12	[1.09-1.16]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	2q35	2	217041109	intergenic	DIRC3-AS1			ENSG00000233143			rs13387042-A	rs13387042	0	13387042	intron_variant	0	0.51	2E-57	56.69897000433602		1.14	[1.11-1.16]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	7E-9	8.154901959985743		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5p12	5	44706396	intergenic	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	2E-37	36.69897000433602		1.13	[1.10-1.15]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	6q14.1	6	81483392	intergenic	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		1012964	8047	rs17530068-G	rs17530068	0	17530068	intergenic_variant	1	0.22	8E-9	8.096910013008056		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	6q25.1	6	151592978	ESR1	CCDC170			ENSG00000120262			rs3757318-A	rs3757318	0	3757318	intron_variant	0	0.07	2E-21	20.69897000433602		1.16	[1.12-1.21]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	8q24.21	8	128182395	"MYC, MIR1208"	PVT1			ENSG00000249859			rs11780156-T	rs11780156	0	11780156	intron_variant	0	0.16	3E-11	10.522878745280337		1.07	[1.04-1.10]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	9q31.2	9	108126198	intergenic	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		28347	500635	rs865686-T	rs865686	0	865686	regulatory_region_variant	1	0.62	1E-34	34		1.12	[1.1-1.14]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10q21.2	10	62518923	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-G	rs10995190	0	10995190	intron_variant	1	0.84	1E-36	36		1.16	[1.14-1.19]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-A	rs2981579	0	2981579	intron_variant	0	0.4	2E-170	169.69897000433602		1.27	[1.24-1.29]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	11p15.5	11	1887776	LSP1	LSP1			ENSG00000130592			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.31	2E-11	10.698970004336019		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	11q13.3	11	69513996	intergenic	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		19044	127160	rs614367-T	rs614367	0	614367	intergenic_variant	1	0.15	2E-63	62.69897000433602		1.21	[1.18-1.24]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	12q24.21	12	115398717	intergenic	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	1	0.58	9E-22	21.045757490560675		1.09	[1.06-1.11]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-A	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.26	2E-114	113.69897000433602		1.24	[1.21-1.27]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	11q24.3	11	129591276	intergenic	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-C	rs11820646	0	11820646	regulatory_region_variant	1	0.59	1E-9	9		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	21q21.1	21	15148511	NRIP1	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		80674	342019	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	7E-16	15.154901959985743		1.09	[1.06-1.11]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	12q22	12	95633983	NTN4	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.7	2E-22	21.69897000433602		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	1p36.22	1	10506158	PEX14	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	2E-10	9.698970004336019		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	14q13.3	14	36663564	"PAX9, SLC25A21"	PAX9			ENSG00000198807			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	2E-13	12.698970004336019		1.08	[1.05-1.1]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	14q24.1	14	68193711	RAD51L1	RAD51B			ENSG00000182185			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.16	1E-10	10		1.08	[1.05-1.11]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	14q32.11	14	91374725	CCDC88C	CCDC88C			ENSG00000015133			rs941764-G	rs941764	0	941764	intron_variant	0	0.34	4E-10	9.397940008672037		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	16q12.2	16	53779455	"FTO, MIR1972-2"	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.6	6E-14	13.221848749616356		1.08	[1.05-1.1]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	16q23.2	16	80616908	CDYL2	CDYL2			ENSG00000166446			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.22	2E-16	15.698970004336019		1.08	[1.05-1.10]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	18q11.2	18	26757460	intergenic	AQP4-AS1			ENSG00000260372			rs527616-G	rs527616	0	527616	intron_variant	0	0.62	2E-10	9.698970004336019		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	19p13.11	19	18460331	"SSBP4, ISYNA1, ELL"	ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.65	5E-15	14.301029995663981		1.08	[1.05-1.1]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5q11.2	5	56736057	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		129825	79492	rs889312-C	rs889312	0	889312	intergenic_variant	1	0.28	3E-36	35.52287874528034		1.12	[1.10-1.15]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	9p21.3	9	22062135	"CDKN2A, CDKN2B"	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.17	6E-8	7.221848749616356		1.06	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10q22.3	10	79081391	ZMIZ1	ZMIZ1			ENSG00000108175			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	7E-22	21.154901959985743		1.08	[1.06-1.10]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	6p23	6	13722291	RANBP9	RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		10456	64266	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.43	8E-9	8.096910013008056		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	7q35	7	144377836	"ARHGEF5, NOBOX"	ARHGEF5			ENSG00000050327			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	7E-11	10.154901959985743		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	8p12	8	29652100	intergenic	RPL17P33 - LINC00589	ENSG00000243844	ENSG00000251191		19456	21822	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	9E-14	13.045757490560675		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	8q21.13	8	75318066	intergenic	CASC9			ENSG00000249395			rs6472903-T	rs6472903	0	6472903	intron_variant	0	0.82	2E-17	16.69897000433602		1.1	[1.08-1.12]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	8q24.21	8	127343372	intergenic	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.41	1E-27	27		1.09	[1.07-1.12]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	9q31.2	9	107543834	intergenic	PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	0.39	1E-8	8		1.06	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10p12.31	10	21744013	"DNAJC1, MLLT10"	MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	0.29	4E-14	13.397940008672037		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10q25.2	10	113014168	TCF7L2	TCF7L2			ENSG00000148737			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	3E-8	7.522878745280337		1.06	[1.04-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10q26.12	10	121334387	intergenic	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		148421	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	2E-8	7.698970004336019		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	18q11.2	18	26990703	CHST9	"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	3E-8	7.522878745280337		1.04	[1.02-1.06]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	11q13.1	11	65815595	"DKFZp761E198, OVOL1, SNX32, CFL1, MUS81"	OVOL1 - CFL1	ENSG00000172818	ENSG00000172757		18381	7427	rs3903072-G	rs3903072	0	3903072	intergenic_variant	1	0.53	9E-12	11.045757490560675		1.05	[1.04-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	17q22	17	54979110	COX11	STXBP4			ENSG00000166263			rs6504950-G	rs6504950	0	6504950	intron_variant	0	0.72	2E-13	12.698970004336019		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	12p13.1	12	14260997	intergenic	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		5771	95845	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	4E-8	7.3979400086720375		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	1p11.2	1	121538815	intergenic	"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.4	2E-26	25.69897000433602		1.09	[1.07-1.11]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	13q13.1	13	32398489	"BRCA2, N4BP2L1, N4BP2L2"	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.008	5E-8	7.301029995663981		1.26	[1.14-1.39]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	1p13.2	1	113905767	"BCL2L15, AP4B1, DCLRE1B, HIPK1, PTPN22"	DCLRE1B			ENSG00000118655			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.17	2E-8	7.698970004336019		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	2q14.2	2	120487546	intergenic	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.902	4E-11	10.397940008672037		1.1	[1.06-1.14]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	2q31.1	2	172108243	"METAP1D, DLX1, DLX2"	DLX2-DT			ENSG00000236651			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.52	1E-8	8		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	2q35	2	217431785	DIRC3	DIRC3			ENSG00000231672			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	1E-15	15		1.08	[1.06-1.10]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	3p26.1	3	4700592	"ITPR1, EGOT"	ITPR1			ENSG00000150995			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.4	2E-12	11.698970004336019		1.07	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	3p24.1	3	30641447	TGFBR2	TGFBR2			ENSG00000163513			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.35	2E-8	7.698970004336019		1.06	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	4q24	4	105163621	TET2	TET2			ENSG00000168769			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.23	4E-8	7.3979400086720375		1.05	[1.03-1.08]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	4q34.1	4	174925275	ADAM29	ADAM29			ENSG00000168594			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.87	4E-16	15.397940008672037		1.11	[1.09-1.15]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5q11.2	5	58888234	RAB3C	RAB3C - PDE4D	ENSG00000152932	ENSG00000113448		28840	80804	rs10472076-C	rs10472076	0	10472076	regulatory_region_variant	1	0.38	3E-8	7.522878745280337		1.05	[1.03-1.07]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5q33.3	5	158817075	EBF1	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	2E-14	13.698970004336019		1.07	[1.05-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	6p25.3	6	1318643	FOXQ1	FOXQ1 - LINC01394	ENSG00000164379	ENSG00000281809		3885	3055	rs11242675-T	rs11242675	0	11242675	intergenic_variant	1	0.61	7E-9	8.154901959985743		1.06	[1.04-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	12p11.22	12	28002147	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-A	rs10771399	0	10771399	intergenic_variant	1	0.88	8E-31	30.096910013008056		1.16	[1.14-1.2]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	14q24.1	14	68567965	RAD51L1	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	3E-19	18.522878745280337		1.09	[1.06-1.11]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	2q31.1	2	173348166	CDCA7	RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.84	3E-8	7.522878745280337		1.06	[1.03-1.09]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	5q11.2	5	59041654	PDE4D	PDE4D			ENSG00000113448			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.905	3E-8	7.522878745280337		1.09	[1.05-1.12]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	8q21.13	8	75505702	HNF4G	HNF4G			ENSG00000164749			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.07	6E-15	14.221848749616356		1.13	[1.09-1.17	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535729	Michailidou K	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535729	Large-scale genotyping identifies 41 new loci associated with breast cancer risk.	Breast cancer	"10,052 European ancestry cases, 12,575 European ancestry controls"	"45,290 European ancestry cases, 41,880 European ancestry controls"	10p12.31	10	22026914	DNAJC1	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		23145	136078	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	9E-16	15.045757490560675		1.26	[1.18-1.35]	"Affymetrix, Illumina [~ 2600000] (imputed)"	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001937	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.321	5E-12	11.301029995663981		1.15	[1.11-1.20]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	6q14.1	6	81483392	intergenic	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		1012964	8047	rs17530068-C	rs17530068	0	17530068	intergenic_variant	1	0.237	3E-6	5.522878745280337		1.09	[1.05-1.13]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	6q25.1	6	151627231	ESR1	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038	29460	rs2046210-A	rs2046210	0	2046210	regulatory_region_variant	1	0.423	5E-16	15.301029995663981		1.15	[1.11-1.19]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	10q21.2	10	62518923	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-G	rs10995190	0	10995190	intron_variant	1	0.846	1E-7	7		1.12	[1.08-1.18]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	12p11.22	12	28002147	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-T	rs10771399	0	10771399	intergenic_variant	1	0.895	2E-12	11.698970004336019		1.2	[1.15-1.27]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	16q12.1	16	52552429	TOX3	CASC16			ENSG00000249231			rs3803662-T	rs3803662	0	3803662	non_coding_transcript_exon_variant	0	0.267	6E-13	12.221848749616356		1.14	[1.10-1.18]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	19p13.11	19	17278895	MERIT40	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-A	rs8170	0	8170	synonymous_variant	0	0.191	9E-13	12.045757490560675		1.15	[1.11-1.20]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	1p36.22	1	10506158	PEX14	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.665	1E-8	8		1.1	[1.06-1.14]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	5q33.3	5	158817075	EBF1	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.435	7E-6	5.154901959985743		1.08	[1.04-1.11]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	12q22	12	95633983	NTN4	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.702	9E-6	5.045757490560675		1.09	[1.04-1.12]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	13q13.1	13	32398489	"BRCA2, N4BP2L1"	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.496	6E-6	5.221848749616356		1.52	[1.31-1.77]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	16q12.2	16	53779455	"FTO, MIR1972-2"	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.526	6E-7	6.221848749616356		1.09	[1.05-1.12]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	22q13.1	22	40480230	MKL1	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.107	2E-6	5.698970004336019		1.14	[1.08-1.20]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	1q32.1	1	204549714	"LRRN2, PIK3C2B, MDM4"	MDM4			ENSG00000198625			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.26	2E-12	11.698970004336019		1.14	[1.10-1.18]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	1q32.1	1	202218048	"LGR6, UBE2T, PTPN7"	LGR6			ENSG00000133067			rs6678914-?	rs6678914	0	6678914	intron_variant	0	0.59	1E-8	8		1.1	[1.06-1.13]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	2p24.1	2	19121042	intergenic	LINC01376			ENSG00000236204			rs12710696-?	rs12710696	0	12710696	intron_variant	0	0.36	5E-8	7.301029995663981		1.1	[1.06-1.13]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
9/12/2013	23535733	Garcia-Closas M	4/1/2013	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535733	Genome-wide association studies identify four ER negative-specific breast cancer risk loci.	Breast cancer	"4,193 European ancestry cases, 35,194 European ancestry controls"	"6,514 European ancestry cases, 41,455 European ancestry controls"	16q12.2	16	53821379	"FTO, KIAA1752"	FTO			ENSG00000140718			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	4E-8	7.3979400086720375		1.11	[1.07-1.15]	Illumina [NR]	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST001930	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	5q33.3	5	158817075	NR	EBF1			ENSG00000164330			rs1432679-?	rs1432679	0	1432679	intron_variant	0	0.44	2E-6	5.698970004336019		1.04	[1.00-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	8p11.23	8	37000965	NR	KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		64840	94185	rs13365225-?	rs13365225	0	13365225	intergenic_variant	1	0.81	7E-6	5.154901959985743		1.0416667	[0.99-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	11q24.3	11	129591276	NR	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-?	rs11820646	0	11820646	regulatory_region_variant	1	0.62	9E-6	5.045757490560675		1.0752687	[1.03-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	12q22	12	95633983	NR	PGAM1P5			ENSG00000257150			rs17356907-?	rs17356907	0	17356907	intron_variant	0	0.71	5E-7	6.301029995663981		1.0526316	[1-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	17q25.3	17	79807926	NR	CBX8 - LINC01977	ENSG00000141570	ENSG00000262772		6243	11157	rs745570-?	rs745570	0	745570	intergenic_variant	1	0.51	6E-6	5.221848749616356		1.0416667	[1-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	22q13.1	22	40480230	NR	MRTFA			ENSG00000196588			rs6001930-?	rs6001930	0	6001930	intron_variant	0	0.11	2E-6	5.698970004336019		1.07	[1.01-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	1p36.22	1	10503552	PEX14	PEX14			ENSG00000142655			rs10864459-?	rs10864459	0	10864459	intron_variant	0	0.69	5E-10	9.301029995663981		1.0526316	[1.01-1.1] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	1q32.1	1	202209914	LGR6	LGR6			ENSG00000133067			rs17489300-?	rs17489300	0	17489300	intron_variant	0	0.61	2E-8	7.698970004336019		1.0309278	[0.99-1.08] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	1q32.1	1	204549714	MDM4	MDM4			ENSG00000198625			rs4245739-?	rs4245739	0	4245739	3_prime_UTR_variant	0	0.28	8E-18	17.096910013008056		1.09	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	2p24.1	2	19121042	Intergenic	LINC01376			ENSG00000236204			rs12710696-?	rs12710696	0	12710696	intron_variant	0	0.39	2E-6	5.698970004336019		1.01	[0.97-1.05] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	2q14.2	2	120330606	INHBB	RALB - INHBB	ENSG00000144118	ENSG00000163083		35896	15530	rs11903787-?	rs11903787	0	11903787	intergenic_variant	1	0.74	7E-10	9.154901959985743		1.098901	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	5p15.33	5	1279913	TERT	TERT			ENSG00000164362			rs2242652-?	rs2242652	0	2242652	intron_variant	0	0.22	8E-28	27.096910013008056		1.22	[1.16-1.28] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	5p15.33	5	1282204	TERT	TERT			ENSG00000164362			rs7726159-?	rs7726159	0	7726159	intron_variant	0	0.35	3E-8	7.522878745280337		1.07	[1.02-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	5p15.33	5	1297373	TERT	TERT - MIR4457	ENSG00000164362	ENSG00000263670		2305	11937	rs2736108-?	rs2736108	0	2736108	regulatory_region_variant	1	0.71	3E-14	13.522878745280337		1.1235955	[1.08-1.16] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	6q25.1	6	151597721	ESR1	CCDC170			ENSG00000120262			rs12662670-?	rs12662670	0	12662670	intron_variant	0	0.09	1E-19	19		1.19	[1.11-1.27] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	6q25.1	6	151625017	ESR1	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		3824	31674	rs11155804-?	rs11155804	0	11155804	intergenic_variant	1	0.36	4E-28	27.397940008672037		1.15	[1.11-1.20] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	10q21.2	10	62518923	ZNF365	ZNF365 - LINC02929	ENSG00000138311	ENSG00000285551		38635	1525	rs10995190-?	rs10995190	0	10995190	intron_variant	1	0.84	8E-6	5.096910013008056		1.010101	[0.96-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	10q25.2	10	113023044	TCF7L2	TCF7L2			ENSG00000148737			rs6585202-?	rs6585202	0	6585202	intron_variant	0	0.47	1E-9	9		1.1	[1.05-1.14] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	11p15.5	11	1880867	LSP1	LSP1			ENSG00000130592			rs4980383-?	rs4980383	0	4980383	non_coding_transcript_exon_variant	0	0.45	9E-9	8.045757490560675		1.07	[1.03-1.11] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	12p11.22	12	28021884	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-?	rs7297051	0	7297051	TF_binding_site_variant	1	0.77	3E-20	19.522878745280337		1.1235955	[1.08-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	12p11.22	12	28002147	PTHLH	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		29414	131102	rs10771399-?	rs10771399	0	10771399	intergenic_variant	1	0.9	7E-18	17.154901959985743		1.1627907	[1.1-1.25] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-?	rs4784227	0	4784227	intron_variant	0	0.26	6E-15	14.221848749616356		1.07	[1.02-1.12] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	16q12.2	16	53779455	FTO	FTO			ENSG00000140718			rs17817449-?	rs17817449	0	17817449	intron_variant	0	0.59	5E-8	7.301029995663981		1.0526316	[1.01-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	16q12.2	16	53821379	FTO	FTO			ENSG00000140718			rs11075995-?	rs11075995	0	11075995	intron_variant	0	0.24	2E-6	5.698970004336019		1.01	[0.97-1.06] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	19p13.11	19	17278895	MERIT40	"BABAM1, USHBP1"			"ENSG00000105393, ENSG00000130307"			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	7E-21	20.154901959985743		1.17	[1.11-1.23] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	19p13.11	19	17283116	ADHB8	ANKLE1			ENSG00000160117			rs56069439-?	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.3	1E-32	32		1.19	[1.14-1.24] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	2p23.2	2	28896719	WDR43	WDR43			ENSG00000163811			rs67073037-?	rs67073037	0	67073037	intron_variant	0	0.8	5E-9	8.301029995663981		1.0869565	[1.04-1.15] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	2q33.1	2	201071148	"FAM126B, NDUFB3, CLK1, PPIL3"	HYCC2			ENSG00000155744			rs114962751-?	rs114962751	0	114962751	intron_variant	0	0.02	7E-8	7.154901959985743		1.22	[1.05-1.42] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	13q22.1	13	73383544	"KLF5, KLF12"	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		156284	24224	rs6562760-?	rs6562760	0	6562760	intergenic_variant	1	0.8	5E-10	9.301029995663981		1.1235955	[1.06-1.18] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	13q22.1	13	73232845	"KLF12, KLF5"	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		5585	174923	rs12870942-?	rs12870942	0	12870942	intergenic_variant	1	0.3	4E-8	7.3979400086720375		1.06	[1.01-1.10] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
3/31/2017	27117709	Couch FJ	4/27/2016	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/27117709	Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.	Breast cancer	"4,939 European ancestry estrogen receptor-negative cases, 14,352 European ancestry controls"	"7,333 European ancestry estrogen receptor-negative cases, 7,797 European ancestry BRCA1 mutation carrier cases, 7,455  European ancestry BRCA1 mutation carrier controls, 42,468 European ancestry controls"	2q35	2	217431785	NR	DIRC3			ENSG00000231672			rs16857609-?	rs16857609	0	16857609	intron_variant	0	0.26	7E-6	5.154901959985743		1.04	[1.00-1.09] (BRCA1 carriers)	Illumina [10909381] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST003845	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:112007756-T	chr12:112007756	0			1	0.5115	6E-7	6.221848749616356	(EA)	0.0311	[0.019-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:112200150-C	chr12:112200150	0			1	0.5706	9E-6	5.045757490560675	(EA)	0.0282	[0.016-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:112610714-A	chr12:112610714	0			1	0.4254	2E-6	5.698970004336019	(EA)	0.0299	[0.018-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:112840766-G	chr12:112840766	0			1	0.4307	3E-6	5.522878745280337	(EA)	0.0297	[0.017-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:115108361-C	chr12:115108361	0			1	0.2663	1E-9	9	(EA)	0.0432	[0.029-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:115558575-C	chr12:115558575	0			1	0.3599	4E-6	5.3979400086720375	(EA)	0.0296	[0.017-0.042] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:115835798-A	chr12:115835798	0			1	0.4164	2E-39	38.69897000433602	(EA)	0.0824	[0.07-0.095] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:115990594-G	chr12:115990594	0			1	0.5027	1E-6	6	(EA)	0.0303	[0.018-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:116347863-G	chr12:116347863	0			1	0.4696	4E-7	6.3979400086720375	(EA)	0.0334	[0.02-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:120832146-T	chr12:120832146	0			1	0.1566	4E-8	7.3979400086720375	(EA)	0.0487	[0.031-0.066] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:14413931-C	chr12:14413931	0			1	0.2589	4E-15	14.397940008672037	(EA)	0.0552	[0.041-0.069] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28347382-T	chr12:28347382	0			1	0.2168	3E-19	18.522878745280337	(EA)	0.0687	[0.054-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28452497-A	chr12:28452497	0			1	0.299	1E-16	16	(EA)	0.0564	[0.043-0.07] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28569325-T	chr12:28569325	0			1	0.3056	3E-15	14.522878745280337	(EA)	0.0532	[0.04-0.066] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28672110-A	chr12:28672110	0			1	0.3063	4E-14	13.397940008672037	(EA)	0.0511	[0.038-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28775813-G	chr12:28775813	0			1	0.019	2E-6	5.698970004336019	(EA)	0.1157	[0.068-0.163] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:28928139-G	chr12:28928139	0			1	0.0139	1E-6	6	(EA)	0.1404	[0.084-0.197] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:29140260-A	chr12:29140260	0			1	0.9138	3E-10	9.522878745280337	(EA)	0.0713	[0.049-0.093] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:29247350-A	chr12:29247350	0			1	0.0847	3E-9	8.522878745280337	(EA)	0.0674	[0.045-0.09] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:29489004-G	chr12:29489004	0			1	0.0508	1E-6	6	(EA)	0.0725	[0.043-0.102] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:31952412-C	chr12:31952412	0			1	0.314	4E-6	5.3979400086720375	(EA)	0.0329	[0.019-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:57282235-G	chr12:57282235	0			1	0.0063	2E-7	6.698970004336019	(EA)	0.2341	[0.15-0.32] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:57484602-T	chr12:57484602	0			1	0.0097	1E-7	7	(EA)	0.1913	[0.12-0.26] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:57602279-A	chr12:57602279	0			1	0.0117	4E-6	5.3979400086720375	(EA)	0.1557	[0.089-0.222] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:57848639-A	chr12:57848639	0			1	0.559	4E-6	5.3979400086720375	(EA)	0.0291	[0.017-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q21.3	4	86302033	NR	MAPK10			ENSG00000109339			rs11284646-C	rs11284646	0	11284646	intron_variant	0	0.2932	4E-6	5.3979400086720375	(EA)	0.032	[0.018-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.1	9	104248836	NR	SMC2 - TOPORSLP	ENSG00000136824	ENSG00000242111		107417	21392	rs11290052-T	rs11290052	0	11290052	intergenic_variant	1	0.4068	8E-6	5.096910013008056	(EA)	0.0323	[0.018-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q12.1	3	99682866	NR	COL8A1			ENSG00000144810			rs11298677-T	rs11298677	0	11298677	intron_variant	0	0.6142	5E-9	8.301029995663981	(EA)	0.0373	[0.025-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p25.1	2	11561717	NR	"5S_rRNA, GREB1"			"ENSG00000285674, ENSG00000196208"			rs113084984-A	rs113084984	0	113084984	non_coding_transcript_exon_variant	0	0.2192	5E-6	5.301029995663981	(EA)	0.0367	[0.021-0.052] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q27	6	166087862	NR	GAPDHP72 - TBXT	ENSG00000216624	ENSG00000164458		21834	69794	rs113289039-AG	rs113289039	0	113289039	intergenic_variant	1	0.3138	3E-7	6.522878745280337	(EA)	0.0366	[0.023-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p21.1	9	32455676	NR	RIGI			ENSG00000107201			rs1133071-G	rs1133071	0	1133071	3_prime_UTR_variant	0	0.3001	3E-6	5.522878745280337	(EA)	0.0335	[0.02-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	80641622	NR	ZNF704			ENSG00000164684			rs113410521-T	rs113410521	0	113410521	intron_variant	0	0.0645	2E-6	5.698970004336019	(EA)	0.0603	[0.035-0.085] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.2	11	66569918	NR	CTSF - CCDC87	ENSG00000174080	ENSG00000182791		1039	20258	rs11344495-C	rs11344495	0	11344495	intergenic_variant	1	0.334	2E-6	5.698970004336019	(EA)	0.0327	[0.019-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p14.2	11	27063657	NR	"BBOX1, BBOX1-AS1"			"ENSG00000129151, ENSG00000254560"			rs11354714-C	rs11354714	0	11354714	intron_variant	0	0.4193	3E-6	5.522878745280337	(EA)	0.0318	[0.018-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	27587278	NR	CD83P1 - RNU6-471P	ENSG00000219738	ENSG00000206671		25534	9134	rs113780580-AACAC	rs113780580	1	60273536	intergenic_variant	1	0.078	4E-9	8.397940008672037	(EA)	0.0786	[0.053-0.105] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q14.11	13	42941617	NR	EPSTI1			ENSG00000133106			rs11383827-GA	rs11383827	0	11383827	intron_variant	0	0.228	4E-6	5.3979400086720375	(EA)	0.0372	[0.022-0.053] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28684743	NR	TTC28 - CHEK2	ENSG00000100154	ENSG00000183765		4903	3000	rs62235681-G	rs62235681	0	62235681	intergenic_variant	1	0.0085	2E-37	36.69897000433602	(EA)	0.4558	[0.39-0.53] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28876649	NR	XBP1 - ZNRF3	ENSG00000100219	ENSG00000183579		76052	6923	rs62235753-T	rs62235753	0	62235753	intergenic_variant	1	0.0171	3E-20	19.522878745280337	(EA)	0.2221	[0.17-0.27] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	40868537	NR	XPNPEP3			ENSG00000196236			rs62237039-G	rs62237039	0	62237039	intron_variant	0	0.0366	5E-9	8.301029995663981	(EA)	0.101	[0.067-0.135] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28156710	NR	TTC28			ENSG00000100154			rs62237573-T	rs62237573	0	62237573	intron_variant	0	0.0092	7E-36	35.15490195998574	(EA)	0.4256	[0.36-0.49] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28343127	NR	TTC28			ENSG00000100154			rs62237615-G	rs62237615	0	62237615	intron_variant	0	0.0082	4E-33	32.39794000867204	(EA)	0.4404	[0.37-0.51] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q13.2	4	67215843	NR	RNU6-699P - RNU1-63P	ENSG00000252890	ENSG00000206629		318472	213748	rs62315512-A	rs62315512	0	62315512	intergenic_variant	1	0.1778	5E-6	5.301029995663981	(EA)	0.04	[0.023-0.057] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q24	4	105147856	NR	TET2			ENSG00000168769			rs62331150-T	rs62331150	0	62331150	intron_variant	0	0.2263	2E-11	10.698970004336019	(EA)	0.0494	[0.035-0.064] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	56757708	NR	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		151476	57841	rs62355901-C	rs62355901	0	62355901	intergenic_variant	1	0.1602	3E-98	97.52287874528034	(EA)	0.1734	[0.16-0.19] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q35	7	144351809	NR	OR2A1-AS1			ENSG00000244479			rs62485509-T	rs62485509	0	62485509	intron_variant	0	0.2292	4E-12	11.397940008672037	(EA)	0.0545	[0.039-0.07] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	108123199	NR	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		25348	503634	rs630965-T	rs630965	0	630965	intergenic_variant	1	0.6196	3E-54	53.52287874528034	(EA)	0.0992	[0.087-0.112] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p25.1	2	11895429	NR	MIR3681HG			ENSG00000224184			rs6432241-C	rs6432241	0	6432241	intron_variant	0	0.6883	3E-6	5.522878745280337	(EA)	0.0313	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q23.1	11	111765903	NR	PPP2R1B			ENSG00000137713			rs643506-G	rs643506	0	643506	5_prime_UTR_variant	0	0.6757	2E-7	6.698970004336019	(EA)	0.0344	[0.021-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217858732	NR	TNS1			ENSG00000079308			rs6436017-G	rs6436017	0	6436017	intron_variant	0	0.5042	3E-10	9.522878745280337	(EA)	0.0399	[0.028-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q13.1	5	67683422	NR	LINC02997			ENSG00000249364			rs6449898-T	rs6449898	0	6449898	intron_variant	0	0.3027	2E-6	5.698970004336019	(EA)	0.033	[0.019-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q24	4	103450498	NR	LINC02428			ENSG00000248740			rs10016947-C	rs10016947	0	10016947	intron_variant	0	0.0567	9E-6	5.045757490560675	(EA)	0.0611	[0.034-0.088] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q31.3	5	142290274	NR	NDFIP1 - SPRY4	ENSG00000131507	ENSG00000187678		135834	20153	rs10051199-T	rs10051199	0	10051199	regulatory_region_variant	1	0.476	2E-6	5.698970004336019	(EA)	0.0293	[0.017-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.11	8	117869627	NR	EXT1			ENSG00000182197			rs10103490-C	rs10103490	0	10103490	intron_variant	0	0.3554	4E-6	5.3979400086720375	(EA)	0.0319	[0.018-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p24.1	2	19212878	NR	LINC01376			ENSG00000236204			rs10169133-C	rs10169133	0	10169133	intron_variant	0	0.6206	1E-8	8	(EA)	0.0364	[0.024-0.049] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.3	7	94758031	NR	ATP5PBP2 - GRPEL2P3	ENSG00000214342	ENSG00000230682		18620	24855	rs10269006-T	rs10269006	0	10269006	intergenic_variant	1	0.3178	5E-7	6.301029995663981	(EA)	0.0335	[0.021-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q23.2	5	123142308	NR	PRDM6			ENSG00000061455			rs10629804-GCTTCA	rs10629804	0	10629804	intron_variant	0	0.7425	1E-6	6	(EA)	0.0345	[0.021-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.2	7	92022865	NR	AKAP9			ENSG00000127914			rs10644111-AAAC	rs10644111	0	10644111	protein_altering_variant	0	0.3903	3E-11	10.522878745280337	(EA)	0.0424	[0.03-0.055] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							rs10695717-ATTC	rs10695717	0	10695717		1	0.5971	1E-6	6	(EA)	0.0315	[0.019-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155446537	NR	ASH1L			ENSG00000116539			rs10796944-A	rs10796944	0	10796944	intron_variant	0	0.2299	7E-10	9.154901959985743	(EA)	0.0457	[0.031-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p21.3	9	22067594	NR	CDKN2B-AS1			ENSG00000240498			rs10811650-G	rs10811650	0	10811650	intron_variant	0	0.4205	2E-13	12.698970004336019	(EA)	0.0461	[0.034-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q24.32	10	102125800	NR	LDB1 - PPRC1	ENSG00000198728	ENSG00000148840		5432	7194	rs10883710-C	rs10883710	0	10883710	intergenic_variant	1	0.4601	3E-6	5.522878745280337	(EA)	0.0291	[0.017-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.2	10	113017911	NR	TCF7L2			ENSG00000148737			rs10885405-T	rs10885405	0	10885405	intron_variant	0	0.46	5E-14	13.301029995663981	(EA)	0.0465	[0.034-0.059] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p13	10	13865236	NR	FRMD4A			ENSG00000151474			rs10906522-C	rs10906522	0	10906522	intron_variant	0	0.4708	1E-7	7	(EA)	0.0332	[0.021-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p24.1	9	5956008	NR	KIAA2026			ENSG00000183354			rs10975370-G	rs10975370	0	10975370	intron_variant	0	0.2043	3E-6	5.522878745280337	(EA)	0.0356	[0.021-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p11.2	11	47325389	NR	MADD			ENSG00000110514			rs11039183-A	rs11039183	0	11039183	intron_variant	0	0.3501	6E-6	5.221848749616356	(EA)	0.0301	[0.017-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.3	7	94655778	NR	SGCE			ENSG00000127990			rs111307654-GAAA	rs111307654	1	35011167	intron_variant	0	0.7248	1E-12	12	(EA)	0.0497	[0.036-0.063] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.1	6	43259403	NR	TTBK1			ENSG00000146216			rs111342015-A	rs111342015	0	111342015	intron_variant	0	0.098	9E-8	7.045757490560675	(EA)	0.0571	[0.036-0.078] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.3	5	158803005	NR	EBF1			ENSG00000164330			rs11135046-T	rs11135046	0	11135046	intron_variant	0	0.5529	5E-31	30.30102999566398	(EA)	0.0717	[0.06-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.1	5	81972251	NR	ATG10			ENSG00000152348			rs111549985-G	rs111549985	0	111549985	5_prime_UTR_variant	0	0.2474	6E-12	11.221848749616356	(EA)	0.0498	[0.036-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121795069	NR	ATE1			ENSG00000107669			rs111605422-A	rs111605422	0	111605422	intron_variant	0	0.0569	9E-13	12.045757490560675	(EA)	0.0936	[0.068-0.119] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.13	19	13158012	NR	RPL12P42			ENSG00000213253			rs111730030-T	rs111730030	0	111730030	intron_variant	0	0.0484	2E-8	7.698970004336019	(EA)	0.0837	[0.054-0.113] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.2	1	149934520	NR	MTMR11			ENSG00000014914			rs11205303-C	rs11205303	0	11205303	missense_variant	0	0.3998	1E-14	14	(EA)	0.0497	[0.037-0.062] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.3	14	78743396	NR	NRXN3			ENSG00000021645			rs112056657-G	rs112056657	0	112056657	intron_variant	0	0.0103	2E-6	5.698970004336019	(EA)	0.1986	[0.12-0.28] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p24.1	9	7195019	NR	KDM4C - RPL4P5	ENSG00000107077	ENSG00000230207		19371	282026	rs112332509-C	rs112332509	0	112332509	intron_variant	1	0.5004	4E-6	5.3979400086720375	(EA)	0.0335	[0.019-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	156183252	NR	SEMA4A - SLC25A44	ENSG00000196189	ENSG00000160785		5500	10680	rs11264454-G	rs11264454	0	11264454	intergenic_variant	1	0.4278	7E-7	6.154901959985743	(EA)	0.0327	[0.02-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:59581708-A	chr12:59581708	0			1	0.0108	7E-6	5.154901959985743	(EA)	0.161	[0.091-0.231] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:78820565-A	chr12:78820565	0			1	0.0053	7E-6	5.154901959985743	(EA)	0.4799	[0.27-0.69] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:83063443-A	chr12:83063443	0			1	0.1019	2E-6	5.698970004336019	(EA)	0.0551	[0.033-0.078] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:85009437-C	chr12:85009437	0			1	0.3376	3E-8	7.522878745280337	(EA)	0.0387	[0.025-0.052] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:96027759-G	chr12:96027759	0			1	0.2985	1E-39	39	(EA)	0.0898	[0.076-0.103] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:96141866-G	chr12:96141866	0			1	0.1717	4E-7	6.3979400086720375	(EA)	0.0438	[0.027-0.061] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr13:32866927-CAATAAATA	chr13:32866927	0			1	0.0104	1E-16	16	(EA)	0.2691	[0.21-0.33] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr14:35412105-GA	chr14:35412105	0			1	0.2975	6E-6	5.221848749616356	(EA)	0.0325	[0.018-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr14:68118802-GTGGGT	chr14:68118802	0			1	0.0195	2E-7	6.698970004336019	(EA)	0.1317	[0.083-0.181] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr14:93112310-A	chr14:93112310	0			1	0.1751	9E-13	12.045757490560675	(EA)	0.0598	[0.043-0.076] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr15:86218049-ATATGTATG	chr15:86218049	0			1	0.2897	6E-6	5.221848749616356	(EA)	0.0333	[0.019-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr16:53908992-G	chr16:53908992	0			1	0.1092	9E-6	5.045757490560675	(EA)	0.0523	[0.029-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr17:43658516-T	chr17:43658516	0			1	0.1751	5E-12	11.301029995663981	(EA)	0.0587	[0.042-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr17:44759766-A	chr17:44759766	0			1	0.1408	2E-8	7.698970004336019	(EA)	0.0562	[0.037-0.076] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr18:42517419-C	chr18:42517419	0			1	0.1239	7E-8	7.154901959985743	(EA)	0.0557	[0.036-0.076] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr2:6178372-AGTT	chr2:6178372	0			1	0.0083	8E-6	5.096910013008056	(EA)	0.1885	[0.11-0.27] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr4:187503860-GTCTCTCTC	chr4:187503860	0			1	0.4564	8E-7	6.096910013008056	(EA)	0.0312	[0.019-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr4:84370124-TA	chr4:84370124	0			1	0.5328	2E-9	8.698970004336019	(EA)	0.0384	[0.026-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr5:43263364-T	chr5:43263364	0			1	0.0112	1E-6	6	(EA)	0.2075	[0.12-0.29] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr5:52482315-C	chr5:52482315	0			1	0.0183	8E-7	6.096910013008056	(EA)	0.1168	[0.07-0.163] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr5:58365353-C	chr5:58365353	0			1	0.0903	2E-10	9.698970004336019	(EA)	0.0718	[0.05-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr6:151715281-GA	chr6:151715281	0			1	0.6249	2E-7	6.698970004336019	(EA)	0.0367	[0.023-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr6:28709151-G	chr6:28709151	0			1	0.0981	1E-8	8	(EA)	0.0649	[0.043-0.087] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr6:32677587-C	chr6:32677587	0			1	0.0176	5E-6	5.301029995663981	(EA)	0.1523	[0.087-0.218] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chrX:118630622-G	chrX:118630622	0			1	0.6807	7E-6	5.154901959985743	(EA)	0.2721	[0.15-0.39] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	81677422	NR	TENT5A			ENSG00000112773			rs6912005-A	rs6912005	0	6912005	intron_variant	0	0.2419	2E-11	10.698970004336019	(EA)	0.0483	[0.034-0.062] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.3	6	20728282	NR	CDKAL1			ENSG00000145996			rs6928012-T	rs6928012	0	6928012	intron_variant	0	0.5967	2E-6	5.698970004336019	(EA)	0.0303	[0.018-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.3	6	85210757	NR	TBX18 - RPL31P32	ENSG00000112837	ENSG00000216902		446159	46571	rs6934651-C	rs6934651	0	6934651	intergenic_variant	1	0.0775	6E-6	5.221848749616356	(EA)	0.0522	[0.029-0.075] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q24.1	15	74843920	NR	SCAMP2			ENSG00000140497			rs6938-G	rs6938	0	6938	3_prime_UTR_variant	0	0.6551	9E-8	7.045757490560675	(EA)	0.0364	[0.023-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q27	6	170017397	NR	LINC00574 - RPL12P23	ENSG00000231690	ENSG00000218716		214524	182372	rs6940159-C	rs6940159	0	6940159	regulatory_region_variant	1	0.6162	3E-7	6.522878745280337	(EA)	0.033	[0.02-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	103251337	NR	"DPY19L2P2, DPY19L2P2"			"ENSG00000291139, ENSG00000170629"			rs6946892-C	rs6946892	0	6946892	intron_variant	0	0.7489	1E-7	7	(EA)	0.0413	[0.026-0.057] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.21	8	128192016	NR	PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		4915	28488	rs7017073-C	rs7017073	0	7017073	intergenic_variant	1	0.2115	2E-14	13.698970004336019	(EA)	0.0572	[0.043-0.072] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p21.3	8	19828398	NR	INTS10			ENSG00000104613			rs7017697-T	rs7017697	0	7017697	intron_variant	0	0.6711	1E-6	6	(EA)	0.0319	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.23	1	7857016	NR	UTS2 - TNFRSF9	ENSG00000049247	ENSG00000049249		3504	58855	rs707475-A	rs707475	0	707475	regulatory_region_variant	1	0.393	1E-7	7	(EA)	0.035	[0.022-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	21545607	NR	MLLT10			ENSG00000078403			rs7098100-A	rs7098100	0	7098100	intron_variant	0	0.3537	1E-18	18	(EA)	0.0572	[0.044-0.07] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q24.3	11	129360950	NR	ZNF123P - BARX2	ENSG00000255259	ENSG00000043039		64469	14898	rs7102494-T	rs7102494	0	7102494	intergenic_variant	1	0.1044	6E-7	6.221848749616356	(EA)	0.0508	[0.031-0.071] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q23.2	11	113863644	NR	USP28			ENSG00000048028			rs71063528-C	rs71063528	0	71063528	intron_variant	0	0.7244	8E-7	6.096910013008056	(EA)	0.0381	[0.023-0.053] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	48311089	NR	SPINK8			ENSG00000229453			rs71281886-CAA	rs71281886	0	71281886	intron_variant	0	0.0232	2E-6	5.698970004336019	(EA)	0.1168	[0.069-0.165] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.1	10	27189770	NR	ACBD5			ENSG00000107897			rs71386921-A	rs71386921	0	71386921	intron_variant	0	0.7961	3E-6	5.522878745280337	(EA)	0.0366	[0.021-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q21.23	4	85740190	NR	ARHGAP24			ENSG00000138639			rs71599425-A	rs71599425	0	71599425	intron_variant	0	0.0382	6E-6	5.221848749616356	(EA)	0.0797	[0.045-0.114] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q22.2	16	71918418	NR	IST1			ENSG00000182149			rs71695136-C	rs71695136	0	71695136	intron_variant	0	0.7841	7E-7	6.154901959985743	(EA)	0.0427	[0.026-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.1	9	103912867	NR	RNA5SP291 - SMC2-DT	ENSG00000253031	ENSG00000270332		223290	164441	rs718857-C	rs718857	0	718857	intergenic_variant	1	0.6384	2E-6	5.698970004336019	(EA)	0.0311	[0.018-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							rs72127681-CT	rs72127681	0	72127681		1	0.3527	6E-11	10.221848749616356	(EA)	0.0454	[0.032-0.059] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	21863269	NR	DNAJC1			ENSG00000136770			rs72806318-A	rs72806318	0	72806318	intron_variant	0	0.0153	5E-19	18.30102999566398	(EA)	0.2218	[0.17-0.27] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q11.2	17	30884649	NR	ATAD5			ENSG00000176208			rs7223535-A	rs7223535	0	7223535	intron_variant	0	0.268	4E-10	9.397940008672037	(EA)	0.0439	[0.03-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q26	6	160665585	NR	LPA - PLG	ENSG00000198670	ENSG00000122194		1310	36609	rs72314471-C	rs72314471	1	60130137	intergenic_variant	1	0.8389	8E-6	5.096910013008056	(EA)	0.0385	[0.022-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	26576054	NR	KCTD1			ENSG00000134504			rs7240205-T	rs7240205	0	7240205	intron_variant	0	0.6096	2E-8	7.698970004336019	(EA)	0.0365	[0.024-0.049] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	17099805	NR	MYO9B			ENSG00000099331			rs7249698-A	rs7249698	0	7249698	intron_variant	0	0.3594	4E-7	6.3979400086720375	(EA)	0.0327	[0.02-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75393550	NR	PKMP4 - HNF4G	ENSG00000254023	ENSG00000164749		16536	14364	rs72658071-T	rs72658071	0	72658071	intergenic_variant	1	0.0877	3E-28	27.522878745280337	(EA)	0.1182	[0.097-0.139] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45984331	NR	HCN1 - EMB	ENSG00000164588	ENSG00000170571		287833	4411861	rs72751936-A	rs72751936	0	72751936	intergenic_variant	1	0.1354	4E-12	11.397940008672037	(EA)	0.0667	[0.048-0.086] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	80887958	NR	ZNF704 - PAG1	ENSG00000164684	ENSG00000076641		13177	79852	rs6473252-T	rs6473252	0	6473252	intergenic_variant	1	0.4116	8E-7	6.096910013008056	(EA)	0.0309	[0.019-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p21.3	8	22634616	NR	BIN3			ENSG00000147439			rs6558174-G	rs6558174	0	6558174	intron_variant	0	0.7027	3E-6	5.522878745280337	(EA)	0.0362	[0.021-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p13.3	2	69023500	NR	ANTXR1			ENSG00000169604			rs66686620-A	rs66686620	0	66686620	intron_variant	0	0.1433	1E-7	7	(EA)	0.0469	[0.029-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	119716347	NR	PHGDH			ENSG00000092621			rs666930-C	rs666930	0	666930	intron_variant	0	0.5338	5E-8	7.301029995663981	(EA)	0.0347	[0.022-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p14.3	5	22642425	NR	CDH12			ENSG00000154162			rs66783663-T	rs66783663	0	66783663	intron_variant	0	0.1419	5E-6	5.301029995663981	(EA)	0.0408	[0.023-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p23.3	8	220692	NR	RPL23AP53			ENSG00000223508			rs66823261-C	rs66823261	0	66823261	intron_variant	0	0.2289	3E-7	6.522878745280337	(EA)	0.041	[0.025-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.31	19	43484866	NR	PHLDB3			ENSG00000176531			rs66849333-T	rs66849333	0	66849333	intron_variant	0	0.0561	1E-6	6	(EA)	0.0693	[0.041-0.097] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.2	10	62201406	NR	RTKN2			ENSG00000182010			rs66964413-C	rs66964413	0	66964413	intron_variant	0	0.0368	5E-9	8.301029995663981	(EA)	0.1034	[0.069-0.138] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	40508704	NR	MRTFA			ENSG00000196588			rs66987842-C	rs66987842	0	66987842	intron_variant	0	0.11	3E-35	34.52287874528034	(EA)	0.1233	[0.1-0.14] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q24.2	15	75637960	NR	SNUPN - IMP3	ENSG00000169371	ENSG00000177971		11491	1125	rs67079557-A	rs67079557	1	59356490	intron_variant	1	0.2423	1E-6	6	(EA)	0.0362	[0.022-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p23.3	2	24748307	NR	NCOA1			ENSG00000084676			rs6710503-A	rs6710503	0	6710503	intron_variant	0	0.2615	5E-6	5.301029995663981	(EA)	0.0323	[0.018-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p22.1	9	19457614	NR	ACER2 - MAP1LC3BP1	ENSG00000177076	ENSG00000231909		5109	3312	rs67500807-TG	rs67500807	1	34710228	TF_binding_site_variant	1	0.3727	4E-6	5.3979400086720375	(EA)	0.0396	[0.023-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p13.3	2	69945455	NR	MXD1 - ASPRV1	ENSG00000059728	ENSG00000244617		2510	14634	rs6756513-A	rs6756513	0	6756513	intergenic_variant	1	0.2887	4E-7	6.3979400086720375	(EA)	0.0366	[0.022-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q23	3	141547651	NR	RASA2			ENSG00000155903			rs6776003-A	rs6776003	0	6776003	intron_variant	0	0.4178	3E-10	9.522878745280337	(EA)	0.0394	[0.027-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p26.1	3	4686890	NR	ITPR1			ENSG00000150995			rs6787391-T	rs6787391	0	6787391	intron_variant	0	0.3807	9E-19	18.045757490560675	(EA)	0.0567	[0.044-0.069] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p22.3	3	34938860	NR	FECHP1 - KRT8P18	ENSG00000235534	ENSG00000228767		65006	276845	rs6789440-A	rs6789440	0	6789440	intergenic_variant	1	0.1495	3E-6	5.522878745280337	(EA)	0.0403	[0.023-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	25710343	NR	SCGN - H2AC1	ENSG00000079689	ENSG00000164508		8560	13054	rs68006638-A	rs68006638	0	68006638	intron_variant	1	0.0774	2E-7	6.698970004336019	(EA)	0.0646	[0.04-0.089] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q32.3	7	130989722	NR	LINC-PINT			ENSG00000231721			rs68056147-A	rs68056147	0	68056147	intron_variant	0	0.299	5E-13	12.301029995663981	(EA)	0.0501	[0.037-0.064] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p14	10	9175196	NR	LINC02676 - LINC00709	ENSG00000234752	ENSG00000230014		260600	100637	rs68140948-T	rs68140948	0	68140948	regulatory_region_variant	1	0.1201	3E-6	5.522878745280337	(EA)	0.0481	[0.028-0.068] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q31.21	4	145775911	NR	ZNF827			ENSG00000151612			rs6818581-G	rs6818581	0	6818581	synonymous_variant	0	0.0113	9E-6	5.045757490560675	(EA)	0.1608	[0.09-0.232] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q31.1	5	132304843	NR	SLC22A4			ENSG00000197208			rs6860806-G	rs6860806	0	6860806	intron_variant	0	0.5391	8E-8	7.096910013008056	(EA)	0.0335	[0.021-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q23.2	5	124400713	NR	LINC01170			ENSG00000253807			rs6878727-G	rs6878727	0	6878727	intron_variant	0	0.3599	6E-6	5.221848749616356	(EA)	0.0335	[0.019-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	56964779	NR	MIER3			ENSG00000155545			rs6890270-G	rs6890270	0	6890270	intron_variant	0	0.1871	5E-67	66.30102999566398	(EA)	0.1349	[0.12-0.15] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.2	5	154976135	NR	MRPL22 - KIF4B	ENSG00000082515	ENSG00000226650		6724	37620	rs6890610-T	rs6890610	0	6890610	intergenic_variant	1	0.2557	6E-6	5.221848749616356	(EA)	0.0327	[0.019-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	151734843	NR	ESR1			ENSG00000091831			rs6904031-T	rs6904031	0	6904031	intron_variant	0	0.0643	7E-26	25.154901959985743	(EA)	0.1314	[0.11-0.16] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	46090449	NR	HCN1 - EMB	ENSG00000164588	ENSG00000170571		393951	4305743	rs72755643-G	rs72755643	0	72755643	intergenic_variant	1	0.1333	3E-11	10.522878745280337	(EA)	0.0652	[0.046-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.1	5	81820020	NR	SSBP2 - SEM1P1	ENSG00000145687	ENSG00000214857		68223	72470	rs72774916-T	rs72774916	0	72774916	intron_variant	1	0.0924	2E-8	7.698970004336019	(EA)	0.0648	[0.042-0.088] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q11.2	21	14855305	NR	LINC02246			ENSG00000281903			rs7278690-G	rs7278690	0	7278690	intron_variant	0	0.926	6E-6	5.221848749616356	(EA)	0.0583	[0.033-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA				NR							chr5:45333860-?	chr5:45333860	0			1	NR	4E-21	20.397940008672037				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	1p13.3	1	109680280	NR	GSTM2			ENSG00000213366			rs5776993-C	rs5776993	0	5776993	intron_variant	0	0.88	3E-8	7.522878745280337		1.0526316	[1.04-1.09]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	5p12	5	44145829	NR	RNU6-381P - FGF10	ENSG00000212561	ENSG00000070193		79098	154418	rs11749176-?	rs11749176	0	11749176	intergenic_variant	1	NR	9E-10	9.045757490560675				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	6p22.3	6	21903302	NR	CASC15			ENSG00000272168			rs7760611-C	rs7760611	0	7760611	intron_variant	0	0.53	2E-9	8.698970004336019		1.0416667	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA				NR							chr1:145126177-?	chr1:145126177	0			1	NR	1E-8	8	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	12q24.11	12	111162330	NR	CUX2			ENSG00000111249			rs11065822-G	rs11065822	0	11065822	intron_variant	0	0.63	6E-9	8.221848749616356		1.0416667	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	5q13.1	5	68128294	NR	LINC02997 - RNU6-1232P	ENSG00000249364	ENSG00000252108		321694	30767	rs138044103-?	rs138044103	1	3048766	intergenic_variant	1	NR	2E-9	8.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	18q12.3	18	45320927	NR	SLC14A2			ENSG00000132874			rs17743054-T	rs17743054	0	17743054	intron_variant	0	0.72	2E-10	9.698970004336019		1.0416667	[1.03-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	17p13.1	17	7668434	NR	TP53			ENSG00000141510			rs78378222-?	rs78378222	0	78378222	3_prime_UTR_variant	0	NR	2E-9	8.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	3p14.2	3	59388019	NR	CFAP20DC-DT			ENSG00000243295			rs2886671-C	rs2886671	0	2886671	intron_variant	0	0.57	4E-8	7.3979400086720375		1.0309278	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	20p12.2	20	11521971	NR	RPS11P1 - PGAM3P	ENSG00000235544	ENSG00000237256		176116	99080	rs141526427-?	rs141526427	0	141526427	intergenic_variant	1	NR	3E-8	7.522878745280337	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	8q23.3	8	115667320	NR	TRPS1			ENSG00000104447			rs13277568-A	rs13277568	0	13277568	intron_variant	0	0.63	2E-8	7.698970004336019		1.0309278	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	2p14	2	67654625	NR	LINC02831 - LINC01812	ENSG00000224173	ENSG00000237013		34080	141429	rs9712235-?	rs9712235	0	9712235	intron_variant	1	NR	2E-7	6.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	11p11.2	11	44347342	NR	ALX4 - RPL7AP79	ENSG00000052850	ENSG00000255106		37203	192436	rs10838267-A	rs10838267	0	10838267	intergenic_variant	1	0.55	5E-8	7.301029995663981		1.0309278	[1.02-1.04]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	7q21.3	7	98397243	NR	BAIAP2L1			ENSG00000006453			rs79518236-?	rs79518236	0	79518236	intron_variant	0	NR	2E-8	7.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	2p13.3	2	69164996	NR	ANTXR1			ENSG00000169604			rs4602255-A	rs4602255	0	4602255	intron_variant	0	0.45	2E-9	8.698970004336019		1.04	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	12q24.21	12	114670331	NR	TBX3			ENSG00000135111			rs1061657-?	rs1061657	0	1061657	3_prime_UTR_variant	0	NR	6E-9	8.221848749616356	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	18q11.2	18	22897971	NR	RBBP8			ENSG00000101773			rs12962334-G	rs12962334	0	12962334	intron_variant	0	0.32	4E-9	8.397940008672037		1.04	[1.03-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	18q12.3	18	45320927	NR	SLC14A2			ENSG00000132874			rs17743054-?	rs17743054	0	17743054	intron_variant	0	NR	2E-8	7.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	7q11.23	7	74926919	NR	SPDYE12 - CASTOR2	ENSG00000184616	ENSG00000274070		11841	37786	rs188092014-C	rs188092014	1	78816009	regulatory_region_variant	1	0.19	2E-8	7.698970004336019		1.05	[1.03-1.07]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	1p12	1	119942712	NR	NOTCH2			ENSG00000134250			rs6697258-?	rs6697258	0	6697258	intron_variant	0	NR	2E-15	14.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	1q32.1	1	200372918	NR	LINC00862			ENSG00000203721			rs6677545-?	rs6677545	0	6677545	intron_variant	0	NR	4E-8	7.3979400086720375	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	5p12	5	45374788	NR	HCN1			ENSG00000164588			rs56826596-?	rs56826596	0	56826596	intron_variant	0	NR	8E-12	11.096910013008056	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	5p12	5	45939192	NR	HCN1 - EMB	ENSG00000164588	ENSG00000170571		242694	4457000	rs139331653-?	rs139331653	0	139331653	intergenic_variant	1	NR	2E-9	8.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	10q21.3	10	63497603	NR	JMJD1C			ENSG00000171988			rs34044188-?	rs34044188	0	34044188	intron_variant	0	NR	9E-9	8.045757490560675	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA				NR							chr12:29140260-A	chr12:29140260	0			1	0.91	8E-12	11.096910013008056		1.0752687	[1.05-1.1]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	1p12	1	120044057	NR	NOTCH2			ENSG00000134250			rs150157076-?	rs150157076	1	711759	intron_variant	0	NR	1E-10	10				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	3q25.31	3	156818170	NR	LINC00886 - LEKR1	ENSG00000240875	ENSG00000197980		1108	7311	rs34052812-A	rs34052812	0	34052812	regulatory_region_variant	1	0.67	3E-8	7.522878745280337		1.0416667	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	10q21.3	10	63089177	NR	EGR2 - RNU6-543P	ENSG00000122877	ENSG00000199446		270010	20962	rs12765365-?	rs12765365	0	12765365	intergenic_variant	1	NR	9E-9	8.045757490560675				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	7q21.3	7	98397243	NR	BAIAP2L1			ENSG00000006453			rs79518236-ACT	rs79518236	0	79518236	intron_variant	0	0.77	7E-9	8.154901959985743		1.0416667	[1.03-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	4p16.3	4	1985245	NR	NELFA			ENSG00000185049			rs495367-?	rs495367	0	495367	intron_variant	0	NR	2E-8	7.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	17q24.3	17	72408954	NR	LINC00511			ENSG00000227036			rs11652463-C	rs11652463	0	11652463	intron_variant	0	0.69	4E-8	7.3979400086720375		1.0416667	[1.03-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	11q23.3	11	120362917	NR	ARHGEF12			ENSG00000196914			rs7924772-?	rs7924772	0	7924772	intron_variant	0	NR	4E-8	7.3979400086720375	(fixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	3p24.3	3	16737360	NR	CDYLP1 - PLCL2	ENSG00000224039	ENSG00000154822		43158	65291	rs1375631-G	rs1375631	0	1375631	intergenic_variant	1	0.5	7E-9	8.154901959985743		1.0309278	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	18p11.22	18	10354652	NR	VAPA - LINC01254	ENSG00000101558	ENSG00000260913		394631	50481	rs206435-?	rs206435	0	206435	intron_variant	1	NR	2E-7	6.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	8p21.2	8	23622741	NR	RNU4-71P - SINHCAFP3	ENSG00000252067	ENSG00000253488		22603	12135	rs142890050-C	rs142890050	1	10581440	intergenic_variant	1	0.54	4E-8	7.3979400086720375		1.0309278	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	20q12	20	40619625	NR	LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		608302	66223	rs6065254-?	rs6065254	0	6065254	intergenic_variant	1	NR	2E-9	8.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	9q31.1	9	104094512	NR	SMC2			ENSG00000136824			rs4742903-C	rs4742903	0	4742903	intron_variant	0	0.56	3E-8	7.522878745280337		1.0309278	[1.02-1.04]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	6p22.3	6	21903302	NR	CASC15			ENSG00000272168			rs7760611-?	rs7760611	0	7760611	intron_variant	0	NR	2E-9	8.698970004336019	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	2p14	2	67654625	NR	LINC02831 - LINC01812	ENSG00000224173	ENSG00000237013		34080	141429	rs9712235-G	rs9712235	0	9712235	intron_variant	1	0.26	5E-8	7.301029995663981		1.04	[1.02-1.05]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA				NR							chr12:29140260-?	chr12:29140260	0			1	NR	4E-9	8.397940008672037	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	12q24.21	12	114670331	NR	TBX3			ENSG00000135111			rs1061657-C	rs1061657	0	1061657	3_prime_UTR_variant	0	0.26	3E-10	9.522878745280337		1.04	[1.03-1.06]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	18q11.2	18	22897971	NR	RBBP8			ENSG00000101773			rs12962334-?	rs12962334	0	12962334	intron_variant	0	NR	4E-8	7.3979400086720375	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	20q13.2	20	53680310	NR	RNU7-14P - SUMO1P1	ENSG00000238468	ENSG00000241721		11552	194942	rs13039563-A	rs13039563	0	13039563	intergenic_variant	1	0.24	3E-9	8.522878745280337		1.04	[1.03-1.06]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	20q13.2	20	53680310	NR	RNU7-14P - SUMO1P1	ENSG00000238468	ENSG00000241721		11552	194942	rs13039563-?	rs13039563	0	13039563	intergenic_variant	1	NR	1E-9	9	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	8p21.2	8	25974262	NR	EBF2			ENSG00000221818			rs13256025-T	rs13256025	0	13256025	intron_variant	0	0.2	1E-8	8		1.05	[1.03-1.06]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	21q22.3	21	46360308	NR	PCNT			ENSG00000160299			rs9808759-T	rs9808759	0	9808759	intron_variant	0	0.07	6E-9	8.221848749616356		1.07	[1.05-1.09]	Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	5q31.1	5	132304843	NR	SLC22A4			ENSG00000197208			rs6860806-?	rs6860806	0	6860806	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	5q11.2	5	51952440	NR	KATNBL1P4 - LINC02118	ENSG00000249270	ENSG00000248789		20404	55591	rs141930488-?	rs141930488	0	141930488	intergenic_variant	1	NR	4E-8	7.3979400086720375				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Breast cancer	"133,384 European ancestry cases, 113,789 European ancestry controls"	NA	1q22	1	156183252	NR	SEMA4A - SLC25A44	ENSG00000196189	ENSG00000160785		5500	10680	rs11264454-?	rs11264454	0	11264454	intergenic_variant	1	NR	2E-8	7.698970004336019				Illumina [~ 10800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010098	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q22	17	55132413	intergenic	STXBP4			ENSG00000166263			rs2787486-A	rs2787486	0	2787486	intron_variant	0	0.7	6E-29	28.221848749616356	(EA)	1.0752687	[1.06-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	18460331	ELL	ELL			ENSG00000105656			rs4808801-A	rs4808801	0	4808801	intron_variant	0	0.66	5E-28	27.30102999566398	(EA)	1.0752687	[1.05-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.2	6	152115881	ESR1	ESR1			ENSG00000091831			rs2747652-C	rs2747652	0	2747652	intron_variant	0	0.52	1E-26	26	(EA)	1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75318066	intergenic	CASC9			ENSG00000249395			rs6472903-T	rs6472903	0	6472903	intron_variant	0	0.83	4E-21	20.397940008672037	(EA)	1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.22	1	10506158	PEX14	PEX14			ENSG00000142655			rs616488-A	rs616488	0	616488	intron_variant	0	0.67	5E-20	19.30102999566398	(EA)	1.0638298	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.3	5	91436408	ARRDC3	ARRDC3-AS1			ENSG00000281357			rs10474352-C	rs10474352	0	10474352	intron_variant	0	0.84	5E-11	10.301029995663981	(EA)	1.0638298	[1.03-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q21.1	21	15148511	NRIP1	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		80674	342019	rs2823093-G	rs2823093	0	2823093	intergenic_variant	1	0.73	2E-20	19.69897000433602	(EA)	1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q26.1	15	90968837	PRC1	"PRC1-AS1, PRC1"			"ENSG00000258725, ENSG00000198901"			rs2290203-G	rs2290203	0	2290203	3_prime_UTR_variant	0	0.79	8E-10	9.096910013008056		1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q31.1	2	173348166	CDCA7	RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654	6654	rs1550623-A	rs1550623	0	1550623	intron_variant	1	0.85	5E-10	9.301029995663981	(EA)	1.0526316	[1.02-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q31.1	2	172108243	DLX2-AS1	DLX2-DT			ENSG00000236651			rs2016394-G	rs2016394	0	2016394	intron_variant	0	0.53	6E-12	11.221848749616356	(EA)	1.0526316	[1.03-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q22.1	13	73383544	intergenic	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		156284	24224	rs6562760-G	rs6562760	0	6562760	intergenic_variant	1	0.76	2E-9	8.698970004336019	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	26990703	CHST9	"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs1436904-T	rs1436904	0	1436904	intron_variant	0	0.6	1E-14	14	(EA)	1.0526316	[1.03-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.2	16	53779455	FTO	FTO			ENSG00000140718			rs17817449-T	rs17817449	0	17817449	intron_variant	0	0.59	3E-21	20.522878745280337	(EA)	1.0526316	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	59041654	PDE4D	PDE4D			ENSG00000113448			rs1353747-T	rs1353747	0	1353747	intron_variant	0	0.91	4E-9	8.397940008672037	(EA)	1.0416667	[1.01-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.2	5	82242227	ATG10	ATG10			ENSG00000152348			rs7707921-A	rs7707921	0	7707921	intron_variant	0	0.75	2E-12	11.698970004336019	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.12	10	121334387	intergenic	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		148421	76529	rs11199914-C	rs11199914	0	11199914	intergenic_variant	1	0.68	7E-12	11.154901959985743	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q24.3	11	129591276	intergenic	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53162	20840	rs11820646-C	rs11820646	0	11820646	regulatory_region_variant	1	0.6	2E-14	13.698970004336019	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.12	14	92637727	RIN3	RIN3			ENSG00000100599			rs11627032-T	rs11627032	0	11627032	intron_variant	0	0.75	4E-11	10.397940008672037	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q32.3	7	130982362	FLJ43663	LINC-PINT			ENSG00000231721			rs4593472-C	rs4593472	0	4593472	intron_variant	0	0.65	2E-11	10.698970004336019	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.1	11	65815595	intergenic	OVOL1 - CFL1	ENSG00000172818	ENSG00000172757		18381	7427	rs3903072-G	rs3903072	0	3903072	intergenic_variant	1	0.53	2E-12	11.698970004336019	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.1	1	145790097	RNF115	RNF115			ENSG00000265491			rs12405132-C	rs12405132	0	12405132	intron_variant	0	0.63	6E-10	9.221848749616356	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	26757460	intergenic	AQP4-AS1			ENSG00000260372			rs527616-G	rs527616	0	527616	intron_variant	0	0.62	7E-15	14.154901959985743	(EA)	1.0309278	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q11.2	17	30903503	ATAD5	TEFM			ENSG00000172171			rs146699004-GGT	rs146699004	1	10612648	intron_variant	0	0.73	2E-9	8.698970004336019	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	28958443	intergenic	LINC01556 - KRT18P1	ENSG00000204709	ENSG00000228666		13906	10687	rs9257408-C	rs9257408	0	9257408	TF_binding_site_variant	1	0.41	7E-8	7.154901959985743	(EA)	1.02	[1-1.04] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p13.3	5	32567626	intergenic	SUB1			ENSG00000113387			rs2012709-T	rs2012709	0	2012709	intron_variant	0	0.48	1E-8	8	(EA)	1.02	[1-1.04] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	58888234	RAB3C	RAB3C - PDE4D	ENSG00000152932	ENSG00000113448		28840	80804	rs10472076-C	rs10472076	0	10472076	regulatory_region_variant	1	0.38	1E-8	8	(EA)	1.03	[1.01-1.04] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.2	7	92001306	AKAP9	AKAP9			ENSG00000127914			rs6964587-T	rs6964587	0	6964587	missense_variant	0	0.39	9E-11	10.045757490560675	(EA)	1.03	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q23.3	8	116197325	LINC00536	LINC00536			ENSG00000249917			rs13267382-A	rs13267382	0	13267382	intron_variant	0	0.36	2E-11	10.698970004336019	(EA)	1.03	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.2	10	113014168	TCFL2	TCF7L2			ENSG00000148737			rs7904519-G	rs7904519	0	7904519	intron_variant	0	0.46	2E-13	12.698970004336019	(EA)	1.03	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p24.1	2	19121042	intergenic	LINC01376			ENSG00000236204			rs12710696-T	rs12710696	0	12710696	intron_variant	0	0.37	1E-8	8	(EA)	1.03	[1.01-1.04] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.11	14	91374725	CCDC88C	CCDC88C			ENSG00000015133			rs941764-G	rs941764	0	941764	intron_variant	0	0.35	8E-13	12.096910013008056	(EA)	1.03	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.3	17	79807926	intergenic	CBX8 - LINC01977	ENSG00000141570	ENSG00000262772		6243	11157	rs745570-A	rs745570	0	745570	intergenic_variant	1	0.5	4E-10	9.397940008672037	(EA)	1.03	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.2	16	53821379	FTO	FTO			ENSG00000140718			rs11075995-A	rs11075995	0	11075995	intron_variant	0	0.24	9E-9	8.045757490560675	(EA)	1.03	[1.01-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	17290595	intergenic	ANKLE1 - ABHD8	ENSG00000160117	ENSG00000127220		2949	1536	rs67397200-G	rs67397200	0	67397200	intergenic_variant	1	0.3	2E-8	7.698970004336019	(EA)	1.03	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.2	1	149955122	OTUD7B	OTUD7B			ENSG00000264522			rs12048493-C	rs12048493	0	12048493	intron_variant	0	0.38	9E-14	13.045757490560675	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p13.2	1	113905767	DCLRE1B	DCLRE1B			ENSG00000118655			rs11552449-T	rs11552449	0	11552449	missense_variant	0	0.17	5E-11	10.301029995663981	(EA)	1.04	[1.01-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q24	4	105163621	TET2	TET2			ENSG00000168769			rs9790517-T	rs9790517	0	9790517	intron_variant	0	0.23	5E-11	10.301029995663981	(EA)	1.04	[1.01-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p26.1	3	4700592	EGOT/ITPR1	ITPR1			ENSG00000150995			rs6762644-G	rs6762644	0	6762644	intron_variant	0	0.38	4E-18	17.397940008672037	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	30641447	TGFBR2	TGFBR2			ENSG00000163513			rs12493607-C	rs12493607	0	12493607	intron_variant	0	0.34	7E-14	13.154901959985743	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p14.1	3	63982224	ATNX7	ATXN7			ENSG00000163635			rs1053338-G	rs1053338	0	1053338	missense_variant	0	0.14	5E-11	10.301029995663981	(EA)	1.05	[1.02-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.21	8	128182395	MYC	PVT1			ENSG00000249859			rs11780156-T	rs11780156	0	11780156	intron_variant	0	0.17	1E-13	13	(EA)	1.05	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	21744013	DNAJC1	MLLT10 - DNAJC1	ENSG00000078403	ENSG00000136770		383	12535	rs7072776-A	rs7072776	0	7072776	intergenic_variant	1	0.29	2E-19	18.69897000433602	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q34	7	140242504	intergenic	RNU1-58P - PPP1R2P6	ENSG00000199283	ENSG00000241661		472	50248	rs11977670-A	rs11977670	0	11977670	TF_binding_site_variant	1	0.43	1E-16	16	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	108074895	intergenic	RPL31P43 - CHCHD4P2	ENSG00000213557	ENSG00000237360		34303	22537	rs13294895-T	rs13294895	0	13294895	regulatory_region_variant	1	0.18	7E-17	16.154901959985743	(EA)	1.06	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	8E-17	16.096910013008056	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	107543834	intergenic	PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	0.29	2E-18	17.69897000433602	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217431785	DIRC3	DIRC3			ENSG00000231672			rs16857609-T	rs16857609	0	16857609	intron_variant	0	0.26	2E-25	24.69897000433602	(EA)	1.06	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.1	14	68193711	RAD51B	RAD51B			ENSG00000182185			rs2588809-T	rs2588809	0	2588809	intron_variant	0	0.17	6E-14	13.221848749616356	(EA)	1.06	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q22.3	10	79081391	ZMZ1	ZMIZ1			ENSG00000108175			rs704010-T	rs704010	0	704010	intron_variant	0	0.38	2E-35	34.69897000433602	(EA)	1.07	[1.05-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.3	5	158817075	EBF1	EBF1			ENSG00000164330			rs1432679-C	rs1432679	0	1432679	intron_variant	0	0.43	7E-31	30.154901959985743	(EA)	1.08	[1.06-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q24.2	2	160772472	NR	RBMS1 - RN7SL423P	ENSG00000153250	ENSG00000244372		278665	105075	rs146071273-A	rs146071273	0	146071273	intergenic_variant	1	0.0867	7E-6	5.154901959985743	(EA)	0.052	[0.029-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	47364189	NR	KLHL18 - PTPN23-DT	ENSG00000114648	ENSG00000260236		17373	14900	rs146331761-A	rs146331761	0	146331761	regulatory_region_variant	1	0.0367	5E-7	6.301029995663981	(EA)	0.0875	[0.053-0.122] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.2	5	82217129	NR	ATG10			ENSG00000152348			rs146817970-T	rs146817970	0	146817970	intron_variant	0	0.2459	4E-13	12.397940008672037	(EA)	0.0532	[0.039-0.068] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q21.1	14	38968140	NR	LINC00639 - Y_RNA	ENSG00000259070	ENSG00000202522		19867	19141	rs147032157-A	rs147032157	0	147032157	intergenic_variant	1	0.1018	4E-6	5.3979400086720375	(EA)	0.0483	[0.028-0.069] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q33.3	13	107031171	NR	PPIAP24 - NALF1	ENSG00000174408	ENSG00000204442		166885	132339	rs148731571-GCTTAGATATTAC	rs148731571	0	148731571	intergenic_variant	1	0.0639	6E-6	5.221848749616356	(EA)	0.0712	[0.04-0.102] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p11.2	1	121695219	NR	LINC01691 - RNA5SP533	ENSG00000224857	ENSG00000252830		114695	21744386	rs149253773-T	rs149253773	1	78533661	intergenic_variant	1	0.5359	6E-40	39.221848749616356	(EA)	0.0944	[0.08-0.108] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28532870	NR	TTC28			ENSG00000100154			rs149936356-C	rs149936356	0	149936356	intron_variant	0	0.0246	1E-18	18	(EA)	0.176	[0.14-0.22] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.2	17	41094871	NR	KRTAP4-7 - KRTAP4-8	ENSG00000240871	ENSG00000204880		9727	2110	rs150537328-C	rs150537328	0	150537328	intergenic_variant	1	0.0647	2E-6	5.698970004336019	(EA)	0.0642	[0.038-0.091] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.12	14	91422581	NR	CCDC88C-DT - PPP4R3A	ENSG00000258798	ENSG00000100796		1405	34927	rs150658557-TA	rs150658557	0	150658557	intergenic_variant	1	0.2029	2E-13	12.698970004336019	(EA)	0.0605	[0.044-0.077] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q22.33	15	67115961	NR	SMAD3			ENSG00000166949			rs151090251-GGACTTCTGTAGAGA	rs151090251	0	151090251	intron_variant	0	0.0524	2E-6	5.698970004336019	(EA)	0.0719	[0.042-0.101] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q28.3	4	132819226	NR	LINC01256 - PCDH10-DT	ENSG00000251398	ENSG00000250241		140723	256085	rs151170584-T	rs151170584	0	151170584	intergenic_variant	1	0.0362	9E-6	5.045757490560675	(EA)	0.0989	[0.055-0.143] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	42807276	NR	CNTD1			ENSG00000176563			rs151329939-A	rs151329939	0	151329939	intron_variant	0	0.01	5E-9	8.301029995663981	(EA)	0.1879	[0.12-0.25] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p31.3	1	64370963	NR	UBE2U - RNU7-62P	ENSG00000177414	ENSG00000238653		103595	13435	rs1514964-C	rs1514964	0	1514964	intergenic_variant	1	0.0453	9E-6	5.045757490560675	(EA)	0.071	[0.04-0.102] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.12	8	120102785	NR	COL14A1			ENSG00000187955			rs1519814-G	rs1519814	0	1519814	intron_variant	0	0.7773	8E-7	6.096910013008056	(EA)	0.0365	[0.022-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.1	1	145730328	NR	CD160			ENSG00000117281			rs1552172-A	rs1552172	0	1552172	intron_variant	0	0.3563	1E-8	8	(EA)	0.0382	[0.025-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q13.2	5	73943871	NR	ARHGEF28 - LINC02122	ENSG00000214944	ENSG00000248474		1878	140197	rs157554-T	rs157554	0	157554	intergenic_variant	1	0.3171	7E-6	5.154901959985743	(EA)	0.0308	[0.017-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29882943	NR	HCP5B - HLA-H	ENSG00000281831	ENSG00000206341		9160	4809	rs1611579-C	rs1611579	0	1611579	intron_variant	1	0.098	8E-7	6.096910013008056	(EA)	0.058	[0.035-0.081] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4p16.3	4	1983006	NR	NELFA			ENSG00000185049			rs16342-TAACA	rs16342	0	16342	3_prime_UTR_variant	0	0.359	1E-6	6	(EA)	0.0361	[0.022-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.31	19	43779080	NR	KCNN4			ENSG00000104783			rs1685191-T	rs1685191	0	1685191	intron_variant	0	0.5647	4E-20	19.397940008672037	(EA)	0.0586	[0.046-0.071] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.11	8	117178381	NR	SLC30A8 - MED30	ENSG00000164756	ENSG00000164758		1667	342332	rs16889471-A	rs16889471	0	16889471	intergenic_variant	1	0.2051	9E-6	5.045757490560675	(EA)	0.0344	[0.019-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	80443628	NR	RNU6-1213P - Y_RNA	ENSG00000252884	ENSG00000202522		38019	40961	rs16907718-T	rs16907718	0	16907718	intron_variant	1	0.1658	7E-6	5.154901959985743	(EA)	0.0404	[0.023-0.058] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	22212015	NR	EBLN1			ENSG00000223601			rs16922097-C	rs16922097	0	16922097	intron_variant	0	0.0189	1E-18	18	(EA)	0.1968	[0.15-0.24] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17p13.3	17	2195889	NR	SMG6			ENSG00000070366			rs16952006-T	rs16952006	0	16952006	intron_variant	0	0.1051	3E-6	5.522878745280337	(EA)	0.0524	[0.031-0.074] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121677436	NR	FGFR2 - ATE1	ENSG00000066468	ENSG00000107669		78978	31957	rs1696803-C	rs1696803	0	1696803	intergenic_variant	1	0.8367	2E-45	44.69897000433602	(EA)	0.116	[0.1-0.132] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q12.3	5	67215707	NR	CD180 - TILRLS	ENSG00000134061	ENSG00000251206		18908	52315	rs1697139-G	rs1697139	0	1697139	intergenic_variant	1	0.5355	9E-6	5.045757490560675	(EA)	0.028	[0.016-0.04] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	151621059	ESR1	CCDC170			ENSG00000120262			rs3757322-G	rs3757322	0	3757322	3_prime_UTR_variant	0	0.32	3E-41	40.52287874528034		1.08	[1.06-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p11.2	1	121538815	EMBP1	"EMBP1, EMBP1"			"ENSG00000291141, ENSG00000231752"			rs11249433-G	rs11249433	0	11249433	intron_variant	0	0.41	2E-52	51.69897000433602	(EA)	1.11	[1.09-1.13] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	27374522	SLC4A7	SLC4A7			ENSG00000033867			rs4973768-T	rs4973768	0	4973768	3_prime_UTR_variant	0	0.47	5E-57	56.30102999566398	(EA)	1.11	[1.09-1.13] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	108074792	intergenic	RPL31P43 - CHCHD4P2	ENSG00000213557	ENSG00000237360		34200	22640	rs10816625-G	rs10816625	0	10816625	regulatory_region_variant	1	0.06	5E-18	17.30102999566398		1.11	[1.07-1.15] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	44706396	"FGF10, MRPS30"	LINC02224 - RN7SL383P	ENSG00000249203	ENSG00000263556		47827	9797	rs10941679-G	rs10941679	0	10941679	intergenic_variant	1	0.25	6E-73	72.22184874961636		1.15	[1.13-1.18] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q43	1	241870961	EXO1	EXO1			ENSG00000174371			rs72755295-G	rs72755295	0	72755295	intron_variant	0	0.03	2E-14	13.698970004336019	(EA)	1.15	[1.09-1.2] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121580797	FGFR2	FGFR2			ENSG00000066468			rs2981578-C	rs2981578	0	2981578	intron_variant	0	0.47	1E-245	245		1.23	[1.21-1.25] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.1	16	52565276	TOX3	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0	0.24	7E-201	200.15490195998575		1.23	[1.2-1.25] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.3	11	69564393	CCND1	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		69441	76763	rs75915166-A	rs75915166	0	75915166	intergenic_variant	1	0.06	4E-95	94.39794000867204	(EA)	1.28	[1.24-1.33] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q35	7	144377836	"NOBOX, ARHGEF6"	ARHGEF5			ENSG00000050327			rs720475-G	rs720475	0	720475	intron_variant	0	0.75	1E-11	11	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	149287738	TAB2	TAB2			ENSG00000055208			rs9485372-G	rs9485372	0	9485372	intron_variant	0	0.81	4E-6	5.3979400086720375	(EA)	1.0416667	[1.02-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	81418669	intergenic	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		948241	72770	rs17529111-C	rs17529111	0	17529111	intergenic_variant	1	0.22	1E-9	9	(EA)	1.02	[1-1.04] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12p13.1	12	14260997	intergenic	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		5771	95845	rs12422552-C	rs12422552	0	12422552	regulatory_region_variant	1	0.26	4E-15	14.397940008672037	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				"APOBEC3A, APOBEC3B"							chr22:39359355-D10	chr22:39359355	0			1	0.1	5E-12	11.301029995663981	(EA)	1.1	[1.07-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.21	8	127343372	intergenic	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs13281615-G	rs13281615	0	13281615	intron_variant	0	0.41	2E-57	56.69897000433602	(EA)	1.11	[1.09-1.13] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	22026914	DNAJC1	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		23145	136078	rs11814448-C	rs11814448	0	11814448	intergenic_variant	1	0.02	6E-18	17.221848749616356	(EA)	1.12	[1.06-1.19] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.3	11	69516874	CCND1	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21922	124282	rs554219-G	rs554219	0	554219	regulatory_region_variant	1	0.13	6E-47	46.221848749616356	(EA)	1.21	[1.18-1.24] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	28725099	CHEK2	CHEK2			ENSG00000183765			rs17879961-G	rs17879961	0	17879961	missense_variant	0	0.005	1E-8	8	(EA)	1.26	[1.11-1.42] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.1	1	45548287	NR	PRDX1 - AKR1A1	ENSG00000117450	ENSG00000117448		5555	2256	rs144366570-ATT	rs144366570	0	144366570	intergenic_variant	1	0.1936	2E-7	6.698970004336019	(EA)	0.0423	[0.026-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	52398145	NR	RPS17P11 - MFSD4BP1	ENSG00000244621	ENSG00000250827		115286	181410	rs144727871-A	rs144727871	0	144727871	intergenic_variant	1	0.0318	4E-6	5.3979400086720375	(EA)	0.0842	[0.049-0.12] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p14.1	3	64074452	NR	"PRICKLE2-AS1, PRICKLE2-AS1"			"ENSG00000241572, ENSG00000241111"			rs1450985-A	rs1450985	0	1450985	intron_variant	0	0.4155	6E-8	7.221848749616356	(EA)	0.035	[0.022-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.1	5	50491020	NR	EMB - PARP8	ENSG00000170571	ENSG00000151883		47772	174879	rs145106188-CT	rs145106188	0	145106188	intergenic_variant	1	0.4459	3E-7	6.522878745280337	(EA)	0.0343	[0.021-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	48024338	NR	MAP4			ENSG00000047849			rs145407011-T	rs145407011	0	145407011	intron_variant	0	0.0268	1E-6	6	(EA)	0.0978	[0.059-0.137] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	Xp21.1	X	32564969	NR	DMD			ENSG00000198947			rs145455135-A	rs145455135	0	145455135	intron_variant	0	0.0208	9E-6	5.045757490560675	(EA)	0.1571	[0.088-0.227] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p25.1	6	4445101	NR	RNA5SP202 - LINC02533	ENSG00000201185	ENSG00000260239		17020	43697	rs145711907-T	rs145711907	0	145711907	intron_variant	1	0.4615	2E-6	5.698970004336019	(EA)	0.0299	[0.018-0.042] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	30003183	NR	POLR1HASP			ENSG00000204623			rs3094146-C	rs3094146	0	3094146	non_coding_transcript_exon_variant	0	0.1057	7E-7	6.154901959985743	(EA)	0.0543	[0.033-0.076] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.31	22	44323082	NR	SHISAL1 - LINC01656	ENSG00000138944	ENSG00000232655		10131	120245	rs201681753-CCCAT	rs201681753	0	201681753	intergenic_variant	1	0.0337	3E-6	5.522878745280337	(EA)	0.1129	[0.065-0.16] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q21.32	18	60214129	NR	RNU4-17P - MC4R	ENSG00000202468	ENSG00000166603		50422	156933	rs2045438-T	rs2045438	0	2045438	intergenic_variant	1	0.2669	4E-6	5.3979400086720375	(EA)	0.0323	[0.019-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	1995678	NR	H19			ENSG00000130600			rs217727-A	rs217727	0	217727	non_coding_transcript_exon_variant	0	0.1929	4E-14	13.397940008672037	(EA)	0.0598	[0.044-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.23	1	8035440	NR	ERRFI1-DT			ENSG00000238290			rs225132-G	rs225132	0	225132	intron_variant	0	0.187	3E-6	5.522878745280337	(EA)	0.0375	[0.022-0.053] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q11.22	7	69359109	NR	MTCO1P25 - RNU6-229P	ENSG00000229031	ENSG00000252423		25476	42093	rs2271032-G	rs2271032	0	2271032	non_coding_transcript_exon_variant	1	0.1372	8E-6	5.096910013008056	(EA)	0.0407	[0.023-0.059] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.2	14	100851974	NR	"MEG3, MIR493HG"			"ENSG00000214548, ENSG00000258399"			rs2295389-G	rs2295389	0	2295389	non_coding_transcript_exon_variant	0	0.3539	2E-6	5.698970004336019	(EA)	0.0345	[0.02-0.049] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q13	16	56497273	NR	BBS2			ENSG00000125124			rs2303282-G	rs2303282	0	2303282	non_coding_transcript_exon_variant	0	0.6029	3E-7	6.522878745280337	(EA)	0.0323	[0.02-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	26923543	NR	"AQP4-AS1, CHST9"			"ENSG00000260372, ENSG00000154080"			rs2307561-A	rs2307561	0	2307561	intron_variant	0	0.2815	8E-18	17.096910013008056	(EA)	0.0608	[0.047-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p11.1	10	38234698	NR	PLD5P1			ENSG00000283930			rs2384736-A	rs2384736	0	2384736	intron_variant	0	0.3687	1E-6	6	(EA)	0.0319	[0.019-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q21.1	21	15202135	NR	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		134298	288395	rs2403907-A	rs2403907	0	2403907	intron_variant	1	0.3159	2E-32	31.69897000433602	(EA)	0.0796	[0.066-0.093] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.2	5	82340549	NR	ATP6AP1L			ENSG00000205464			rs2407156-G	rs2407156	0	2407156	intron_variant	0	0.2383	2E-6	5.698970004336019	(EA)	0.0354	[0.021-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	58332828	NR	PGAM1P1 - PLK2	ENSG00000248271	ENSG00000145632		171076	121154	rs245279-A	rs245279	0	245279	intergenic_variant	1	0.1059	9E-7	6.045757490560675	(EA)	0.0493	[0.03-0.069] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.22	1	10535965	NR	PEX14			ENSG00000142655			rs2506889-T	rs2506889	0	2506889	non_coding_transcript_exon_variant	0	0.3185	2E-20	19.69897000433602	(EA)	0.0615	[0.048-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	30107326	NR	"TRIM31, TRIM31-AS1"			"ENSG00000204616, ENSG00000231226"			rs2523992-G	rs2523992	0	2523992	intron_variant	0	0.1571	2E-7	6.698970004336019	(EA)	0.0468	[0.029-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45653810	NR	HCN1			ENSG00000164588			rs2589161-C	rs2589161	0	2589161	intron_variant	0	0.4172	3E-8	7.522878745280337	(EA)	0.0348	[0.022-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	1453229	NR	SLC6A3 - LPCAT1	ENSG00000142319	ENSG00000275079		7789	3251	rs2617583-A	rs2617583	0	2617583	intergenic_variant	1	0.5554	9E-7	6.045757490560675	(EA)	0.0311	[0.019-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201384985	NR	TRAK2			ENSG00000115993			rs2714486-T	rs2714486	0	2714486	intron_variant	0	0.1738	7E-10	9.154901959985743	(EA)	0.0498	[0.034-0.066] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q32.2	1	207903511	NR	CD34			ENSG00000174059			rs2724379-C	rs2724379	0	2724379	intron_variant	0	0.3341	2E-7	6.698970004336019	(EA)	0.0346	[0.022-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q24	4	105274384	NR	TET2			ENSG00000168769			rs2726492-C	rs2726492	0	2726492	intron_variant	0	0.7943	4E-10	9.397940008672037	(EA)	0.0475	[0.033-0.062] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	46277538	NR	ARL17B			ENSG00000228696			rs2732699-C	rs2732699	0	2732699	intron_variant	0	0.8401	1E-10	10	(EA)	0.0595	[0.041-0.078] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29693039	NR	ZFP57 - ZDHHC20P1	ENSG00000204644	ENSG00000233916		11884	15086	rs3116813-A	rs3116813	0	3116813	intergenic_variant	1	0.1026	6E-7	6.221848749616356	(EA)	0.0553	[0.034-0.077] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q34.2	9	133463535	NR	CACFD1			ENSG00000160325			rs3124765-C	rs3124765	0	3124765	missense_variant	0	0.8475	2E-6	5.698970004336019	(EA)	0.0437	[0.026-0.062] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29388554	NR	OR5V1			ENSG00000243729			rs9257809-G	rs9257809	0	9257809	intron_variant	0	0.1004	3E-8	7.522878745280337	(EA)	0.0627	[0.041-0.085] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.33	6	30682249	NR	PPP1R18			ENSG00000146112			rs9262142-A	rs9262142	0	9262142	intron_variant	0	0.1166	3E-6	5.522878745280337	(EA)	0.0489	[0.028-0.069] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.1	18	32526319	NR	WBP11P1 - KLHL14	ENSG00000260389	ENSG00000197705		11685	146354	rs191218575-A	rs191218575	0	191218575	intron_variant	1	0.0195	8E-6	5.096910013008056	(EA)	0.1234	[0.069-0.177] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.1	10	51918266	NR	PRKG1			ENSG00000185532			rs1937680-A	rs1937680	0	1937680	intron_variant	0	0.6658	3E-7	6.522878745280337	(EA)	0.0341	[0.021-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	118111143	NR	SPAG17			ENSG00000155761			rs1962373-A	rs1962373	0	1962373	intron_variant	0	0.3161	1E-6	6	(EA)	0.0335	[0.02-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q34.1	4	175011701	NR	ADAM29 - TSEN2P1	ENSG00000168594	ENSG00000251174		33521	482913	rs1966977-C	rs1966977	0	1966977	intergenic_variant	1	0.1984	6E-7	6.221848749616356	(EA)	0.0422	[0.026-0.059] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p23.3	2	25068670	NR	EFR3B			ENSG00000084710			rs1971136-T	rs1971136	0	1971136	intron_variant	0	0.5264	5E-9	8.301029995663981	(EA)	0.0381	[0.025-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	1877434	NR	LSP1			ENSG00000130592			rs1973765-C	rs1973765	0	1973765	intron_variant	0	0.4001	1E-37	37	(EA)	0.0817	[0.069-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	46788237	NR	WNT3			ENSG00000108379			rs199498-C	rs199498	0	199498	intron_variant	0	0.2094	2E-8	7.698970004336019	(EA)	0.0433	[0.028-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4p12	4	48056416	NR	NIPAL1 - TXK	ENSG00000163293	ENSG00000074966		16243	9977	rs199501877-G	rs199501877	0	199501877	intergenic_variant	1	0.4866	4E-7	6.3979400086720375	(EA)	0.0315	[0.019-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q22.1	5	112032901	NR	NREP-AS1 - EPB41L4A	ENSG00000250095	ENSG00000129595		15592	109540	rs199817973-T	rs199817973	0	199817973	intergenic_variant	1	0.05	1E-6	6	(EA)	0.0722	[0.043-0.101] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p11.2	1	120948545	NR	LINC00623			ENSG00000226067			rs200087884-T	rs200087884	1	61802814	intron_variant	0	0.7046	7E-7	6.154901959985743	(EA)	0.0824	[0.05-0.115] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75626598	NR	HNF4G - RNU2-54P	ENSG00000164749	ENSG00000222231		59764	638945	rs200255906-A	rs200255906	0	200255906	intergenic_variant	1	0.081	2E-14	13.698970004336019	(EA)	0.0911	[0.068-0.114] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q31.1	2	173340858	NR	RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		42346	13962	rs200725404-A	rs200725404	0	200725404	intron_variant	1	0.8437	4E-10	9.397940008672037	(EA)	0.055	[0.038-0.072] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q12.12	13	24412252	NR	TPTE2P6			ENSG00000205822			rs201073821-TG	rs201073821	0	201073821	intron_variant	0	0.0485	8E-6	5.096910013008056	(EA)	0.0738	[0.041-0.106] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q11.23	20	35933106	NR	PHF20			ENSG00000025293			rs201177249-C	rs201177249	1	112208395	intron_variant	0	0.1351	4E-6	5.3979400086720375	(EA)	0.0462	[0.027-0.066] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p11.1	10	38338906	NR	PLD5P1			ENSG00000283930			rs2754412-G	rs2754412	0	2754412	intron_variant	0	0.4603	6E-7	6.221848749616356	(EA)	0.0312	[0.019-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q23.33	10	92388574	NR	MARCHF5 - MARK2P9	ENSG00000198060	ENSG00000232709		34610	30093	rs2771267-T	rs2771267	0	2771267	intergenic_variant	1	0.7549	1E-6	6	(EA)	0.0393	[0.023-0.055] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q32.1	1	203938990	NR	HSPE1P6 - CBX1P3	ENSG00000232917	ENSG00000237379		34977	15650	rs2810650-G	rs2810650	0	2810650	intergenic_variant	1	0.2068	3E-9	8.522878745280337	(EA)	0.0453	[0.03-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	1295234	NR	TERT - MIR4457	ENSG00000164362	ENSG00000263670		166	14076	rs2853669-G	rs2853669	0	2853669	TF_binding_site_variant	1	0.3061	4E-21	20.397940008672037	(EA)	0.0651	[0.052-0.079] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	43072659	NR	TTLL1			ENSG00000100271			rs28599928-T	rs28599928	0	28599928	intron_variant	0	0.113	2E-6	5.698970004336019	(EA)	0.047	[0.028-0.066] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p15.2	7	25529928	NR	TSEN15P3 - LINC03007	ENSG00000234922	ENSG00000223561		263638	63376	rs289997-T	rs289997	0	289997	intergenic_variant	1	0.1623	3E-7	6.522878745280337	(EA)	0.0448	[0.028-0.062] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.11	10	117502854	NR	EMX2OS			ENSG00000229847			rs2901157-G	rs2901157	0	2901157	intron_variant	0	0.1133	2E-6	5.698970004336019	(EA)	0.0474	[0.028-0.067] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75498626	NR	HNF4G			ENSG00000164749			rs2926585-G	rs2926585	0	2926585	intron_variant	0	0.0762	3E-24	23.522878745280337	(EA)	0.1156	[0.093-0.138] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q31.3	13	91903032	NR	GPC5			ENSG00000179399			rs3029748-CTT	rs3029748	0	3029748	intron_variant	0	0.535	4E-6	5.3979400086720375	(EA)	0.0298	[0.017-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p14	2	67755147	NR	LINC02831 - LINC01812	ENSG00000224173	ENSG00000237013		134602	40907	rs3036802-ACAT	rs3036802	0	3036802	intergenic_variant	1	0.7844	3E-6	5.522878745280337	(EA)	0.0426	[0.025-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p21.3	9	21964884	NR	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		27233	2045	rs3057314-C	rs3057314	0	3057314	intron_variant	1	0.3185	7E-25	24.154901959985743	(EA)	0.0695	[0.056-0.083] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	26175638	NR	H2BC6			ENSG00000274290			rs17598658-C	rs17598658	0	17598658	intron_variant	0	0.0823	2E-9	8.698970004336019	(EA)	0.0726	[0.049-0.097] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.2	11	66301747	NR	TMEM151A - CD248	ENSG00000179292	ENSG00000174807		5083	12747	rs1783730-G	rs1783730	0	1783730	intergenic_variant	1	0.5553	3E-7	6.522878745280337	(EA)	0.0339	[0.021-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	30643415	NR	TGFBR2			ENSG00000163513			rs17838698-T	rs17838698	0	17838698	intron_variant	0	0.2978	2E-14	13.698970004336019	(EA)	0.0517	[0.039-0.065] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.2	1	41532093	NR	HIVEP3			ENSG00000127124			rs181270898-A	rs181270898	0	181270898	intron_variant	0	0.0298	5E-7	6.301029995663981	(EA)	0.097	[0.059-0.135] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q26.3	15	100366889	NR	SPATA41 - CERS3-AS1	ENSG00000189419	ENSG00000259430		16164	6047	rs181337095-A	rs181337095	1	12441640	intergenic_variant	1	0.8674	3E-7	6.522878745280337	(EA)	0.0521	[0.032-0.072] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201140114	NR	CFLAR			ENSG00000003402			rs182731523-C	rs182731523	0	182731523	intron_variant	0	0.1861	8E-8	7.096910013008056	(EA)	0.0426	[0.027-0.058] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	29581329	NR	NIPSNAP1 - NF2	ENSG00000184117	ENSG00000186575		2	22227	rs183421746-C	rs183421746	0	183421746	regulatory_region_variant	1	0.0094	3E-11	10.522878745280337	(EA)	0.2452	[0.17-0.32] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q14	15	37206970	NR	MEIS2 - Metazoa_SRP	ENSG00000134138	ENSG00000274701		105671	9647	rs184531260-A	rs184531260	0	184531260	intergenic_variant	1	0.0113	4E-7	6.3979400086720375	(EA)	0.21	[0.13-0.29] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q13.1	5	68315658	NR	PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		13837	539252	rs184886-C	rs184886	0	184886	regulatory_region_variant	1	0.724	2E-6	5.698970004336019	(EA)	0.0333	[0.02-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	29457633	NR	RFPL1S			ENSG00000225465			rs185004002-T	rs185004002	0	185004002	intron_variant	0	0.0148	2E-12	11.698970004336019	(EA)	0.1896	[0.14-0.24] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	119254406	NR	WARS2-AS1			ENSG00000231365			rs185028854-A	rs185028854	0	185028854	intron_variant	0	0.0088	7E-6	5.154901959985743	(EA)	0.1578	[0.089-0.227] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.1	10	104612026	NR	LINC02620 - SORCS3	ENSG00000225768	ENSG00000156395		131752	29264	rs1855581-G	rs1855581	0	1855581	intron_variant	1	0.235	7E-6	5.154901959985743	(EA)	0.0326	[0.018-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	67640136	NR	CTNNA3			ENSG00000183230			rs186036693-G	rs186036693	0	186036693	intron_variant	0	0.007	2E-6	5.698970004336019	(EA)	0.216	[0.13-0.31] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	30509501	NR	SEC14L4 - SEC14L6	ENSG00000133488	ENSG00000214491		3790	13298	rs187201341-T	rs187201341	0	187201341	intergenic_variant	1	0.0087	1E-6	6	(EA)	0.1861	[0.11-0.26] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17p11.2	17	17835546	NR	SREBF1			ENSG00000072310			rs187408367-A	rs187408367	0	187408367	intron_variant	0	0.0051	8E-7	6.096910013008056	(EA)	0.2318	[0.14-0.32] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	67750937	NR	"AKR1B10P1, CTNNA3"			"ENSG00000213606, ENSG00000183230"			rs189157202-T	rs189157202	0	189157202	non_coding_transcript_exon_variant	0	0.007	2E-6	5.698970004336019	(EA)	0.2152	[0.13-0.3] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q24.3	1	172361919	NR	DNM3			ENSG00000197959			rs1894633-G	rs1894633	0	1894633	intron_variant	0	0.3337	2E-6	5.698970004336019	(EA)	0.0312	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	80636316	NR	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		165888	855123	rs1902066-C	rs1902066	0	1902066	intergenic_variant	1	0.5571	7E-6	5.154901959985743	(EA)	0.0281	[0.016-0.04] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							rs190817902-G	rs190817902	1	1570070540		1	0.055	7E-7	6.154901959985743	(EA)	0.1165	[0.07-0.163] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	43545632	NR	PAIP1			ENSG00000172239			rs191057893-G	rs191057893	0	191057893	intron_variant	0	0.0079	8E-6	5.096910013008056	(EA)	0.2573	[0.14-0.37] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p21	2	41931164	NR	LINC01913 - LINC01914	ENSG00000214691	ENSG00000234362		37114	435	rs17029056-C	rs17029056	0	17029056	TF_binding_site_variant	1	0.2148	4E-6	5.3979400086720375	(EA)	0.0354	[0.02-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q22.2	18	69220817	NR	CCDC102B - DOK6	ENSG00000150636	ENSG00000206052		165628	180071	rs17080623-G	rs17080623	0	17080623	intergenic_variant	1	0.2314	5E-6	5.301029995663981	(EA)	0.0344	[0.02-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	18522945	NR	ELL - FKBP8	ENSG00000105656	ENSG00000105701		829	8806	rs172032-C	rs172032	0	172032	regulatory_region_variant	1	0.4209	1E-16	16	(EA)	0.0531	[0.041-0.066] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.1	14	68214759	NR	RAD51B			ENSG00000182185			rs1744947-T	rs1744947	0	1744947	intron_variant	0	0.16	2E-14	13.698970004336019	(EA)	0.0645	[0.048-0.081] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.3	5	158905372	NR	EBF1			ENSG00000164330			rs17543752-C	rs17543752	0	17543752	intron_variant	0	0.3836	2E-19	18.69897000433602	(EA)	0.0574	[0.045-0.07] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	59180291	NR	PDE4D			ENSG00000113448			rs9292195-C	rs9292195	0	9292195	intron_variant	0	0.8454	4E-7	6.3979400086720375	(EA)	0.0434	[0.027-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	44822356	NR	MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		1928	432592	rs930395-A	rs930395	0	930395	intergenic_variant	1	0.2206	2E-58	57.69897000433602	(EA)	0.1187	[0.1-0.13] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.3	14	77005236	NR	RN7SL356P - IRF2BPL	ENSG00000266553	ENSG00000119669		37471	19307	rs9323635-T	rs9323635	0	9323635	regulatory_region_variant	1	0.979	1E-6	6	(EA)	0.1122	[0.067-0.157] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.3	6	21905495	NR	CASC15			ENSG00000272168			rs9350395-G	rs9350395	0	9350395	intron_variant	0	0.5936	3E-7	6.522878745280337	(EA)	0.0323	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	81545215	NR	TENT5A			ENSG00000112773			rs9361840-G	rs9361840	0	9361840	intron_variant	0	0.2368	7E-14	13.154901959985743	(EA)	0.0541	[0.04-0.068] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p24.3	6	7231610	NR	RREB1			ENSG00000124782			rs9379084-A	rs9379084	0	9379084	missense_variant	0	0.1206	3E-6	5.522878745280337	(EA)	0.0486	[0.028-0.069] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.11	10	119567672	NR	RGS10 - TIAL1	ENSG00000148908	ENSG00000151923		24953	4130	rs9421352-T	rs9421352	0	9421352	intergenic_variant	1	0.2453	1E-7	7	(EA)	0.0389	[0.024-0.053] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	80496839	NR	RPSAP72 - TENT5A	ENSG00000219361	ENSG00000112773		26411	994600	rs9449003-A	rs9449003	0	9449003	intergenic_variant	1	0.4925	3E-6	5.522878745280337	(EA)	0.0295	[0.017-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.3	6	20923044	NR	CDKAL1			ENSG00000145996			rs9460578-A	rs9460578	0	9460578	intron_variant	0	0.2834	1E-6	6	(EA)	0.0337	[0.02-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q14.3	13	50521772	NR	"DLEU7, DLEU1"			"ENSG00000186047, ENSG00000176124"			rs9562987-A	rs9562987	0	9562987	intron_variant	0	0.3219	4E-6	5.3979400086720375	(EA)	0.0305	[0.018-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q12.3	13	29543880	NR	SLC7A1			ENSG00000139514			rs9578106-C	rs9578106	0	9578106	intron_variant	0	0.1076	7E-6	5.154901959985743	(EA)	0.0461	[0.026-0.066] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	38798063	NR	DNAL4 - NPTXR	ENSG00000100246	ENSG00000221890		3865	20389	rs9619765-T	rs9619765	0	9619765	intergenic_variant	1	0.0324	1E-6	6	(EA)	0.0914	[0.054-0.128] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	23047728	NR	RBBP8 - CABLES1	ENSG00000101773	ENSG00000134508		21240	86836	rs9675999-A	rs9675999	0	9675999	intergenic_variant	1	0.6392	7E-7	6.154901959985743	(EA)	0.0319	[0.019-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.13	8	123726378	NR	ANXA13			ENSG00000104537			rs970821-T	rs970821	0	970821	intron_variant	0	0.401	2E-12	11.698970004336019	(EA)	0.0445	[0.032-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p14	2	67654625	NR	LINC02831 - LINC01812	ENSG00000224173	ENSG00000237013		34080	141429	rs9712235-A	rs9712235	0	9712235	intron_variant	1	0.7397	7E-7	6.154901959985743	(EA)	0.0357	[0.022-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q22.3	21	46360308	NR	PCNT			ENSG00000160299			rs9808759-C	rs9808759	0	9808759	intron_variant	0	0.9253	4E-7	6.3979400086720375	(EA)	0.0597	[0.037-0.083] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p12.1	3	86154659	NR	CADM2 - RNU6-1129P	ENSG00000175161	ENSG00000251773		80230	80662	rs9833726-T	rs9833726	0	9833726	intergenic_variant	1	0.1358	6E-6	5.221848749616356	(EA)	0.0429	[0.024-0.062] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q12.1	3	100105841	NR	"FILIP1L, CMSS1"			"ENSG00000168386, ENSG00000184220"			rs9837602-A	rs9837602	0	9837602	intron_variant	0	0.2261	1E-9	9	(EA)	0.0448	[0.03-0.059] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	47241865	NR	"KIF9-AS1, KIF9"			"ENSG00000227398, ENSG00000088727"			rs9867461-T	rs9867461	0	9867461	intron_variant	0	0.0312	2E-6	5.698970004336019	(EA)	0.0964	[0.057-0.136] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q28	3	190056667	NR	P3H2			ENSG00000090530			rs9882792-T	rs9882792	0	9882792	intron_variant	0	0.2218	2E-6	5.698970004336019	(EA)	0.0377	[0.022-0.053] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q22.1	4	91717049	NR	CCSER1 - KRT19P6	ENSG00000184305	ENSG00000249891		111754	167997	rs9884765-C	rs9884765	0	9884765	intergenic_variant	1	0.3701	5E-7	6.301029995663981	(EA)	0.0353	[0.022-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.3	18	45308832	NR	SLC14A2			ENSG00000132874			rs9952980-C	rs9952980	0	9952980	intron_variant	0	0.3504	2E-13	12.698970004336019	(EA)	0.0478	[0.035-0.061] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.3	18	44831838	NR	SETBP1			ENSG00000152217			rs9954058-C	rs9954058	0	9954058	intron_variant	0	0.0721	3E-13	12.522878745280337	(EA)	0.0891	[0.065-0.113] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.1	18	27826891	NR	PA2G4P3 - CDH2	ENSG00000263405	ENSG00000170558		373234	105988	rs9959491-T	rs9959491	0	9959491	intergenic_variant	1	0.7115	5E-7	6.301029995663981	(EA)	0.0345	[0.021-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:69124241-T	chr12:69124241	0			1	0.2711	7E-7	6.154901959985743	(EA)	0.0358	[0.022-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29280372	NR	"LINC03003, LINC03003"			"ENSG00000290496, ENSG00000197171"			rs3130834-C	rs3130834	0	3130834	intron_variant	0	0.0955	5E-9	8.301029995663981	(EA)	0.0672	[0.045-0.09] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.33	6	30576624	NR	ABCF1			ENSG00000204574			rs3132610-G	rs3132610	0	3132610	intron_variant	0	0.1198	1E-6	6	(EA)	0.0499	[0.03-0.07] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	30473526	NR	SUCLA2P1 - RANP1	ENSG00000224936	ENSG00000236603		3275	12414	rs3132615-T	rs3132615	0	3132615	intron_variant	1	0.1154	2E-6	5.698970004336019	(EA)	0.0507	[0.03-0.071] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.3	5	91493653	NR	ARRDC3-AS1			ENSG00000281357			rs332529-A	rs332529	0	332529	intron_variant	0	0.1605	9E-12	11.045757490560675	(EA)	0.0606	[0.043-0.078] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p13.3	1	108114736	NR	LINC02785 - SLC25A24	ENSG00000226822	ENSG00000085491		38716	19307	rs33960734-ATT	rs33960734	1	5776927	regulatory_region_variant	1	0.8248	5E-6	5.301029995663981	(EA)	0.0375	[0.021-0.054] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	63497603	NR	JMJD1C			ENSG00000171988			rs34044188-T	rs34044188	0	34044188	intron_variant	0	0.0373	3E-7	6.522878745280337	(EA)	0.0953	[0.059-0.132] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	28594471	NR	SCAND3			ENSG00000232040			rs34119086-T	rs34119086	0	34119086	intron_variant	0	0.093	8E-9	8.096910013008056	(EA)	0.0679	[0.045-0.091] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	62961440	NR	EGR2 - RNU6-543P	ENSG00000122877	ENSG00000199446		142273	148699	rs34146356-T	rs34146356	0	34146356	intergenic_variant	1	0.0418	5E-8	7.301029995663981	(EA)	0.0861	[0.055-0.117] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	27457865	NR	ZNF184			ENSG00000096654			rs34196306-C	rs34196306	0	34196306	intron_variant	0	0.0846	1E-9	9	(EA)	0.0747	[0.051-0.099] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q11.21	22	19774906	NR	TBX1			ENSG00000184058			rs34331122-CTT	rs34331122	0	34331122	intron_variant	0	0.4557	7E-6	5.154901959985743	(EA)	0.0288	[0.016-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.3	11	69646918	NR	CCND1			ENSG00000110092			rs34507830-T	rs34507830	0	34507830	intron_variant	0	0.0206	7E-31	30.154901959985743	(EA)	0.2629	[0.22-0.31] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	26993501	NR	"LARRPM, LINC00240"			"ENSG00000287966, ENSG00000224843"			rs34546498-T	rs34546498	0	34546498	intron_variant	0	0.0846	9E-10	9.045757490560675	(EA)	0.0747	[0.051-0.099] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	28106103	NR	ZSCAN16-AS1			ENSG00000269293			rs34662244-A	rs34662244	0	34662244	intron_variant	0	0.092	3E-9	8.522878745280337	(EA)	0.0691	[0.046-0.092] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155697170	NR	DAP3			ENSG00000132676			rs348196-C	rs348196	0	348196	intron_variant	0	0.2375	2E-8	7.698970004336019	(EA)	0.0407	[0.027-0.055] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q31.21	4	143318872	NR	Y_RNA - GAB1	ENSG00000202522	ENSG00000109458		9306	18004	rs34853779-C	rs34853779	0	34853779	intron_variant	1	0.584	9E-6	5.045757490560675	(EA)	0.0288	[0.016-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	43891334	NR	NNT - RNU6-381P	ENSG00000112992	ENSG00000212561		183929	175290	rs35029702-A	rs35029702	0	35029702	intergenic_variant	1	0.0911	1E-7	7	(EA)	0.0609	[0.038-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121904429	NR	ATE1			ENSG00000107669			rs7899628-T	rs7899628	0	7899628	intron_variant	0	0.3585	9E-10	9.045757490560675	(EA)	0.0396	[0.027-0.052] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q26.31	3	172363569	NR	FNDC3B			ENSG00000075420			rs12152414-A	rs12152414	0	12152414	intron_variant	0	0.036	5E-6	5.301029995663981	(EA)	0.083	[0.048-0.118] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29107311	NR	OR2J1 - OR2J3	ENSG00000204702	ENSG00000204701		4610	747	rs3129178-A	rs3129178	0	3129178	intergenic_variant	1	0.0951	6E-9	8.221848749616356	(EA)	0.0669	[0.044-0.089] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q32.1	1	203832121	NR	"ZBED6, ZC3H11A"			"ENSG00000257315, ENSG00000058673"			rs59867004-C	rs59867004	0	59867004	intron_variant	0	0.2724	1E-10	10	(EA)	0.0446	[0.031-0.058] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q22.1	14	51819674	NR	OR7E159P - GNG2	ENSG00000258849	ENSG00000186469		47588	6521	rs35072154-T	rs35072154	0	35072154	non_coding_transcript_exon_variant	1	0.3652	3E-6	5.522878745280337	(EA)	0.0301	[0.018-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	57890836	NR	LINC02225			ENSG00000249584			rs35100619-A	rs35100619	0	35100619	intron_variant	0	0.1115	6E-6	5.221848749616356	(EA)	0.0507	[0.029-0.073] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	119894128	NR	ADAM30			ENSG00000134249			rs35273427-C	rs35273427	0	35273427	missense_variant	0	0.0602	2E-7	6.698970004336019	(EA)	0.0707	[0.044-0.098] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.2	10	62719072	NR	LINC02929 - ALDH7A1P4	ENSG00000285551	ENSG00000234489		47061	22136	rs35306388-G	rs35306388	0	35306388	intron_variant	1	0.0391	2E-10	9.698970004336019	(EA)	0.1041	[0.072-0.136] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	149265193	NR	TAB2			ENSG00000055208			rs35409891-C	rs35409891	0	35409891	intron_variant	0	0.293	3E-9	8.522878745280337	(EA)	0.0457	[0.031-0.061] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.32	14	102882582	NR	TRAF3			ENSG00000131323			rs368131309-GT	rs368131309	0	368131309	intron_variant	0	0.2559	4E-6	5.3979400086720375	(EA)	0.0371	[0.021-0.053] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	102478605	NR	POLR2J			ENSG00000005075			rs369574511-C	rs369574511	1	62483813	intron_variant	0	0.6318	2E-7	6.698970004336019	(EA)	0.0364	[0.023-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p23	6	13713134	NR	RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		1299	73423	rs418053-C	rs418053	0	418053	regulatory_region_variant	1	0.5685	1E-13	13	(EA)	0.0465	[0.034-0.059] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p11.23	8	36992428	NR	KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		56303	102722	rs4286946-G	rs4286946	0	4286946	intergenic_variant	1	0.1739	9E-22	21.045757490560675	(EA)	0.0799	[0.064-0.096] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.4	11	10299114	NR	SBF2			ENSG00000133812			rs4345958-A	rs4345958	0	4345958	intron_variant	0	0.2764	3E-6	5.522878745280337	(EA)	0.0322	[0.019-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	27873148	NR	H4C13			ENSG00000275126			rs45509595-C	rs45509595	0	45509595	3_prime_UTR_variant	0	0.0906	5E-9	8.301029995663981	(EA)	0.0684	[0.045-0.091] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.12	19	14901422	NR	OR7A1P - OR7A3P	ENSG00000268834	ENSG00000269787		8618	1810	rs4594370-G	rs4594370	0	4594370	intergenic_variant	1	0.0309	7E-6	5.154901959985743	(EA)	0.1022	[0.058-0.147] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	216883915	NR	DIRC3-AS1			ENSG00000233143			rs4674124-T	rs4674124	0	4674124	intron_variant	0	0.1771	1E-11	11	(EA)	0.056	[0.04-0.072] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.1	5	16233510	NR	NACAP6 - LINC02150	ENSG00000248403	ENSG00000248150		40801	139851	rs4702131-C	rs4702131	0	4702131	intergenic_variant	1	0.5612	1E-11	11	(EA)	0.0424	[0.03-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.2	11	15431096	NR	INSC - LINC02751	ENSG00000188487	ENSG00000254946		183888	121759	rs4757319-G	rs4757319	0	4757319	intergenic_variant	1	0.3857	3E-6	5.522878745280337	(EA)	0.0298	[0.017-0.042] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	45394123	NR	ARHGAP27			ENSG00000159314			rs4763-A	rs4763	0	4763	3_prime_UTR_variant	0	0.1745	2E-8	7.698970004336019	(EA)	0.0464	[0.03-0.063] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20p11.23	20	19772894	NR	RIN2			ENSG00000132669			rs4814894-A	rs4814894	0	4814894	intron_variant	0	0.4507	7E-7	6.154901959985743	(EA)	0.0323	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	38174306	NR	PLA2G6			ENSG00000184381			rs4820318-A	rs4820318	0	4820318	intron_variant	0	0.3753	1E-13	13	(EA)	0.0475	[0.035-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	42745087	NR	A4GALT - Y_RNA	ENSG00000128274	ENSG00000202522		23789	17773	rs4820477-C	rs4820477	0	4820477	intergenic_variant	1	0.4847	9E-7	6.045757490560675	(EA)	0.0307	[0.019-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q14.2	2	120481784	NR	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		15566	169489	rs4848599-C	rs4848599	0	4848599	intergenic_variant	1	0.8845	2E-20	19.69897000433602	(EA)	0.0933	[0.074-0.113] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q12	4	57013626	NR	POLR2B			ENSG00000047315			rs4865169-T	rs4865169	0	4865169	intron_variant	0	0.5239	7E-6	5.154901959985743	(EA)	0.0278	[0.016-0.04] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q21.33	18	63178058	NR	BCL2			ENSG00000171791			rs4940575-C	rs4940575	0	4940575	intron_variant	0	0.1666	4E-6	5.3979400086720375	(EA)	0.04	[0.023-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45333758	NR	HCN1			ENSG00000164588			rs55821517-C	rs55821517	0	55821517	intron_variant	0	0.266	5E-19	18.30102999566398	(EA)	0.0639	[0.05-0.078] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	27104763	NR	VN1R11P - RNU2-62P	ENSG00000219770	ENSG00000222800		20616	5027	rs55834529-G	rs55834529	0	55834529	intergenic_variant	1	0.0874	3E-9	8.522878745280337	(EA)	0.071	[0.048-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.2	11	66710394	NR	SPTBN2			ENSG00000173898			rs55908905-A	rs55908905	0	55908905	intron_variant	0	0.2681	8E-6	5.096910013008056	(EA)	0.032	[0.018-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q23.1	16	79190071	NR	WWOX			ENSG00000186153			rs55986698-A	rs55986698	0	55986698	intron_variant	0	0.183	4E-6	5.3979400086720375	(EA)	0.0421	[0.024-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	17283116	NR	ANKLE1			ENSG00000160117			rs56069439-A	rs56069439	0	56069439	non_coding_transcript_exon_variant	0	0.2968	9E-9	8.045757490560675	(EA)	0.0387	[0.026-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	27307055	NR	POM121L2			ENSG00000158553			rs56114371-T	rs56114371	0	56114371	intron_variant	0	0.0885	2E-9	8.698970004336019	(EA)	0.071	[0.048-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	27608457	NR	Y_RNA - RPS27P11	ENSG00000202522	ENSG00000223968		60599	15745	rs56138756-G	rs56138756	0	56138756	intergenic_variant	1	0.1527	7E-9	8.154901959985743	(EA)	0.0508	[0.034-0.068] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q31.1	1	186763038	NR	PACERR - PLA2G4A	ENSG00000273129	ENSG00000116711		79873	65911	rs56160832-A	rs56160832	0	56160832	TF_binding_site_variant	1	0.1044	5E-6	5.301029995663981	(EA)	0.0463	[0.026-0.066] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.2	7	92143417	NR	"LRRD1, CYP51A1-AS1"			"ENSG00000240720, ENSG00000188693"			rs35417517-C	rs35417517	0	35417517	intron_variant	0	0.392	8E-11	10.096910013008056	(EA)	0.0416	[0.029-0.054] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.2	10	62303692	NR	LINC02621			ENSG00000234756			rs35419901-T	rs35419901	0	35419901	non_coding_transcript_exon_variant	0	0.0377	8E-11	10.096910013008056	(EA)	0.1123	[0.078-0.146] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.2	7	92243559	NR	KRIT1			ENSG00000001631			rs35522438-AT	rs35522438	0	35522438	5_prime_UTR_variant	0	0.3913	1E-9	9	(EA)	0.0389	[0.026-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	63349742	NR	JMJD1C			ENSG00000171988			rs35632171-G	rs35632171	0	35632171	intron_variant	0	0.0418	3E-7	6.522878745280337	(EA)	0.0915	[0.057-0.126] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q22.2	8	100298199	NR	RNF19A			ENSG00000034677			rs35748790-TA	rs35748790	0	35748790	intron_variant	0	0.3649	3E-6	5.522878745280337	(EA)	0.0317	[0.018-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.2	10	22681806	NR	PIP4K2A			ENSG00000150867			rs370356098-C	rs370356098	0	370356098	intron_variant	0	0.0399	2E-7	6.698970004336019	(EA)	0.0837	[0.052-0.115] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	120018691	NR	NOTCH2			ENSG00000134250			rs372562666-G	rs372562666	1	3879977	intron_variant	0	0.2648	6E-27	26.221848749616356	(EA)	0.1005	[0.082-0.119] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q13.2	20	53956286	NR	BCAS1			ENSG00000064787			rs375506010-T	rs375506010	1	141973238	intron_variant	0	0.1809	5E-6	5.301029995663981	(EA)	0.0395	[0.022-0.057] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201258707	NR	CASP8			ENSG00000064012			rs3769821-T	rs3769821	0	3769821	intron_variant	0	0.6683	4E-18	17.397940008672037	(EA)	0.0565	[0.044-0.069] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q16.2	6	99643666	NR	Y_RNA - MCHR2	ENSG00000202522	ENSG00000152034		1319	274853	rs377527229-C	rs377527229	0	377527229	intergenic_variant	1	0.2282	6E-6	5.221848749616356	(EA)	0.0341	[0.019-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.3	19	2226677	NR	DOT1L			ENSG00000104885			rs3815308-A	rs3815308	0	3815308	missense_variant	0	0.4348	7E-6	5.154901959985743	(EA)	0.0288	[0.016-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p14.1	3	63956021	NR	ATXN7			ENSG00000163635			rs3821902-G	rs3821902	0	3821902	intron_variant	0	0.1358	3E-12	11.522878745280337	(EA)	0.0623	[0.045-0.08] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.2	6	36676721	NR	CDKN1A			ENSG00000124762			rs3829964-C	rs3829964	0	3829964	intron_variant	0	0.4864	9E-8	7.045757490560675	(EA)	0.0331	[0.021-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	63197831	NR	JMJD1C			ENSG00000171988			rs35997229-C	rs35997229	0	35997229	intron_variant	0	0.0431	3E-7	6.522878745280337	(EA)	0.0829	[0.051-0.115] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q24.2	17	68904663	NR	ABCA8			ENSG00000141338			rs36059695-T	rs36059695	0	36059695	intron_variant	0	0.035	6E-8	7.221848749616356	(EA)	0.1031	[0.066-0.14] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q23.3	5	128227188	NR	SLC12A2 - FBN2	ENSG00000064651	ENSG00000138829		37511	30721	rs36715-A	rs36715	0	36715	intergenic_variant	1	0.7576	4E-6	5.3979400086720375	(EA)	0.0339	[0.019-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.1	1	145607339	NR	"NBPF25P, NBPF25P"			"ENSG00000272150, ENSG00000291005"			rs368032757-G	rs368032757	0	368032757	intron_variant	0	0.0183	5E-6	5.301029995663981	(EA)	0.1759	[0.1-0.25] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.1	1	146069686	NR	NBPF10			ENSG00000271425			rs368121891-A	rs368121891	1	61813408	missense_variant	0	0.3735	9E-8	7.045757490560675	(EA)	0.0405	[0.026-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p11.2	1	121121848	NR	H3P4 - RPL22P6	ENSG00000213244	ENSG00000268993		3238	20203	rs369304377-G	rs369304377	1	61804016	intron_variant	1	0.3892	2E-29	28.69897000433602	(EA)	0.0885	[0.073-0.104] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.2	7	92344194	NR	ANKIB1			ENSG00000001629			rs369328859-G	rs369328859	1	67933063	intron_variant	0	0.3748	2E-8	7.698970004336019	(EA)	0.0369	[0.024-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.3	10	113678604	NR	NRAP - CASP7	ENSG00000197893	ENSG00000165806		14534	558	rs369832192-C	rs369832192	1	71007438	TF_binding_site_variant	1	0.4764	4E-6	5.3979400086720375	(EA)	0.0302	[0.017-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p11.2	11	44347927	NR	ALX4 - RPL7AP79	ENSG00000052850	ENSG00000255106		37788	191851	rs3853291-A	rs3853291	0	3853291	intergenic_variant	1	0.5472	3E-7	6.522878745280337	(EA)	0.0318	[0.02-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	102160260	NR	CUX1			ENSG00000257923			rs411624-C	rs411624	0	411624	intron_variant	0	0.9557	2E-6	5.698970004336019	(EA)	0.0767	[0.045-0.108] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.31	19	43919418	NR	"ZNF45, ZNF45-AS1"			"ENSG00000124459, ENSG00000267191"			rs375066-C	rs375066	0	375066	intron_variant	0	0.5141	2E-14	13.698970004336019	(EA)	0.0474	[0.035-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q11.23	7	74860783	NR	GTF2IRD2 - STAG3L2	ENSG00000196275	ENSG00000277072		9178	21922	rs377629160-T	rs377629160	0	377629160	intron_variant	1	0.1887	6E-7	6.221848749616356	(EA)	0.0431	[0.026-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q23.3	16	82039249	NR	HSD17B2			ENSG00000086696			rs56169712-TAC	rs56169712	0	56169712	intron_variant	0	0.5726	7E-6	5.154901959985743	(EA)	0.0319	[0.018-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	103143080	NR	NAPEPLD			ENSG00000161048			rs56196003-A	rs56196003	0	56196003	intron_variant	0	0.2198	5E-6	5.301029995663981	(EA)	0.0363	[0.021-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16p13.3	16	4058158	NR	ADCY9			ENSG00000162104			rs56278937-T	rs56278937	0	56278937	intron_variant	0	0.5071	1E-6	6	(EA)	0.0317	[0.019-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	46846708	NR	MYL3			ENSG00000160808			rs56387622-C	rs56387622	0	56387622	intron_variant	0	0.1012	5E-19	18.30102999566398	(EA)	0.0942	[0.073-0.115] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							rs56949123-GTT	rs56949123	0	56949123		1	0.0478	4E-6	5.3979400086720375	(EA)	0.0692	[0.04-0.099] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17p13.1	17	7298013	NR	YBX2 - EIF5A	ENSG00000006047	ENSG00000132507		3374	8986	rs57275132-CCGAGGTGGGCGGATCA	rs57275132	0	57275132	intergenic_variant	1	0.6241	9E-6	5.045757490560675	(EA)	0.0311	[0.017-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q21.2	1	149811268	NR	H2BC18			ENSG00000203814			rs57324102-A	rs57324102	0	57324102	intron_variant	0	0.0453	6E-6	5.221848749616356	(EA)	0.0885	[0.05-0.127] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.31	5	7290571	NR	Metazoa_SRP - LINC02123	ENSG00000274701	ENSG00000250668		50553	56415	rs57380813-AG	rs57380813	0	57380813	intron_variant	1	0.7003	8E-6	5.096910013008056	(EA)	0.0313	[0.018-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p13.3	1	109680280	NR	GSTM2			ENSG00000213366			rs5776993-C	rs5776993	0	5776993	intron_variant	0	0.8767	2E-7	6.698970004336019	(EA)	0.0563	[0.035-0.077] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q32.2	1	207761719	NR	"CD46, MIR29B2CHG"			"ENSG00000117335, ENSG00000203709"			rs5780403-CA	rs5780403	0	5780403	non_coding_transcript_exon_variant	0	0.2059	9E-6	5.045757490560675	(EA)	0.0378	[0.021-0.054] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.2	11	15309178	NR	INSC - LINC02751	ENSG00000188487	ENSG00000254946		61970	243677	rs5789877-ACT	rs5789877	0	5789877	intergenic_variant	1	0.6881	2E-6	5.698970004336019	(EA)	0.0324	[0.019-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q13.2	14	35130485	NR	PRORP			ENSG00000100890			rs58327846-C	rs58327846	0	58327846	intron_variant	0	0.3512	4E-6	5.3979400086720375	(EA)	0.0311	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	200849597	NR	RNA5SP115 - CLK1	ENSG00000223092	ENSG00000013441		453	3412	rs5837757-C	rs5837757	0	5837757	intergenic_variant	1	0.1716	1E-7	7	(EA)	0.0438	[0.028-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18p11.21	18	13110432	NR	CEP192			ENSG00000101639			rs58685532-A	rs58685532	0	58685532	intron_variant	0	0.1721	4E-6	5.3979400086720375	(EA)	0.041	[0.024-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	40623944	NR	MRTFA			ENSG00000196588			rs6001982-A	rs6001982	0	6001982	intron_variant	0	0.1066	1E-34	34	(EA)	0.1207	[0.1-0.14] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	107541528	NR	KLF4 - PPIAP88	ENSG00000136826	ENSG00000227350		51046	1623	rs60037937-T	rs60037937	0	60037937	intergenic_variant	1	0.2004	1E-26	26	(EA)	0.0853	[0.07-0.101] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q24.2	1	168127440	NR	GPR161			ENSG00000143147			rs60504827-T	rs60504827	0	60504827	intron_variant	0	0.1245	2E-7	6.698970004336019	(EA)	0.053	[0.033-0.073] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	27290919	NR	NEK10			ENSG00000163491			rs60936670-C	rs60936670	0	60936670	intron_variant	0	0.5245	8E-64	63.096910013008056	(EA)	0.1056	[0.093-0.118] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	151634779	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		13586	21912	rs60954078-G	rs60954078	0	60954078	intergenic_variant	1	0.07	3E-54	53.52287874528034	(EA)	0.1817	[0.16-0.2] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	49129027	NR	LAMB2			ENSG00000172037			rs61729152-T	rs61729152	0	61729152	missense_variant	0	0.0203	6E-6	5.221848749616356	(EA)	0.1081	[0.061-0.155] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.1	11	65935052	NR	DRAP1 - TSGA10IP	ENSG00000175550	ENSG00000175513		13489	10428	rs617791-C	rs617791	0	617791	intergenic_variant	1	0.501	7E-6	5.154901959985743	(EA)	0.0281	[0.016-0.04] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	62822722	NR	EGR2 - RNU6-543P	ENSG00000122877	ENSG00000199446		3555	287417	rs61865900-C	rs61865900	0	61865900	intron_variant	1	0.0623	2E-9	8.698970004336019	(EA)	0.078	[0.053-0.103] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.3	17	82597601	NR	FOXK2			ENSG00000141568			rs62079673-C	rs62079673	0	62079673	intron_variant	0	0.5948	1E-6	6	(EA)	0.0329	[0.02-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201666541	NR	MPP4			ENSG00000082126			rs62193398-C	rs62193398	0	62193398	intron_variant	0	0.4196	1E-7	7	(EA)	0.0332	[0.021-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	53399007	NR	RPL13AP13 - FST	ENSG00000213940	ENSG00000134363		191831	81619	rs4254863-C	rs4254863	0	4254863	intergenic_variant	1	0.0979	5E-6	5.301029995663981	(EA)	0.0472	[0.027-0.068] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	27799398	NR	MN1			ENSG00000169184			rs45589338-A	rs45589338	0	45589338	missense_variant	0	0.0352	2E-10	9.698970004336019	(EA)	0.1112	[0.077-0.145] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.1	9	104094512	NR	SMC2			ENSG00000136824			rs4742903-C	rs4742903	0	4742903	intron_variant	0	0.5563	2E-7	6.698970004336019	(EA)	0.0325	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q21.2	15	50402109	NR	GABPB1-AS1 - AHCYP7	ENSG00000244879	ENSG00000259465		29907	15276	rs4774565-G	rs4774565	0	4774565	intergenic_variant	1	0.3462	2E-6	5.698970004336019	(EA)	0.0329	[0.019-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	29273659	NR	EWSR1			ENSG00000182944			rs4820803-C	rs4820803	0	4820803	intron_variant	0	0.1732	2E-6	5.698970004336019	(EA)	0.0394	[0.023-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q23.1	11	111636465	NR	SIK2			ENSG00000170145			rs505372-C	rs505372	0	505372	intron_variant	0	0.7201	3E-6	5.522878745280337	(EA)	0.0322	[0.019-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p15.1	10	5752689	NR	TASOR2			ENSG00000108021			rs55910451-G	rs55910451	0	55910451	intron_variant	0	0.218	4E-7	6.3979400086720375	(EA)	0.0377	[0.023-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.2	16	54107655	NR	FTO			ENSG00000140718			rs56077980-CT	rs56077980	0	56077980	intron_variant	0	0.3172	2E-7	6.698970004336019	(EA)	0.0346	[0.021-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p32.3	1	51001425	NR	CDKN2C - MIR4421	ENSG00000123080	ENSG00000265538		26791	58412	rs56168262-C	rs56168262	0	56168262	intergenic_variant	1	0.4737	2E-8	7.698970004336019	(EA)	0.0372	[0.024-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.2	10	22581150	NR	PIP4K2A			ENSG00000150867			rs56333866-T	rs56333866	0	56333866	intron_variant	0	0.9624	3E-8	7.522878745280337	(EA)	0.0928	[0.06-0.126] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	102824786	NR	FBXL13			ENSG00000161040			rs57237364-C	rs57237364	0	57237364	intron_variant	0	0.3408	5E-7	6.301029995663981	(EA)	0.0331	[0.02-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q25.2	1	177930963	NR	"SEC16B, CRYZL2P-SEC16B"			"ENSG00000120341, ENSG00000254154"			rs575908-C	rs575908	0	575908	intron_variant	0	0.2891	3E-6	5.522878745280337	(EA)	0.032	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q11.2	17	29372674	NR	RPL35AP35 - RNU4-34P	ENSG00000239256	ENSG00000222363		31852	15886	rs57968892-TTTTTGTTTTG	rs57968892	0	57968892	intron_variant	1	0.3296	5E-6	5.301029995663981	(EA)	0.0317	[0.018-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.3	10	113490891	NR	PPIAP39 - HABP2	ENSG00000230018	ENSG00000148702		7778	59946	rs58742730-G	rs58742730	0	58742730	intron_variant	1	0.1799	6E-9	8.221848749616356	(EA)	0.0467	[0.031-0.062] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.33	14	103585480	NR	"KLC1, COA8"			"ENSG00000126214, ENSG00000256053"			rs60226654-C	rs60226654	0	60226654	intron_variant	0	0.4798	8E-6	5.096910013008056	(EA)	0.0299	[0.017-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p21.2	1	100414772	NR	CDC14A			ENSG00000079335			rs612683-T	rs612683	0	612683	intron_variant	0	0.4047	3E-7	6.522878745280337	(EA)	0.0327	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	45941122	NR	MAPT			ENSG00000186868			rs62061734-C	rs62061734	0	62061734	intron_variant	0	0.2103	8E-12	11.096910013008056	(EA)	0.0526	[0.038-0.068] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	27918624	NR	PITPNB			ENSG00000180957			rs62235635-A	rs62235635	0	62235635	intron_variant	0	0.0065	1E-27	27	(EA)	0.4659	[0.38-0.55] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr11:111742493-CAAAAA	chr11:111742493	0			1	0.3637	2E-7	6.698970004336019	(EA)	0.0353	[0.022-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr11:18403271-C	chr11:18403271	0			1	0.6699	2E-6	5.698970004336019	(EA)	0.0336	[0.02-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr11:65601650-C	chr11:65601650	0			1	0.4928	2E-13	12.698970004336019	(EA)	0.0458	[0.034-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr11:9686139-CG	chr11:9686139	0			1	0.0061	5E-7	6.301029995663981	(EA)	0.3415	[0.21-0.47] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:103097070-G	chr12:103097070	0			1	0.1128	2E-6	5.698970004336019	(EA)	0.0459	[0.027-0.065] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:111600134-T	chr12:111600134	0			1	0.3705	9E-8	7.045757490560675	(EA)	0.0351	[0.022-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:111720125-C	chr12:111720125	0			1	0.4875	2E-6	5.698970004336019	(EA)	0.0318	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr12:111826477-AAATT	chr12:111826477	0			1	0.5084	6E-8	7.221848749616356	(EA)	0.0345	[0.022-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.1	18	32397726	GAREM1	GAREM1			ENSG00000141441			rs117618124-T	rs117618124	0	117618124	intron_variant	0	0.95	6E-12	11.221848749616356	(EA)	1.1235955	[1.09-1.18] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	26680470	intergenic	ZNF322 - GUSBP2	ENSG00000181315	ENSG00000290474		20718	191014	rs71557345-G	rs71557345	0	71557345	intron_variant	1	0.93	4E-10	9.397940008672037	(EA)	1.0869565	[1.04-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.2	1	41671640	HIVEP3	HIVEP3			ENSG00000127124			rs79724016-T	rs79724016	0	79724016	intron_variant	0	0.97	4E-8	7.3979400086720375	(EA)	1.0752687	[1.03-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.1	5	50345811	intergenic	HCN1 - EMB	ENSG00000164588	ENSG00000170571		4649313	50381	rs72749841-T	rs72749841	0	72749841	intergenic_variant	1	0.84	7E-10	9.154901959985743	(EA)	1.0752687	[1.04-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q23.1	8	105346392	ZFPM3	ZFPM2			ENSG00000169946			rs12546444-A	rs12546444	0	12546444	intron_variant	0	0.9	8E-11	10.096910013008056	(EA)	1.0752687	[1.04-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	101909160	CUX1	CUX1			ENSG00000257923			rs71559437-G	rs71559437	0	71559437	intron_variant	0	0.88	5E-12	11.301029995663981	(EA)	1.0752687	[1.04-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p12.1	3	86988393	VGLL3	VGLL3			ENSG00000206538			rs13066793-A	rs13066793	0	13066793	intron_variant	0	0.91	1E-9	9	(EA)	1.0638298	[1.03-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q23.1	6	130027974	L3MBTL3	L3MBTL3			ENSG00000198945			rs6569648-T	rs6569648	0	6569648	intron_variant	0	0.76	3E-12	11.522878745280337	(EA)	1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q31.1	5	133071366	HSPA4	HSPA4			ENSG00000170606			rs6596100-C	rs6596100	0	6596100	intron_variant	0	0.75	8E-9	8.096910013008056	(EA)	1.0638298	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q33.1	9	116551207	ASTN2	"ASTN2-AS1, ASTN2"			"ENSG00000229105, ENSG00000148219"			rs1895062-A	rs1895062	0	1895062	intron_variant	0	0.59	1E-14	14	(EA)	1.0638298	[1.05-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q28.1	4	125922349	intergenic	TMEM248P1 - LINC02379	ENSG00000249555	ENSG00000251649		198132	141779	rs77528541-G	rs77528541	0	77528541	intron_variant	1	0.87	1E-9	9	(EA)	1.0526316	[1.03-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.31	17	46175102	KANSL1	KANSL1			ENSG00000120071			rs2532263-G	rs2532263	0	2532263	intron_variant	0	0.81	7E-13	12.154901959985743	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	38172826	PLA2G6	PLA2G6			ENSG00000184381			rs738321-C	rs738321	0	738321	intron_variant	0	0.62	1E-13	13	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q41	1	217047232	ESRRG	ESRRG			ENSG00000196482			rs11117758-G	rs11117758	0	11117758	intron_variant	0	0.79	4E-9	8.397940008672037	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.1	5	50899260	intergenic	PARP8 - LINC02106	ENSG00000151883	ENSG00000251573		52741	69957	rs35951924-A	rs35951924	0	35951924	regulatory_region_variant	1	0.68	1E-11	11	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12q21.31	12	84615658	intergenic	RPL6P25 - SLC6A15	ENSG00000213270	ENSG00000072041		1463468	243833	rs202049448-T	rs202049448	0	202049448	intergenic_variant	1	0.66	3E-8	7.522878745280337	(EA)	1.0526316	[1.03-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.3	6	16399326	ATXN1	ATXN1			ENSG00000124788			rs3819405-C	rs3819405	0	3819405	intron_variant	0	0.67	2E-8	7.698970004336019	(EA)	1.0416667	[1.03-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q36.3	2	226362236	intergenic	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		632349	296474	rs12479355-A	rs12479355	0	12479355	intergenic_variant	1	0.79	2E-8	7.698970004336019	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p23.3	2	24906604	ADCY3	ADCY3			ENSG00000138031			rs6725517-A	rs6725517	0	6725517	intron_variant	0	0.59	3E-12	11.522878745280337	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	803017	PIDD1	PIDD1			ENSG00000177595			rs6597981-G	rs6597981	0	6597981	3_prime_UTR_variant	0	0.52	1E-12	12	(EA)	1.0416667	[1.03-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q24.2	16	87051631	intergenic	LINC02188 - LINC02181	ENSG00000261175	ENSG00000232190		309548	6153	rs4496150-C	rs4496150	0	4496150	intergenic_variant	1	0.75	8E-9	8.096910013008056	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p15.3	7	21901342	"DNAH11, CDCA7L"	"DNAH11, CDCA7L"			"ENSG00000105877, ENSG00000164649"			rs7971-A	rs7971	0	7971	3_prime_UTR_variant	0	0.65	2E-8	7.698970004336019	(EA)	1.0416667	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p32.3	1	50380361	intergenic	LINC02808 - HMGB1P45	ENSG00000284696	ENSG00000229316		59169	18464	rs140850326-CAAAGGGCAAGATCTCCTTTTT	rs140850326	0	140850326	intergenic_variant	1	0.51	4E-8	7.3979400086720375	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.12	19	13843757	intergenic	MIR23AHG - NANOS3	ENSG00000267519	ENSG00000187556		829	18306	rs2594714-G	rs2594714	0	2594714	regulatory_region_variant	1	0.77	1E-8	8	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.1	6	80384570	intergenic	RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		10001	85501	rs12207986-A	rs12207986	0	12207986	intergenic_variant	1	0.53	2E-9	8.698970004336019	(EA)	1.0309278	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q13.1	13	32601963	NR	PDS5B			ENSG00000083642			rs113855064-C	rs113855064	0	113855064	intron_variant	0	0.0081	1E-7	7	(EA)	0.1877	[0.12-0.26] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p12.1	6	54862053	NR	FAM83B			ENSG00000168143			rs924712-G	rs924712	0	924712	intron_variant	0	0.579	4E-6	5.3979400086720375	(EA)	0.0291	[0.017-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr17:44252468-A	chr17:44252468	0			1	0.182	7E-13	12.154901959985743	(EA)	0.0605	[0.044-0.077] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr4:106507402-?	chr4:106507402	0			1	0.0752	2E-6	5.698970004336019	(EA)	0.07	[0.041-0.099] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr5:49484480-G	chr5:49484480	0			1	0.1506	4E-9	8.397940008672037	(EA)	0.0664	[0.044-0.089] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr5:58680596-G	chr5:58680596	0			1	0.0444	1E-7	7	(EA)	0.1061	[0.067-0.145] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr9:136151579-T	chr9:136151579	0			1	0.2027	1E-8	8	(EA)	0.0446	[0.029-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.21	8	127359926	NR	"CASC8, POU5F1B, PCAT1"			"ENSG00000246228, ENSG00000212993, ENSG00000253438"			rs10096351-G	rs10096351	0	10096351	intron_variant	0	0.5441	2E-64	63.69897000433602	(EA)	0.1055	[0.093-0.118] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121568362	NR	FGFR2			ENSG00000066468			rs10510097-T	rs10510097	0	10510097	intron_variant	0	0.1104	2E-58	57.69897000433602	(EA)	0.1546	[0.14-0.17] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.1	1	45688904	NR	TMEM69			ENSG00000159596			rs10683143-A	rs10683143	0	10683143	intron_variant	0	0.4739	2E-6	5.698970004336019	(EA)	0.0319	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.1	11	18642694	NR	SPTY2D1 - SRSF3P1	ENSG00000179119	ENSG00000257043		7903	22356	rs10832963-G	rs10832963	0	10832963	intergenic_variant	1	0.7217	9E-6	5.045757490560675	(EA)	0.0331	[0.019-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	118488075	NR	RNA5SP56 - PSMC1P12	ENSG00000222209	ENSG00000226126		223586	126258	rs10923574-C	rs10923574	0	10923574	regulatory_region_variant	1	0.3321	4E-7	6.3979400086720375	(EA)	0.0344	[0.021-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q23.3	5	128098106	NR	SLC12A2			ENSG00000064651			rs1112956-G	rs1112956	0	1112956	intron_variant	0	0.7711	9E-6	5.045757490560675	(EA)	0.0328	[0.018-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p11.1	10	38856846	NR	CHEK2P5 - KSR1P1	ENSG00000234541	ENSG00000229485		137617	3292464	rs11146838-T	rs11146838	0	11146838	intergenic_variant	1	0.4416	1E-6	6	(EA)	0.0312	[0.019-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q11.2	17	30560116	NR	TBC1D29P			ENSG00000266733			rs111780165-A	rs111780165	0	111780165	splice_acceptor_variant	0	0.0706	8E-8	7.096910013008056	(EA)	0.067	[0.043-0.092] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201003582	NR	HYCC2			ENSG00000155744			rs112257290-A	rs112257290	0	112257290	intron_variant	0	0.058	2E-7	6.698970004336019	(EA)	0.07	[0.044-0.096] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.3	5	159008453	NR	EBF1			ENSG00000164330			rs11288072-C	rs11288072	0	11288072	intron_variant	0	0.3116	3E-13	12.522878745280337	(EA)	0.0501	[0.037-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p11.23	8	37106253	NR	SMARCE1P4 - LINC01605	ENSG00000253650	ENSG00000253161		10863	315088	rs113167076-A	rs113167076	0	113167076	intergenic_variant	1	0.0228	9E-7	6.045757490560675	(EA)	0.1213	[0.073-0.17] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.2	1	42592453	NR	CCDC30			ENSG00000186409			rs113319441-T	rs113319441	0	113319441	3_prime_UTR_variant	0	0.0308	6E-6	5.221848749616356	(EA)	0.0908	[0.051-0.13] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p12	8	36450915	NR	RNU6-533P - RPL23P10	ENSG00000206871	ENSG00000244708		141225	130265	rs113687142-T	rs113687142	0	113687142	intron_variant	1	0.0149	2E-6	5.698970004336019	(EA)	0.1493	[0.089-0.21] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q24.1	11	123095918	NR	CLMP			ENSG00000166250			rs7121616-G	rs7121616	0	7121616	intron_variant	0	0.2854	7E-6	5.154901959985743	(EA)	0.0314	[0.018-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q13.3	14	36667340	NR	PAX9			ENSG00000198807			rs7149262-A	rs7149262	0	7149262	intron_variant	0	0.2113	2E-21	20.69897000433602	(EA)	0.0724	[0.058-0.087] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p16.1	2	60408219	NR	MIR4432HG			ENSG00000228590			rs72001329-C	rs72001329	1	55975914	intron_variant	0	0.4786	3E-6	5.522878745280337	(EA)	0.0312	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	19684648	NR	ZNF101 - ZNF14	ENSG00000181896	ENSG00000105708		1139	25824	rs72396995-T	rs72396995	0	72396995	intergenic_variant	1	0.2556	1E-7	7	(EA)	0.0383	[0.024-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	18422832	NR	SSBP4			ENSG00000130511			rs7258465-C	rs7258465	0	7258465	intron_variant	0	0.3436	3E-28	27.522878745280337	(EA)	0.0725	[0.06-0.085] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.1	17	74776908	NR	TMEM104			ENSG00000109066			rs62084913-T	rs62084913	0	62084913	intron_variant	0	0.3982	9E-6	5.045757490560675	(EA)	0.0307	[0.017-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p23.3	2	25222417	NR	LINC01381 - DNMT3A	ENSG00000230452	ENSG00000119772		13215	5438	rs113953597-A	rs113953597	0	113953597	regulatory_region_variant	1	0.2188	1E-8	8	(EA)	0.0446	[0.029-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155928952	NR	KHDC4			ENSG00000132680			rs11406084-CA	rs11406084	0	11406084	intron_variant	0	0.1995	7E-6	5.154901959985743	(EA)	0.0378	[0.021-0.054] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	442473	NR	ANO9 - PTDSS2	ENSG00000185101	ENSG00000174915		462	5795	rs11410354-CT	rs11410354	0	11410354	intergenic_variant	1	0.8001	2E-6	5.698970004336019	(EA)	0.039	[0.023-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.12	10	121334478	NR	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		148512	76438	rs11462858-GT	rs11462858	0	11462858	intergenic_variant	1	0.3215	2E-12	11.698970004336019	(EA)	0.0471	[0.034-0.06] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20p12.2	20	11399194	NR	RPS11P1 - PGAM3P	ENSG00000235544	ENSG00000237256		53339	221857	rs1154723-C	rs1154723	0	1154723	intergenic_variant	1	0.9475	9E-6	5.045757490560675	(EA)	0.0681	[0.038-0.098] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p22.2	1	87963341	NR	PKN2-AS1			ENSG00000237505			rs11583393-A	rs11583393	0	11583393	intron_variant	0	0.249	4E-8	7.3979400086720375	(EA)	0.0396	[0.025-0.054] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q32.1	2	188005044	NR	LINC01090			ENSG00000231689			rs116183959-C	rs116183959	0	116183959	intron_variant	0	0.1291	2E-6	5.698970004336019	(EA)	0.0439	[0.026-0.062] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.1	14	68513118	NR	RAD51B			ENSG00000182185			rs11624333-C	rs11624333	0	11624333	intron_variant	0	0.2595	7E-42	41.15490195998574	(EA)	0.0968	[0.083-0.111] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	52083172	NR	LINC02118 - RPS17P11	ENSG00000248789	ENSG00000244621		2185	199395	rs116464256-C	rs116464256	0	116464256	intergenic_variant	1	0.0318	4E-6	5.3979400086720375	(EA)	0.0855	[0.049-0.122] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q13	16	56871774	NR	SLC12A3			ENSG00000070915			rs11646723-T	rs11646723	0	11646723	intron_variant	0	0.0578	4E-6	5.3979400086720375	(EA)	0.0718	[0.041-0.102] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	21230606	NR	NEBL			ENSG00000078114			rs116478824-C	rs116478824	0	116478824	intron_variant	0	0.0455	5E-6	5.301029995663981	(EA)	0.0675	[0.038-0.097] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q24.3	17	72408954	NR	LINC00511			ENSG00000227036			rs11652463-G	rs11652463	0	11652463	intron_variant	0	0.3083	8E-8	7.096910013008056	(EA)	0.04	[0.025-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q24.2	17	68557338	NR	FAM20A			ENSG00000108950			rs11655740-C	rs11655740	0	11655740	intron_variant	0	0.0302	7E-6	5.154901959985743	(EA)	0.0906	[0.051-0.13] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q31.1	2	171513371	NR	DAP3P2 - RPS15P4	ENSG00000228507	ENSG00000233762		21440	3899	rs11680449-A	rs11680449	0	11680449	regulatory_region_variant	1	0.2823	4E-9	8.397940008672037	(EA)	0.0404	[0.027-0.054] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p24.1	2	19111157	NR	LINC01376			ENSG00000236204			rs11684853-T	rs11684853	0	11684853	intron_variant	0	0.5606	1E-12	12	(EA)	0.0442	[0.032-0.056] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q22.3	2	144845739	NR	TEX41			ENSG00000226674			rs11690035-T	rs11690035	0	11690035	intron_variant	0	0.0749	6E-6	5.221848749616356	(EA)	0.0534	[0.03-0.077] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217427435	NR	DIRC3			ENSG00000231672			rs11693806-G	rs11693806	0	11693806	non_coding_transcript_exon_variant	0	0.7288	3E-26	25.522878745280337	(EA)	0.0739	[0.06-0.088] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q21.1	21	17368480	NR	NEK4P1 - RNU6-113P	ENSG00000225735	ENSG00000252462		157133	63067	rs11700530-A	rs11700530	0	11700530	intergenic_variant	1	0.6155	4E-6	5.3979400086720375	(EA)	0.0323	[0.019-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41501983	NR	ACO2			ENSG00000100412			rs117078955-T	rs117078955	0	117078955	intron_variant	0	0.0178	1E-6	6	(EA)	0.1235	[0.074-0.173] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.42	19	55305310	NR	BRSK1			ENSG00000160469			rs1172821-T	rs1172821	0	1172821	splice_polypyrimidine_tract_variant	0	0.3632	4E-6	5.3979400086720375	(EA)	0.0297	[0.017-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q21.1	21	15315098	NR	LINC02920 - CYCSP42	ENSG00000236471	ENSG00000224524		247261	175432	rs117512673-G	rs117512673	0	117512673	intergenic_variant	1	0.0112	6E-6	5.221848749616356	(EA)	0.1749	[0.099-0.25] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.3	10	130453365	NR	LINC02646			ENSG00000236303			rs117649165-T	rs117649165	0	117649165	intron_variant	0	0.016	1E-6	6	(EA)	0.1396	[0.083-0.196] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.4	11	9906964	NR	SBF2			ENSG00000133812			rs117698693-G	rs117698693	0	117698693	intron_variant	0	0.0224	4E-6	5.3979400086720375	(EA)	0.117	[0.067-0.167] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.13	19	12846836	NR	"HOOK2, MAST1"			"ENSG00000095066, ENSG00000105613"			rs117758012-T	rs117758012	0	117758012	intron_variant	0	0.0574	5E-7	6.301029995663981	(EA)	0.0718	[0.044-0.1] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	30051113	NR	HORMAD2-AS1			ENSG00000227117			rs188460188-C	rs188460188	0	188460188	intron_variant	0	0.0077	3E-8	7.522878745280337	(EA)	0.237	[0.15-0.32] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	467862	NR	"EXOC3, PP7080"			"ENSG00000180104, ENSG00000188242"			rs190811224-T	rs190811224	0	190811224	3_prime_UTR_variant	0	0.7316	5E-6	5.301029995663981	(EA)	0.037	[0.021-0.053] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.13	1	17380437	NR	PADI6			ENSG00000276747			rs1924553-G	rs1924553	0	1924553	intron_variant	0	0.2602	5E-7	6.301029995663981	(EA)	0.0386	[0.024-0.054] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q21.23	4	83549680	NR	GPAT3			ENSG00000138678			rs1963045-C	rs1963045	0	1963045	intron_variant	0	0.4688	2E-6	5.698970004336019	(EA)	0.0296	[0.017-0.042] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.12	7	86844997	NR	GRM3			ENSG00000198822			rs1989796-C	rs1989796	0	1989796	intron_variant	0	0.5861	2E-6	5.698970004336019	(EA)	0.0311	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.22	1	10637822	NR	CASZ1			ENSG00000130940			rs199867187-G	rs199867187	0	199867187	3_prime_UTR_variant	0	0.2745	1E-6	6	(EA)	0.0381	[0.023-0.054] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q13	2	111433700	NR	MIR4435-2HG			ENSG00000172965			rs200484318-G	rs200484318	1	62160698	intron_variant	0	0.571	7E-6	5.154901959985743	(EA)	0.0431	[0.024-0.062] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q23.3	11	116897884	NR	SIK3			ENSG00000160584			rs201462698-C	rs201462698	0	201462698	intron_variant	0	0.0921	1E-6	6	(EA)	0.0571	[0.034-0.08] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q11.2	21	14992435	NR	NRIP1			ENSG00000180530			rs2822999-G	rs2822999	0	2822999	non_coding_transcript_exon_variant	0	0.173	2E-11	10.698970004336019	(EA)	0.0589	[0.042-0.076] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.3	6	156907180	NR	ARID1B			ENSG00000049618			rs28648619-G	rs28648619	0	28648619	intron_variant	0	0.0804	5E-6	5.301029995663981	(EA)	0.0551	[0.031-0.079] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q31.3	5	143376439	NR	NR3C1			ENSG00000113580			rs2963155-G	rs2963155	0	2963155	intron_variant	0	0.2523	7E-6	5.154901959985743	(EA)	0.0339	[0.019-0.049] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	30365728	NR	UBQLN1P1 - MICC	ENSG00000236405	ENSG00000226577		1448	48987	rs3094054-T	rs3094054	0	3094054	intergenic_variant	1	0.1132	1E-7	7	(EA)	0.056	[0.035-0.077] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q25.31	3	156645453	NR	SSR3 - TIPARP-AS1	ENSG00000114850	ENSG00000243926		90304	26406	rs2136690-G	rs2136690	0	2136690	intergenic_variant	1	0.5774	4E-6	5.3979400086720375	(EA)	0.0289	[0.017-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	122041907	NR	TACC2			ENSG00000138162			rs2253762-C	rs2253762	0	2253762	intron_variant	0	0.2971	2E-9	8.698970004336019	(EA)	0.0419	[0.028-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	19535463	NR	YJEFN3			ENSG00000250067			rs2304098-C	rs2304098	0	2304098	intron_variant	0	0.3469	2E-11	10.698970004336019	(EA)	0.0434	[0.031-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q22.32	9	95606163	NR	PTCH1 - ERCC6L2-AS1	ENSG00000185920	ENSG00000175611		89106	153068	rs2405064-T	rs2405064	0	2405064	intron_variant	1	0.0992	4E-6	5.3979400086720375	(EA)	0.0484	[0.028-0.069] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q32	5	149053986	NR	SH3TC2			ENSG00000169247			rs250677-C	rs250677	0	250677	intron_variant	0	0.2221	8E-6	5.096910013008056	(EA)	0.0343	[0.019-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.1	5	50793817	NR	PARP8			ENSG00000151883			rs26067-A	rs26067	0	26067	intron_variant	0	0.6263	2E-8	7.698970004336019	(EA)	0.0369	[0.024-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q22.1	4	88058377	NR	PKD2			ENSG00000118762			rs2725207-A	rs2725207	0	2725207	intron_variant	0	0.1439	6E-7	6.221848749616356	(EA)	0.0455	[0.028-0.063] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p21.2	8	23801998	NR	NKX2-6 - STC1	ENSG00000180053	ENSG00000159167		95242	39931	rs310291-A	rs310291	0	310291	intergenic_variant	1	0.4075	6E-8	7.221848749616356	(EA)	0.0341	[0.022-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.33	6	30793795	NR	HCG20 - LINC00243	ENSG00000228022	ENSG00000214894		1545	4416	rs3129984-T	rs3129984	0	3129984	intergenic_variant	1	0.1179	8E-6	5.096910013008056	(EA)	0.0465	[0.026-0.067] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q13.13	20	50826118	NR	BCAS4			ENSG00000124243			rs6020772-T	rs6020772	0	6020772	intron_variant	0	0.2491	1E-6	6	(EA)	0.0348	[0.021-0.049] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q13.33	20	64247978	NR	MYT1 - PCMTD2	ENSG00000196132	ENSG00000203880		5725	7717	rs6062356-G	rs6062356	0	6062356	intron_variant	1	0.1495	3E-6	5.522878745280337	(EA)	0.0405	[0.023-0.058] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q23.1	17	59769155	NR	VMP1			ENSG00000062716			rs61495451-C	rs61495451	0	61495451	intron_variant	0	0.7935	3E-6	5.522878745280337	(EA)	0.0398	[0.023-0.056] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.2	16	53769311	NR	FTO			ENSG00000140718			rs62048402-A	rs62048402	0	62048402	intron_variant	0	0.4156	4E-23	22.397940008672037	(EA)	0.0624	[0.05-0.075] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q13	16	56387075	AMFR	AMFR			ENSG00000159461			rs2432539-A	rs2432539	0	2432539	intron_variant	0	0.4	4E-8	7.3979400086720375	(EA)	1.03	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q33.3	9	126634155	LMX1B	LMX1B			ENSG00000136944			rs10760444-G	rs10760444	0	10760444	intron_variant	0	0.43	9E-9	8.045757490560675	(EA)	1.03	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				HELQ							4:84370124-TAA	4:84370124	0			1	0.47	2E-9	8.698970004336019	(EA)	1.04	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.3	6	20621007	CDKAL1	CDKAL1			ENSG00000145996			rs2223621-T	rs2223621	0	2223621	intron_variant	0	0.38	3E-10	9.522878745280337	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.11	19	19434887	"GATAD2A, MIR640"	GATAD2A			ENSG00000167491			rs2965183-A	rs2965183	0	2965183	intron_variant	0	0.35	6E-12	11.221848749616356	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.33	14	104745925	ADSSL1	ADSS1			ENSG00000185100			rs10623258-CTT	rs10623258	0	10623258	intron_variant	0	0.45	2E-8	7.698970004336019	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q22.1	4	88322666	LOC105369192	PPM1K-DT			ENSG00000246375			rs10022462-T	rs10022462	0	10022462	intron_variant	0	0.44	2E-9	8.698970004336019	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q23.33	10	93532431	intergenic	CEP55 - FFAR4	ENSG00000138180	ENSG00000186188		3339	34234	rs140936696-CAA	rs140936696	1	59954380	intergenic_variant	1	0.18	4E-8	7.3979400086720375	(EA)	1.04	[1.02-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q35.1	5	170164483	intergenic	KRT18P41 - LINC01187	ENSG00000253219	ENSG00000249601		22543	27096	rs4562056-T	rs4562056	0	4562056	intergenic_variant	1	0.33	5E-10	9.301029995663981	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12q24.31	12	120394343	intergenic	RPS27P25 - COX6A1	ENSG00000239881	ENSG00000111775		22655	43747	rs206966-T	rs206966	0	206966	intron_variant	1	0.16	4E-8	7.3979400086720375	(EA)	1.05	[1.02-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.32	19	45679774	GIPR	GIPR			ENSG00000010310			rs71338792-AT	rs71338792	0	71338792	intron_variant	0	0.23	4E-9	8.397940008672037	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.2	16	54648152	intergenic	LINC02183 - CRNDE	ENSG00000283304	ENSG00000245694		89052	197037	rs28539243-A	rs28539243	0	28539243	intron_variant	1	0.49	9E-15	14.045757490560675	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p22.3	1	87691240	intergenic	PKN2-AS1			ENSG00000237505			rs17426269-A	rs17426269	0	17426269	intron_variant	0	0.15	2E-8	7.698970004336019	(EA)	1.05	[1.02-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q22.3	8	101466731	intergenic	RN7SL563P - GRHL2	ENSG00000239211	ENSG00000083307		68798	25708	rs514192-A	rs514192	0	514192	intron_variant	1	0.32	6E-9	8.221848749616356	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.31	22	45887417	intergenic	ATXN10 - WNT7B	ENSG00000130638	ENSG00000188064		42110	32949	rs28512361-A	rs28512361	0	28512361	intron_variant	1	0.11	2E-8	7.698970004336019	(EA)	1.05	[1.02-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155176305	TRIM46	TRIM46			ENSG00000163462			rs4971059-A	rs4971059	0	4971059	intron_variant	0	0.35	5E-11	10.301029995663981	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.3	7	94484487	intergenic	COL1A2 - RNU6-1328P	ENSG00000164692	ENSG00000222870		53260	10812	rs17268829-C	rs17268829	0	17268829	intergenic_variant	1	0.28	5E-13	12.301029995663981	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q13.13	20	50329374	intergenic	LINC01271 - RN7SL636P	ENSG00000233077	ENSG00000244376		7888	99816	rs6122906-G	rs6122906	0	6122906	intergenic_variant	1	0.18	3E-10	9.522878745280337	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p15.1	7	28317270	CREB5	CREB5			ENSG00000146592			rs17156577-C	rs17156577	0	17156577	intron_variant	0	0.11	4E-9	8.397940008672037	(EA)	1.05	[1.02-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p36.13	1	18480845	KLHDC7A	IGSF21 - KLHDC7A	ENSG00000117154	ENSG00000179023		102362	85	rs2992756-T	rs2992756	0	2992756	intergenic_variant	1	0.49	2E-15	14.698970004336019	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q23	3	141394018	ZBTB38	ZBTB38			ENSG00000177311			rs34207738-C	rs34207738	0	34207738	intron_variant	0	0.41	3E-15	14.522878745280337	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.2	1	40914768	intergenic	CITED4 - UBE2V1P8	ENSG00000179862	ENSG00000233118		52405	27483	rs4233486-T	rs4233486	0	4233486	intergenic_variant	1	0.64	9E-9	8.045757490560675	(EA)	1.0309278	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.1	1	46135245	"PIK3R3, LOC101929626"	P3R3URF-PIK3R3			ENSG00000278139			rs1707302-G	rs1707302	0	1707302	intron_variant	0	0.66	3E-8	7.522878745280337	(EA)	1.0416667	[1.02-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q22.1	5	111882089	NREP	NREP			ENSG00000134986			rs6882649-T	rs6882649	0	6882649	intron_variant	0	0.66	4E-9	8.397940008672037	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p13	3	71482962	FOXP1	FOXP1			ENSG00000114861			rs6805189-T	rs6805189	0	6805189	intron_variant	0	0.52	5E-8	7.301029995663981	(EA)	1.0309278	[1.01-1.05] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4p15.32	4	17386536	NR	SNORA75B - RPS7P6	ENSG00000206780	ENSG00000215278		65654	41160	rs77485526-T	rs77485526	0	77485526	intergenic_variant	1	0.0325	2E-6	5.698970004336019	(EA)	0.0895	[0.052-0.127] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q26.1	15	90965985	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		2860	55	rs77554484-A	rs77554484	0	77554484	intergenic_variant	1	0.1319	1E-15	15	(EA)	0.0741	[0.056-0.092] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q23.3	11	117214494	NR	PCSK7			ENSG00000160613			rs77683187-C	rs77683187	0	77683187	non_coding_transcript_exon_variant	0	0.0608	2E-6	5.698970004336019	(EA)	0.0613	[0.036-0.087] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201502866	NR	C2CD6			ENSG00000155754			rs77688320-G	rs77688320	0	77688320	intron_variant	0	0.1668	3E-9	8.522878745280337	(EA)	0.0489	[0.033-0.065] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q14.3	6	84379128	NR	CEP162 - LINC01611	ENSG00000135315	ENSG00000231776		151485	41900	rs7768862-A	rs7768862	0	7768862	intergenic_variant	1	0.5075	6E-6	5.221848749616356	(EA)	0.028	[0.016-0.04] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q24	4	105435604	NR	PPA2			ENSG00000138777			rs77928427-A	rs77928427	0	77928427	intron_variant	0	0.2392	3E-8	7.522878745280337	(EA)	0.04	[0.026-0.054] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p21.3	7	12721416	NR	ARL4A - RN7SKP228	ENSG00000122644	ENSG00000222974		30458	155268	rs7810893-C	rs7810893	0	7810893	intergenic_variant	1	0.3487	4E-6	5.3979400086720375	(EA)	0.0299	[0.017-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.21	8	127677080	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		194941	9263	rs7833090-C	rs7833090	0	7833090	intergenic_variant	1	0.2535	2E-6	5.698970004336019	(EA)	0.0339	[0.02-0.048] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p12	8	30372068	NR	TUBBP1 - RBPMS-AS1	ENSG00000127589	ENSG00000254109		18550	10051	rs7834448-C	rs7834448	0	7834448	intergenic_variant	1	0.667	7E-6	5.154901959985743	(EA)	0.0309	[0.017-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75751646	NR	HNF4G - RNU2-54P	ENSG00000164749	ENSG00000222231		184812	513897	rs7844233-G	rs7844233	0	7844233	intergenic_variant	1	0.0642	6E-11	10.221848749616356	(EA)	0.0813	[0.057-0.106] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.3	11	69516650	NR	LINC01488 - CCND1	ENSG00000285094	ENSG00000110092		21698	124506	rs78540526-T	rs78540526	0	78540526	regulatory_region_variant	1	0.0756	2E-131	130.69897000433602	(EA)	0.2758	[0.25-0.3] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q25.31	3	156800880	NR	LINC00886			ENSG00000240875			rs78579487-GTT	rs78579487	1	35231283	intron_variant	0	0.614	4E-7	6.3979400086720375	(EA)	0.0324	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q22.32	9	95008323	NR	AOPEP			ENSG00000148120			rs7862618-A	rs7862618	0	7862618	intron_variant	0	0.0134	5E-6	5.301029995663981	(EA)	0.1381	[0.079-0.197] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.3	10	113127459	NR	TCF7L2			ENSG00000148737			rs7906315-G	rs7906315	0	7906315	intron_variant	0	0.6218	2E-8	7.698970004336019	(EA)	0.0357	[0.023-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.1	10	27080233	NR	ANKRD26			ENSG00000107890			rs7918232-C	rs7918232	0	7918232	intron_variant	0	0.8143	8E-6	5.096910013008056	(EA)	0.036	[0.02-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q12.3	11	62126500	NR	INCENP			ENSG00000149503			rs7937840-T	rs7937840	0	7937840	intron_variant	0	0.2591	1E-6	6	(EA)	0.035	[0.021-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.3	7	98397243	NR	BAIAP2L1			ENSG00000006453			rs79518236-A	rs79518236	0	79518236	intron_variant	0	0.2327	1E-7	7	(EA)	0.0396	[0.025-0.054] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p25.3	6	1319077	NR	FOXQ1 - LINC01394	ENSG00000164379	ENSG00000281809		4319	2621	rs80199833-T	rs80199833	0	80199833	intergenic_variant	1	0.2071	7E-6	5.154901959985743	(EA)	0.0356	[0.02-0.051] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q24.2	15	75516399	NR	PTPN9			ENSG00000169410			rs8027365-C	rs8027365	0	8027365	intron_variant	0	0.2707	1E-7	7	(EA)	0.038	[0.024-0.052] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q33.1	9	116672011	NR	ASTN2			ENSG00000148219			rs803903-G	rs803903	0	803903	intron_variant	0	0.6805	8E-12	11.096910013008056	(EA)	0.0456	[0.032-0.059] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.3	17	81397410	NR	BAHCC1			ENSG00000266074			rs8074440-C	rs8074440	0	8074440	intron_variant	0	0.5239	3E-6	5.522878745280337	(EA)	0.0353	[0.02-0.05] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q11.2	17	30689342	NR	LRRC37BP1 - RN7SL316P	ENSG00000250462	ENSG00000241631		52040	13162	rs8081187-A	rs8081187	0	8081187	intergenic_variant	1	0.0843	2E-7	6.698970004336019	(EA)	0.0607	[0.038-0.083] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.3	17	79797749	NR	CBX8			ENSG00000141570			rs8082452-G	rs8082452	0	8082452	intron_variant	0	0.4562	1E-10	10	(EA)	0.0418	[0.029-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q21.3	7	98065546	NR	RN7SL478P - LMTK2	ENSG00000277946	ENSG00000164715		66924	41316	rs847577-A	rs847577	0	847577	intergenic_variant	1	0.4176	6E-6	5.221848749616356	(EA)	0.0284	[0.016-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q13.3	14	36808438	NR	SLC25A21			ENSG00000183032			rs848087-G	rs848087	0	848087	intron_variant	0	0.5682	6E-11	10.221848749616356	(EA)	0.0427	[0.03-0.055] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q26.31	3	172567447	intergenic	LINC02068			ENSG00000223387			rs58058861-A	rs58058861	0	58058861	intron_variant	0	0.21	2E-10	9.698970004336019	(EA)	1.06	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4p14	4	38814717	intergenic	TLR1			ENSG00000174125			rs6815814-C	rs6815814	0	6815814	intron_variant	0	0.26	6E-13	12.221848749616356	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p12	1	117687599	intergenic	VDAC2P3 - PNRC2P1	ENSG00000213262	ENSG00000228217		45960	90488	rs7529522-C	rs7529522	0	7529522	regulatory_region_variant	1	0.23	2E-10	9.698970004336019	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q12.1	3	100004736	"CMSS1, FILIP1L"	"CMSS1, FILIP1L"			"ENSG00000184220, ENSG00000168386"			rs9833888-T	rs9833888	0	9833888	intron_variant	0	0.22	5E-10	9.301029995663981	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	344994	AHRR	"PDCD6-AHRR, AHRR"			"ENSG00000288622, ENSG00000063438"			rs116095464-C	rs116095464	1	62641919	intron_variant	0	0.05	4E-9	8.397940008672037	(EA)	1.06	[1.02-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41642782	XRCC6	XRCC6			ENSG00000196419			rs73161324-T	rs73161324	0	73161324	intron_variant	0	0.06	2E-9	8.698970004336019	(EA)	1.06	[1.02-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p25.1	2	9995553	GRHL1	GRHL1			ENSG00000134317			rs113577745-G	rs113577745	0	113577745	intron_variant	0	0.1	4E-10	9.397940008672037	(EA)	1.08	[1.05-1.11] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q13	2	111168155	BCL2L11	"MIR4435-2HG, BCL2L11"			"ENSG00000172965, ENSG00000153094"			rs71801447-C	rs71801447	1	3833441	3_prime_UTR_variant	0	0.06	4E-8	7.3979400086720375	(EA)	1.09	[1.05-1.13] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p14	10	9046151	intergenic	LINC02676 - LINC00709	ENSG00000234752	ENSG00000230014		131555	229682	rs67958007-T	rs67958007	0	67958007	intergenic_variant	1	0.12	2E-10	9.698970004336019	(EA)	1.09	[1.06-1.12] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20p12.3	20	5967581	MCM8	MCM8			ENSG00000125885			rs16991615-A	rs16991615	0	16991615	missense_variant	0	0.06	2E-9	8.698970004336019	(EA)	1.1	[1.06-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q32.1	1	201468704	PHLDA3	PHLDA3			ENSG00000174307			rs35383942-T	rs35383942	0	35383942	missense_variant	0	0.06	4E-13	12.397940008672037	(EA)	1.12	[1.08-1.17] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.2	17	42684371	CNTNAP1	CNTNAP1			ENSG00000108797			rs72826962-T	rs72826962	0	72826962	intron_variant	0	0.01	5E-9	8.301029995663981	(EA)	1.2	[1.11-1.3] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				ABO							rs8176636-?	rs8176636	0	8176636		1	0.2	1E-8	8	(EA)	1.03	[1.01-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.13	8	123597926	intergenic	RN7SKP155 - KLHL38	ENSG00000251840	ENSG00000175946		8880	46516	rs58847541-A	rs58847541	0	58847541	intergenic_variant	1	0.15	6E-13	12.221848749616356	(EA)	1.08	[1.05-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19p13.13	19	13047463	NFIX1	NFIX			ENSG00000008441			rs78269692-C	rs78269692	0	78269692	intron_variant	0	0.05	2E-9	8.698970004336019	(EA)	1.09	[1.04-1.13] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr1:104145286-A	chr1:104145286	0			1	0.0937	8E-6	5.096910013008056	(EA)	0.0582	[0.033-0.084] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr1:168545508-C	chr1:168545508	0			1	0.0902	6E-6	5.221848749616356	(EA)	0.0526	[0.03-0.075] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr1:21023194-C	chr1:21023194	0			1	0.0051	3E-6	5.522878745280337	(EA)	0.2414	[0.14-0.34] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr1:45833328-AT	chr1:45833328	0			1	0.2323	1E-7	7	(EA)	0.0407	[0.026-0.056] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"				NR							chr10:51462991-GT	chr10:51462991	0			1	0.9445	7E-6	5.154901959985743	(EA)	0.0937	[0.053-0.135] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.31	10	22108073	NR	DNAJC1 - ADIPOR1P1	ENSG00000136770	ENSG00000232497		104304	54919	rs72810771-T	rs72810771	0	72810771	intergenic_variant	1	0.0187	2E-19	18.69897000433602	(EA)	0.2026	[0.16-0.25] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p12.2	10	22383039	NR	SPAG6			ENSG00000077327			rs72814839-C	rs72814839	0	72814839	intron_variant	0	0.0137	4E-13	12.397940008672037	(EA)	0.1943	[0.14-0.25] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p21.2	6	36795636	NR	CPNE5			ENSG00000124772			rs72856431-T	rs72856431	0	72856431	intron_variant	0	0.0219	9E-7	6.045757490560675	(EA)	0.1135	[0.068-0.159] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.3	11	69154575	NR	TPCN2 - SMIM38	ENSG00000162341	ENSG00000284713		18259	903	rs72932540-G	rs72932540	0	72932540	intron_variant	1	0.1056	4E-8	7.3979400086720375	(EA)	0.0553	[0.036-0.075] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q22.1	18	64663607	NR	LINC01924 - LINC01916	ENSG00000267134	ENSG00000264232		240006	760351	rs72942597-G	rs72942597	0	72942597	intergenic_variant	1	0.0068	2E-6	5.698970004336019	(EA)	0.2224	[0.13-0.31] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q32.2	2	189205442	NR	COL5A2			ENSG00000204262			rs73034872-C	rs73034872	0	73034872	intron_variant	0	0.0148	8E-6	5.096910013008056	(EA)	0.1191	[0.067-0.172] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20p12.3	20	5791630	NR	SHLD1			ENSG00000171984			rs73077323-A	rs73077323	0	73077323	intron_variant	0	0.0999	5E-6	5.301029995663981	(EA)	0.0563	[0.032-0.08] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	43410515	NR	CCL28			ENSG00000151882			rs73098691-A	rs73098691	0	73098691	intron_variant	0	0.0681	3E-6	5.522878745280337	(EA)	0.0689	[0.04-0.098] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q24.22	8	130991174	NR	ADCY8			ENSG00000155897			rs73348588-T	rs73348588	0	73348588	intron_variant	0	0.0195	8E-7	6.096910013008056	(EA)	0.1212	[0.073-0.169] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q22.1	18	64514353	NR	LINC01924 - LINC01916	ENSG00000267134	ENSG00000264232		90752	909605	rs73487618-G	rs73487618	0	73487618	intergenic_variant	1	0.0238	6E-6	5.221848749616356	(EA)	0.0989	[0.056-0.142] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	56361879	NR	RNU6ATAC2P - HMGN1P17	ENSG00000210678	ENSG00000250787		64190	19902	rs7378815-T	rs7378815	0	7378815	intergenic_variant	1	0.1244	4E-7	6.3979400086720375	(EA)	0.0494	[0.03-0.069] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	28290744	NR	CMC1			ENSG00000187118			rs73822569-G	rs73822569	0	73822569	intron_variant	0	0.0054	1E-6	6	(EA)	0.2565	[0.15-0.36] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q26.32	3	177768082	NR	LINC00578 - LINC02015	ENSG00000228221	ENSG00000231574		703	48783	rs7430456-G	rs7430456	0	7430456	intergenic_variant	1	0.3718	5E-6	5.301029995663981	(EA)	0.0292	[0.017-0.042] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p14	10	8655165	NR	CHCHD3P1 - RNA5SP299	ENSG00000236420	ENSG00000212505		34557	1551	rs74433033-A	rs74433033	0	74433033	intergenic_variant	1	0.0332	9E-7	6.045757490560675	(EA)	0.09	[0.054-0.126] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	103022031	NR	FBXL13			ENSG00000161040			rs7458786-A	rs7458786	0	7458786	intron_variant	0	0.1665	9E-6	5.045757490560675	(EA)	0.0379	[0.021-0.055] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.12	10	121042949	NR	WDR11 - RPL19P16	ENSG00000120008	ENSG00000236762		133425	90141	rs748476-C	rs748476	0	748476	intergenic_variant	1	0.1763	7E-7	6.154901959985743	(EA)	0.0399	[0.024-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q23.2	16	80614399	NR	CDYL2			ENSG00000166446			rs7500067-G	rs7500067	0	7500067	intron_variant	0	0.2293	4E-27	26.397940008672037	(EA)	0.0785	[0.064-0.093] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q32.2	2	189440322	NR	KRT18P19 - WDR75	ENSG00000213601	ENSG00000115368		128355	1124	rs75116627-T	rs75116627	0	75116627	non_coding_transcript_exon_variant	1	0.0118	1E-6	6	(EA)	0.1517	[0.091-0.213] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p13.2	1	113903258	NR	AP4B1			ENSG00000134262			rs7513707-A	rs7513707	0	7513707	intron_variant	0	0.1661	2E-11	10.698970004336019	(EA)	0.0554	[0.039-0.071] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	51439473	NR	HMGB1P47 - RNA5SP182	ENSG00000249338	ENSG00000251873		29268	447215	rs75282042-C	rs75282042	0	75282042	non_coding_transcript_exon_variant	1	0.0247	2E-6	5.698970004336019	(EA)	0.0971	[0.057-0.137] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p24.2	2	18308590	NR	KCNS3			ENSG00000170745			rs75282989-A	rs75282989	0	75282989	intron_variant	0	0.0134	3E-6	5.522878745280337	(EA)	0.1716	[0.1-0.24] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q23.2	5	123338869	NR	PRDM6 - CEP120	ENSG00000061455	ENSG00000168944		144603	6021	rs75887402-C	rs75887402	0	75887402	intergenic_variant	1	0.0305	3E-7	6.522878745280337	(EA)	0.0919	[0.057-0.127] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p24.1	9	8545593	NR	PTPRD			ENSG00000153707			rs76007978-A	rs76007978	0	76007978	intron_variant	0	0.0123	4E-7	6.3979400086720375	(EA)	0.1781	[0.11-0.25] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q22.31	6	122554525	NR	PKIB			ENSG00000135549			rs76092474-T	rs76092474	0	76092474	intron_variant	0	0.113	3E-6	5.522878745280337	(EA)	0.046	[0.027-0.065] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q23.1	10	81950055	NR	NRG3			ENSG00000185737			rs76340606-A	rs76340606	0	76340606	intron_variant	0	0.0145	4E-6	5.3979400086720375	(EA)	0.1643	[0.095-0.234] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	51555704	NR	HMGB1P47 - RNA5SP182	ENSG00000249338	ENSG00000251873		145499	330984	rs76375990-C	rs76375990	0	76375990	intron_variant	1	0.0248	1E-6	6	(EA)	0.098	[0.058-0.138] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q25.31	3	156927968	NR	LEKR1			ENSG00000197980			rs7637701-A	rs7637701	0	7637701	intron_variant	0	0.5108	1E-6	6	(EA)	0.03	[0.018-0.042] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	2777197	NR	IRX2-DT - LINC01377	ENSG00000186493	ENSG00000249808		21800	400638	rs7709328-A	rs7709328	0	7709328	intergenic_variant	1	0.4164	3E-7	6.522878745280337	(EA)	0.0327	[0.02-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4p14	4	36590617	NR	LINC02505			ENSG00000248215			rs77198337-T	rs77198337	0	77198337	intron_variant	0	0.0128	4E-6	5.3979400086720375	(EA)	0.1641	[0.095-0.234] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p23	9	13942941	NR	LINC00583			ENSG00000205636			rs77457752-A	rs77457752	0	77457752	intron_variant	0	0.1294	8E-7	6.096910013008056	(EA)	0.0462	[0.028-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	44302075	NR	FGF10			ENSG00000070193			rs13186320-T	rs13186320	0	13186320	3_prime_UTR_variant	0	0.515	5E-15	14.301029995663981	(EA)	0.0483	[0.036-0.06] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	29155884	NR	KREMEN1			ENSG00000183762			rs132289-G	rs132289	0	132289	intron_variant	0	0.9822	1E-24	24	(EA)	0.2482	[0.2-0.3] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q23.3	8	115667320	NR	TRPS1			ENSG00000104447			rs13277568-G	rs13277568	0	13277568	intron_variant	0	0.3696	8E-7	6.096910013008056	(EA)	0.0327	[0.02-0.046] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	44933883	NR	MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		113455	321065	rs138060088-TTGA	rs138060088	1	57229548	intergenic_variant	1	0.5804	9E-43	42.045757490560675	(EA)	0.0878	[0.075-0.1] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.12	14	91545453	NR	PPP4R3A - CATSPERB	ENSG00000100796	ENSG00000133962		34899	35243	rs139530473-T	rs139530473	0	139530473	intergenic_variant	1	0.2511	1E-10	10	(EA)	0.0481	[0.033-0.063] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	29714557	NR	CABP7-DT			ENSG00000232396			rs140091-A	rs140091	0	140091	intron_variant	0	0.0148	4E-10	9.397940008672037	(EA)	0.1736	[0.12-0.23] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.3	6	157009956	NR	ARID1B			ENSG00000049618			rs140842923-T	rs140842923	0	140842923	intron_variant	0	0.0214	3E-6	5.522878745280337	(EA)	0.1059	[0.062-0.15] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	67248381	NR	CTNNA3			ENSG00000183230			rs141448180-C	rs141448180	0	141448180	intron_variant	0	0.0073	6E-6	5.221848749616356	(EA)	0.2059	[0.12-0.29] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	51952440	NR	KATNBL1P4 - LINC02118	ENSG00000249270	ENSG00000248789		20404	55591	rs141930488-A	rs141930488	0	141930488	intergenic_variant	1	0.0203	8E-6	5.096910013008056	(EA)	0.111	[0.062-0.16] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p21.2	8	23622741	NR	RNU4-71P - SINHCAFP3	ENSG00000252067	ENSG00000253488		22603	12135	rs142890050-C	rs142890050	1	10581440	intergenic_variant	1	0.5577	7E-8	7.154901959985743	(EA)	0.0345	[0.022-0.047] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p23	6	13722291	RANBP9	RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		10456	64266	rs204247-G	rs204247	0	204247	intergenic_variant	1	0.44	8E-13	12.096910013008056	(EA)	1.04	[1.02-1.06] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	29225488	EM1D1	EMID1			ENSG00000186998			rs132390-C	rs132390	0	132390	intron_variant	0	0.04	1E-8	8	(EA)	1.04	[0.99-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	1887776	LSP1	LSP1			ENSG00000130592			rs3817198-C	rs3817198	0	3817198	intron_variant	0	0.32	1E-18	18	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	19q13.31	19	43782361	"KCCN4, LYPD5"	KCNN4 - LYPD5	ENSG00000104783	ENSG00000159871		1385	3513	rs3760982-A	rs3760982	0	3760982	regulatory_region_variant	1	0.46	1E-16	16	(EA)	1.05	[1.03-1.07] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p12	8	29652100	intergenic	RPL17P33 - LINC00589	ENSG00000243844	ENSG00000251191		19456	21822	rs9693444-A	rs9693444	0	9693444	intergenic_variant	1	0.32	2E-21	20.69897000433602	(EA)	1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q33.1	2	201316524	"CASP8, ALS2CR12"	"FLACC1, CASP8"			"ENSG00000155749, ENSG00000064012"			rs1830298-C	rs1830298	0	1830298	intron_variant	0	0.28	2E-16	15.698970004336019		1.06	[1.04-1.08] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9p21.3	9	22062135	"CDKN2A, CDKN2B"	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	0.16	1E-15	15	(EA)	1.07	[1.04-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75505702	HNF4G	HNF4G			ENSG00000164749			rs2943559-G	rs2943559	0	2943559	intron_variant	0	0.08	4E-24	23.397940008672037	(EA)	1.1	[1.07-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	40480230	MKL1	MRTFA			ENSG00000196588			rs6001930-C	rs6001930	0	6001930	intron_variant	0	0.1	4E-34	33.39794000867204	(EA)	1.12	[1.09-1.16] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	56757896	MAP3K1	C5orf67 - MAP3K1	ENSG00000225940	ENSG00000095015		151664	57653	rs62355902-T	rs62355902	0	62355902	intergenic_variant	1	0.16	7E-98	97.15490195998575	(EA)	1.18	[1.15-1.21] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121580918	FGFR2	FGFR2			ENSG00000066468			rs35054928-GC	rs35054928	0	35054928	intron_variant	0	0.4	2E-322	321.69897000433605		1.27	[1.25-1.3] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.1	5	16187419	intergenic	MARCHF11-DT - NACAP6	ENSG00000250448	ENSG00000248403		1834	4669	rs13162653-G	rs13162653	0	13162653	intergenic_variant	1	0.55	5E-7	6.301029995663981	(EA)	1.010101	[0.99-1.03] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q23.2	16	80616908	CDYL2	CDYL2			ENSG00000166446			rs13329835-G	rs13329835	0	13329835	intron_variant	0	0.23	9E-27	26.045757490560675	(EA)	1.07	[1.05-1.09] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	151631197	ESR1	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		10004	25494	rs9397437-A	rs9397437	0	9397437	regulatory_region_variant	1	0.07	5E-54	53.30102999566398		1.17	[1.14-1.21] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	0.01	3E-15	14.522878745280337	(EA)	1.35	[1.23-1.48] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45846518	NR	HCN1 - EMB	ENSG00000164588	ENSG00000170571		150020	4549674	rs72765759-T	rs72765759	0	72765759	intergenic_variant	1	0.1345	6E-13	12.221848749616356	(EA)	0.0693	[0.05-0.088] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q23.32	10	92172529	NR	CPEB3			ENSG00000107864			rs72807246-G	rs72807246	0	72807246	intron_variant	0	0.139	3E-6	5.522878745280337	(EA)	0.0429	[0.025-0.061] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q23.2	16	80805081	NR	CDYL2 - ARLNC1	ENSG00000166446	ENSG00000260896		483	20993	rs72820985-G	rs72820985	0	72820985	regulatory_region_variant	1	0.1609	1E-6	6	(EA)	0.0423	[0.025-0.059] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217177160	NR	DIRC3-AS1			ENSG00000233143			rs72953532-T	rs72953532	0	72953532	intron_variant	0	0.0319	2E-18	17.69897000433602	(EA)	0.1819	[0.14-0.22] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41323244	NR	ZC3H7B			ENSG00000100403			rs73176670-T	rs73176670	0	73176670	intron_variant	0	0.0618	1E-8	8	(EA)	0.0751	[0.049-0.101] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q31.1	5	132497907	NR	IRF1			ENSG00000125347			rs736801-T	rs736801	0	736801	intron_variant	0	0.3642	8E-8	7.096910013008056	(EA)	0.0349	[0.022-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q22.31	6	122394099	NR	RNU1-18P - HSF2	ENSG00000199932	ENSG00000025156		182288	5452	rs74392007-T	rs74392007	0	74392007	intergenic_variant	1	0.1102	3E-7	6.522878745280337	(EA)	0.0514	[0.032-0.071] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q11.23	7	74696373	NR	"GTF2I, GTF2I-AS1"			"ENSG00000263001, ENSG00000232729"			rs74910854-G	rs74910854	0	74910854	intron_variant	0	0.0674	5E-6	5.301029995663981	(EA)	0.0607	[0.034-0.087] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155302483	NR	PKLR - FDPS	ENSG00000143627	ENSG00000160752		1045	6265	rs7524950-T	rs7524950	0	7524950	intergenic_variant	1	0.2587	3E-9	8.522878745280337	(EA)	0.0419	[0.028-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q13.2	11	66843174	NR	"C11orf80, RCE1"			"ENSG00000173715, ENSG00000173653"			rs7570-C	rs7570	0	7570	synonymous_variant	0	0.2653	8E-6	5.096910013008056	(EA)	0.0319	[0.018-0.046] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.1	3	27468223	NR	SLC4A7			ENSG00000033867			rs7619833-C	rs7619833	0	7619833	intron_variant	0	0.5251	3E-45	44.52287874528034	(EA)	0.0874	[0.075-0.1] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q34.1	4	174906885	NR	ADAM29			ENSG00000168594			rs7697216-C	rs7697216	0	7697216	intron_variant	0	0.8819	2E-26	25.69897000433602	(EA)	0.1039	[0.085-0.123] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.3	5	91594201	NR	ARRDC3-AS1			ENSG00000281357			rs7721647-T	rs7721647	0	7721647	intron_variant	0	0.3015	2E-6	5.698970004336019	(EA)	0.032	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q21.33	9	85664713	NR	AGTPBP1			ENSG00000135049			rs77674461-C	rs77674461	0	77674461	intron_variant	0	0.0358	6E-6	5.221848749616356	(EA)	0.0808	[0.046-0.116] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p14.3	7	28828469	NR	CREB5 - TRIL	ENSG00000146592	ENSG00000255690		2575	124889	rs77702473-G	rs77702473	0	77702473	intergenic_variant	1	0.1066	2E-6	5.698970004336019	(EA)	0.0481	[0.028-0.068] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.2	1	41821259	NR	HIVEP3			ENSG00000127124			rs78295797-A	rs78295797	0	78295797	intron_variant	0	0.0241	9E-6	5.045757490560675	(EA)	0.0953	[0.053-0.137] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	108239892	NR	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		142041	386941	rs7847854-T	rs7847854	0	7847854	intergenic_variant	1	0.6179	5E-18	17.30102999566398	(EA)	0.055	[0.042-0.068] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6q25.1	6	151859461	NR	ESR1			ENSG00000091831			rs78796841-G	rs78796841	0	78796841	intron_variant	0	0.0214	8E-7	6.096910013008056	(EA)	0.1097	[0.066-0.153] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q11.21	8	50831133	NR	SNTG1 - PXDNL	ENSG00000147481	ENSG00000147485		34441	488444	rs79108280-GT	rs79108280	0	79108280	intergenic_variant	1	0.1889	9E-6	5.045757490560675	(EA)	0.0356	[0.02-0.051] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11p15.5	11	2369831	NR	CD81-AS1			ENSG00000238184			rs800132-G	rs800132	0	800132	intron_variant	0	0.0493	8E-6	5.096910013008056	(EA)	0.0689	[0.039-0.099] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q22.2	16	71475893	NR	ZNF19			ENSG00000157429			rs8050871-G	rs8050871	0	8050871	missense_variant	0	0.6727	3E-6	5.522878745280337	(EA)	0.0315	[0.018-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41815785	NR	CCDC134			ENSG00000100147			rs8137282-G	rs8137282	0	8137282	intron_variant	0	0.0421	2E-7	6.698970004336019	(EA)	0.0882	[0.055-0.121] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q25.3	17	82946434	NR	B3GNTL1			ENSG00000175711			rs898097-T	rs898097	0	898097	intron_variant	0	0.6532	2E-6	5.698970004336019	(EA)	0.0311	[0.018-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	Xp21.1	X	32016153	NR	DMD			ENSG00000198947			rs1293906-T	rs1293906	0	1293906	intron_variant	0	0.1708	9E-6	5.045757490560675	(EA)	0.0408	[0.023-0.059] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.1	22	29010231	NR	"ZNRF3, ZNRF3-IT1"			"ENSG00000183579, ENSG00000235786"			rs13054095-T	rs13054095	0	13054095	intron_variant	0	0.0216	4E-16	15.397940008672037	(EA)	0.1792	[0.14-0.22] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p22	8	17926905	NR	PCM1			ENSG00000078674			rs11779988-C	rs11779988	0	11779988	intron_variant	0	0.6061	2E-6	5.698970004336019	(EA)	0.0302	[0.018-0.043] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q22.1	7	100437651	NR	PPP1R35-AS1			ENSG00000240211			rs117911427-A	rs117911427	0	117911427	intron_variant	0	0.02	7E-6	5.154901959985743	(EA)	0.1046	[0.059-0.15] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	11q24.3	11	129591121	NR	RPS27P20 - LINC01395	ENSG00000240121	ENSG00000281097		53007	20995	rs11822830-G	rs11822830	0	11822830	regulatory_region_variant	1	0.5959	2E-14	13.698970004336019	(EA)	0.0483	[0.036-0.061] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.1	5	51032423	NR	LINC02106 - RNU6-480P	ENSG00000251573	ENSG00000207060		62256	22930	rs11960470-C	rs11960470	0	11960470	intergenic_variant	1	0.6236	3E-6	5.522878745280337	(EA)	0.0308	[0.018-0.044] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p11.21	10	37101682	NR	ARL6IP1P2 - ANKRD30A	ENSG00000225355	ENSG00000148513		106097	23916	rs1200921-A	rs1200921	0	1200921	intergenic_variant	1	0.4634	6E-6	5.221848749616356	(EA)	0.0289	[0.016-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p34.1	1	45918469	NR	MAST2			ENSG00000086015			rs12077974-A	rs12077974	0	12077974	intron_variant	0	0.2825	2E-7	6.698970004336019	(EA)	0.0364	[0.023-0.05] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q22	1	155587180	NR	"MSTO1, DAP3P1"			"ENSG00000125459, ENSG00000225082"			rs12091730-A	rs12091730	0	12091730	intron_variant	0	0.2322	2E-10	9.698970004336019	(EA)	0.0464	[0.032-0.061] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1q41	1	216850159	NR	ESRRG			ENSG00000196482			rs12095761-G	rs12095761	0	12095761	intron_variant	0	0.2306	3E-6	5.522878745280337	(EA)	0.037	[0.022-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q14.3	5	91367022	NR	Metazoa_SRP - ARRDC3	ENSG00000274701	ENSG00000113369		52025	1609	rs12110303-T	rs12110303	0	12110303	intergenic_variant	1	0.1597	1E-11	11	(EA)	0.0606	[0.043-0.078] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p22.1	1	91555907	NR	WDR82P2 - HSP90B3P	ENSG00000241318	ENSG00000203914		20314	86609	rs12134245-T	rs12134245	0	12134245	regulatory_region_variant	1	0.4961	4E-6	5.3979400086720375	(EA)	0.0288	[0.017-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	53298177	NR	RPL13AP13 - FST	ENSG00000213940	ENSG00000134363		91001	182449	rs12189522-G	rs12189522	0	12189522	non_coding_transcript_exon_variant	1	0.018	1E-6	6	(EA)	0.1158	[0.069-0.162] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q25.3	10	113368732	NR	RNU7-165P - PPIAP39	ENSG00000238380	ENSG00000230018		15248	113884	rs12250948-C	rs12250948	0	12250948	regulatory_region_variant	1	0.7844	1E-14	14	(EA)	0.0576	[0.043-0.072] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p13.2	1	113630788	NR	MAGI3			ENSG00000081026			rs1230666-G	rs1230666	0	1230666	intron_variant	0	0.8721	4E-10	9.397940008672037	(EA)	0.0592	[0.041-0.078] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	29509637	NR	LINC02829			ENSG00000229274			rs1233480-T	rs1233480	0	1233480	intron_variant	0	0.1095	5E-8	7.301029995663981	(EA)	0.0586	[0.037-0.08] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	27025475	NR	"CHST9, AQP4-AS1"			"ENSG00000154080, ENSG00000260372"			rs12458099-A	rs12458099	0	12458099	intron_variant	0	0.4378	1E-12	12	(EA)	0.0443	[0.032-0.056] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p13.3	2	69207095	NR	ANTXR1			ENSG00000169604			rs12474538-A	rs12474538	0	12474538	intron_variant	0	0.1487	9E-8	7.045757490560675	(EA)	0.0469	[0.03-0.064] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	20q13.2	20	53671071	NR	RNU7-14P - SUMO1P1	ENSG00000238468	ENSG00000241721		2313	204181	rs12481286-T	rs12481286	0	12481286	TF_binding_site_variant	1	0.2403	1E-7	7	(EA)	0.0407	[0.026-0.056] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.1	22	40143521	NR	TNRC6B			ENSG00000100354			rs12483853-C	rs12483853	0	12483853	intron_variant	0	0.1411	1E-18	18	(EA)	0.0783	[0.061-0.096] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q12	4	53046426	NR	SCFD2			ENSG00000184178			rs12506630-C	rs12506630	0	12506630	intron_variant	0	0.3734	1E-6	6	(EA)	0.0323	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p13.3	5	32581080	NR	SUB1			ENSG00000113387			rs12519859-A	rs12519859	0	12519859	intron_variant	0	0.4748	6E-9	8.221848749616356	(EA)	0.0365	[0.024-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8q21.13	8	75988094	NR	HNF4G - RNU2-54P	ENSG00000164749	ENSG00000222231		421260	277449	rs12682248-A	rs12682248	0	12682248	intergenic_variant	1	0.7442	2E-6	5.698970004336019	(EA)	0.0347	[0.02-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q22.3	10	79092621	NR	ZMIZ1			ENSG00000108175			rs1268974-G	rs1268974	0	1268974	intron_variant	0	0.6132	4E-36	35.39794000867204	(EA)	0.0793	[0.067-0.092] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7p11.2	7	55125270	NR	EGFR			ENSG00000146648			rs12718945-G	rs12718945	0	12718945	intron_variant	0	0.5535	4E-6	5.3979400086720375	(EA)	0.0289	[0.017-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.3	10	63089177	NR	EGR2 - RNU6-543P	ENSG00000122877	ENSG00000199446		270010	20962	rs12765365-C	rs12765365	0	12765365	intergenic_variant	1	0.0376	2E-8	7.698970004336019	(EA)	0.0979	[0.064-0.132] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	13q22.1	13	73232845	NR	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		5585	174923	rs12870942-C	rs12870942	0	12870942	intergenic_variant	1	0.3182	4E-9	8.397940008672037	(EA)	0.0391	[0.026-0.052] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	15q24.1	15	74300521	NR	CCDC33			ENSG00000140481			rs12904134-A	rs12904134	0	12904134	intron_variant	0	0.501	8E-6	5.096910013008056	(EA)	0.0286	[0.016-0.041] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16p13.13	16	10609831	NR	EMP2 - TEKT5	ENSG00000213853	ENSG00000153060		29199	17670	rs12918713-C	rs12918713	0	12918713	regulatory_region_variant	1	0.0674	1E-7	7	(EA)	0.0688	[0.043-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16p13.3	16	3942751	NR	LINC02861			ENSG00000262185			rs12920416-T	rs12920416	0	12920416	intron_variant	0	0.2475	8E-7	6.096910013008056	(EA)	0.0412	[0.025-0.057] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q11.2	18	22897971	NR	RBBP8			ENSG00000101773			rs12962334-C	rs12962334	0	12962334	intron_variant	0	0.678	1E-6	6	(EA)	0.0324	[0.019-0.045] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q36.3	2	226474745	NR	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		744858	183965	rs13008686-G	rs13008686	0	13008686	intergenic_variant	1	0.3354	7E-6	5.154901959985743	(EA)	0.0302	[0.017-0.043] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	48542329	NR	PFKFB4			ENSG00000114268			rs13079292-G	rs13079292	0	13079292	intron_variant	0	0.9798	8E-6	5.096910013008056	(EA)	0.1064	[0.06-0.153] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q11.2	5	52225463	NR	LINC02118 - RPS17P11	ENSG00000248789	ENSG00000244621		144476	57104	rs13160295-G	rs13160295	0	13160295	intergenic_variant	1	0.0239	4E-6	5.3979400086720375	(EA)	0.1121	[0.064-0.16] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45074531	NR	MRPS30 - HCN1	ENSG00000112996	ENSG00000164588		254103	180417	rs13183434-A	rs13183434	0	13183434	intron_variant	1	0.1235	4E-17	16.397940008672037	(EA)	0.0777	[0.06-0.096] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	26463346	NR	BTN2A1			ENSG00000112763			rs13195401-T	rs13195401	0	13195401	intron_variant	0	0.0874	2E-9	8.698970004336019	(EA)	0.0718	[0.048-0.095] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.2	6	25874195	NR	SLC17A3			ENSG00000124564			rs13198474-A	rs13198474	0	13198474	5_prime_UTR_variant	0	0.0745	2E-7	6.698970004336019	(EA)	0.0673	[0.042-0.092] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	28364364	NR	ZKSCAN3			ENSG00000189298			rs13214023-A	rs13214023	0	13214023	intron_variant	0	0.0929	1E-9	9	(EA)	0.071	[0.048-0.094] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	7q35	7	144477198	NR	TPK1			ENSG00000196511			rs13230714-G	rs13230714	0	13230714	intron_variant	0	0.3026	1E-6	6	(EA)	0.0338	[0.02-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p21.2	8	25974262	NR	EBF2			ENSG00000221818			rs13256025-T	rs13256025	0	13256025	intron_variant	0	0.1999	2E-7	6.698970004336019	(EA)	0.0428	[0.027-0.059] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p14	2	67879434	NR	LINC01812 - FBXL12P1	ENSG00000237013	ENSG00000235968		53872	144260	rs13416342-G	rs13416342	0	13416342	intergenic_variant	1	0.428	6E-6	5.221848749616356	(EA)	0.0285	[0.016-0.041] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.3	3	16737360	NR	CDYLP1 - PLCL2	ENSG00000224039	ENSG00000154822		43158	65291	rs1375631-G	rs1375631	0	1375631	intergenic_variant	1	0.4975	2E-7	6.698970004336019	(EA)	0.0321	[0.02-0.044] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	6p22.1	6	28468238	NR	OR2E1P - GPX6	ENSG00000219262	ENSG00000198704		12097	35058	rs138024639-T	rs138024639	1	58800837	intergenic_variant	1	0.0932	3E-9	8.522878745280337	(EA)	0.0699	[0.047-0.093] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17q21.2	17	42426015	NR	CAVIN1 - RNU7-97P	ENSG00000177469	ENSG00000238704		2759	14183	rs138672638-C	rs138672638	0	138672638	intergenic_variant	1	0.0096	1E-8	8	(EA)	0.1833	[0.12-0.25] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q12.2	22	30168182	NR	HORMAD2			ENSG00000176635			rs139059349-C	rs139059349	0	139059349	intron_variant	0	0.0142	2E-7	6.698970004336019	(EA)	0.1465	[0.092-0.201] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p12	5	45522877	NR	HCN1			ENSG00000164588			rs139424826-A	rs139424826	0	139424826	intron_variant	0	0.15	5E-13	12.301029995663981	(EA)	0.0657	[0.048-0.084] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5q33.3	5	159141388	NR	LINC02202 - RNF145	ENSG00000245812	ENSG00000145860		23910	16021	rs139824696-C	rs139824696	0	139824696	intergenic_variant	1	0.1183	4E-6	5.3979400086720375	(EA)	0.0448	[0.026-0.064] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	16q12.1	16	50499690	NR	LINC02178 - NKD1	ENSG00000261092	ENSG00000140807		104557	48706	rs140035696-G	rs140035696	0	140035696	intron_variant	1	0.0165	5E-6	5.301029995663981	(EA)	0.1271	[0.072-0.182] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	17p11.2	17	18094293	NR	DRG2			ENSG00000108591			rs140494697-T	rs140494697	0	140494697	intron_variant	0	0.006	4E-6	5.3979400086720375	(EA)	0.2014	[0.12-0.29] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41221553	NR	"L3MBTL2-AS1, L3MBTL2"			"ENSG00000235513, ENSG00000100395"			rs140614180-C	rs140614180	0	140614180	intron_variant	0	0.0176	6E-8	7.221848749616356	(EA)	0.1449	[0.092-0.197] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q12	14	32127443	NR	ARHGAP5			ENSG00000100852			rs140783387-C	rs140783387	0	140783387	intron_variant	0	0.0885	3E-7	6.522878745280337	(EA)	0.0602	[0.037-0.083] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p32.3	1	50882601	NR	FAF1			ENSG00000185104			rs140945602-T	rs140945602	1	60244087	intron_variant	0	0.4877	7E-8	7.154901959985743	(EA)	0.0359	[0.023-0.049] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q32.11	14	89418757	NR	"FOXN3, FOXN3-AS1"			"ENSG00000053254, ENSG00000258920"			rs141061110-C	rs141061110	0	141061110	intron_variant	0	0.1578	5E-6	5.301029995663981	(EA)	0.0408	[0.023-0.058] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	22q13.2	22	41061455	NR	Y_RNA - Y_RNA	ENSG00000202522	ENSG00000202522		15864	4099	rs141447235-C	rs141447235	0	141447235	intergenic_variant	1	0.064	2E-9	8.698970004336019	(EA)	0.0772	[0.052-0.102] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	1p22.3	1	87384812	NR	LINC01364 - RNA5SP52	ENSG00000227290	ENSG00000199318		13129	68428	rs1415174-C	rs1415174	0	1415174	intergenic_variant	1	0.7544	6E-6	5.221848749616356	(EA)	0.0328	[0.018-0.047] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p24.3	3	18422242	NR	"SATB1, TBC1D5"			"ENSG00000182568, ENSG00000131374"			rs141634179-C	rs141634179	0	141634179	intron_variant	0	0.0235	6E-6	5.221848749616356	(EA)	0.1019	[0.058-0.146] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3q22.3	3	138949667	NR	FOXL2NB			ENSG00000206262			rs142253798-T	rs142253798	0	142253798	non_coding_transcript_exon_variant	0	0.0175	8E-6	5.096910013008056	(EA)	0.1218	[0.068-0.175] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p11	5	46394269	NR	HCN1 - EMB	ENSG00000164588	ENSG00000170571		697771	4001923	rs142427110-A	rs142427110	0	142427110	intergenic_variant	1	0.1376	1E-12	12	(EA)	0.069	[0.05-0.088] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	21q22.3	21	43733825	NR	PDXK			ENSG00000160209			rs142471995-T	rs142471995	0	142471995	intron_variant	0	0.0096	2E-6	5.698970004336019	(EA)	0.2003	[0.12-0.28] unit decrease	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10p11.1	10	38105004	NR	"ZNF37A, PLD5P1"			"ENSG00000075407, ENSG00000283930"			rs143072280-TTTTC	rs143072280	0	143072280	intron_variant	0	0.3518	9E-7	6.045757490560675	(EA)	0.0342	[0.02-0.048] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2p23.3	2	25886882	NR	ASXL2 - NDUFB4P4	ENSG00000143970	ENSG00000217718		8395	82	rs144079028-T	rs144079028	1	70950129	intergenic_variant	1	0.7152	9E-6	5.045757490560675	(EA)	0.0312	[0.017-0.045] unit increase	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q26.13	10	121589810	FGFR2	FGFR2			ENSG00000066468			rs45631563-A	rs45631563	0	45631563	intron_variant	0	0.95	7E-37	36.15490195998574	(EA)	1.2345679	[1.18-1.28] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217098337	IGFBP5	DIRC3-AS1			ENSG00000233143			rs34005590-C	rs34005590	0	34005590	intron_variant	0	0.95	3E-41	40.52287874528034	(EA)	1.2195122	[1.16-1.27] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q35	2	217056046	IGFBP5	DIRC3-AS1			ENSG00000233143			rs4442975-G	rs4442975	0	4442975	intron_variant	0	0.5	1E-95	95	(EA)	1.1235955	[1.11-1.15] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12p11.22	12	28021884	intergenic	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-C	rs7297051	0	7297051	TF_binding_site_variant	1	0.76	3E-60	59.52287874528034		1.1235955	[1.1-1.15] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	10q21.2	10	62540131	ZNF365	LINC02929			ENSG00000285551			rs10995201-A	rs10995201	0	10995201	intron_variant	0	0.84	2E-51	50.69897000433602	(EA)	1.1111112	[1.09-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	4q34.1	4	174925275	ADAM29	ADAM29			ENSG00000168594			rs6828523-C	rs6828523	0	6828523	intron_variant	0	0.88	2E-25	24.69897000433602	(EA)	1.098901	[1.08-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	8p11.23	8	37000965	intergenic	KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		64840	94185	rs13365225-A	rs13365225	0	13365225	intergenic_variant	1	0.82	1E-20	20	(EA)	1.098901	[1.08-1.12] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	9q31.2	9	108133073	intergenic	CHCHD4P2 - RPL36P14	ENSG00000237360	ENSG00000169253		35222	493760	rs676256-T	rs676256	0	676256	intergenic_variant	1	0.62	4E-53	52.39794000867204	(EA)	1.098901	[1.08-1.11] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	2q14.2	2	120487546	intergenic	LINC01101 - Y_RNA	ENSG00000280409	ENSG00000202522		21328	163727	rs4849887-C	rs4849887	0	4849887	intergenic_variant	1	0.9	7E-20	19.154901959985743	(EA)	1.098901	[1.06-1.14] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q24.1	14	68567965	RAD51B	RAD51B			ENSG00000182185			rs999737-C	rs999737	0	999737	intron_variant	0	0.77	7E-39	38.15490195998574	(EA)	1.098901	[1.08-1.12] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12q22	12	95633983	NTN4	PGAM1P5			ENSG00000257150			rs17356907-A	rs17356907	0	17356907	intron_variant	0	0.7	1E-39	39	(EA)	1.098901	[1.08-1.11] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	3p21.31	3	46825376	intergenic	PRSS44P - PRSS42P	ENSG00000226074	ENSG00000178055		12890	4166	rs6796502-G	rs6796502	0	6796502	intergenic_variant	1	0.9	6E-15	14.221848749616356	(EA)	1.0869565	[1.05-1.12] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	12q24.21	12	115398717	TBX3	TBX3-AS1 - UBA52P7	ENSG00000257817	ENSG00000241656		630728	193887	rs1292011-A	rs1292011	0	1292011	regulatory_region_variant	1	0.58	4E-39	38.39794000867204		1.0869565	[1.06-1.11] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	18q12.3	18	44819625	SETBP1	SETBP1			ENSG00000152217			rs6507583-A	rs6507583	0	6507583	intron_variant	0	0.93	2E-12	11.698970004336019	(EA)	1.0869565	[1.04-1.12] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	5p15.33	5	1296141	TERT	TERT - MIR4457	ENSG00000164362	ENSG00000263670		1073	13169	rs3215401-A	rs3215401	0	3215401	intergenic_variant	1	0.69	1E-20	20	(EA)	1.0752687	[1.05-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
11/30/2017	29059683	Michailidou K	10/23/2017	Nature	www.ncbi.nlm.nih.gov/pubmed/29059683	Association analysis identifies 65 new breast cancer risk loci.	Breast cancer	"76,192 European ancestry cases, 63,082 European ancestry controls"	"46,785 European ancestry cases, 42,892 European ancestry controls, 14,068 East Asian ancestry cases, 13,104 East Asian ancestry controls"	14q13.3	14	36663564	PAX9	PAX9			ENSG00000198807			rs2236007-G	rs2236007	0	2236007	intron_variant	0	0.79	4E-21	20.397940008672037	(EA)	1.0752687	[1.05-1.1] (Oncoarray)	Illumina [~ 11800000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST004988	Genome-wide genotyping array				
6/24/2020	32424353	Zhang H	5/18/2020	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/32424353	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.	Invasive breast cancer	"106,278 European ancestry cases, 91,477 European ancestry controls"	NA	22q12.2	22	30196819	NR	HORMAD2 - LIF-AS1	ENSG00000176635	ENSG00000232530		19744	42375	rs16988381-?	rs16988381	0	16988381	intron_variant	1	NR	3E-9	8.522878745280337	(mixed effect)			Illumina [~ 9700000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST010099	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	16p13.3	16	4056787	ADCY9	ADCY9			ENSG00000162104			rs11076805-C	rs11076805	0	11076805	intron_variant	0	0.75	1E-8	8		1.0869565	[1.05-1.11] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	6q23.1	6	130027974	L3MBTL3	L3MBTL3			ENSG00000198945			rs6569648-T	rs6569648	0	6569648	intron_variant	0	0.77	8E-10	9.096910013008056		1.0752687	[1.05-1.11] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	11q22.3	11	108474789	KDELC2	POGLUT3			ENSG00000178202			rs11374964-G	rs11374964	0	11374964	3_prime_UTR_variant	0	0.58	4E-13	12.397940008672037		1.0638298	[1.04-1.09] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	18q12.1	18	27821241	CDH2	PA2G4P3 - CDH2	ENSG00000263405	ENSG00000170558		367584	111638	rs36194942-A	rs36194942	0	36194942	intergenic_variant	1	0.7	1E-8	8		1.0638298	[1.04-1.1] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	2p23.3	2	24516826	NCOA1	NCOA1			ENSG00000084676			rs200648189-CT	rs200648189	0	200648189	intron_variant	0	0.81	1E-8	8		1.0638298	[1.03-1.1] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	19p13.2	19	11313027	TSPAN16	TSPAN16			ENSG00000130167			rs322144-C	rs322144	0	322144	intron_variant	0	0.53	7E-9	8.154901959985743		1.0526316	[1.03-1.08] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	19q12	19	29786822	CCNE1	C19orf12 - CCNE1	ENSG00000131943	ENSG00000105173		71033	25169	rs113701136-T	rs113701136	0	113701136	intergenic_variant	1	0.32	7E-9	8.154901959985743		1.07	[1.04-1.09] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	8q24.13	8	123745421	ANXA13	ANXA13 - FAM91A1	ENSG00000104537	ENSG00000176853		8019	23018	rs17350191-T	rs17350191	0	17350191	intergenic_variant	1	0.34	2E-11	10.698970004336019		1.07	[1.04-1.09] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	8p23.3	8	220692	RPL23AP53	RPL23AP53			ENSG00000223508			rs66823261-C	rs66823261	0	66823261	intron_variant	0	0.23	3E-8	7.522878745280337		1.09	[1.06-1.12] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast cancer	"14,135 European ancestry ER- cases, 58,126 European ancestry controls, 7,784 European ancestry  BRCA1 carrrier cases, 7,782 European ancestry BRCA1 carrrier controls"	"7,333 European ancestry ER- cases, 42,468 European ancestry controls, 1,630 European ancestry BRCA1 carrrier cases, 1,712 European ancestry BRCA1 carrrier controls"	11q22.3	11	108486410	KDELC2	POGLUT3			ENSG00000178202			rs74911261-G	rs74911261	0	74911261	missense_variant	0	0.98	5E-11	10.301029995663981		1.22	[1.12-1.33] (BCAC)	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005077	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	11q22.3	11	108486410	KDELC2	POGLUT3			ENSG00000178202			rs74911261-G	rs74911261	0	74911261	missense_variant	0	0.98	2E-6	5.698970004336019		1.3513513	[1.19-1.54]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	2p23.3	2	24516826	NCOA1	NCOA1			ENSG00000084676			rs200648189-CT	rs200648189	0	200648189	intron_variant	0	0.8	3E-7	6.522878745280337		1.1363636	[1.09-1.19]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	12p11.22	12	28021884	NR	PTHLH - CCDC91	ENSG00000087494	ENSG00000123106		49151	111365	rs7297051-C	rs7297051	0	7297051	TF_binding_site_variant	1	0.76	8E-9	8.096910013008056		1.1363636	[1.09-1.18]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	13q22.1	13	73383544	KLF5	RNY1P8 - MARK2P12	ENSG00000206697	ENSG00000229708		156284	24224	rs6562760-G	rs6562760	0	6562760	intergenic_variant	1	0.76	4E-7	6.3979400086720375		1.1235955	[1.08-1.16]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	5p15.33	5	1296141	NR	TERT - MIR4457	ENSG00000164362	ENSG00000263670		1073	13169	rs3215401-A	rs3215401	0	3215401	intergenic_variant	1	0.69	3E-7	6.522878745280337		1.1111112	[1.06-1.15]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	11q22.3	11	108474789	KDELC2	POGLUT3			ENSG00000178202			rs11374964-G	rs11374964	0	11374964	3_prime_UTR_variant	0	0.57	1E-6	6		1.098901	[1.05-1.14]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	6q25.1	6	151621059	ESR1	CCDC170			ENSG00000120262			rs3757322-G	rs3757322	0	3757322	3_prime_UTR_variant	0	0.32	3E-12	11.522878745280337		1.14	[1.10-1.19]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	19p13.11	19	17290595	ANKLE1	ANKLE1 - ABHD8	ENSG00000160117	ENSG00000127220		2949	1536	rs67397200-G	rs67397200	0	67397200	intergenic_variant	1	0.32	3E-17	16.522878745280337		1.18	[1.14-1.23]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	5p15.33	5	1279675	TERT	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.26	4E-16	15.397940008672037		1.18	[1.14-1.23]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
12/19/2017	29058716	Milne RL	10/23/2017	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29058716	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.	Breast Cancer in BRCA1 mutation carriers	"7,784 European ancestry carrier cases, 7,782 European ancestry carrier controls"	"1,630 European ancestry carrier cases, 1,712 European ancestry carrier controls"	6q25.1	6	151631197	NR	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		10004	25494	rs9397437-A	rs9397437	0	9397437	regulatory_region_variant	1	0.07	6E-8	7.221848749616356		1.2	[1.12-1.28]	Illumina [~ 11500000] (imputed)	N	breast carcinoma	http://www.ebi.ac.uk/efo/EFO_0000305	GCST005075	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	11p11.2	11	47538659	NR	CELF1			ENSG00000149187			rs80221606-AT	rs80221606	0	80221606	intron_variant	0	0.103914	1E-10	10		0.76	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	11p11.2	11	47454123	NR	RAPSN - CELF1	ENSG00000165917	ENSG00000149187		4980	11810	rs60882887-A	rs60882887	0	60882887	TF_binding_site_variant	1	0.136868	2E-10	9.698970004336019	(adjusted)	0.82	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41782217	NR	JUP			ENSG00000173801			rs7222250-T	rs7222250	0	7222250	intron_variant	0	0.56431	6E-14	13.221848749616356	(adjusted)	0.81	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41770559	NR	JUP			ENSG00000173801			rs9901834-A	rs9901834	0	9901834	intron_variant	0	0.100527	7E-10	9.154901959985743	(adjusted)	0.72	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41477065	NR	KRT35			ENSG00000197079			rs2239711-G	rs2239711	0	2239711	synonymous_variant	0	0.707844	5E-11	10.301029995663981	(adjusted)	1.18	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41985420	NR	DNAJC7			ENSG00000168259			rs10708222-T	rs10708222	0	10708222	non_coding_transcript_exon_variant	0	0.171748	8E-7	6.096910013008056	(adjusted)	1.18	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41769461	NR	JUP			ENSG00000173801			rs41283425-T	rs41283425	0	41283425	missense_variant	0	0.0597041	4E-7	6.3979400086720375	(adjusted)	0.73	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41701948	NR	EIF1 - GAST	ENSG00000173812	ENSG00000184502		9280	10383	rs56291217-A	rs56291217	0	56291217	intergenic_variant	1	0.563773	7E-8	7.154901959985743	(adjusted)	1.14	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41982764	NR	DNAJC7			ENSG00000168259			rs111637825-A	rs111637825	0	111637825	intron_variant	0	0.063862	4E-7	6.3979400086720375	(adjusted)	0.74	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA				ZMZ1							chr10:80841148-T	chr10:80841148	0			1	0.4	2E-6	5.698970004336019		0.91	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA				TOX3							chr16:52599188-T	chr16:52599188	0			1	0.29	2E-13	12.698970004336019		0.85	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41149524	NR	KRTAP4-5			ENSG00000198271			rs58117746-TGGCAGCAGCTGGGGC	rs58117746	0	58117746	protein_altering_variant	0	0.39	4E-10	9.397940008672037		1.18	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA1 mutation in breast cancer	"7,257 European ancestry cases, 60,212 European ancestry controls"	NA	17q21.2	17	41805306	NR	P3H4			ENSG00000141696			rs5820435-A	rs5820435	0	5820435	intron_variant	0	0.45	1E-11	11		0.82	NR	Illumina [9068301] (imputed)	N	BRCA1 mutation carier status	http://www.ebi.ac.uk/efo/EFO_0011021	GCST011402	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q12.3	13	31088850	NR	WDR95P			ENSG00000231894			rs114300732-T	rs114300732	0	114300732	intron_variant	0	0.07	2E-8	7.698970004336019	(adjusted)	0.67	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	33259673	NR	"STARD13, STARD13-AS"			"ENSG00000133121, ENSG00000236581"			rs2555605-T	rs2555605	0	2555605	intron_variant	0	0.64	5E-8	7.301029995663981	(adjusted)	1.15	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	9q31.2	9	107543834	RP11-438P9.2	PPIAP88 - RNU6-996P	ENSG00000227350	ENSG00000202308		218	119306	rs10759243-A	rs10759243	0	10759243	intergenic_variant	1	0.31	5E-6	5.301029995663981		0.89	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	2p14	2	67406871	NR	ETAA1			ENSG00000143971			rs12470785-G	rs12470785	0	12470785	intron_variant	0	0.3	3E-11	10.522878745280337		0.84	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	31647657	NR	B3GLCT - RXFP2	ENSG00000187676	ENSG00000133105		315381	91869	rs79183898-A	rs79183898	0	79183898	intergenic_variant	1	0.07	3E-10	9.522878745280337		1.33	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	33202369	NR	"STARD13, STARD13-AS"			"ENSG00000133121, ENSG00000236581"			rs736596-T	rs736596	0	736596	intron_variant	0	0.09	3E-12	11.522878745280337		1.37	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.2	13	34802220	NR	LINC00457 - Metazoa_SRP	ENSG00000225179	ENSG00000274701		161417	108325	rs4943263-T	rs4943263	0	4943263	intergenic_variant	1	0.27	8E-11	10.096910013008056		1.17	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	31658546	NR	B3GLCT - RXFP2	ENSG00000187676	ENSG00000133105		326270	80980	rs1623189-T	rs1623189	0	1623189	intergenic_variant	1	0.74	1E-31	31	(adjusted)	0.37	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	33202024	NR	"STARD13, STARD13-AS"			"ENSG00000133121, ENSG00000236581"			rs77889880-T	rs77889880	0	77889880	intron_variant	0	0.1	3E-21	20.522878745280337	(adjusted)	0.51	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/24/2021	33597508	Coignard J	2/17/2021	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/33597508	A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.	BRCA2 mutation in breast cancer	"5,097 European ancestry cases, 57,725 European ancestry controls"	NA	13q13.1	13	33360207	NR	STARD13 - RFC3	ENSG00000133121	ENSG00000133119		9577	457862	rs67776313-A	rs67776313	0	67776313	intron_variant	1	0.33	8E-12	11.096910013008056	(adjusted)	0.81	NR	Illumina [9043830] (imputed)	N	BRCA2 mutation carier statu	http://www.ebi.ac.uk/efo/EFO_0011022	GCST011401	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	2q37.1	2	234605964	NR	ARL4C - LINC01173	ENSG00000188042	ENSG00000280744		108883	76704	rs79539148-?	rs79539148	0	79539148	intergenic_variant	1	NR	5E-6	5.301029995663981		1.3718209	[1.20-1.57]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr5:25384326-?	chr5:25384326	0			1	NR	2E-7	6.698970004336019		1.4273363	[1.25-1.63]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr23:116314278-?	chr23:116314278	0			1	NR	2E-6	5.698970004336019		1.4826204	[1.26-1.75]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	11p15.2	11	14841349	NR	PDE3B			ENSG00000152270			rs139983808-?	rs139983808	0	139983808	intron_variant	0	NR	4E-6	5.3979400086720375		1.5360374	[1.28-1.84]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr8:14246348-?	chr8:14246348	0			1	NR	2E-6	5.698970004336019		1.7325304	[1.38-2.17]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	4q22.3	4	96648409	NR	LINC02267			ENSG00000248510			rs77465470-?	rs77465470	0	77465470	intron_variant	0	NR	6E-6	5.221848749616356		3.9550767	[2.18-7.16]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr2:197460073-?	chr2:197460073	0			1	NR	7E-6	5.154901959985743		0.09968899	[0.04-0.27]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr12:114419436-?	chr12:114419436	0			1	NR	5E-7	6.301029995663981		0.8426682	[0.79-0.90]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	6p21.33	6	31513492	NR	MICB - PPIAP9	ENSG00000204516	ENSG00000219797		2368	5988	rs5875324-?	rs5875324	0	5875324	regulatory_region_variant	1	NR	2E-6	5.698970004336019		0.8744475	[0.83-0.92]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	3p14.1	3	65008088	NR	ADAMTS9-AS2			ENSG00000241684			rs2030217-?	rs2030217	0	2030217	intron_variant	0	NR	2E-6	5.698970004336019		0.9116632	[0.88-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	6p21.2	6	37015416	NR	FGD2			ENSG00000146192			rs12199978-?	rs12199978	0	12199978	intron_variant	0	NR	7E-6	5.154901959985743		0.9202764	[0.89-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	7p21.3	7	11181219	NR	PHF14 - NPM1P11	ENSG00000106443	ENSG00000226827		11596	76462	rs4720945-?	rs4720945	0	4720945	non_coding_transcript_exon_variant	1	NR	7E-6	5.154901959985743		1.0825416	[1.05-1.12]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	11q22.3	11	107933845	NR	RAB39A			ENSG00000179331			rs2442690-?	rs2442690	0	2442690	intron_variant	0	NR	4E-6	5.3979400086720375		1.087098	[1.05-1.13]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	10q22.1	10	69415853	NR	TACR2			ENSG00000075073			rs10998765-?	rs10998765	0	10998765	intron_variant	0	NR	4E-6	5.3979400086720375		1.1018404	[1.06-1.15]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	6p12.3	6	50427424	NR	DEFB112 - TFAP2D	ENSG00000180872	ENSG00000008197		377495	286102	rs370332736-?	rs370332736	1	138719028	intergenic_variant	1	NR	2E-7	6.698970004336019		1.1655464	[1.10-1.24]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	8q24.12	8	118486185	NR	SAMD12			ENSG00000177570			rs10282989-?	rs10282989	0	10282989	intron_variant	0	NR	5E-6	5.301029995663981		1.2000822	[1.11-1.30]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	19q12	19	29613964	NR	POP4			ENSG00000105171			rs61731483-?	rs61731483	0	61731483	missense_variant	0	NR	7E-6	5.154901959985743		1.2875215	[1.15-1.44]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr1:60226999-?	chr1:60226999	0			1	NR	1E-6	6		1.3677144	[1.20-1.55]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	11q23.3	11	114708364	NR	NXPE2 - CADM1	ENSG00000204361	ENSG00000182985		1295	460854	rs111310676-?	rs111310676	0	111310676	intergenic_variant	1	NR	3E-6	5.522878745280337		1.4154564	[1.22-1.64]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	Xq28	X	152138067	NR	MAGEA10			ENSG00000124260			rs5970218-?	rs5970218	0	5970218	intron_variant	0	NR	2E-6	5.698970004336019		1.5139649	[1.28-1.80]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr5:156475855-?	chr5:156475855	0			1	NR	3E-6	5.522878745280337		3.6673157	[2.13-6.33]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	6q27	6	167735333	NR	LINC02487 - LINC01558	ENSG00000203688	ENSG00000146521		39043	49204	rs2784888-?	rs2784888	0	2784888	regulatory_region_variant	1	NR	4E-6	5.3979400086720375		1.1000674	[1.06-1.15]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	9p24.2	9	3708602	NR	RFX3-DT - GLIS3	ENSG00000232104	ENSG00000107249		16788	115525	rs199600662-?	rs199600662	0	199600662	intergenic_variant	1	NR	5E-6	5.301029995663981		0.8728601	[0.82-0.93]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	5q31.1	5	132663184	NR	TH2LCRR			ENSG00000223442			rs1295683-?	rs1295683	0	1295683	intron_variant	0	NR	6E-7	6.221848749616356		0.88253576	[0.84-0.93]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	2q37.3	2	239835651	NR	LINC02991 - NDUFA10	ENSG00000196758	ENSG00000130414		249557	56799	rs57297613-?	rs57297613	0	57297613	intergenic_variant	1	NR	2E-6	5.698970004336019		0.9016192	[0.86-0.94]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	18q22.3	18	71174376	NR	GTSCR1 - LINC01541	ENSG00000263417	ENSG00000260676		523423	345586	rs9807667-?	rs9807667	0	9807667	intron_variant	1	NR	1E-6	6		0.90965927	[0.88-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr7:41400313-?	chr7:41400313	0			1	NR	5E-6	5.301029995663981		0.9135919	[0.88-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr12:116347724-?	chr12:116347724	0			1	NR	4E-6	5.3979400086720375		0.9158884	[0.88-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	10p13	10	15029386	NR	DCLRE1CP1 - OLAH	ENSG00000237470	ENSG00000152463		7523	2841	rs10906806-?	rs10906806	0	10906806	intergenic_variant	1	NR	1E-6	6		0.9229462	[0.89-0.95]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	2p24.2	2	18696829	NR	NT5C1B - LINC01376	ENSG00000185013	ENSG00000236204		107257	289622	rs4525697-?	rs4525697	0	4525697	intergenic_variant	1	NR	6E-6	5.221848749616356		1.078501	[1.04-1.11]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	20q13.32	20	58062454	NR	LINC01742 - C20orf85	ENSG00000275852	ENSG00000124237		57806	88448	rs35523860-?	rs35523860	1	74182754	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.0850825	[1.05-1.12]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr12:121601829-?	chr12:121601829	0			1	NR	5E-6	5.301029995663981		1.0858094	[1.05-1.12]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	6q21	6	105883853	NR	LINC02836 - RN7SKP211	ENSG00000237567	ENSG00000200198		251557	20520	rs9689308-?	rs9689308	0	9689308	intron_variant	1	NR	6E-6	5.221848749616356		1.0898786	[1.05-1.13]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	3q11.2	3	96051005	NR	MTHFD2P1 - HNRNPKP4	ENSG00000244681	ENSG00000243547		367812	298549	rs4462981-?	rs4462981	0	4462981	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.1208384	[1.07-1.18]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	1q42.12	1	224709789	NR	CNIH3			ENSG00000143786			rs72761829-?	rs72761829	0	72761829	intron_variant	0	NR	4E-6	5.3979400086720375		1.1586424	[1.09-1.23]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	14q31.1	14	79896239	NR	NRXN3 - DIO2	ENSG00000021645	ENSG00000211448		27948	301287	rs12892107-?	rs12892107	0	12892107	intron_variant	1	NR	6E-6	5.221848749616356		1.1953834	[1.11-1.29]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	10p15.1	10	4097356	NR	MIR6078 - LINC00702	ENSG00000274809	ENSG00000233117		106097	103785	rs71392427-?	rs71392427	0	71392427	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1988671	[1.11-1.29]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	11q23.3	11	116622438	NR	LINC02151 - LINC02702	ENSG00000236437	ENSG00000237937		121788	16984	rs112319461-?	rs112319461	0	112319461	intergenic_variant	1	NR	1E-6	6		1.2170854	[1.12-1.32]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	14q32.13	14	95024488	NR	LINC02279 - DICER1	ENSG00000258933	ENSG00000100697		61512	61740	rs34877263-?	rs34877263	0	34877263	intergenic_variant	1	NR	2E-6	5.698970004336019		1.280489	[1.16-1.42]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							chr12:69585594-?	chr12:69585594	0			1	NR	5E-6	5.301029995663981		1.3310552	[1.18-1.51]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	14q22.1	14	50772463	NR	NIN			ENSG00000100503			rs61755581-?	rs61755581	0	61755581	synonymous_variant	0	NR	1E-6	6		1.3394284	[1.19-1.51]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	22q12.1	22	28343127	NR	TTC28			ENSG00000100154			rs62237615-?	rs62237615	0	62237615	intron_variant	0	NR	4E-6	5.3979400086720375		1.3701949	[1.20-1.57]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	14q31.1	14	80908984	NR	CEP128			ENSG00000100629			rs113811441-?	rs113811441	0	113811441	intron_variant	0	NR	7E-6	5.154901959985743		0.017834153	[0.003-0.103]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA				NR							rs10684290-?	rs10684290	0	10684290		1	NR	1E-6	6		0.6117436	[0.50-0.75]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	4q31.23	4	149498213	NR	IQCM			ENSG00000234828			rs115988318-?	rs115988318	0	115988318	intron_variant	0	NR	4E-6	5.3979400086720375		0.6740945	[0.57-0.80]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	2p22.3	2	32224803	NR	NLRC4			ENSG00000091106			rs376045897-?	rs376045897	1	3832075	intron_variant	0	NR	9E-7	6.045757490560675		0.71651006	[0.63-0.82]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
3/28/2019	30787463	Escala-Garcia M	2/21/2019	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in breast cancer	"7,697 European ancestry cases, 88,964 European ancestry controls"	NA	2q34	2	213147681	NR	IKZF2			ENSG00000030419			rs6738070-?	rs6738070	0	6738070	missense_variant	0	NR	6E-6	5.221848749616356		0.8472207	[0.79-0.91]	"Affymetrix, Illumina [~ 10400000] (imputed)"	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007477	Genome-wide genotyping array				
